Sentence,class,file
"Black indicates -helical regions, cc stands for pre - dicted coiled-coil domains as determined by Predict Protein (www.predictprotein.org) and the coiled-coil prediction program (http://toolkit.tuebingen.mpg   .de/pcoils).",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201210038/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1038/nature1135 4 Balderhaar, H.J.K., H. Arlt, C.W.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1242/jcs.07197 7 Bi, E., J.B. Chiavetta, H. Chen, G.C.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1016/j.ceb.2008.03.00 9 Brett, C.L., R.L.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1083/jcb.20080100 1 Bröcker, C., A. Kuhlee, C. Gatsogiannis, H.J.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/jbc.M112.43153 6 Cheli, V.T., R.W.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc.E09-11-094 7 Cullen, P.J.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10   .1038/nrm242 7production was induced with IPTG overnight at 18°C.,OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10 .1083/   jcb.20041014 2 Martina, J.A., K. Moriyama, and J.S.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/ jbc.M30129420 0 Mullin, A.P., A. Gokhale, J. Larimore, and V. Faundez.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1007/s12035-011-8183- 3 Nazarian, R., J.M.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1073/   pnas.153204010 0 Newell-Litwa, K., G. Salazar, Y. Smith, and V. Faundez.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc   .E08-05-045 6 Nickerson, D.P., M.R.G.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1038/embor.2008.19 9 Nordmann, M., M. Cabrera, A. Perz, C. Bröcker, C.W.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1016/j.cub.2010.08.00 2 Ostrowicz, C.W., C. Bröcker, F. Ahnert, M. Nordmann, J. Lachmann, K.  Peplowska, A. Perz, K. Auffarth, S. Engelbrecht-Vandré, and C.  Ungermann.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10.1111/j.1600-0854.2010.01097.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1128/MCB.06717-1 1 Poteryaev, D., S. Datta, K. Ackema, M. Zerial, and A. Spang.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1016/j.cell.2010.03.01 1 Puig, O., B. Rutz, B.G.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(19980915)14:12<1139::AID-YEA306>3.0.CO;2- B Raposo, G., and M.S.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1038/nrm225 8 Reggiori, F., and H.R.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"20:5176– 5186. http://dx.doi.org/10.1093/emboj/20.18.517 6 Reggiori, F., M.W.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"122:735– 749. http://dx.doi.org/10.1016/j.cell.2005.06.04 3 Rivera-Molina, F.E., and P.J.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1073/   pnas.090653610 6 Rodriguez-Fernandez, I.A., and E.C.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1007/s10545-008-1014- 7 Salazar, G., B. Craige, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc.E06-02-010 3 Salazar, G., S. Zlatic, B. Craige, A.A. Peden, J. Pohl, and V. Faundez.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10   .1016/j.ceb.2004.05.00 1 Dell’Angelica, E.C.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10   .1016/j.ceb.2009.04.01 4 Di Pietro, S.M., J.M.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10   .1111/j.1600-0854.2004.0171.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc.E06-05-037 9 Gao, X.-D., S. Albert, S.E.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1083/jcb.20030203 8 Gautam, R., S. Chintala, W. Li, Q. Zhang, J. Tan, E.K.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/jbc.M31131120 0 Gerondopoulos, A., L. Langemeyer, J.-R. Liang, A. Linford, and F.A.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1038/ncb129 0 Hayes, M.J., K. Bryon, J. Satkurunathan, and T.P.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2010.01151.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.05.01 5 Huotari, J., and A. Helenius.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"30:3481– 3500. http://dx.doi.org/10.1038/emboj.2011.28 6 Hutagalung, A.H., and P.J.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/   10.1152/physrev.00059.200 9 Janke, C., M.M.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1002/yea.114 2 Kloer, D.P., R. Rojas, V. Ivan, K. Moriyama, T. van Vlijmen, N. Murthy, R.  Ghirlando, P. van der Sluijs, J.H.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/jbc.M109.06908 8 Krogan, N.J., G. Cagney, H. Yu, G. Zhong, X. Guo, A. Ignatchenko, J. Li, S.  Pu, N. Datta, A.P.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1038/nature0467 0 Lachmann, J., C. Ungermann, and S. Engelbrecht-Vandré.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.4161/sgtp.2.3.1670 1 Lachmann, J., F.A.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc   .E11-12-103 0 Lee, H.H., D. Nemecek, C. Schindler, W.J.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/jbc.M111.32574 6 Léon, S., Z. Erpapazoglou, and R. Haguenauer-Tsapis.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc.E08-01-006 8 Lin, C.H., J.A.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10.1016/   j.cell.2008.09.02 5,OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1074/jbc   .M80599120 0 Schu, P.V., K. Takegawa, M.J. Fry, J.H.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/ 10  .1126/science.838536 7 Seaman, M.N.J., M.E.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1242/jcs.04868 6 Shi, Y., C.J.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1091/mbc.E11-05-044 0 Straub, R.E., Y. Jiang, C.J.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10.1086/34175 0 Sung, M.-K., and W.-K. Huh.",OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
"http://dx.doi.org/10   .1002/yea.150 4 Wei, M.L.",Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi   .org/10.1111/j.1600-0749.2005.00289.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
http://dx.doi.org/10.1111/j.1600-0854.2012.01375.,Non-OADS,/arxiv_data1/oa_pdf/c9/ff/JCB_201210038.PMC3613695.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1073/   pnas.071050410 5 Adams, C.L., Y.T.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"142:1105– 1119. http://dx.doi.org/10.1083/jcb.142.4.110 5 Angres, B., A. Barth, and W.J.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.134.2.54 9 Bakolitsa, C., D.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1038/nature0261 0Just by increasing the size of the linker connecting ABD with  the rest of the cadherin molecule, we converted the relatively un - stable, motile junctions into remarkably robust, nondynamic ad - hesive structures.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1006/abbi.2002.277 4 Lin, A.Y., E. Prochniewicz, Z.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi   .org/10.1016/j.ceb.2006.08.00 4 Nagafuchi, A., S. Ishihara, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/   10.1083/jcb.127.1.23 5 Nelson, W.J.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1042/   BST036014 9 Niessen, C.M., D. Leckband, and A.S. Yap.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"195:855–   871. http://dx.doi.org/10.1083/jcb.20110716 2 Ozawa, M. 1998.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1074/jbc.273.45.2952 4 Pappas, D.J., and D.L.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1080/   1541906060072614 2 Pokutta, S., F. Drees, Y. Takai, W.J.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1074/jbc   .M20146320 0 Rangarajan, E.S., and T. Izard.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1038/   nsmb.247 9 Sako, Y., A. Nagafuchi, S. Tsukita, M. Takeichi, and A. Kusumi.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"140:1227– 1240. http://dx.doi.org/10.1083/jcb.140.5.122 7 Taguchi, K., T. Ishiuchi, and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.20110412 4 Torres, M., A. Stoykova, O. Huber, K. Chowdhury, P. Bonaldo, A. Mansouri,  S. Butz, R. Kemler, and P. Gruss.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi   .org/10.1091/mbc.E06-03-019 0 Troyanovsky, R.B., O. Laur, and S.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1091/mbc.E07-   01-008 4 Troyanovsky, S. 2012.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"60:89– 108. http://dx.doi.org/10.1007/978-94-007-4186-7_ 5 Vasioukhin, V., C. Bauer, M. Yin, and E. Fuchs.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81559- 7 Vicente-Manzanares, M., C.K.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi   .org/10.1242/jcs.01856 4 Watabe-Uchida, M., N. Uchida, Y. Imamura, A. Nagafuchi, K. Fujimoto, T.  Uemura, S. Vermeulen, F. van Roy, E.D.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1242/jcs.0032 2 Borgon, R.A., C. Vonrhein, G. Bricogne, P.R.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/   10.1016/j.str.2004.05.00 9 Brasch, J., O.J.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1242/jcs.01436 5 Cavey, M., M. Rauzi, P.F.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1038/nature0695 3 Chu, Y.S., W.A.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi   .org/10.1083/jcb.20040304 3 Cooper, J.A.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.105.4.147 3 Dai, Z., X. Luo, H. Xie, and H.B.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.150.6.132 1 de Beco, S., C. Gueudry, F. Amblard, and S. Coscoy.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1073/   pnas.081125310 6 Gumbiner, B.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10   .1038/nrm169 9 Harrison, O.J., F. Bahna, P.S.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1038/nsmb.178 4 Harrison, O.J., X. Jin, S. Hong, F. Bahna, G. Ahlsen, J. Brasch, Y. Wu, J.  Vendome, K. Felsovalyi, C.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1016/   j.str.2010.11.01 6 Hong, S., R.B.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1073/   pnas.091102710 7 Hong, S., R.B.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.20100611 3 Imamura, Y ., M. Itoh, Y .",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/   jcb.144.6.131 1 Ivanov, A.I., D. Hunt, M. Utech, A. Nusrat, and C.A.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1091/mbc.E05-01-004 3 Kametani, Y., and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1038/ncb152 0 Keep, N.H. 2000.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1007/   s10072007000 6 Kusumi, A., K. Suzuki, and K. Koyasako.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"11:582– 590. http://dx.doi.org/10.1016/S0955-0674(99)00020- 4 Kwiatkowski, A.V., S.L.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi   .org/10.1073/pnas.100734910 7 Lambert, M., D. Choquet, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1083/jcb.20010710 4 Lambert, M., O. Thoumine, J. Brevier, D. Choquet, D. Riveline, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
http://dx.doi.org/10.1016/j.yexcr.2007.07.03 5,OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1016/   S0960-9822(06)00154- 0 Yonemura, S. 2011.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"http://dx.doi.org/10.1016/j.ceb.2011.07.00 1 Zhang, J., M. Betson, J. Erasmus, K. Zeikos, M. Bailly, L.P. Cramer, and V.M.",OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
http://dx.doi   .org/10.1242/jcs.0263 9,Non-OADS,/arxiv_data1/oa_pdf/78/4a/JCB_201211054.PMC3613698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu)g-Catenin dysregulation in AML RG Morgan et al 343 &2013 Macmillan Publishers Limited Leukemia (2013) 336 – 343",Non-OADS,/arxiv_data1/oa_pdf/a1/a7/leu2012221a.PMC3613703.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Leukemia website (http://www.nature.com/leu) Figure 3 MYCT1 expression promotes population expansion without altering lineage distributions in bulk liquid culture.",Non-OADS,/arxiv_data1/oa_pdf/06/7e/leu2011188a.PMC3613704.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6a/de/aws295.PMC3613708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/db/awt032.PMC3613713.pdf
"The most recent appendix tissue archive survey has indicated a prevalence of asymptomaticvariant Creutzfeldt–Jakob disease infection of around 1 in 2000 in the UK population (http://www.hpa.org.uk/hpr/archives/2012/ hpr3212.pdf) (HPA, 2012).The identiﬁcation in 2004 of the ﬁrst case of transfusion associated variant Creutzfeldt–Jakob disease infection (Llewelyn et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/db/awt032.PMC3613713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/a2/awt037.PMC3613715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/b5/awt038.PMC3613716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cb/90/awt075.PMC3613718.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Journal of Perinatology website (http://www.nature.com/jp)Transdisciplinary translational science and the case of preterm birth DK Stevenson et al 258 Journal of Perinatology (2013), 251 – 258 &2013 Nature America, Inc.",Non-OADS,/arxiv_data1/oa_pdf/4d/97/jp2012133a.PMC3613736.pdf
Available online at http://www.who.int/mediacentre/factsheets/fs194/en/.,Non-OADS,/arxiv_data1/oa_pdf/42/53/TOMICROJ-7-53.PMC3613773.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b0/ec/srep01577.PMC3613793.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Schell, A.W.",Non-OADS,/arxiv_data1/oa_pdf/b0/ec/srep01577.PMC3613793.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Alloing, M., Lemaı ˆtre, A., Galopin, E. & Dubin, F. Optically programmable excitonic traps.",Non-OADS,/arxiv_data1/oa_pdf/c3/93/srep01578.PMC3613794.pdf
"http://www.nano-tera.ch (Accessed on March 6, 2013).",Non-OADS,/arxiv_data1/oa_pdf/45/37/srep01576.PMC3613795.pdf
"http://sqt.ait.ac.at/software/projects/hipanq/ (Accessed on March 6, 2013).",OADS,/arxiv_data1/oa_pdf/45/37/srep01576.PMC3613795.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Martinez-Mateo, J., Elkouss, D. & Martin, V. Key Reconciliation for High Performance Quantum Key Distribution.",Non-OADS,/arxiv_data1/oa_pdf/45/37/srep01576.PMC3613795.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sekkal, W. & Zaoui, A. Nanoscale analysis of the morphology and surface stability of calcium carbonate polymorphs.",Non-OADS,/arxiv_data1/oa_pdf/36/a8/srep01587.PMC3613796.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a4/5a/srep01582.PMC3613801.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Mazurek, M.D., Schreiter, K.M., Prevedel, R., Kaltenbaek, R. & Resch, K.J.",Non-OADS,/arxiv_data1/oa_pdf/a4/5a/srep01582.PMC3613801.pdf
Available: http://rapporter.ffi.no/rapporter/2009/01140.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/2b/srep01579.PMC3613802.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: This study was mainly funded by three naval organizations: the US Office of Naval Research, the Norwegian Ministry of Defence and the NetherlandsMinistry of Defence.",Non-OADS,/arxiv_data1/oa_pdf/81/2b/srep01579.PMC3613802.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Cure´,C .et al.",Non-OADS,/arxiv_data1/oa_pdf/81/2b/srep01579.PMC3613802.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/93/srep01581.PMC3613803.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Park, H., Chang, S., Smith, M., Gradec ˇak, S. & Kong, J. Interface engineering of graphene for universal applications as both anode and cathode in organic photovoltaics.",Non-OADS,/arxiv_data1/oa_pdf/33/93/srep01581.PMC3613803.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Quan, T.W.",Non-OADS,/arxiv_data1/oa_pdf/dc/cc/srep01414.PMC3613804.pdf
"World Business Council for Sustainable Development WBCSD, Switzerland http://www.wbcsd.org/home.aspx (2009).",Non-OADS,/arxiv_data1/oa_pdf/6f/27/srep01370.PMC3613806.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/27/srep01370.PMC3613806.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, Y., Ji, S., Gao, Y., Luo, H. & Kanehira, M. Core-shell VO 2@TiO 2 nanorods that combine thermochromic and photocatalytic properties for application as energy-saving smart coatings.",Non-OADS,/arxiv_data1/oa_pdf/6f/27/srep01370.PMC3613806.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/51/srep01586.PMC3613807.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Otsuki, M. & Matsukawa, H. Systematic Breakdown of Amontons’ Law of Friction for an Elastic Object Locally Obeying Amontons’ Law.",Non-OADS,/arxiv_data1/oa_pdf/c6/51/srep01586.PMC3613807.pdf
"( b) Arrows indicated the staining of E-cadherin or vimentin, Magniﬁed /C2200 Figure 6 MiRNA-200b targeted SMAD2 and modulated response to TGF- b1.The putative binding site of miR-200b at position of 334-340 in SMAD2 30-UTR region was predicted by TargetScan 6.2 (http://www.targetscan.org).",OADS,/arxiv_data1/oa_pdf/bf/5e/cddis201322a.PMC3613822.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-200b inhibts EMT and promotes prolieration of IECs Y Chen et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/bf/5e/cddis201322a.PMC3613822.pdf
"To obtain T17M RHO CASP-7 mice, we crossed T17M RHO mice with CASP-7 mice purchased from Jackson, Bar Harbor, ME, USA (http://www.jax.org).",Non-OADS,/arxiv_data1/oa_pdf/92/55/cddis201334a.PMC3613823.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Caspase-7 ablation reprograms apoptosis in T17M rhodopsin retina S Choudhury et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/92/55/cddis201334a.PMC3613823.pdf
cells using the ImageJ software (http://rsb.info.nih.gov).,OADS,/arxiv_data1/oa_pdf/b8/53/cddis201345a.PMC3613824.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)A myosin-Va fragment triggers apoptosis TC Izidoro-Toledo et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b8/53/cddis201345a.PMC3613824.pdf
"Analysis of the dataset with Ingenuity Pathway Analysis (IPA Version 7.5; IPA Tool; IngenuitySystems, Redwood City, CA, USA; http://www.ingenuity.com) software showed top three associated networks as cancer, cellular growth andproliferation, gene expression; hematological system devel- opment and function, hematological disease; cell cycle, cancer, DNA replication, recombination and repair(Table 1(a), Supplementary Table S2).",OADS,/arxiv_data1/oa_pdf/b0/67/cddis201346a.PMC3613825.pdf
Thedataset of genes obtained in the microarray has been deposited in NCBI’s GeneExpression Omnibus (GEO accession number GSE31297) (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE31297).,OADS,/arxiv_data1/oa_pdf/b0/67/cddis201346a.PMC3613825.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-128 induces apoptosis irrespective of p53 status YK Adlakha and N Saini 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b0/67/cddis201346a.PMC3613825.pdf
"However, during the course of this study, pttg3 was classiﬁed as a pseudogene (http://www.ncbi.nlm.nih.gov/nuccore/NR_002734.1) and therefore, excluded from this study.",OADS,/arxiv_data1/oa_pdf/83/5e/cddis201348a.PMC3613826.pdf
"Impor- tantly, pttg3 was also disqualiﬁed as a coding gene from the Intronless Genes Database (http://www.bioinfo-cbs.org).",OADS,/arxiv_data1/oa_pdf/83/5e/cddis201348a.PMC3613826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Role of Pttg2 in EMT and apoptosis CM e´ndez-Vidal et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/83/5e/cddis201348a.PMC3613826.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)AML1/ETO-dependent TRAIL-induced apoptosis V Barbetti et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b8/6a/cddis201349a.PMC3613827.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ROS homeostasis in stem cells Kui Wang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f0/50/cddis201350a.PMC3613828.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Upregulation of c-FLIPs is essential for survival VO Kaminskyy et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/df/6d/cddis201351a.PMC3613829.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)b-cell neogenesis and proliferation in PDL pancreas M Van de Casteele et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e0/25/cddis201352a.PMC3613830.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CPTH6 affects autophagy Y Ragazzoni et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/20/b0/cddis201353a.PMC3613831.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Effects of minocycline on microglia polarization K Kobayashi et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f3/0b/cddis201354a.PMC3613832.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/98/47/cddis201355a.PMC3613833.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/FK506 induces apoptosis of ﬁbroblast J Que et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/78/66/cddis201356a.PMC3613834.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Rac1 and hepatic stress responses A Bopp et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d4/aa/cddis201357a.PMC3613835.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)AMN and free active caspase area in apoptosis M Oropesa-A ´vila et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4a/8c/cddis201358a.PMC3613836.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Microglia induce NPC apoptosis via Puma induction J Guadagno et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/eb/f3/cddis201359a.PMC3613837.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Targeting metabolic enzymes to improve cancer therapy Y Zhao et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d6/70/cddis201360a.PMC3613838.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Training promotes axon remodeling following TBI H Nakagawa et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a3/52/cddis201362a.PMC3613840.pdf
Pixel co-localization and coefﬁcient of co-localizationat various time points were determined using JACoP v2.0 in Image J software(http://rsbweb.nih.gov).,OADS,/arxiv_data1/oa_pdf/59/04/cddis201363a.PMC3613841.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CK2 degrades PML and drives FOXO3a out of nucleus A Chatterjee et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/59/04/cddis201363a.PMC3613841.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Motor neuron degeneration in seipinopathy J Guo et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/98/58/cddis201364a.PMC3613842.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)MiR-17 modulates the different effect of canonical Wnt signaling W Liu et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/65/42/cddis201365a.PMC3613843.pdf
"Published by Oxford University Press on behalf of   the International Society for Behavioral Ecology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/2.5/uk/) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e9/6c/ars092.PMC3613940.pdf
Available at http://www.imca.is/imca/statistics/2012.,OADS,/arxiv_data1/oa_pdf/2a/b5/GAS-48-439.PMC3613943.pdf
"XML Template (2013) [6.3.2013–12:46pm] [1–22] //blrnas3/cenpro/ApplicationFiles/Journals/TandF/3B2/BCLS/Vol05001/120001/APPFile/TF-BCLS120001.3d (BCLS) [INVALID Stage] http://informahealthcare.com/lab ISSN: 1040-8363 (print), 1549-781X (electronic) Crit Rev Clin Lab Sci, 2013; 50(1): 1–22 !2013 Informa Healthcare USA, Inc. DOI: 10.3109/10408363.2012.750262 REVIEW ARTICLE Common variants of the vitamin D binding protein gene and adverse health outcomes Suneil Malik1, Lei Fu2,3, David James Juras1, Mohamed Karmali1, Betty Y. L. Wong2, Agnes Gozdzik4, and David E. C. Cole2,3,5,6 1Office of Biotechnology, Genomics and Population Health, Public Health Agency of Canada, Toronto, ON, Canada,2Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada,3Departments of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, ON, Canada,4Department of Anthropology, University of Toronto at Mississauga, Mississauga, ON, Canada,5Department of Medicine, and 6Department of Genetics, University of Toronto, Toronto, ON, Canada Abstract The vitamin D binding protein (DBP) is the major plasma carrier for vitamin D and its metabolites, but it is also an actin scavenger, and is the precursor to the immunomodulatoryprotein, Gc-MAF.",Non-OADS,/arxiv_data1/oa_pdf/8e/0b/LAB-50-1.PMC3613945.pdf
Available from: http://variantgps.nci.nih.- gov/cgfseq/pages/snp500.do [last accessed 22 Jan 2013].,OADS,/arxiv_data1/oa_pdf/8e/0b/LAB-50-1.PMC3613945.pdf
Available from: http://www.endotext.org/parathyroid/index.htm.51.,OADS,/arxiv_data1/oa_pdf/8e/0b/LAB-50-1.PMC3613945.pdf
"XML Template (2013) [6.3.2013–12:46pm] [23–36] //blrnas3/cenpro/ApplicationFiles/Journals/TandF/3B2/BCLS/Vol05001/130001/APPFile/TF-BCLS130001.3d (LAB) [INVALID Stage] http://informahealthcare.com/lab ISSN: 1040-8363 (print), 1549-781X (electronic) Crit Rev Clin Lab Sci, 2013; 50(1): 23–36 !2013 Informa Healthcare USA, Inc. DOI: 10.3109/10408363.2013.764490 REVIEW ARTICLE Biomarkers of sepsis James D. Faix Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA Abstract Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection, and it probably represents a pattern of response by the immune system to injury.",Non-OADS,/arxiv_data1/oa_pdf/9f/2c/LAB-50-23.PMC3613962.pdf
Available from: http://www.cdc.gov/nchs/data/databriefs/db62.htm [last accessed 2 Jan 2013].,OADS,/arxiv_data1/oa_pdf/9f/2c/LAB-50-23.PMC3613962.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/9f/2c/LAB-50-23.PMC3613962.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/7f/e9/JMGM-07-315.PMC3614187.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/3d/d9/JMGM-07-309.PMC3614188.pdf
Colours were  added with FigTree software (http://tree.bio.ed.ac.uk/).,Non-OADS,/arxiv_data1/oa_pdf/3d/d9/JMGM-07-309.PMC3614188.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use,   distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a2/0a/djt032.PMC3614506.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)ChIP-chip and ChIP-seq of Smads M Morikawa et al 1615 &2013 Macmillan Publishers Limited Oncogene (2013) 1609 – 1615",Non-OADS,/arxiv_data1/oa_pdf/af/e5/onc2012191a.PMC3615190.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Role of MEK inhibitors in multiple myeloma C Chang-Yew Leow et al 8 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/72/db/bcj20131a.PMC3615214.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Blood Cancer Journal website (http://www.nature.com/bcj)Nelﬁnavir in bortezomib-resistant myeloma M Kraus et al 9 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/97/17/bcj20132a.PMC3615215.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Letter to the Editor 2 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/fe/ba/bcj20133a.PMC3615216.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Efﬁcacy of PI-9-resistant granzyme B mutants S Schiffer et al 7 &2013 Macmillan Publishers Limited Blood Cancer Journal",Non-OADS,/arxiv_data1/oa_pdf/93/0c/bcj20134a.PMC3615217.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MR-1 inhibits blast cell differentiation W Zhao et al 10 Blood Cancer Journal &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/b4/44/bcj20135a.PMC3615218.pdf
"(2013), 14(1),  1-6 http://dx.doi.org/10.4142/jvs.2013.14.1.1 Received: 18 May 2012, Revised: 18 Jul.",Non-OADS,/arxiv_data1/oa_pdf/24/09/jvs-14-1.PMC3615225.pdf
"(2013), 14(1),  103-106 http://dx.doi.org/10.4142/jvs.2013.14.1.103 Received: 23 Mar.",Non-OADS,/arxiv_data1/oa_pdf/f3/6f/jvs-14-103.PMC3615226.pdf
"(2013), 14(1),  15-20 http://dx.doi.org/10.4142/jvs.2013.14.1.15 Received: 3 Mar.",Non-OADS,/arxiv_data1/oa_pdf/ac/f3/jvs-14-15.PMC3615227.pdf
"(2013), 14(1),  21-26 http://dx.doi.org/10.4142/jvs.2013.14.1.21 Received: 30 Dec. 2011, Revised: 27 Mar.",Non-OADS,/arxiv_data1/oa_pdf/dd/04/jvs-14-21.PMC3615228.pdf
"(2013), 14(1),  27-36 http://dx.doi.org/10.4142/jvs.2013.14.1.27 Received: 14 Oct. 2011, Revised: 21 Mar.",Non-OADS,/arxiv_data1/oa_pdf/a1/23/jvs-14-27.PMC3615229.pdf
"(2013), 14(1),  37-43 http://dx.doi.org/10.4142/jvs.2013.14.1.37 Received: 26 Apr.",Non-OADS,/arxiv_data1/oa_pdf/48/c6/jvs-14-37.PMC3615230.pdf
"(2013), 14(1),  45-51 http://dx.doi.org/10.4142/jvs.2013.14.1.45 Received: 11 May 2012, Revised: 1 Aug. 2012, Accepted: 8 Aug. 2 012 Original Article *Corresponding author: Tel: +32-2-379-05-47; Fax: +3 2-2-379-04-79; E-mail: stefan.roels@coda-cerva.be ⓒ 2013 The Korean Society of Veterinary Science.",Non-OADS,/arxiv_data1/oa_pdf/d7/d6/jvs-14-45.PMC3615231.pdf
"(2013), 14(1),  53-60 http://dx.doi.org/10.4142/jvs.2013.14.1.53 Received: 17 Oct. 2011, Revised: 17 Jan. 2012, Accepted: 19 Apr .",Non-OADS,/arxiv_data1/oa_pdf/8b/a2/jvs-14-53.PMC3615232.pdf
"(2013), 14(1),  61-67 http://dx.doi.org/10.4142/jvs.2013.14.1.61 Received: 26 Sep. 2011, Revised: 21 Dec. 2011, Accepted: 4 Apr.",Non-OADS,/arxiv_data1/oa_pdf/16/32/jvs-14-61.PMC3615233.pdf
"(2013), 14(1),  69-76 http://dx.doi.org/10.4142/jvs.2013.14.1.69 Received: 6 Apr.",Non-OADS,/arxiv_data1/oa_pdf/f5/66/jvs-14-69.PMC3615234.pdf
"(2013), 14(1),  7-14 http://dx.doi.org/10.4142/jvs.2013.14.1.7 Received: 1 Jun.",Non-OADS,/arxiv_data1/oa_pdf/0c/a9/jvs-14-7.PMC3615235.pdf
"(2013), 14(1),  77-84 http://dx.doi.org/10.4142/jvs.2013.14.1.77 Received: 17 Dec. 2010, Revised: 27 Mar.",Non-OADS,/arxiv_data1/oa_pdf/62/03/jvs-14-77.PMC3615236.pdf
"(2013), 14(1),  85-90 http://dx.doi.org/10.4142/jvs.2013.14.1.85 Received: 13 Feb. 2012, Revised: 8 Jun.",Non-OADS,/arxiv_data1/oa_pdf/2f/eb/jvs-14-85.PMC3615237.pdf
"(2013), 14(1),  91-94 http://dx.doi.org/10.4142/jvs.2013.14.1.91 Received: 26 Apr.",Non-OADS,/arxiv_data1/oa_pdf/38/fb/jvs-14-91.PMC3615238.pdf
"(2013), 14(1),  95-98 http://dx.doi.org/10.4142/jvs.2013.14.1.95 Received: 30 Sep. 2011, Revised: 13 Jan. 2012, Accepted: 4 Apr.",Non-OADS,/arxiv_data1/oa_pdf/78/fc/jvs-14-95.PMC3615239.pdf
"(2013), 14(1),  99-102 http://dx.doi.org/10.4142/jvs.2013.14.1.99 Received: 27 Jan. 2012, Revised: 29 Feb. 2012, Accepted: 19 Apr .",Non-OADS,/arxiv_data1/oa_pdf/7d/9c/jvs-14-99.PMC3615240.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yang, G.M.",Non-OADS,/arxiv_data1/oa_pdf/23/96/srep01596.PMC3615332.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/d5/srep01599.PMC3615333.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xian, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/40/d5/srep01599.PMC3615333.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/67/47/srep01603.PMC3615334.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Aryan, A., Anderson, M.A.E., Myles, K.M.",Non-OADS,/arxiv_data1/oa_pdf/67/47/srep01603.PMC3615334.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/77/srep01600.PMC3615337.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kyutoku, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/77/srep01600.PMC3615337.pdf
"SPIE Newsroom, http://spie.org/x14501.xml?ArticleID 5 x14501 (2007).",Non-OADS,/arxiv_data1/oa_pdf/b8/40/srep01594.PMC3615338.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b8/40/srep01594.PMC3615338.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Santagiustina, M., Chin, S., Primerov, N., Ursini, L. & The ´venaz, L. All-optical signal processing using dynamic Brillouin gratings.",Non-OADS,/arxiv_data1/oa_pdf/b8/40/srep01594.PMC3615338.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7c/cd/srep01595.PMC3615339.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Uesugi, E., Goto, H., Eguchi, R., Fujiwara, A.",Non-OADS,/arxiv_data1/oa_pdf/7c/cd/srep01595.PMC3615339.pdf
"Finally, further functional analysis of the genes involved in the virus-infected splicing events with the DAVID program (http://davi-d.abcc.ncifcrf.gov/) revealed that these genes were functionallyenriched in different biological processes, including the alternativesplicing, acetylation and phosphorylation.",OADS,/arxiv_data1/oa_pdf/d6/5c/srep01601.PMC3615340.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d6/5c/srep01601.PMC3615340.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zou, W. et al.",Non-OADS,/arxiv_data1/oa_pdf/d6/5c/srep01601.PMC3615340.pdf
"Head motion parameters were included as nuisance regressors in individual scans.For presentation purposes, individual, statistical parametric activation maps with the ﬁrst contrast were projected on individuals’ inﬂated brains, using FreeSurfer (http://surfer.nmr.mgh.harvard.edu/).",OADS,/arxiv_data1/oa_pdf/d4/e4/ncomms2571.PMC3615341.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Makin, T. R. et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/e4/ncomms2571.PMC3615341.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2571 8 NATURE COMMUNICATIONS | 4:1570 | DOI: 10.1038/ncomms2571 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d4/e4/ncomms2571.PMC3615341.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/cercor/bhs061 Advance Access publication April 17, 2012Cerebral Cortex May 2013;23:1025– 1030",Non-OADS,/arxiv_data1/oa_pdf/ab/97/bhs061.PMC3615342.pdf
MAF and LD were calculated using PLINK-v1.07 (http://pngu.mgh.harvard.edu/purcell/plink/).,OADS,/arxiv_data1/oa_pdf/ab/97/bhs061.PMC3615342.pdf
"In order to replicate the ﬁndings of the discovery sample, we performed the same analysis in our replication sample, using only the signiﬁcant ﬁndings from the discovery sample as regions of interest (ROIs) to apply a small volume correction (SVC) to the results using the MarsBar toolbox implemented in SPM5 (http://marsbar.sourceforge.net/).",OADS,/arxiv_data1/oa_pdf/ab/97/bhs061.PMC3615342.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/ab/97/bhs061.PMC3615342.pdf
http://dx.doi.org/10.1016/j.neuroimage.2011.10.063.,OADS,/arxiv_data1/oa_pdf/ab/97/bhs061.PMC3615342.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/cercor/bhs069 Advance Access publication April 18, 2012Cerebral Cortex May 2013;23:1061– 1072",Non-OADS,/arxiv_data1/oa_pdf/37/fc/bhs069.PMC3615344.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/37/fc/bhs069.PMC3615344.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Advance Access publication April 2012Cerebral Cortex May 2013;23:1073– 1084 doi:10.1093/cercor/bhs070 17,",Non-OADS,/arxiv_data1/oa_pdf/40/15/bhs070.PMC3615345.pdf
"2009) http://www.macbrain.org/resources.htm (date last accessed 8 March 2012), the Karolinska Directed Emotional Faces (KDEF) imageset (Lundqvist and Litton 1998) http://www.emotionlab.se/resources/kdef (date last accessed 8 March 2012), and the FERET database(Phillips et al.",OADS,/arxiv_data1/oa_pdf/40/15/bhs070.PMC3615345.pdf
2000) http://www.itl.nist.gov/iad/humanid/feret/ (datelast accessed 8 March 2012) Color photographs of famous faceswere obtained from the worldwide web.,Non-OADS,/arxiv_data1/oa_pdf/40/15/bhs070.PMC3615345.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/40/15/bhs070.PMC3615345.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/cercor/bhs089 Advance Access publication April 17, 2012Cerebral Cortex May 2013;23:1118– 1125",Non-OADS,/arxiv_data1/oa_pdf/56/97/bhs089.PMC3615348.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5),which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex May 2013;23:1167 –1178 doi:10.1093/cercor/bhs106 Advance Access publication April 24, 2012",Non-OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
"Tarr, Center for the Neural Basis of Cognition and Department of Psychology, Carnegie Mellon University, http://www.tarrlab.org/ and were different from the stimuli used in the main experiment.",OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
The program to present the stimuli and collect responses was written in Matlab using Psychtoolbox extensions ( http://www.psychtoolbox.,OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
"Results are shown in Figure 3, rendered on an in ﬂated template brain from the Freesurfer toolbox ( http://surfer.nmr.mgh.harvard.edu ) using the spm_surfrend toolbox ( http://spmsurfrend.sourceforge.net) and displayed using the Neurolens software ( http://www.neurolens.org ).",OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
Available from: http://www.nature.com/doiﬁ nder/10.1038/369313a0 .,Non-OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
Available from: http://www.perceptionweb.,Non-OADS,/arxiv_data1/oa_pdf/02/1c/bhs106.PMC3615350.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Cerebral Cortex May 2013;23:1190 –1197 doi:10.1093/cercor/bhs110Advance Access publication May 10, 2012",Non-OADS,/arxiv_data1/oa_pdf/03/08/bhs110.PMC3615351.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/8e/09/ncomms2542.PMC3615354.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Guo, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/8e/09/ncomms2542.PMC3615354.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2542 12 NATURE COMMUNICATIONS | 4:1566 | DOI: 10.1038/ncomms2542 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8e/09/ncomms2542.PMC3615354.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e9/0c/ncomms2573.PMC3615373.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Khodagholy, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/0c/ncomms2573.PMC3615373.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2573 ARTICLE NATURE COMMUNICATIONS | 4:1575 | DOI: 10.1038/ncomms2573 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e9/0c/ncomms2573.PMC3615373.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b3/ec/ncomms2532.PMC3615374.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lee, J.-G. et al.",Non-OADS,/arxiv_data1/oa_pdf/b3/ec/ncomms2532.PMC3615374.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2532 12 NATURE COMMUNICATIONS | 4:1568 | DOI: 10.1038/ncomms2532 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ec/ncomms2532.PMC3615374.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/30/af/ncomms2554.PMC3615375.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Stern, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/30/af/ncomms2554.PMC3615375.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2554 ARTICLE NATURE COMMUNICATIONS | 4:1548 | DOI: 10.1038/ncomms2554 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/30/af/ncomms2554.PMC3615375.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/94/d2/ncomms2516.PMC3615376.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Rybczynski, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/94/d2/ncomms2516.PMC3615376.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2516 ARTICLE NATURE COMMUNICATIONS | 4:1550 | DOI: 10.1038/ncomms2516 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/94/d2/ncomms2516.PMC3615376.pdf
Preprint at ohttp://arxiv.org/abs/1208.4030 4(2012).,Non-OADS,/arxiv_data1/oa_pdf/91/ad/ncomms2544.PMC3615377.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/ncomms2544.PMC3615377.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Roche B. et al.,Non-OADS,/arxiv_data1/oa_pdf/91/ad/ncomms2544.PMC3615377.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2544 ARTICLE NATURE COMMUNICATIONS | 4:1581 | DOI: 10.1038/ncomms2544 | www.nature.com/naturecommunications 5 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/91/ad/ncomms2544.PMC3615377.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shalaby, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/86/9d/ncomms2572.PMC3615378.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2572 ARTICLE NATURE COMMUNICATIONS | 4:1558 | DOI: 10.1038/ncomms2572 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/86/9d/ncomms2572.PMC3615378.pdf
"Journal of  Preventive Medicine  & Public Health 105  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:105-110   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.105 Trends in Reports on Climate Change in 2009-2011 in the  Korean Press Based on Daily Newspapers’ Ownership  Structure  Jihye Lee1, Yeon-pyo Hong1, Hyunsook Kim2, Youngtak Hong3, Weonyoung Lee1 1Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul; 2Department of Public Health, The Graduate School of  Social Development, Chung-Ang University, Seoul; 3Department of Mechanical and Aerospace Engineering , College of Engineering, Seoul National  University, Seoul, KoreaBrief Report Objectives: The mass media play a crucial role in risk communication regarding climate change.",Non-OADS,/arxiv_data1/oa_pdf/09/2c/jpmph-46-105.PMC3615379.pdf
"Key words:  Press report, Climate change, Daily newspaper, Ownership, Risk communication Received:  November 20, 2012 Accepted:  February 13, 2013 Corresponding author:  Yeon-pyo Hong, MD, PhD 84 Heukseok-ro, Dongjak-gu, Seoul 156-861, Korea Tel: +82-2-820-5667, Fax: +82-2-815-9509 E-mail : hyp026@cau.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION  Climate change is also known as ‘global warming’ or anthro - pogenic climate change [1].",Non-OADS,/arxiv_data1/oa_pdf/09/2c/jpmph-46-105.PMC3615379.pdf
Available from: http://chammal.org/3168 (Kore - an).,Non-OADS,/arxiv_data1/oa_pdf/09/2c/jpmph-46-105.PMC3615379.pdf
Available from: http://blog.daum.net/airgirl620/   2 (Korean).,Non-OADS,/arxiv_data1/oa_pdf/09/2c/jpmph-46-105.PMC3615379.pdf
"Journal of  Preventive Medicine  & Public Health 61  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:61  •  http://dx.doi.org/10.3961/jpmph.2013.46.2.61Editorial pISSN 1975-8375  eISSN 2233-4521  Recognizing Our Peer Reviewers of 2012 Last year, 92 peer reviewers contributed their time and expertise to reviewing the submitted man - uscripts to the Journal of Preventive Medicine & Public Health.",Non-OADS,/arxiv_data1/oa_pdf/f7/ea/jpmph-46-61.PMC3615380.pdf
"Journal of  Preventive Medicine  & Public Health 62 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:62-73   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.62 Epidemiological Investigation of an Outbreak of Hepatitis  A at a Residential Facility for the Disabled, 2011 Hyun-Sul Lim, Kumbal Choi, Saerom Lee Department of Preventive Medicine, Dongguk University College of Medicine, Gyeongju, KoreaOriginal Article Objectives: An outbreak of hepatitis A occurred at a residential facility for the disabled in July 10, 2011.",Non-OADS,/arxiv_data1/oa_pdf/cb/3b/jpmph-46-62.PMC3615381.pdf
"Key words:  Hepatitis A, Disease outbreaks, Hand disinfection, Voluntary workers, Residential facilities Received:  July 16, 2012 Accepted:  December 26, 2012 Corresponding author:  Hyun-Sul Lim, MD, PhD 123 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82-54-770-2401, Fax: +82-54-770-2438 E-mail : wisewine@dongguk.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Hepatitis A is a viral infection transmitted via the fecal-oral  route.",Non-OADS,/arxiv_data1/oa_pdf/cb/3b/jpmph-46-62.PMC3615381.pdf
"Journal of  Preventive Medicine  & Public Health 74 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:74-81   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.74 Improving the Performance of Risk-adjusted Mortality  Modeling for Colorectal Cancer Surgery by Combining  Claims Data and Clinical Data Won Mo Jang1, Jae-Hyun Park2, Jong-Hyock Park3, Jae Hwan Oh4, Yoon Kim5,6 1People’s Health Institution, Seoul; 2Department of Social and Preventive Medicine, Sungkyunkwan University, Suwon; 3Division of Cancer Policy  and Management, National Cancer Control Research Institute, National Cancer Center, Goyang; 4Center for Colorectal Cancer, National Cancer  Center, Goyang; 5Institute of Health Policy and Management, Medical Research Center, Seoul National University, Seoul; 6Department of Health  Policy and Management, Seoul National University College of Medicine, Seoul, KoreaOriginal Article Objectives: The objective of this study was to evaluate the performance of risk-adjusted mortality models for colorectal cancer surgery.",Non-OADS,/arxiv_data1/oa_pdf/70/40/jpmph-46-74.PMC3615382.pdf
"Key words:  Quality of health care, Colorectal neoplasms, Colorectal surgery Received:  November 22, 2012 Accepted:  February 19, 2013 Corresponding author:  Yoon Kim, MD, PhD 103 Daehak-ro, Jongno-gu 110-799, Seoul, Korea Tel: +82-2-740-8362, Fax: +82-2-743-2009  E-mail : yoonkim@snu.ac.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Measuring the quality of healthcare services facilitates deci - sions about the selection of providers, the creation of financial  incentives, and quality improvement for consumers, purchas - ers, and providers.",Non-OADS,/arxiv_data1/oa_pdf/70/40/jpmph-46-74.PMC3615382.pdf
"Journal of  Preventive Medicine  & Public Health 82 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:82-88   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.82 Perceived Relevance of Educative Information on Public  (Skin) Health: A Cross-sectional Questionnaire Survey Daniela Haluza, Renate Cervinka Institute of Environmental Health, Center for Public Health, Medical University of Vienna, Vienna, AustriaOriginal Article Objectives: Unprotected leisure time exposure to ultraviolet radiation from the sun or artificial tanning beds is the most important  environmental risk factor for melanoma, a malignant skin cancer with increasing incidences over the past decades.",Non-OADS,/arxiv_data1/oa_pdf/cc/72/jpmph-46-82.PMC3615383.pdf
"Key words:  Gender, Health education, Melanoma prevention, Public Health, Skin health promotion, Sun protection Received:  October 24, 2012 Accepted:  March 2, 2013 Corresponding author:  Daniela Haluza, MD Kinderspitalgasse 15, A-1090 Vienna, Austria Tel: +43-1-40160-34933, Fax: +43-1-40160-934903 E-mail : daniela.haluza@meduniwien.ac.at This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Ultraviolet (UV) radiation initiates damage of epidermal cells  associated with skin tanning and is a causative factor for the  development of the malignant skin cancer melanoma [1].",Non-OADS,/arxiv_data1/oa_pdf/cc/72/jpmph-46-82.PMC3615383.pdf
Available from: http://www.zamg.ac.at/cms/de/ klima/klima-aktuell/monatsrueckblick/temperaturmittel/?jah r=2010&monat =08 (German).,Non-OADS,/arxiv_data1/oa_pdf/cc/72/jpmph-46-82.PMC3615383.pdf
"Journal of  Preventive Medicine  & Public Health 89  Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:89-95   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.89 Physical Activity in Adolescence Has a Positive Effect on  Bone Mineral Density in Young Men Jinhyun Kim1*, Moonki Jung1*, Yeon-pyo Hong2, Jung-Duck Park2, Byung-Sun Choi2 1Chung-Ang University College of Medicine, Seoul; 2Department of Preventive Medicine, Chung-Ang University College of Medicine, Seoul, KoreaOriginal Article Objectives: Little is yet known about the determinants of bone mineral density (BMD) in young adults.",Non-OADS,/arxiv_data1/oa_pdf/08/a3/jpmph-46-89.PMC3615384.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.INTRODUCTION Osteoporosis is a systematic condition of the bones that de - creases the bone mineral density (BMD) and leads to an in - creased risk of fracture [1].",Non-OADS,/arxiv_data1/oa_pdf/08/a3/jpmph-46-89.PMC3615384.pdf
Available from: http://www.who.int/chp/steps/GPAQ/   en/index.html.,OADS,/arxiv_data1/oa_pdf/08/a3/jpmph-46-89.PMC3615384.pdf
Available from: http://www.ars.usda.gov/Ser - vices/docs.htm?docid =22114.,Non-OADS,/arxiv_data1/oa_pdf/08/a3/jpmph-46-89.PMC3615384.pdf
"Journal of  Preventive Medicine  & Public Health 96 Copyright © 2013  The Korean Society for Preventive MedicineJ Prev Med Public Health 2013;46:96-104   •  http://dx.doi.org/10.3961/jpmph.2013.46.2.96 Inappropriate Survey Design Analysis of the Korean   National Health and Nutrition Examination Survey May  Produce Biased Results Yangho Kim1, Sunmin Park2, Nam-Soo Kim3, Byung-Kook Lee4 1Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan;  2Department of Food and Nutrition, Hoseo University, Asan; 3Institue of Environmental & Occupational Medicine, Soonchunhyang University, Asan;  4Korea Industrial Health Association, Seoul, KoreaOriginal Article Objectives: The inherent nature of the Korean National Health and Nutrition Examination Survey (KNHANES) design requires special  analysis by incorporating sample weights, stratification, and clustering not used in ordinary statistical procedures.",Non-OADS,/arxiv_data1/oa_pdf/68/40/jpmph-46-96.PMC3615385.pdf
"Key words:  Korean National Health and Nutrition Examination Survey, Complex survey design, Design-based analysis, Ordinary statis - tical data analysis, Multi-stage stratified sampling Received:  November 13, 2012 Accepted:  March 15, 2013 Corresponding author:  Byung-Kook Lee, MD 179 Hyoryeong-ro, Seocho-gu, Seoul 137-870, Korea Tel: +82-2-585-1584, Fax: +82-2-585-1584 E-mail : bklee@kiha21.or.kr This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0/) which permits unrestricted non-commercial use, distribution, and repro - duction in any medium, provided the original work is properly cited.pISSN 1975-8375  eISSN 2233-4521  INTRODUCTION The Korean National Health and Nutrition Examination Sur - vey (KNHANES) is one of a series of health-related programs  sponsored by the Korean Centers for Disease Control and Pre - vention [1].",Non-OADS,/arxiv_data1/oa_pdf/68/40/jpmph-46-96.PMC3615385.pdf
Available from:  http://www.cdc.gov/nchs/tutorials/nhanes/SurveyDesign/ Weighting/intro.htm.,OADS,/arxiv_data1/oa_pdf/68/40/jpmph-46-96.PMC3615385.pdf
Available from: http://www.cdc.gov/nchs/data/ nhanes/nhanes_07_08/overviewbrochure_0708.pdf.,OADS,/arxiv_data1/oa_pdf/68/40/jpmph-46-96.PMC3615385.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/f2/srep01604.PMC3615386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/11/f2/srep01604.PMC3615386.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ji, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/f8/35/srep01605.PMC3615387.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Han, T., Yuan, T., Li, B.",Non-OADS,/arxiv_data1/oa_pdf/52/d6/srep01593.PMC3615408.pdf
miRNA target prediction and Pathway analysis .miRNA targets were predicted using miRecords (http://mirecords.biolead.org/) and the pathways in which these genes lie were identified using KEGG database 29.,OADS,/arxiv_data1/oa_pdf/cc/c6/srep01555.PMC3615409.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cc/c6/srep01555.PMC3615409.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Shwetha, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/c6/srep01555.PMC3615409.pdf
"To generate an interaction network, gene identiﬁers were uploaded to the string database (http://string-db.org, version 9.0) 53.",OADS,/arxiv_data1/oa_pdf/84/f2/ncomms2575.PMC3615466.pdf
Grouping according to biological function was performed according to literature cited in the main text and gene annotation in theSaccharomyces Genome Database (http://www.yeastgenome.org).,OADS,/arxiv_data1/oa_pdf/84/f2/ncomms2575.PMC3615466.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/f2/ncomms2575.PMC3615466.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Kaiser, C.J.O.",Non-OADS,/arxiv_data1/oa_pdf/84/f2/ncomms2575.PMC3615466.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2575 ARTICLE NATURE COMMUNICATIONS | 4:1571 | DOI: 10.1038/ncomms2575 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/84/f2/ncomms2575.PMC3615466.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/43/ac/ncomms2580.PMC3615467.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Thapa, P. et al.",Non-OADS,/arxiv_data1/oa_pdf/43/ac/ncomms2580.PMC3615467.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2580 ARTICLE NATURE COMMUNICATIONS | 4:1582 | DOI: 10.1038/ncomms2580 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/43/ac/ncomms2580.PMC3615467.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/8b/7f/ncomms2581.PMC3615468.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Sun, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/8b/7f/ncomms2581.PMC3615468.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2581 14 NATURE COMMUNICATIONS | 4:1594 | DOI: 10.1038/ncomms2581 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/8b/7f/ncomms2581.PMC3615468.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Marra, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/54/bc/ncomms2591.PMC3615469.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2591 ARTICLE NATURE COMMUNICATIONS | 4:1578 | DOI: 10.1038/ncomms2591 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/54/bc/ncomms2591.PMC3615469.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/24/fb/ncomms2585.PMC3615470.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Honda, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/24/fb/ncomms2585.PMC3615470.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2585 ARTICLE NATURE COMMUNICATIONS | 4:1574 | DOI: 10.1038/ncomms2585 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/24/fb/ncomms2585.PMC3615470.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/21/ncomms2607.PMC3615471.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gutierrez, A. et al.b-lactam antibiotics promote bacterial mutagenesis via an RpoS-mediated reduction in replication ﬁdelity.",Non-OADS,/arxiv_data1/oa_pdf/bc/21/ncomms2607.PMC3615471.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2607 ARTICLE NATURE COMMUNICATIONS | 4:1610 | DOI: 10.1038/ncomms2607 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bc/21/ncomms2607.PMC3615471.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lin, E.C.",Non-OADS,/arxiv_data1/oa_pdf/36/19/ncomms2590.PMC3615472.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2590 8 NATURE COMMUNICATIONS | 4:1636 | DOI: 10.1038/ncomms2590 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/36/19/ncomms2590.PMC3615472.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/83/b4/ncomms2599.PMC3615473.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Ray, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/ncomms2599.PMC3615473.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2599 12 NATURE COMMUNICATIONS | 4:1598 | DOI: 10.1038/ncomms2599 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/83/b4/ncomms2599.PMC3615473.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/29/ncomms2602.PMC3615479.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Danial, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/29/ncomms2602.PMC3615479.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2602 6 NATURE COMMUNICATIONS | 4:1597 | DOI: 10.1038/ncomms2602 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/ce/29/ncomms2602.PMC3615479.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests : The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/d9/ncomms2596.PMC3615480.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chen, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/d9/ncomms2596.PMC3615480.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2596 ARTICLE NATURE COMMUNICATIONS | 4:1595 | DOI: 10.1038/ncomms2596 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/f4/d9/ncomms2596.PMC3615480.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/af/bd/ncomms2603.PMC3615481.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Rozzi, C. A. et al.",Non-OADS,/arxiv_data1/oa_pdf/af/bd/ncomms2603.PMC3615481.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2603 ARTICLE NATURE COMMUNICATIONS | 4:1602 | DOI: 10.1038/ncomms2603 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/af/bd/ncomms2603.PMC3615481.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: A.C.G.,Non-OADS,/arxiv_data1/oa_pdf/05/bd/ncomms2605.PMC3615483.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article: Walker, P.G.T.",Non-OADS,/arxiv_data1/oa_pdf/05/bd/ncomms2605.PMC3615483.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2605 ARTICLE NATURE COMMUNICATIONS | 4:1609 | DOI: 10.1038/ncomms2605 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/05/bd/ncomms2605.PMC3615483.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/4f/26/ncomms2641.PMC3615484.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Geng, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/4f/26/ncomms2641.PMC3615484.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2641 ARTICLE NATURE COMMUNICATIONS | 4:1632 | DOI: 10.1038/ncomms2641 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/4f/26/ncomms2641.PMC3615484.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ncomms2643.PMC3615485.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Shimada A. et al.,Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ncomms2643.PMC3615485.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2643 8 NATURE COMMUNICATIONS | 4:1639 | DOI: 10.1038/ncomms2643 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c6/d0/ncomms2643.PMC3615485.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/b6/8c/ncomms2635.PMC3615486.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zrazhevskiy, P. and Gao, X. Quantum dot imaging platform for single-cell molecular proﬁling.",OADS,/arxiv_data1/oa_pdf/b6/8c/ncomms2635.PMC3615486.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2635 12 NATURE COMMUNICATIONS | 4:1619 | DOI: 10.1038/ncomms2635 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b6/8c/ncomms2635.PMC3615486.pdf
"To achieve external acceptance and compatibility of the  developed ontology and meta standards, collaborations have been established with the Clinical Data Interchange Standards Consortium, the Ricordo 4 project to scope the integration of  semantic relationships within the framework, the Pistoia Alli-ance to achieve endorsement, and the IMI consortia Open  PHACTS (http://www.openphacts.org) and EHR4CR (http:// www.ehr4cr.eu) to ensure compatibility of standards.",Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
"Because external acceptance and contribution is vital for the long-term success of this initiative, we will continue  to engage with stakeholders and the community by making  outcomes public at http://www.ddmore.eu and through com-munications at conferences and workshops.",Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
"The authors thank and acknowledge all  contributing members of Drug and Disease Model  Resources  (DDMoRe), the names of whom appear on the DDMoRe  homepage at: http://www.ddmore.eu/partners.",Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
<http://www.imi.,Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
"Notes 4, 313 (2011) <http://www.biomedcentral.com/1756- 0500/4/313>.",Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
<http://www.page-meeting.org/?abstract=xxxx>.,Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
Supplementary Information accompanies this paper on the Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)CPT: Pharmacometrics & Systems Pharmacology is an   open-access journal published by Nature Publishing  Group.,Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/72/d2/psp201310a.PMC3615532.pdf
"Following the success of the Pediatric Pharma-cology Research Units network as an infrastructure for high quality pediatric labeling and translational studies, the National Institute of Child Health and Development now sup- ports an active network of Obstetric-Fetal Pharmacology  Research Units (http://opru.rti.org) to carry out pharmacology research to enhance understanding of obstetrical pharma-cokinetics and pharmacodynamics, and improve appropri-ate therapeutics during pregnancy.",Non-OADS,/arxiv_data1/oa_pdf/8d/95/psp20139a.PMC3615533.pdf
"2,4 Earlier this year, the FDA’s Pharmaceuti- cal Science and Clinical Pharmacology Advisory Commit-tee voted in support of extending the use PBPK modeling for pediatric drug development although several members  of the committee emphasized the need for more data and  prospective evaluation and validation of the models with observed data (http://www.fda.gov).",Non-OADS,/arxiv_data1/oa_pdf/8d/95/psp20139a.PMC3615533.pdf
<http://www.rosaandco.com/webinarArchive.html>.,Non-OADS,/arxiv_data1/oa_pdf/8d/95/psp20139a.PMC3615533.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/8d/95/psp20139a.PMC3615533.pdf
The network was visualized using the yEd software  (http://www.yworks.com) and customized MATLAB scripts.,OADS,/arxiv_data1/oa_pdf/88/04/psp201311a.PMC3615534.pdf
"To view a copy of  this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary information accompanies this paper on the Pharmacometrics & Systems Pharmacology website   (http://www.nature.com/psp)",Non-OADS,/arxiv_data1/oa_pdf/88/04/psp201311a.PMC3615534.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/43/srep01580.PMC3615570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Saha, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/43/srep01580.PMC3615570.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gaspar, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/4c/srep01469.PMC3615571.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.1 pISSN 2093-3665   eISSN 2093-3673 The immune modulating properties of the heat shock proteins after brain injury Jong Y oul Kim, Midori A. Y enari Department of Neurology, University of California, San Francisco and the San Francisco Veterans Affairs Medical Center, San Fra ncisco, CA, USA   Abstract:  Inflammation within the central nervous system often accompanies ischemia, trauma, infection, and other neuronal  injuries.",Non-OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
Anat Cell Biol 2013;46:1-7 Jong Y oul Kim and Midori A. Y enari 2 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.1subsequent generation and expression of more Hsps [10].,OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
"Heat shock protein in brain injury http://dx.doi.org/10.5115/acb.2013.46.1.1Anat Cell Biol 2013;46:1-7 3 www.acbjournal.orgHow immune responses are regulated are complex, but  the NF-kB deserves some mention as a major and prototypic pro-inflammatory transcription factor widely expressed in the CNS [29].",Non-OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
Anat Cell Biol 2013;46:1-7 Jong Y oul Kim and Midori A. Y enari 4 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.1signaling functions [42].,OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
"Heat shock protein in brain injury http://dx.doi.org/10.5115/acb.2013.46.1.1Anat Cell Biol 2013;46:1-7 5 www.acbjournal.orgas TNF-α and IL-1 [47], while overexpression of Hsp70 in  macrophages blocked LPS-induced increases in TNF, IL-1, IL-10, and IL-12 [48].",Non-OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
Anat Cell Biol 2013;46:1-7 Jong Y oul Kim and Midori A. Y enari 6 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.1Genet 1988;22:631-77.,OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
Heat shock protein in brain injury http://dx.doi.org/10.5115/acb.2013.46.1.1Anat Cell Biol 2013;46:1-7 7 www.acbjournal.org40.,Non-OADS,/arxiv_data1/oa_pdf/53/1b/acb-46-1.PMC3615608.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.19 pISSN 2093-3665   eISSN 2093-3673 Molecular regulation of kidney development Ok-Hee Chai1, Chang-Ho Song1,2, Sung-Kwang Park2,3, Won Kim2,3, Eui-Sic Cho2,4 1Department of Anatomy, Institute for Medical Sciences, 2Biomedical Research Institute, 3Department of Internal Medicine, Research Institute of Clinical  Medicine, Chonbuk National University Medical School, 4Laboratory for Craniofacial Biology, Institute of Oral Biosciences, Chonbuk National University  School of Dentistry, Jeonju, Korea Abstract:  Genetically engineered mice have provided much information about gene function in the field of developmental  biology.",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 20 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19the nephron, the functional unit of the kidney.",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 21 www.acbjournal.orggrowth and transcriptional factors, and cell membrane  receptors that are necessary for the cascade of events to occur to form a kidney and that are targeted to date using the kidney-specific Cre/ loxP strategy.",Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 22 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19and others generating endothelial cells of the renal vas- culature.",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 23 www.acbjournal.orgtubules, and a part of the developing metanephros.",Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 24 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19including UB ectopia, double ureters/collecting systems, and  hypoplastic metanephros [49].",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 25 www.acbjournal.org[70].,Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 26 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19These proteins bind GBM matrix molecules via their  extracellular domain and are coupled to the actin cytoskeleton intracellularly.",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 27 www.acbjournal.orgConclusion Genetic engineering in mice has provided much informa- tion about gene function in the field of developmental bio-logy.,OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 28 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19morphogenesis will certainly assist in the diagnosis and  treatment of renal disease as well as allow the regulation or re-initiation of nephrogenesis in the future.",Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 29 www.acbjournal.orgHartner A, Hilgers KF, Amann K. Early glomerular alterations  in genetically determined low nephron number.",Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anat Cell Biol 2013;46:19-31 Ok-Hee Chai, et al 30 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.19nephrogenesis and for regulation of gene expression in nascent  nephrons.",OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
Regulation of nephrogenesis  http://dx.doi.org/10.5115/acb.2013.46.1.19Anat Cell Biol 2013;46:19-31 31 www.acbjournal.orgRC.,Non-OADS,/arxiv_data1/oa_pdf/38/42/acb-46-19.PMC3615609.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.32 pISSN 2093-3665   eISSN 2093-3673 Spatial relationship between expression of cytokeratin-19 and that of connexin-43 in human fetal kidney Keisuke Hieda1, Shogo Hayashi2, Ji Hyun Kim3, Gen Murakami4, Baik Hwan Cho5, Akio Matsubara1 1Department of Urology, Hiroshima University School of Medicine, Hiroshima, 2Medical Education Center, Aichi Medical University School of Medicine,  Nagakute, Japan, 3Department of Anatomy, Chonbuk National University Medical School, Jeonju, Korea, 4Division of Internal Medicine, Iwamizawa Kojin- kai Hospital, Iwamizawa, Japan, 5Department of Surgery, Chonbuk National University Medical School, Jeonju, Korea Abstract:  Connexin-43, a major gap junction protein, and cytokeratin-19, one of the intermediate filament keratins, are known  to be markers of well-differentiated epithelium.",OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"CK19 and CX 43 in human fetal kidney http://dx.doi.org/10.5115/acb.2013.46.1.32Anat Cell Biol 2013;46:32-38 33 www.acbjournal.orgas a promoter in experimental systems employing dermal- epidermal cells [29, 30].",Non-OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"Anat Cell Biol 2013;46:32-38 Keisuke Hieda, et al 34 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.32proximal tubule systems (Figs.",OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"CK19 and CX 43 in human fetal kidney http://dx.doi.org/10.5115/acb.2013.46.1.32Anat Cell Biol 2013;46:32-38 35 www.acbjournal.orgadult rat kidney: the inner medullary collecting ducts showed  the highest level of expression, followed by the cortical collecting ducts; this was in contrast to the significantly lower expression that was observed in the proximal convoluted tubules, proximal straight tubules, medullary thick ascending limb, and distal convoluted tubules.",Non-OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"Anat Cell Biol 2013;46:32-38 Keisuke Hieda, et al 36 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.32Despite the fact that CK14 has been widely used as an  epithelial marker in studies on the maxillofacial region (see Introduction), it did not appear to be expressed in other parts of the gastrointestinal tract in the human fetuses used in the current study.",OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
CK19 and CX 43 in human fetal kidney http://dx.doi.org/10.5115/acb.2013.46.1.32Anat Cell Biol 2013;46:32-38 37 www.acbjournal.organd disappeared at 11 weeks.,Non-OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"Anat Cell Biol 2013;46:32-38 Keisuke Hieda, et al 38 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.32Proc Natl Acad Sci U S A 2002;99:3639-44.",OADS,/arxiv_data1/oa_pdf/0c/0b/acb-46-32.PMC3615610.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.39 pISSN 2093-3665   eISSN 2093-3673 Distribution of elastic fibers in the head and neck: a histological study using late-stage human fetuses  Hideaki Kinoshita1, Takashi Umezawa1, Yuya Omine1, Masaaki Kasahara1, José Francisco Rodríguez- Vázquez2, Gen Murakami3, Shinichi Abe1 1Department of Anatomy, Tokyo Dental College, Chiba, Japan, 2Department of Anatomy and Embryology II, Faculty of Medicine, Complutense University,  Madrid, Spain, 3Division of Internal Medicine, Iwamizawa Kojin-kai Hospital, Iwamizawa, Japan  Abstract:  There is little or no information about the distribution of elastic fibers in the human fetal head.",Non-OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anat Cell Biol 2013;46:39-48 Hideaki Kinoshita, et al 40 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.39flavum) [6, 7], the skin dermis [8], and the facet capsule  of the vertebral column [9].",OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
Distribution of elastic fibers http://dx.doi.org/10.5115/acb.2013.46.1.39Anat Cell Biol 2013;46:39-48 41 www.acbjournal.orgvisions of the Declaration of Helsinki 1995 (as revised in  Edinburgh 2000).,OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anat Cell Biol 2013;46:39-48 Hideaki Kinoshita, et al 42 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.39types of staining: 1) aldehyde-fuchsin staining [26, 27]  and 2) elastica-Masson staining, a variation of Masson-Goldner staining [28-30].",Non-OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
Distribution of elastic fibers http://dx.doi.org/10.5115/acb.2013.46.1.39Anat Cell Biol 2013;46:39-48 43 www.acbjournal.orgcontained elastic fibers in the center of each fragment (Fig.,OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anat Cell Biol 2013;46:39-48 Hideaki Kinoshita, et al 44 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.39unaccompanied by elastic fibe rs (Fig.",OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
Distribution of elastic fibers http://dx.doi.org/10.5115/acb.2013.46.1.39Anat Cell Biol 2013;46:39-48 45 www.acbjournal.orgspecific developmental pattern of connective tissues.,OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anat Cell Biol 2013;46:39-48 Hideaki Kinoshita, et al 46 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.39phalanges of the hand [37] and tail tendons of animals [38].",OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Distribution of elastic fibers http://dx.doi.org/10.5115/acb.2013.46.1.39Anat Cell Biol 2013;46:39-48 47 www.acbjournal.orgfibers of nuchal ligament, aorta, and lung of fetal and post natal  sheep: an ultrastructural and electron microscopic immuno-histochemical study.",Non-OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anat Cell Biol 2013;46:39-48 Hideaki Kinoshita, et al 48 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.39fiber assembly.",OADS,/arxiv_data1/oa_pdf/4f/af/acb-46-39.PMC3615611.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.49 pISSN 2093-3665   eISSN 2093-3673 Qualitative changes in fetal trabecular  meshwork fibers at the human iridocorneal angle Fumio Hosaka1, Jose Francisco Rodríguez-Vázquez2, Hiroshi Abe3, Gen Murakami4, Mineko Fujimiya5,  Hiroshi Ohguro6 1Division of Ophthalmology, Iwamizawa Municipal Hospital, Iwamizawa, Japan, 2Department of Anatomy and Embryology II, Faculty of Medicine,  Complutense University, Madrid, Spain, 3Department of Anatomy, Akita University School of Medicine, Akita, 4Division of Internal Medicine, Iwamizawa  Kojin-kai Hospital, Iwamizawa, Departments of 5Anatomy and 6Ophthalmology, Sapporo Medical University, Sapporo, Japan Abstract:  We examined a series of changes that occur in the trabecular meshwork fibers of human eyes during fetal  development at 12–30 weeks of gestation.",Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Anat Cell Biol 2013;46:49-56 Fumio Hosaka, et al 50 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.49“sliding” (a relative topographical change) of the iridocorneal  angle or lateral expansion of the anterior chamber due to more rapid growth of the cornea and sclera relative to the uvea after 20 weeks of gestation; the TM acquires a position anterior to the ciliary muscle from this point onward.",Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Fetal development of trabecular meshwork http://dx.doi.org/10.5115/acb.2013.46.1.49Anat Cell Biol 2013;46:49-56 51 www.acbjournal.orgspecimens, our aim was to describe the morphology that was  commonly evident in fetuses at each stage.",Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Anat Cell Biol 2013;46:49-56 Fumio Hosaka, et al 52 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.49inserted into the red-colored fibers of the spur (i.e., type I  collagen-predominant).",OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
Fetal development of trabecular meshwork http://dx.doi.org/10.5115/acb.2013.46.1.49Anat Cell Biol 2013;46:49-56 53 www.acbjournal.orgstepwise changes in the color and thickness of composite  fibers of the TM and surrounding structures.,Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Anat Cell Biol 2013;46:49-56 Fumio Hosaka, et al 54 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.49fered and has been attributed to 1) the long extending iris, 2)  ciliary muscle contraction, and 3) elevated pressure within the fetal eye.",Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
Fetal development of trabecular meshwork http://dx.doi.org/10.5115/acb.2013.46.1.49Anat Cell Biol 2013;46:49-56 55 www.acbjournal.org[30].,Non-OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Anat Cell Biol 2013;46:49-56 Fumio Hosaka, et al 56 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.49H, Fujimiya M. Fetal check ligament connected between the  conjunctiva and the medial and lateral recti.",OADS,/arxiv_data1/oa_pdf/d6/bc/acb-46-49.PMC3615612.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.57 pISSN 2093-3665   eISSN 2093-3673 Caffeine-induced endothelial cell death and the inhibition of angiogenesis  Hua Li1, Sheng-Yu Jin2, Hyun-Joon Son1, Je Hoon Seo1, Goo-Bo Jeong3 1Department of Anatomy, Chungbuk National University Medical School, Cheongju, Korea, 2Department of Hematology, Affiliated Hospital of Yanbian  University, Y anji, China, 3Department of Anatomy and Cell Biology, Gachon University School of Medicine, Incheon, Korea  Abstract:  Numerous studies have shown that adenosine or adenosine agon ists can stimulate angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anat Cell Biol 2013;46:57-67 Hua Li, et al 58 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.57coupled 7 transmembrane super family of cell surface  receptors, which are composed of A1, A2A, A2B, and A3  subtypes [4-8].",OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
Angiogenesis inhibition by caffeine http://dx.doi.org/10.5115/acb.2013.46.1.57Anat Cell Biol 2013;46:57-67 59 www.acbjournal.orgremaining cells.,Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anat Cell Biol 2013;46:57-67 Hua Li, et al 60 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.57was measured using a protein assay kit (Bio-Rad).",OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Angiogenesis inhibition by caffeine http://dx.doi.org/10.5115/acb.2013.46.1.57Anat Cell Biol 2013;46:57-67 61 www.acbjournal.org10% normal goat serum for 30 minutes at room temperature,  incubated with polyclonal anti-TSP-1 antibody (NeoMarkers, Fremont, CA, USA) for 30 minutes at 37°C, washed three times, and labeled with 5 μg/ml Alexa Fluor 594-conjugated goat anti-rabbit IgG (Molecular Probes) for 30 minutes.",Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anat Cell Biol 2013;46:57-67 Hua Li, et al 62 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.57dependently inhibits the formation of new blood vessels in  chick embryonic CAMs.",Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Angiogenesis inhibition by caffeine http://dx.doi.org/10.5115/acb.2013.46.1.57Anat Cell Biol 2013;46:57-67 63 www.acbjournal.orgEffects of caffeine on the  expression of TSP-1 in  endothelial cells Because it has been previously reported that adenosine and  adenosine receptor agonists decrease the expression of the anti-angiogenic protein TSP-1 [9-15], we examined the effect of caffeine on TSP-1 expression in HUVECs.",Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anat Cell Biol 2013;46:57-67 Hua Li, et al 64 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.57to 191.3% and 305.8%, respectively (Fig.",OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Angiogenesis inhibition by caffeine http://dx.doi.org/10.5115/acb.2013.46.1.57Anat Cell Biol 2013;46:57-67 65 www.acbjournal.orgTo explore the mechanisms responsible for this inhibition  of angiogenesis by caffeine, we examined the effects of caffeine on endothelial cell proliferation, which are essential the first steps of angiogenesis.",Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anat Cell Biol 2013;46:57-67 Hua Li, et al 66 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.57References 1.",OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
Angiogenesis inhibition by caffeine http://dx.doi.org/10.5115/acb.2013.46.1.57Anat Cell Biol 2013;46:57-67 67 www.acbjournal.org31.,Non-OADS,/arxiv_data1/oa_pdf/09/2b/acb-46-57.PMC3615613.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.68 pISSN 2093-3665   eISSN 2093-3673 Expression of transient receptor potential channels in the ependymal cells of the developing rat brain Kwang Deog Jo1, Kyu-Seok Lee2, Won Taek Lee3, Mi-Sun Hur2, Ho-Jeong Kim2 1Department of Neurology, Gangneung Asan Hospital, University of Ulsan College of Medicine, 2Department of Anatomy, Kwandong University College of  Medicine, Gangneung, 3Department of Anatomy, Y onsei University College of Medicine, Seoul, Korea Abstract:  Cerebrospinal fluid (CSF) plays an important role in providin g brain tissue with a stable internal environment as  well as in absorbing mechanical and thermal stresses.",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"TRP channels in developing ependyma http://dx.doi.org/10.5115/acb.2013.46.1.68Anat Cell Biol 2013;46:68-78 69 www.acbjournal.orgdients, is produced by a class of glial cells, called ependymal  cells, lining the ventricular surface that is located inside the brain.",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anat Cell Biol 2013;46:68-78 Kwang Deog Jo, et al 70 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.68stage with that for the adult stage may give insight into the  adaptation and maturation of ependymal cells.",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
TRP channels in developing ependyma http://dx.doi.org/10.5115/acb.2013.46.1.68Anat Cell Biol 2013;46:68-78 71 www.acbjournal.orgwith biotinylated secondary antibodies (Vector Labs Inc.)  diluted in blocking sera for 60 minutes at room temperature.,Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anat Cell Biol 2013;46:68-78 Kwang Deog Jo, et al 72 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.68basal ganglia typically were growing from the anterolateral  wall of the telencephalon.",OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
TRP channels in developing ependyma http://dx.doi.org/10.5115/acb.2013.46.1.68Anat Cell Biol 2013;46:68-78 73 www.acbjournal.orgagainst TRPA1 was mostly visible at the apical region of  CPE cytoplasm in the 15-day embryo.,OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anat Cell Biol 2013;46:68-78 Kwang Deog Jo, et al 74 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.68had not been observed in the previous stages.",OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
TRP channels in developing ependyma http://dx.doi.org/10.5115/acb.2013.46.1.68Anat Cell Biol 2013;46:68-78 75 www.acbjournal.orgof VLE by TRPA1 antibody was consistently observed in both  the lateral and fourth ventricles throughout all the stages.,Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anat Cell Biol 2013;46:68-78 Kwang Deog Jo, et al 76 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.68contour by the 19th day.",OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"TRP channels in developing ependyma http://dx.doi.org/10.5115/acb.2013.46.1.68Anat Cell Biol 2013;46:68-78 77 www.acbjournal.orgis known to be isotonic with maternal plasma, but gradually  becomes hypotonic [23].",Non-OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anat Cell Biol 2013;46:68-78 Kwang Deog Jo, et al 78 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.688.",OADS,/arxiv_data1/oa_pdf/b8/3a/acb-46-68.PMC3615614.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.79 pISSN 2093-3665   eISSN 2093-3673 Unilateral duplication of vas deferens: a cadaveric case report  Srinivasa Rao Sirasanagandla1, Satheesha B. Nayak1, Raghu Jetti1, Kumar M. R. Bhat2 1Department of Anatomy, Melaka Manipal Medical College, 2Department of Anatomy, Kasturba Medical College, Manipal University, Manipal, Karnataka, India Abstract:  Duplication of vas deferens is a rare congenital anomaly.",Non-OADS,/arxiv_data1/oa_pdf/7b/e8/acb-46-79.PMC3615615.pdf
"Anat Cell Biol 2013;46:79-81 Srinivasa Rao Sirasanagandla, et al 80 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.79located testis and epididymis (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7b/e8/acb-46-79.PMC3615615.pdf
"Unilateral duplication of vas deferens http://dx.doi.org/10.5115/acb.2013.46.1.79Anat Cell Biol 2013;46:79-81 81 www.acbjournal.orgfused at the level of the deep inguinal ring, after traversing the  inguinal canal.",Non-OADS,/arxiv_data1/oa_pdf/7b/e8/acb-46-79.PMC3615615.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.8 pISSN 2093-3665   eISSN 2093-3673 Gastric stem cells and gastric cancer stem cells Myoung-Eun Han1,2, Sae-Ock Oh1,2 1Department of Anatomy, Pusan National University School of Medicine, 2Medical Research Center for Ischemic Tissue Regeneration, Pusan National  University, Y angsan, Korea Abstract:  The gastric epithelium is continuously regenerated by gast ric stem cells, which give rise to various kinds of daughter  cells, including parietal cells, chief cells, surface mucous cells, mucous neck cells, and enteroendocr ine cells.",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Gastric stem cells and gastric cancer stem cells http://dx.doi.org/10.5115/acb.2013.46.1.8Anat Cell Biol 2013;46:8-18 9 www.acbjournal.orgGastric Stem Cells The stomach is divided into 4 sections: the cardia, fundus,  body, and pylorus.",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Anat Cell Biol 2013;46:8-18 Myoung-Eun Han and Sae-Ock Oh 10 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.8a receptor for hedgehog signaling,  is expressed in gastric  epithelial cells and mesenchymal cells [19, 20].",OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Gastric stem cells and gastric cancer stem cells http://dx.doi.org/10.5115/acb.2013.46.1.8Anat Cell Biol 2013;46:8-18 11 www.acbjournal.orgboth epithelial and mesenchymal cells of the stomach [18,  19, 41-43].",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Anat Cell Biol 2013;46:8-18 Myoung-Eun Han and Sae-Ock Oh 12 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.8Isolation of gastric cancer stem cell from patients After the demonstration of cancer stem cells in leukemia  by John Dick’s group, cancer stem cells were successfully  isolated from numerous solid cancers, including brain cancer, breast cancer, and pancreatic cancer [2, 3].",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Gastric stem cells and gastric cancer stem cells http://dx.doi.org/10.5115/acb.2013.46.1.8Anat Cell Biol 2013;46:8-18 13 www.acbjournal.orgcancer stem cells, including breast  cancer, medulloblastoma,  and pancreatic cancer [73].",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Anat Cell Biol 2013;46:8-18 Myoung-Eun Han and Sae-Ock Oh 14 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.8of cancer stem cells, which finally affects their self-renewal.",Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
Gastric stem cells and gastric cancer stem cells http://dx.doi.org/10.5115/acb.2013.46.1.8Anat Cell Biol 2013;46:8-18 15 www.acbjournal.org14.,Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
Oncogene 2012 Jun 4 [Epub] http://dx.doi.org/10.1038/onc.2012.224.,OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
Anat Cell Biol 2013;46:8-18 Myoung-Eun Han and Sae-Ock Oh 16 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.8and BMP receptor expression during murine organogenesis.,OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
Gastric stem cells and gastric cancer stem cells http://dx.doi.org/10.5115/acb.2013.46.1.8Anat Cell Biol 2013;46:8-18 17 www.acbjournal.orgMS.,Non-OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
Anat Cell Biol 2013;46:8-18 Myoung-Eun Han and Sae-Ock Oh 18 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.8 Watabe K. Bone morphogenetic protein 7 in dormancy and   metastasis of prostate cancer stem-like cells in bone.,OADS,/arxiv_data1/oa_pdf/e9/5d/acb-46-8.PMC3615616.pdf
"Anatomy & Cell Biologyhttp://dx.doi.org/10.5115/acb.2013.46.1.82 pISSN 2093-3665   eISSN 2093-3673 A peculiar liver with surgically and radiologically important variations: a case report  Satheesha B. Nayak, Snigdha Mishra, Bincy M. George, Surekha D. Shetty, Naveen Kumar, Anitha Guru, Srinivasa S. Rao, Ashwini Aithal  Department of Anatomy, Melaka Manipal Medical College (Manipal Campus), Manipal University, Manipal, Karnataka State, India  Abstract:  A peculiar liver was found in an adult male cadaver during  a dissection class for undergraduate medical students.",Non-OADS,/arxiv_data1/oa_pdf/55/11/acb-46-82.PMC3615617.pdf
A peculiar liver http://dx.doi.org/10.5115/acb.2013.46.1.82Anat Cell Biol 2013;46:82-84 83 www.acbjournal.orgCase Report We found an anatomically peculiar liver during a routine  dissection class for undergraduate medical students.,Non-OADS,/arxiv_data1/oa_pdf/55/11/acb-46-82.PMC3615617.pdf
"Anat Cell Biol 2013;46:82-84 Satheesha B. Nayak, et al 84 www.acbjournal.org http://dx.doi.org/10.5115/acb.2013.46.1.82coexistence of multiple anomalies of the hepatobiliary system.",OADS,/arxiv_data1/oa_pdf/55/11/acb-46-82.PMC3615617.pdf
Scanned images were analysed using ImageJ (http://rsb.info.NIH.gov/nih-image/).,OADS,/arxiv_data1/oa_pdf/50/f0/embor201315a.PMC3615658.pdf
Supplementary information is available at EMBO reports online (http://www.emboreports.org).,Non-OADS,/arxiv_data1/oa_pdf/50/f0/embor201315a.PMC3615658.pdf
This article is licensed under a Creative Commons Attribution Noncommercial Share Alike 3.0 Unported License [http://creativecommons.org/licenses/by-nc-sa/3.0]Neuronal activity stimulates tau release A.M. Pooler et al scientific report 394 EMBO reports VOL 14 | NO 4 | 2013 &2013 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION,Non-OADS,/arxiv_data1/oa_pdf/50/f0/embor201315a.PMC3615658.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc- nd/3.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslationalGastroenterology website (http://www.nature.com/ctg)Survival Beneﬁt after R0 Resection Tummala et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/ac/ctg20134a.PMC3615697.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Insulin/Insulin-Like Growth Factor-1 Pathway Greer et al .",Non-OADS,/arxiv_data1/oa_pdf/3a/55/ctg20132a.PMC3615698.pdf
"A signiﬁcant score is also obtained for miR-147b, conﬁrming the close functional proximity of miR-210 and miR-147b11 Table 1 List of the top miR-210 predicted targets signiﬁcantly downregulated in the pmiR-210 A549 cell line Symbol Gene ID AVEEXPR LOGFC Description CORO1C 23603 11.68 /C00.44 Coronin, actin binding protein, 1C DIMT1L 27292 12.13 /C00.89 DIM1 dimethyladenosine transferase 1-like ELFN2 114794 9.27 /C00.61 Extracellular leucine-rich repeat and ﬁbronectin type III domain containing 2 ENOX2 10495 9.65 /C00.54 Ecto-NOX disulﬁde-thiol exchanger 2 FGFRL1 53834 8.56 /C00.75 Fibroblast growth factor receptor-like 1 GPD1L 23171 9.58 /C00.55 Glycerol-3-phosphate dehydrogenase 1-like INF2 64423 10.78 /C00.62 Inverted formin, FH2 and WH2 domain containing ISCU1/2 23479 13.06 /C00.58 Iron-sulfur cluster scaffold homolog MITF 4286 9.84 /C00.52 Microphthalmia-associated transcription factor NDUFA4 4697 14.87 /C00.58 NADH dehydrogenase (ubiquinone) 1 asubcomplex, 4, 9 kDa SDF2 6388 10.63 /C00.61 Stromal cell-derived factor 2 SDHD 6392 11.06 /C00.46 Succinate dehydrogenase complex, subunit D, integral membrane protein ST6GAL2 84620 10.20 /C00.57 ST6 b-galactosamide a-2,6-sialyltranferase 2 TMEM20 159371 7.98 /C00.49 Transmembrane protein 20 TNPO1 3842 9.69 /C00.41 Transportin 1 VAMP7 6845 11.21 /C00.78 Vesicle-associated membrane protein 7 Sixteen of the miR-210 predicted transcripts selected using the bioinformatics tool miRonTop (http://www.microarray.fr:8080/miRonTop/index) are listed.",Non-OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
"Gene ID: corresponds to NCBI Gene ID (http://www.ncbi.nlm.nih.gov/gene)miR-210, hypoxia and radioresistance S Grosso et al 3 Cell Death and Disease",OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
The experimental data andmicroarray design have been deposited in the NCBI Gene Expression Omnibus(http://www.ncbi.nlm.nih.gov/geo/) under series GSE43622.,OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
Statistical analysis : Normalization was performed using the Limma package available from Bioconductor (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
Biological theme analysis : Data from expression microarrays were analyzed for enrichment in biological themes (Gene Ontology molecular functionand biological process) using Ingenuity Pathway Analysis software (http://www.ingenuity.com/) and Mediante (http://www.microarray.fr:8080/merge/index).,OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)miR-210, hypoxia and radioresistance S Grosso et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3a/df/cddis201371a.PMC3615727.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Smac mimetic stimulates migration and invasion via NF- jB A Tchoghandjian et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/96/7a/cddis201370a.PMC3615728.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)B12 deﬁciency induces SIRT1-dependent ER stress R Ghemrawi et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/92/e3/cddis201369a.PMC3615730.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HAMLET-induced autophagy modulate apoptosis by p62 Y-B Zhang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/66/4d/cddis201377a.PMC3615731.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)hnRNP K cleavage by Caspase-3 IS Naarmann-de Vries et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d2/fc/cddis201375a.PMC3615732.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/Anti-inﬂammatory roles of TCM in atherosclerosis L Wang et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/32/48/cddis201366a.PMC3615733.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Ophiobolin-induced paraptosis in glioblastoma M Bury et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1b/f8/cddis201385a.PMC3615734.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Functional interaction between RASSF5 and Itch R Suryaraja et al 10 Cell Death and Disease",OADS,/arxiv_data1/oa_pdf/b0/a5/cddis201391a.PMC3615736.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CLSP is an agonist for the Humanin receptor Y Hashimoto et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/96/d7/cddis201380a.PMC3615737.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Axonal growth inhibitory signal and axonal regeneration N Uesugi et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/06/61/cddis201383a.PMC3615738.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Effect of Ntn-1 on hypoxia-induced MSC apoptosis TW Son 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a3/82/cddis201394a.PMC3615739.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)IAV NP induces apoptosis by targeting Clusterin S Tripathi et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a5/b6/cddis201389a.PMC3615740.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Cd induced Drp1-dependent mt ﬁssion in hepatotoxicity SX u et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/74/2a/cddis20137a.PMC3615741.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Metabolic effects of TiO 2-NP on human keratinocytes P Tucci et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/81/3b/cddis201376a.PMC3615742.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Autophagy and microRNAs in Parkinson’s decrease L Alvarez-Erviti et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d5/16/cddis201373a.PMC3615743.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Redox-mediated apoptosis in tumor P Zhu et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/90/4a/cddis201368a.PMC3615744.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Dissecting NMDAR in neuronal fate XZ h o u et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b4/e6/cddis201382a.PMC3615746.pdf
"For erbB3 receptor, because of its lack of or low kinase activity, 51,52blocking Ab is the only strategy currently under preclinical53,54and clinical studies (http://www.clinical- trials.gov/).",Non-OADS,/arxiv_data1/oa_pdf/59/98/cddis201379a.PMC3615747.pdf
"As a selective class I HDACi, entinostat inhibits cell proliferation and induces apoptosis in breast cancer cells.17–20 Because of its low toxicity and easy administration (taken orally), entinostat is currently in clinical trials of human cancers, including estrogen receptor-positive and triple-negative breast cancer patients (http://www.clinicaltrials.gov/ ct2/results?term=entinostat).",Non-OADS,/arxiv_data1/oa_pdf/59/98/cddis201379a.PMC3615747.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Entinostat targets erbB2/erbB3 via miRNA induction S Wang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/59/98/cddis201379a.PMC3615747.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/b8/40/mtna20137a.PMC3615817.pdf
"SupT1 cells (NIH AIDS Research and Reference  Reagent Program, http://www.aidsreagent.org/) and X-CGD  PLB-985 cells, derived from the PLB-985 myelomonocytic leukemia cell line by disrupting the gp91 phox gene by homolo- gous recombination,26 were grown in RMPI (Gibco, Invitrogen,  Merelbeke, Belgium) supplemented with 10% heat-inacti-vated fetal calf serum (Sigma-Aldrich, Bornem, Belgium) and  50 µg/ml gentamicin (Gibco).",Non-OADS,/arxiv_data1/oa_pdf/4c/66/mtna20134a.PMC3615818.pdf
49 Analysis  was carried out using R (http://www.r-project.org).,OADS,/arxiv_data1/oa_pdf/4c/66/mtna20134a.PMC3615818.pdf
Frequency of integration sites near oncogenes or within tumor suppres- sor genes was calculated using a list of genes that were col- lected to generate a comprehensive list of cancer-related genes (http://www.bushmanlab.org/links/genelists).,OADS,/arxiv_data1/oa_pdf/4c/66/mtna20134a.PMC3615818.pdf
Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)Molecular Therapy–Nucleic Acids is an open-access  journal published by Nature Publishing Group.,Non-OADS,/arxiv_data1/oa_pdf/4c/66/mtna20134a.PMC3615818.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/4c/66/mtna20134a.PMC3615818.pdf
Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)Molecular Therapy–Nucleic Acids is an open-access  journal published by Nature Publishing Group.,Non-OADS,/arxiv_data1/oa_pdf/2d/00/mtna20139a.PMC3615819.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/2d/00/mtna20139a.PMC3615819.pdf
Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)Molecular Therapy–Nucleic Acids is an open-access  journal published by Nature Publishing Group.,Non-OADS,/arxiv_data1/oa_pdf/9d/97/mtna20135a.PMC3615820.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/9d/97/mtna20135a.PMC3615820.pdf
"To view a copy of this license, visit  http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on the Molecular Therapy–Nucleic Acids website (http://www.nature.com/mtna)",Non-OADS,/arxiv_data1/oa_pdf/6d/57/mtna201310a.PMC3615821.pdf
Rattner; Email: barbara@landesbioscience.com Submitted: 04/09/12; Accepted: 04/09/12http://dx.doi.org/10.4161/trns.20354Regulation of Metabolism by p53   pp.,Non-OADS,/arxiv_data1/oa_pdf/84/73/tran-3-105.PMC3616077.pdf
"Do not distribute.www.landesbioscience.com  Transcription  115Transcription 3:3, 115-118; May/June 2012; © 2012 Landes BiosciencePOINT-OF-VIEW Keywords:  RNA polymerase,   transcription, active center, hydrolysis,  transcription factor Abbreviations:  RNAP, RNA polymerase;  TL, trigger loop; EC, elongation complexSubmitted: 02/29/12Revised: 03/02/12Accepted: 03/02/12http://dx.doi.org/10.4161/trns.19887 *Correspondence to: Nikolay Zenkin;   Email: n.zenkin@ncl.ac.ukThe active center of multi-subunit  RNA polymerase consists of two  modules, the Mg2+ module, holding the  catalytic Mg2+ ion, and a module made  of a flexible domain, the Trigger Loop.",Non-OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Genes Dev 2008; 22:1934- 47; PMID:18628399; http://dx.doi.org/10.1101/ gad.471908.,Non-OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Cell  2004; 117:299-310; PMID:15109491; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nat Struct  Mol Biol 2005; 12:1086-93; PMID:16273103;  http://dx.doi.org/10.1038/nsmb1015.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
J Mol Biol 2007; 366:1243- 57; PMID:17207814; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Cell 2010; 141:595- 605; PMID:20478253; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
PLoS Genet 2009; 5:1000345; PMID:19148274; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nucleic Acids Res  2011; PMID:22210857; http://dx.doi.org/10.1093/ nar/gkr1273.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Proc Natl Acad Sci USA  2004; 101:4373-8; PMID:15070725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
EMBO J 2010;  29:1205-14; PMID:20186121; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nature  1998; 391:231-2; PMID:9440683; http://dx.doi.org/10.1038/34542.,Non-OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Science 2006; 313:518-20; PMID:16873663; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Cell 1993; 72:459-66;  PMID:8431948; http://dx.doi.org/10.1016/0092-8674(93)90121-6.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nature  2007; 448:163-8; PMID:17581591; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Cell 2006; 127:941-54; PMID:17129781; http://dx.doi.org/10.1016/j.cell.2006.11.023.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nat Struct Mol Biol 2010; 17:99-104; PMID:19966797;  http://dx.doi.org/10.1038/nsmb.1732.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
BMC Biol  2010; 8:54; PMID:20459653; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Proc Natl Acad Sci USA 2010; 107:10878-83; PMID:20534498; http://dx.doi.org/10.1073/ pnas.0914424107.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nature 2010; 468:978-82; PMID:21124318; http://dx.doi.org/10.1038/ nature09573.,Non-OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
J Mol Biol 2006; 356:179-88; PMID:16337964; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
EMBO J 2006; 25:2131-41; PMID:16628221; http://dx.doi.org/10.1038/sj.emboj.7601094.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
Nucleic Acids Res  2011; 39:4352-9; PMID:21266474; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/50/2e/tran-3-115.PMC3616080.pdf
"1 Lab Anim Res 2013: 29(1), 1-6 http://dx.doi.org/10.5625/lar.2013.29.1.1 Serum leptin concentrations, leptin mRNA expression, and food  intake during the estrous cycle in rats Wirasak Fungfuang1,7, Tomoaki Nakada1, Nobuhiro Nakao2, Misao Terada3, Makoto Yokosuka1, Sveinbjorn Gizurarson4, Jann Hau5, Changjong Moon6, Toru R. Saito1* 1Behavioral Neuroscience Laboratory, Graduate School of Veterinary Medicine, Nippon Veterinary and Life Science  University, Tokyo, Japan 2Laboratory of Animal Physiology, Nippon Veterinary and Life Science University, Tokyo, Japan  3Department of Laboratory Animal science, Dokkyo University School of Medicine, Tochigi, Japan 4Faculty of Pharmaceutical Sciences, University of Iceland, Reykjavik, Iceland 5Department of Experimental Medicine, University of Copenhagen, Copenhagen, Denmark 6Department of Veterinary Anatomy, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea  7Department of Zoology, Faculty of Science, Kasetsart University, Bangkok, Thailand  The aim of this study was to investigate food intake, serum leptin levels, and leptin mRNA expression during the sexual cycle in rats.",OADS,/arxiv_data1/oa_pdf/f4/5c/lar-29-1.PMC3616203.pdf
"12 Lab Anim Res 2013: 29(1), 12-18 http://dx.doi.org/10.5625/lar.2013.29.1.12 Stereological study of the diabetic heart of male rats Ali Noorafshan1,2, Hajar Khazraei3, Hossein Mirkhani3, Saied Karbalay-Doust1,2* 1Histomorphometry & Stereology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran 2Anatomy Department, Shiraz University of Medical Sciences, Shiraz, Iran 3Pharmacology Department, Shiraz University of Medical Sciences, Shiraz, Iran The present study aimed to quantitatively compare the normal and diabetic hearts of rats usingstereological methods.",Non-OADS,/arxiv_data1/oa_pdf/4a/95/lar-29-12.PMC3616204.pdf
"19 Lab Anim Res 2013: 29(1), 19-26 http://dx.doi.org/10.5625/lar.2013.29.1.19 Age-associated changes in pancre atic exocrine secretion of the  isolated perfused rat pancreas Zheng-er Jiang1, ChengZhe Jiang2, Baihui Chen3, Chin Su Koh3, Jun-Hwan Yong4, Dae-Hun Park5*, Moo-Ho Won6, Yun-Lyul Lee3* 1Teaching Center of Functional Experimental Science, College of Basic Medicine, Yanbian University, Yanji, China  2Department of Veterinary Medicine, College of Agriculture, Yanbian University, Yanji, China 3Department of Physiology, and Institute of Neurodegeneration and Neuroregeneration, College of Medicine, Hallym University, Chuncheon, Korea 4Department of Occupational Therapy, Dongnam Health College, Suwon, Korea 5Department of Oriental Medicine Materials, Dongshin University, Naju, Korea 6Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, Korea Gut functions, such as gastrointestinal motility, gastric secretion and pancreatic secretion, were reduced with age.",Non-OADS,/arxiv_data1/oa_pdf/7d/21/lar-29-19.PMC3616205.pdf
"27 Lab Anim Res 2013: 29(1), 27-32 http://dx.doi.org/10.5625/lar.2013.29.1.27 Usefulness of a Helicobacter pylori  stool antigen test for diagnosing H. pylori  infected C57BL/6 mice Dae-In Moon1,2, Eun-Hye Shin2, Hong-Geun Oh2, Jin-Sik Oh3, Sunhwa Hong1, Yungho Chung4, Okjin Kim1* 1Center for Animal Resources Development, Wonkwang University, Iksan, Korea 2Huvet.",Non-OADS,/arxiv_data1/oa_pdf/ff/dc/lar-29-27.PMC3616206.pdf
"33 Lab Anim Res 2013: 29(1), 33-38 http://dx.doi.org/10.5625/lar.2013.29.1.33 A high resolution genetic mapping of the faded ( fe) gene to a region between D10mit156  and D10mit193 on mouse chromosome 10 Seung-Hun Oh1, Hajin Nam2, Jun-Gyo Suh1,2* 1Department of Medical Genetics, College of Medicine, Hallym University, Chuncheon, Korea 2Institute of Natural Medicine, Hallym University, Chuncheon, Korea The C57BL/6J- fe/fe mouse is a coat color mutant.",Non-OADS,/arxiv_data1/oa_pdf/96/f0/lar-29-33.PMC3616207.pdf
"39 Lab Anim Res 2013: 29(1), 39-47 http://dx.doi.org/10.5625/lar.2013.29.1.39 Effects of dietary high fat on prostate intraepithelial neoplasia in TRAMP mice Sung-Hoon Park1#, Seo-Na Chang1#, Min-Won Baek1, Dong-Jae Kim1, Yi-Rang Na1, Seung-Hyeok Seok1, Byoung-Hee Lee2, Kyung-Sul Kim3, Jae-Hak Park1* 1Department of Laboratory Animal Medicine, College of Veterinary Medicine, Seoul National University, Seoul, Korea 2Biological Resources Coordination Division, National Institute of Biological Resources, Incheon, Korea 3Department of Applied Bioscience, CHA University, Seoul, Korea Increased fat intake is known to be a major cause of prostate cancer.",Non-OADS,/arxiv_data1/oa_pdf/b7/78/lar-29-39.PMC3616208.pdf
"48 Lab Anim Res 2013: 29(1), 48-54 http://dx.doi.org/10.5625/lar.2013.29.1.48 4-Week repeated oral dose toxicity study of 1,4-dichlorobutane in rats Wook-Joon Yu1#, In-Chul Lee2#, Jinsoo Lee1, Sang-Min Lee2, Sung-Hwan Kim2, Hyung-Seon Baek2, Changjong Moon2, Sung-Ho Kim2, Yong-Hyun Chung3, Jong-Choon Kim2* 1Korea Institute of Toxicology, KRICT, Daejeon, Korea 2College of Veterinary Medicine, Chonnam National University, Gwangju, Korea 3Chemical Safety and Health Research Center, Occupational Safety and Health Research Institute, Daejeon, Korea The present study investigated the potential subacute toxicity of 1,4-dichlorobutane by a 4-week repeated oral dose in Sprague-Dawley rats.",Non-OADS,/arxiv_data1/oa_pdf/b3/b1/lar-29-48.PMC3616209.pdf
"55 Lab Anim Res 2013: 29(1), 55-62 http://dx.doi.org/10.5625/lar.2013.29.1.55 Establishment of a murine model for radiation-induced bone loss  using micro-computed tomography in adult C3H/HeN mice Jin-Hee Lee1#, Hae-June Lee2#, Miyoung Yang3, Changjong Moon3, Jong-Choon Kim3, Sung-Kee Jo4, Jong-Sik Jang5, Sung-Ho Kim3* 1General Toxicity Team, Korea Testing & Research Institute, Seoul, Korea 2Radiological Effect Research Department, Korea Institute of Radiological & Medical Science, Seoul, Korea 3College of Veterinary Medicine, Chonnam National University, Gwangju, Korea 4Division of Radiation Biotechnology, Advanced Radiation Technology Institute, Jeongeup, Korea 5Faculty of Animal Science & Biotechnology, Kyungpook National University, Sangju, Korea  Bone changes are common sequela of radiation therapy for cancer.",Non-OADS,/arxiv_data1/oa_pdf/b0/13/lar-29-55.PMC3616210.pdf
"7 Lab Anim Res 2013: 29(1), 7-11 http://dx.doi.org/10.5625/lar.2013.29.1.7 Specific nephrotoxicity and cardiotoxicity of BT-CAL®, Sigma Anti-bonding Molecule Calcium Carbonate, in mice Ja-Young Jang#, Jingmei Cai#, Jihyun Kim, Jangbeen Kyung, Dajeong Kim, Ehn-Kyoung Choi, Youngeun Kim, Kwang-Sei Kim, Dongsun Park, Hyun-Gu Kang, Yun-Bae Kim* College of Veterinary Medicine, Chungbuk National University, Cheongju, Korea According to a high anti-osteoporotic efficacy of Sigma Anti-bonding Molecule Calcium Carbonate (SAC), repeated-dose toxicities of SAC were investigated to assess its feasibility as drug or functional food ingredient.",OADS,/arxiv_data1/oa_pdf/8d/df/lar-29-7.PMC3616211.pdf
"com & http://www.btcal.ca] was obtained from NTS Research & Inc. (Coquitlam, BC, Canada).",OADS,/arxiv_data1/oa_pdf/8d/df/lar-29-7.PMC3616211.pdf
US FDA Center for Drug Evaluation and Research; 2001. http://www.fda.gov/downloads/Drugs/DevelopmentApproval Process/DevelopmentResources/ucm073483.pdf .,OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
US FDA Center for Drug Evaluation and Research; 1999. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
2007. http://frwebgate.access.gpo.gov/cgi-bin/get doc.cgi?dbname=110_cong_public_laws&docid=f:publ085.110.,OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
2002. http://www.fda.gov/Drugs/Develop mentApprovalProcess/DevelopmentResources/ucm049876.htm .,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
1997. http://www.fda.gov/Regulatory Information/Legislation/FederalFoodDrugandCosmeticActFDC Act/SigniﬁcantAmendmentstotheFDCAct/FDAMA/FullTextofFDAMAlaw/default.htm .,OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
US FDA Center for Drug Evaluation and Research; 2007. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ucm 121776.pdf .,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
US FDA Center for Drug Evaluation and Research; 2006. http://www.fda.gov/ downloads/Drugs/DevelopmentApprovalProcess/Development Resources/ucm121774.pdf .,OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
US FDA Center for Drug Evaluation and Research; 2005. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
US FDA Center for Drug Evaluation and Research; 2005. http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/ce/3c/40272_2013_Article_12.PMC3616221.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:195-201 http://dx.doi.org/10.4174/jkss.2013.84.4.195 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received November 12, 2012, Revised January 22, 2013, Accepted February 12, 2013 Correspondence to: Euy Young Soh  Department of Surgery, Ajou University School of Medi cine, 206 Worldcup-ro, Yeongtong-gu, Suwon 443-721, Korea Tel: ＋82-31-219-5200, Fax: ＋82-31-219-5755, E-mail: sohey@ajou.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/dd/56/jkss-84-195.PMC3616272.pdf
Avail- able from: http://www.cancer.go.kr/mbs/cancer/jsp/album/  gallery.jsp?spage=1&boardId=31817&boardSeq=179615&,Non-OADS,/arxiv_data1/oa_pdf/dd/56/jkss-84-195.PMC3616272.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:202-208 http://dx.doi.org/10.4174/jkss.2013.84.4.202 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received November 6, 2012, Revised January 23, 2013, Accepted January 31, 2013 Correspondence to: Dongho Choi Department of Surgery, Soonchunhyang University Seoul Hospital , Soonchunhyang University College of Medicine, 59 Daesagwan-ro,  Yongsan-gu, Seoul 140-743, KoreaTel: ＋82-2-709-9479, Fax: ＋82-2-795-1687, E-mail: dhchoi@schmc.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/33/e0/jkss-84-202.PMC3616273.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:209-215 http://dx.doi.org/10.4174/jkss.2013.84.4.209 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 2, 2012, Revised January 8, 2013, Accepted February 20, 2013 Correspondence to: Sun-Whe Kim Department of Surgery, Cancer Research In stitute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seou l  110-744, KoreaTel: ＋82-2-2072-2315, Fax: ＋82-2-745-2282, E-mail: sunkim@plaza.snu.ac.kr Co-correspondence to: Jin-Young Jang Department of Surgery, Cancer Research In stitute, Seoul National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seou l  110-744, KoreaTel: ＋82-2-2072-2194, Fax: ＋82-2-766-3975, E-mail: jangjy4@snu.ac.kr *These authors contributed equally to this study.cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/7a/62/jkss-84-209.PMC3616274.pdf
Available from: http://www.nccn.org/profes-sionals/physician_gls/pdf/ovarian.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7a/62/jkss-84-209.PMC3616274.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:216-224 http://dx.doi.org/10.4174/jkss.2013.84.4.216 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received September 26, 2012, Revised January 30, 2013, Accepted February 12, 2013 Correspondence to: Jin Ho Lee Department of Advanced Materials, Hannam Universi ty, 70 Hannam-ro, Daedeok-gu, Daejeon 306-791, Korea Tel: ＋82-42-629-8859, Fax: ＋82-42-626-8854, E-mail: jhlee@hnu.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/04/73/jkss-84-216.PMC3616275.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:225-230 http://dx.doi.org/10.4174/jkss.2013.84.4.225 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received December 6, 2012, Revised February 11, 2013, Accepted February 12, 2013 Correspondence to: Moo-Kyung Seong Department of Surgery, Konkuk University Medical Center, 120 Neungdong-ro, Gwangjin-gu, Seoul 143-729, KoreaTel: ＋82-2-2030-7582, Fax: ＋82-2-2030-7746, E-mail: recto@kuh.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/1b/98/jkss-84-225.PMC3616276.pdf
Available from: http://www.romecriteria.org/criteria.,Non-OADS,/arxiv_data1/oa_pdf/1b/98/jkss-84-225.PMC3616276.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:231-237 http://dx.doi.org/10.4174/jkss.2013.84.4.231 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 22, 2012, Revised February 6, 2013, Accepted February 12, 2013 Correspondence to: Yong-Geul Joh Department of Surgery, Pusan National University Yangsan Hospital, 20 Geumo-ro, Yangsan 626-787, Korea Tel: ＋82-55-360-2124, Fax: ＋82-55-360-2154, E-mail: brosisjoh@naver.com The poster presentation at the Annual meeting of the American So ciety of Colon and Rectual Surgeo ns (ASCRS), San Antonio, Texas ,  June  2-6, 2012. cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/7b/85/jkss-84-231.PMC3616277.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:238-244 http://dx.doi.org/10.4174/jkss.2013.84.4.238 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received October 17, 2012, Revised January 9, 2013, Accepted February 12, 2013 Correspondence to: Seung Huh Division of Transplantation and Vascular Surgery, Department of Surgery, Kyungpook National University School of Medicine, 130 Dongdeok-ro, Jung-gu, Daegu 700-721, KoreaTel: ＋82-53-420-6520, Fax: ＋82-53-421-0510, E-mail: shuh@knu.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/fe/65/jkss-84-238.PMC3616278.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:245-251 http://dx.doi.org/10.4174/jkss.2013.84.4.245 ORIGINAL ARTICLEJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received September 25, 2012, Revised December 26, 2012, Accepted January 13, 2013 Correspondence to: Seong Hoon Kim Center for Liver Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 410-769, KoreaTel: ＋82-31-920-1647, Fax: ＋82-31-920-1138, E-mail: kshlj@hanmail.net Co-correspondence to: In Sung Moon Department of Surgery, Seoul St. Mary’s Hospital, The Catholic  University of Korea College of Medicine, 222 Banpo-daero, Seocho -gu, Seoul 137-701, KoreaTel: ＋82-2-2258-6098, Fax: ＋82-2-595-2992, E-mail: ismoon@catholic.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/94/a3/jkss-84-245.PMC3616279.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:252-255 http://dx.doi.org/10.4174/jkss.2013.84.4.252 CASE REPORTJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received June 25, 2012, Revised December 7, 2012, Accepted December 14, 2012 Correspondence to: Ye Seob Jee Department of Surgery, Dankook University Hospital, Dankook University College of Medicine, 201 Manghyang-ro, Dongnam-gu, Cheonan 330-180, KoreaTel: ＋82-41-550-3873, Fax: ＋82-41-550-3928, E-mail: ysjee@dkuh.co.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/48/a8/jkss-84-252.PMC3616280.pdf
"Copyright © 2013, the Korean Surgical SocietyJ Korean Surg Soc 2013;84:256-260 http://dx.doi.org/10.4174/jkss.2013.84.4.256 CASE REPORTJKSSJKSSJKSS Journal of the Korean Surgical Society  pISSN 2233-7903 ㆍeISSN 2093-0488 Received April 30, 2012, Revised February 12, 2013, Accepted February 12, 2013 Correspondence to: Kyung Jong Kim Department of Surgery, Chosun University School of Me dicine, 309 Pilmun-daero, Dong-gu, Gwangju 501-759, Korea Tel: ＋82-62-220-3068, Fax: ＋82-62-228-3441, E-mail: kjkim@chosun.ac.kr cc Journal of the Korean Surgical Society is an Open Access Jo urnal.",Non-OADS,/arxiv_data1/oa_pdf/0c/e7/jkss-84-256.PMC3616281.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/a8/46/emboj201344a.PMC3616289.pdf
To view acopy of this licence visit http://creativecommons.org/licenses/by-nc-nd/3.0/.GW182 proteins release PABP from miRNA targets L Zekri et al 1065 &2013 European Molecular Biology Organization The EMBO Journal VOL 32 |NO 7 |2013,Non-OADS,/arxiv_data1/oa_pdf/a8/46/emboj201344a.PMC3616289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0",Non-OADS,/arxiv_data1/oa_pdf/d7/9a/cr20132a.PMC3616429.pdf
Available from: http://guidance.nice.org.uk/CG17/NICEGuidance/ pdf/English.,Non-OADS,/arxiv_data1/oa_pdf/c4/bb/ctg20133a.PMC3616453.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc- nd/3.0/Test-and-Treat for Dyspepsia Gisbert and Calvet 17 Clinical and Translational Gastroenterology",Non-OADS,/arxiv_data1/oa_pdf/c4/bb/ctg20133a.PMC3616453.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/e7/72/mt201314a.PMC3616527.pdf
"Early diagnosis of lung cancer David E. Midthun Address: Department of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 1 st Street SW, Rochester, Minnesota, USA, 55905 Email: midthun.david@mayo.edu F1000Prime Reports 2013, 5:12 (doi:10.12703/P5-12) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/12 Abstract A large randomized controlled trial, The National Lung Screening Study (NLST), has demonstrated that screening with low-dose spiral computed tomography saved lives from lung cancer when compared with screening with chest radiographs.",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"Page 2 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"of cancers detectedSurgical stage I Deaths from lung cancerMortality reduction DANTE [22] CT: 1276 27.5% 58 (4.5%) 71% 11 NR No screen: 1196 nr 25 (2.1%) 52% 10 Depiscan [21] CT: 336 45.2% 8 (2.4%) 37.5% nr NR CXR: 285 7.4% 1 (0.4%) 100% nr DLSCT [23] CT: 2052 27.3% 69 (3.4%) 68% 15 None No screen: 2052 nr 24 (1.2%) 21 11 ITALUNG [20] CT: 1406 30%* 21 (1.5%) 47.6% nr NR No screen: 1593 nr nr nr nr NELSON [19] CT: 7557 50.5% 70 (0.9%) 63.9% nr NR No screen: nr nr nr nr nr NLST [16] CT: 26722 27.3** 1060 50% 356 20.0% CXR: 26732 9.2 941 30.7% 443 NR: not reported * reported as positive if a nodule ≥5 mm was detected ** reported as positive if a nodule ≥4 mm was detected Page 3 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"Page 4 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"Page 5 of 7 (page number not for citation purposes) F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"Saghir Z, Dirksen A, Ashraf H, Bach KS, Brodersen J, Clementsen PF, Døssing M, Hansen H, Kofoed KF, Larsen KR, Mortensen J, Rasmussen JF, Seersholm N, Skov BG, Thorsen H, Tønnesen P, Page 6 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
36. http://www.lung.org/lung-disease/lung-cancer/lung-cancer-screening- guidelines/ 37.,Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"Page 7 of 7 (page number not for citation purposes)F1000Prime Reports 2013, 5:12 http://f1000.com/prime/reports/m/5/12",Non-OADS,/arxiv_data1/oa_pdf/04/a0/medrep-05-12.PMC3616602.pdf
"This is an open access article, published  under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/2.5).",Non-OADS,/arxiv_data1/oa_pdf/78/24/JVR-04-001.PMC3616638.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/06/bgs400.PMC3616669.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/e4/gkt066.PMC3616695.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/da/gkt058.PMC3616696.pdf
miRNA target prediction The potential targets of miR-10a* in the CVB3 genome were predicted by RNAHybrid 2.2 (http://bibiserv.techfak.uni-bielefeld.de/rnahybrid) and Miranda 3.2a(http://www.microrna.org/microrna) according to thecomplementary sequence and minimum free energy(mfe) (39).,OADS,/arxiv_data1/oa_pdf/cf/da/gkt058.PMC3616696.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/52/4c/gkt072.PMC3616697.pdf
The sequences of tRNA and rRNA were obtained from Ensembl Genes 59 (http://biomart.org/) (37).,OADS,/arxiv_data1/oa_pdf/52/4c/gkt072.PMC3616697.pdf
Six hundred seventy-two known mouse pre-miRNA sequences were downloaded from miRBase v16.0 (http://www.mirbase.,Non-OADS,/arxiv_data1/oa_pdf/52/4c/gkt072.PMC3616697.pdf
AVAILABILITY Illumina sequencing data have been submitted to the Short Read Archive at NCBI (http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi?),OADS,/arxiv_data1/oa_pdf/52/4c/gkt072.PMC3616697.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/6a/gkt006.PMC3616698.pdf
"CPAT needs only the sequenceor coordinate ﬁle as input, and it is straightforward to use.We expanded the availability of CPAT to a larger scien-tiﬁc audience via a web interface, which allows users tosubmit sequences and receive the prediction results backalmost instantaneously (http://lilab.research.bcm.edu/cpat/index.php).",OADS,/arxiv_data1/oa_pdf/be/6a/gkt006.PMC3616698.pdf
AVAILABILITY AND IMPLEMENTATION Source code was implemented in C and Python and is freely available at: http://code.google.com/p/cpat/.,OADS,/arxiv_data1/oa_pdf/be/6a/gkt006.PMC3616698.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
Data were downloaded from the webpage http://bit.ly/12oO1NL that redirects to the respective archives.,OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
oCNEs search in Oikopleura and amphioxus Oikopleura genome assembly version 3 was downloaded at JGI from http://bit.ly/VPjaD7 with relative annotations from http://bit.ly/TYKrTY and proteome from http:// bit.ly/V5Q8yC.,OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
Amphioxus genome version 2 was down- loaded at JGI from http://bit.ly/12oNxXJ with relative annotations from http://bit.ly/UcbKOg and proteome from http://bit.ly/ZievBL.,OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
Amphioxus gene pair analysis We used the proteomes of mouse and sea squirt from Ensembl 49 and the amphioxus proteome version 1 down-loaded at JGI from http://bit.ly/ZievBL.,OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
"To analyze the overlap of oCNEs with validated UCEs, we downloaded all theelements found in the enhancer browser database (48), together with the functional validation results on 14 November 2012 from http://enhancer.lbl.gov/.",OADS,/arxiv_data1/oa_pdf/fd/c3/gkt030.PMC3616699.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/15/gkt059.PMC3616700.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/e1/gkt068.PMC3616702.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ca/04/gks1473.PMC3616703.pdf
"To promote the use of our approach, we produced a software application that implements the optimizationprocess, which is available at http://bioinformatics.ua.pt/software/mRNA-optimiser SUPPLEMENTARY DATA Supplementary Data are available at NAR Online: Supplementary Material.FUNDING The European FP7 projects GEN2PHEN and Mephitis; FCT/FEDER project [PTDC/BiA-GEN/110383/2009]; Fundac ¸a˜o para a Cie ˆncia e Tecnologia (FCT) [SFRH/ BD/71063/2010 to P.G.].",Non-OADS,/arxiv_data1/oa_pdf/ca/04/gks1473.PMC3616703.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/60/8b/gkt041.PMC3616704.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/02/0d/gkt010.PMC3616705.pdf
"Figures were generated with CueMol (http://www.cuemol.org/) and PyMOL (Delano Scientiﬁc).Nucleic Acids Research, 2013, Vol.",OADS,/arxiv_data1/oa_pdf/02/0d/gkt010.PMC3616705.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/60/gks1467.PMC3616706.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/db/77/gkt070.PMC3616707.pdf
"To conduct this kind of analysis, we made use of the STRING database (SearchTool for the Retrieval of Interacting Genes/Proteins 8.3; http://string-db.org/) (25).",OADS,/arxiv_data1/oa_pdf/db/77/gkt070.PMC3616707.pdf
The network was generated with the STRING tool (http://string.embl.de/).,OADS,/arxiv_data1/oa_pdf/db/77/gkt070.PMC3616707.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d3/95/gkt065.PMC3616708.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/15/gkt009.PMC3616709.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/56/gkt047.PMC3616710.pdf
"MATERIALS AND METHODS Data generation In total,>20 000 human pseudogenes and their cognate genes were obtained from the Ensembl database (Ensembl63, GRCH37) using BioMart (http://www.ensembl.org/ index.html).",OADS,/arxiv_data1/oa_pdf/66/56/gkt047.PMC3616710.pdf
Genomic sequences were collected from UCSC hg19 (http://hgdownload.cse.ucsc.edu/downloads.html).,OADS,/arxiv_data1/oa_pdf/66/56/gkt047.PMC3616710.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/e5/gkt089.PMC3616711.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/83/gkt073.PMC3616712.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/8e/gkt055.PMC3616713.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fb/1b/gkt050.PMC3616714.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/46/1b/gkt079.PMC3616715.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/42/gkt060.PMC3616716.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/gkt056.PMC3616717.pdf
Concentration of the protein was determined spectrophotometrically using e280= 58745 M/C01cm/C01 calculated with EXPASY tools (http://ca.expasy.org/ tools/).,OADS,/arxiv_data1/oa_pdf/9c/a1/gkt056.PMC3616717.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/35/gks1460.PMC3616718.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7f/ab/gkt044.PMC3616719.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/2b/gkt071.PMC3616721.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/e4/gkt067.PMC3616722.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/04/gkt064.PMC3616723.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/13/5c/gkt040.PMC3616724.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5f/ed/gkt061.PMC3616725.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/3f/gks1466.PMC3616726.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/32/53/gkt036.PMC3616727.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/ca/gkt063.PMC3616728.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/a9/gkt078.PMC3616729.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/7d/gkt038.PMC3616730.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/ab/gks1455.PMC3616731.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/01/f3/gkt062.PMC3616732.pdf
"Sequencing reads were mapped to the S. cerevisiae genome (version sacCer1), the snRNAs and pre-mRNAs (19,20) using cross_match (http://www.phrap.org/phredphra pconsed.html).",OADS,/arxiv_data1/oa_pdf/01/f3/gkt062.PMC3616732.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0d/98/gks1463.PMC3616733.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a1/5d/gks1443.PMC3616734.pdf
"Brieﬂy, sequencing reads were aligned to the human genome reference GRCh37 (hg19) using bwa (17), quality scores recalibrated using the Genome Analysis Toolkit (11) and sequencing metrics calculated using the Picard suite of tools (http://picard.sourceforge.",OADS,/arxiv_data1/oa_pdf/a1/5d/gks1443.PMC3616734.pdf
"These and other analysis tools are described on our website, http://www.broadinstitute.org/cancer/cga.e67 Nucleic Acids Research, 2013, Vol.",Non-OADS,/arxiv_data1/oa_pdf/a1/5d/gks1443.PMC3616734.pdf
"As a user-friendly web-server, iRSpot-PseDNC is freely accessible at http://lin.uestc.edu.cn/server/iRSpot-PseDNC.",OADS,/arxiv_data1/oa_pdf/bc/42/gks1450.PMC3616736.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/42/gks1450.PMC3616736.pdf
"Because of its wide and increasing usage, in 2012, a powerful software called PseAAC-Builder (http://www.pseb.sf.net) (24) was estab-lished for generating various special modes of PseAAC, inaddition to the earlier web-server PseAAC (http://www.csbio.sjtu.edu.cn/bioinf/PseAAC) (25) built in 2008.",OADS,/arxiv_data1/oa_pdf/bc/42/gks1450.PMC3616736.pdf
"Step 1 Open the web server at http://lin.uestc.edu.cn/server/ iRSpot-PseDNC and you will see the top page ofiRSpot-PseDNC on your computer screen, as shown inFigure 3.",Non-OADS,/arxiv_data1/oa_pdf/bc/42/gks1450.PMC3616736.pdf
Its website address is at http://lin.uestc.edu.cn/ server/iRSpot-PseDNC.,Non-OADS,/arxiv_data1/oa_pdf/bc/42/gks1450.PMC3616736.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9e/49/gkt053.PMC3616737.pdf
"Anomalous difference maps forselenomethionine data set were calculated both in CNS1.3 and in Phenix giving essentially the same results.Structural analyses, including superpositions and second-ary structure assignments, were performed in Pymol(http://www.pymol.org).",OADS,/arxiv_data1/oa_pdf/9e/49/gkt053.PMC3616737.pdf
261572; http://www.wenmr.eu to D.I.S.,Non-OADS,/arxiv_data1/oa_pdf/9e/49/gkt053.PMC3616737.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/94/gkt049.PMC3616738.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/b8/gkt074.PMC3616739.pdf
"In parallel with these studies, we learned of unpublished coordinates 4FU6 deposited in the PDB by the StructuralGenomics consortium (http://www.thesgc.org/).",OADS,/arxiv_data1/oa_pdf/e3/b8/gkt074.PMC3616739.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/14/gks1352.PMC3616740.pdf
Principal component analysis (PCA) was performed using R. Data visualization Circosplots of log2 intensity ratios and DNA-copy number calls were drawn using circos ‘http://circos.ca/’(47).,OADS,/arxiv_data1/oa_pdf/c9/14/gks1352.PMC3616740.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/b1/gkt046.PMC3616741.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/64/6d/gkt076.PMC3616742.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/90/70/gkt034.PMC3616743.pdf
MEME-ChIP tool from MEME suite [http://meme.sdsc.,OADS,/arxiv_data1/oa_pdf/90/70/gkt034.PMC3616743.pdf
"Gene ontology analysis Gene ontology (GO)-enrichment analysis was performed using the Database for Annotation, Visualization andIntegrated Discovery [DAVID, http://david.abcc.ncifcrf.gov/,(29)] for the model-speciﬁc and knockdown-validatedLXR atarget genes with a binding site.",OADS,/arxiv_data1/oa_pdf/90/70/gkt034.PMC3616743.pdf
"Networks were visualized using Cytoscape (36).Differentiation between already known and new LXR a target genes and interactors were done with BIOGRID,NEXTBIO, Nuclear Receptor Resource [(37,38); http://nrresource.org] databases and most recent publicationson LXR a(19,39).3520 Nucleic Acids Research, 2013, Vol.",OADS,/arxiv_data1/oa_pdf/90/70/gkt034.PMC3616743.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/7b/gfs493.PMC3616759.pdf
104http://dx.doi.org/10.4046/trd.2013.74.3.104   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:104-110 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/c6/a9/trd-74-104.PMC3617129.pdf
"13, 2013 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Tuberculosis (TB) is still a global epidemic that needs  to be controlled.",Non-OADS,/arxiv_data1/oa_pdf/c6/a9/trd-74-104.PMC3617129.pdf
Available from: http://kostat.go.,Non-OADS,/arxiv_data1/oa_pdf/c6/a9/trd-74-104.PMC3617129.pdf
111http://dx.doi.org/10.4046/trd.2013.74.3.111   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:111-119 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/b2/c2/trd-74-111.PMC3617130.pdf
"Department of Internal Medicine, Soonchunhyang University  Cheonan Hospital, Soonchunhyang University College of Medicine, 31 Suncheonhyang 6-gil, Dongnam-gu, Cheonan  330-930, Korea Phone: 82-41-570-3666, Fax: 82-41-574-5762 E-mail: juokna@schmc.ac.kr  Received: Nov. 14, 2012 Revised: Nov. 27, 2012Accepted: Feb. 15, 2013 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Bronchial artery embolization (BAE) has been estab- lished as an effective and useful means to achieve treat- ment of chronic and recurrent hemoptysis, as well as immediate control of massive hemoptysis and to man- age inoperable patients who had poor pulmonary func-tion or chronic pulmonary diseases 1-3.",Non-OADS,/arxiv_data1/oa_pdf/b2/c2/trd-74-111.PMC3617130.pdf
120http://dx.doi.org/10.4046/trd.2013.74.3.120   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:120-123 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/84/27/trd-74-120.PMC3617131.pdf
"19, 2012Accepted: Aug. 15, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Methane is a component of natural gas, mainly used  as a fuel source and chemical feedstock in industries.",Non-OADS,/arxiv_data1/oa_pdf/84/27/trd-74-120.PMC3617131.pdf
124http://dx.doi.org/10.4046/trd.2013.74.3.124   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:124-128 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/ed/f7/trd-74-124.PMC3617132.pdf
"30, 2012Accepted: Aug. 15, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Pulmonary disease is one of the most common mani- festations of non-tuberculous mycobacteria (NTM) in-fections, and  Mycobacterium intracellulare  is the most  common causative organism1-9.",Non-OADS,/arxiv_data1/oa_pdf/ed/f7/trd-74-124.PMC3617132.pdf
129http://dx.doi.org/10.4046/trd.2013.74.3.129   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:129-133 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/fc/f6/trd-74-129.PMC3617133.pdf
"29, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Epidermal growth factor receptor-tyrosine kinase in- h i b i t o r  ( E G F R - T K I )  h a s  i m p r o v e d  t h e  o u t c o m e  o f  a d -vanced non-small cell lung cancer (NSCLC).",Non-OADS,/arxiv_data1/oa_pdf/fc/f6/trd-74-129.PMC3617133.pdf
134http://dx.doi.org/10.4046/trd.2013.74.3.134   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:134-139 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/2c/97/trd-74-134.PMC3617134.pdf
"25, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Splenosis is a rare condition that results from auto- transplantation of splenic tissue into abnormal sites,  such as the peritoneal cavity, thoracic cavity, subcuta-neous tissue, and pericardium.",Non-OADS,/arxiv_data1/oa_pdf/2c/97/trd-74-134.PMC3617134.pdf
97http://dx.doi.org/10.4046/trd.2013.74.3.97   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:97-103 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/54/53/trd-74-97.PMC3617135.pdf
"Department of Internal Medicine, Inje University Ilsan Paik  Hospital, Inje University College of Medicine, 170 Juhwa-ro,  Ilsanseo-gu, Goyang 411-706, Korea Phone: 82-31-910-7013, Fax: 82-31-910-7518E-mail: gusrud9@paik.ac.kr Received: Dec. 26, 2012 Revised: Jan. 4, 2013Accepted: Jan. 9, 2013 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   A lung cyst is an air-filled lucent area with sharply  demarcated thin walls ( ＜3  m m ), a  w e ll-circu m scrib e d  round structure surrounded by lung parenchyma1.",Non-OADS,/arxiv_data1/oa_pdf/54/53/trd-74-97.PMC3617135.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Reduced Radiation Dose in Diagnostic Radiology Dong Wook Sung and Kyung Eun Shin Department of Diagnostic Radiology, Kyung Hee University Hospital, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2013.28.4.495 • J Korean Med Sci 2013; 28: 495-496EDITORIAL Medical Imaging Within the past 20 years, the radiographic examination in the  medical field has increased by a factor of about 3 to 5 times, while the total radiation dose has increased by a factor of about 200-400.",Non-OADS,/arxiv_data1/oa_pdf/b1/cb/jkms-28-495.PMC3617299.pdf
• Reduced Radiation Dose in Diagnostic Radiology 496  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.495created in 2013.,Non-OADS,/arxiv_data1/oa_pdf/b1/cb/jkms-28-495.PMC3617299.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Value of Ultrasound in Rheumatologic Diseases The use of musculoskeletal ultrasound in rheumatology clinical practice has rapidly increased over the past decade.",Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
"Key Words:  Rheumatology Ultrasound; Musculoskeletal Ultrasound; Doppler; ArthritisTaeyoung Kang,1,2 Laura Horton,2  Paul Emery,2 and Richard J. Wakefield2 1Department of Rheumatology, Yonsei Univeristy  Wonju College of Medicine, Wonju, Korea;   2Division of Rheumatic and Musculoskeletal Disease  and NIHR Leeds Musculoskeletal Biomedical  Research Unit (LMBRU), University of Leeds, Leeds,  UK Received: 30 May 2012 Accepted: 25 January 2013 Address for Correspondence: Dr. Richard J. Wakefield  Division of Rheumatic and Musculoskeletal Disease and NIHR Leeds Musculoskeletal Biomedical Research Unit (LMBRU), Chapel Allerton Hospital, Leeds LS7 4SA, United Kingdom Tel: +44.1 13-392-4916, Fax: +44.1 13-392-4991 E-mail: R.J.Wakefield@leeds.ac.ukhttp://dx.doi.org/10.3346/jkms.2013.28.4.497 • J Korean Med Sci 2013; 28: 497-507REVIEW Immunology, Allergic Disorders & Rheumatology INTRODUCTION The use of musculoskeletal ultrasound in rheumatology has in - creased dramatically over the past decade both as a result of  technological developments and a desire to identify and treat inflammation early.",Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology 498  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.497with a resultant 2-D image reproduced on an oscilloscope.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology http://jkms.org   499  http://dx.doi.org/10.3346/jkms.2013.28.4.497internal Doppler signals and a thickened surrounding tendon  sheath which may exhibit Doppler (Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology 500  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.497rheumatoid arhtritis using MRI as the gold standard (29).,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
"• Ultrasound in Rheumatology http://jkms.org   501  http://dx.doi.org/10.3346/jkms.2013.28.4.497osteoarthritis patients, suggesting ultrasound as a useful non- invasive method to study articular cartilage (42).",Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology 502  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.497fasciitis.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
"• Ultrasound in Rheumatology http://jkms.org   503  http://dx.doi.org/10.3346/jkms.2013.28.4.497in rheumatology has expanded to Wegener’s granulomatosis  (74), finger arteritis in systemic sclerosis (75) and Raynaud’s phenomenon (76), in which ultrasound showed superiority to visualize the narrowed lumen with thicken arterial wall.",Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
"• Ultrasound in Rheumatology 504  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.497in sagittal, coronal and axial planes and relatively operator in - dependent compared to two dimensional (2D) ultrasound im - aging.",Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology http://jkms.org   505  http://dx.doi.org/10.3346/jkms.2013.28.4.497thritis: synovitis and tenosynovitis.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology 506  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.49743: 2762-70.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
• Ultrasound in Rheumatology http://jkms.org   507  http://dx.doi.org/10.3346/jkms.2013.28.4.49769.,Non-OADS,/arxiv_data1/oa_pdf/8c/56/jkms-28-497.PMC3617300.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Association of the Length of Doctor-Patient Relationship with Primary Care Quality in Seven Family Practices in Korea Countries with historically unlimited patient choice of medical provider, such as Korea, have been promoting rational health care pathways.",Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
"Key Words:  Primary Health Care; Quality Assurance; Health Care Policy; KoreaJae-Ho Lee,1 Yong-Jun Choi,2  Seung Hwa Lee,3 Nak-Jin Sung,4  Soo-Young Kim,5 and Jee Young Hong6 1Department of Family Medicine, The Catholic  University of Korea College of Medicine, Seoul;  2Department of Social and Preventive Medicine,  Hallym University College of Medicine, Chuncheon;  3Department of Family Medicine, Ajou University  College of Medicine, Suwon; 4Department of Family  Medicine, Ilsan Hospital, Dongguk University,  Goyang; 5Department of Family Medicine, Hallym  University College of Medicine, Kangdong Sacred Heart Hospital, Seoul;  6Department of Preventive  Medicine, Konyang University College of Medicine, Daejeon, Korea Received: 29 September 2012 Accepted: 6 February 2013 Address for Correspondence: Jae-Ho Lee, MD  Department of Family Medicine, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu,   Seoul 137-701, Korea  Tel: +82.2-2258-6288, Fax: +82.2-2258-2907  E-mail: jaeholee@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.508 • J Korean Med Sci 2013; 28: 508-515ORIGINAL ARTICLE Medicine General & Social Medicine INTRODUCTION Evidence of the value of primary care in health systems contin - ues to accumulate.",Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
• Length of Doctor-Patient Relationship in Primary Care http://jkms.org   509  http://dx.doi.org/10.3346/jkms.2013.28.4.508efits of this knowledge can be expected to accrue in a variety of  ways.,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
"• Length of Doctor-Patient Relationship in Primary Care 510  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.508ranged from 0.69 to 0.78, except within the first contact domain  which consists of five independent subscales (first contact-uti - lization, facility accessibility, cost appropriateness, demograph - ic accessibility, and basic health care) (22).",Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
"• Length of Doctor-Patient Relationship in Primary Care http://jkms.org   51 1  http://dx.doi.org/10.3346/jkms.2013.28.4.508income (1,500-2,900 USD equivalent per month) group tended  to have shorter term ( < 2 yr) relationship with their family phy - sicians ( P= 0.007).",Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
• Length of Doctor-Patient Relationship in Primary Care 512  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.508primary care physician’s commitment to people.,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
• Length of Doctor-Patient Relationship in Primary Care http://jkms.org   513  http://dx.doi.org/10.3346/jkms.2013.28.4.508from informational to longitudinal to interpersonal (31).,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
• Length of Doctor-Patient Relationship in Primary Care 514  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.508among the 5 primary care attribute domains of the K-PCAT.,OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Available at http://www.euro.who.int/__data/assets/pdf_file/0019/101476/E93762.pdf [accessed on 28 February 2013].,OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Available at: http://dx.doi.org/10.1787/health_glance-2011-en [accessed on 10 March 2012].,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Available at: http://www.bokjiro.go.kr/data/sta - tusView.do?board_sid=297&data_sid=5802964 [accessed on 28 Febru - ary 2013].,OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Available at http://www.ahrq.gov/qual/careatlas/careatlas.pdf [accessed on 8 March 2012].,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Available at http://search.oecd.org/official - documents/displaydocumentpdf/?cote=DELSA/HEA/WD/HWP(2010) 1&docLanguage=En [accessed on 28 February 2013].,OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
• Length of Doctor-Patient Relationship in Primary Care http://jkms.org   515  http://dx.doi.org/10.3346/jkms.2013.28.4.50832.,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
Avail - able at http://hawelsis.kihasa.re.kr/websquare.html?w2xPath=/web/stats/HSIW001_01NP.xml&stast_id=H0101-109-2012-0000105&clss_cd=H0101&up_clss_cd=H0100 [accessed on 28 February 2013].,Non-OADS,/arxiv_data1/oa_pdf/83/ce/jkms-28-508.PMC3617301.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Association between Prenatal Exposure to Cadmium and Atopic Dermatitis in Infancy Our objective was to evaluate the relationship between intrauterine exposure to cadmium and the presence of atopic dermatitis in infants 6 months of age, adjusted for covariates including exposure to other heavy metals.",Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
"Key Words:  Atopy; Cadmium; Lead; Cord; Dermatitis, Atopic Ja Hyeong Kim,1 Kyoung Sook Jeong,2  Eun-Hee Ha,3,4 Hyesook Park,3,4  Mina Ha,5 Yun-Chul Hong,6  Soo-Jeong Lee,7 Kyung Yeon Lee,1  Joseph Jeong,8 and Yangho Kim9 1Department of Pediatrics, University of Ulsan  College of Medicine, Ulsan University Hospital,  Ulsan; 2Department of Occupational and  Environmental Medicine, Dongguk University-Seoul,  Graduate School of Medicine, Dongguk University  Ilsan Hospital, Goyang; 3Department of Preventive  Medicine, School of Medicine, Ewha Womans  University, Seoul; 4Medical Research Institute, Ewha  Global Challenge Center, Ewha Womans University, Seoul;  5Department of Preventive Medicine,  Dankook University College of Medicine, Cheonan;  6Department of Preventive Medicine, Seoul National  University College of Medicine, Seoul; Departments of  7Obstetrics and Gynecology, 8Laboratory  Medicine, and 9Occupational and Environmental  Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, Ulsan, Korea Received: 27 July 2012 Accepted: 21 January 2013 Address for Correspondence: Yangho Kim, MD Department of Occupational and Environmental Medicine, University of Ulsan College of Medicine, Ulsan University Hospital, 877 Bangeojinsunhwan-doro, Dong-gu, Ulsan   682-714, KoreaTel: +82.10-2294-5973, Fax: +82.52-250-7289 E-mail: yanghokm@nuri.net This work was supported by a Mothers’ and Children’s  Environmental Health (MOCEH) study funded by the Ministry of the Environment, Republic of Korea (2006-2009).http://dx.doi.org/10.3346/jkms.2013.28.4.516 • J Korean Med Sci 2013; 28: 516-521ORIGINAL ARTICLE Occupation & Environmental Medicine INTRODUCTION The prevalence of atopic dermatitis among children, especially  infants, is rising in Korea (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
• Prenatal Exposure to Cadmium and Atopic Disease in Infancy http://jkms.org   517  http://dx.doi.org/10.3346/jkms.2013.28.4.516lead and development of atopic disease in infancy have ap - peared (17).,Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
• Prenatal Exposure to Cadmium and Atopic Disease in Infancy 518  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.516and Ulsan University Hospital (Ulsan) (approval No.,Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
• Prenatal Exposure to Cadmium and Atopic Disease in Infancy http://jkms.org   519  http://dx.doi.org/10.3346/jkms.2013.28.4.516in the present study.,Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
"• Prenatal Exposure to Cadmium and Atopic Disease in Infancy 520  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.516 Earlier data suggested that lead exposure may alter compo - nents of the immune system known to be involved in the devel - opment of atopic dermatitis and asthma (14, 15).",Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
• Prenatal Exposure to Cadmium and Atopic Disease in Infancy http://jkms.org   521  http://dx.doi.org/10.3346/jkms.2013.28.4.51616.,Non-OADS,/arxiv_data1/oa_pdf/d7/d0/jkms-28-516.PMC3617302.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Association between MSX1  SNPs and Nonsyndromic Cleft Lip  with or without Cleft Palate in the Korean Population The purpose of this study was to investigate the contribution of MSX1  gene to the risk of  nonsyndromic cleft lip with or without cleft palate (NS-CL ±P) in the Korean population.",Non-OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
"This research was supported by the Basic Science Research  Program, the National Research Foundation of Korea (NRF 2009-0069859) funded by the Ministry of Education, Science and Technology, Republic of Korea.http://dx.doi.org/10.3346/jkms.2013.28.4.522 • J Korean Med Sci 2013; 28: 522-526ORIGINAL ARTICLE Human Genetics & Genomics INTRODUCTION Nonsyndromic cleft lip and/or palate (NS-CL/P) is a common  congenital craniofacial deformity in humans and is known to be caused by a combination of genes and environmental inter - actions.",Non-OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
• Association between MSX1  SNPs and Oral Cleft http://jkms.org   523  http://dx.doi.org/10.3346/jkms.2013.28.4.522age relationship about tag SNPs in the Korean population and  to confine the samples with nonsyndromic cleft lip with or with - out cleft palate (NS-CL ± P) in order to get meaningful results for epidemiologic studies of cleft patients.,Non-OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
Selection of SNPs SNP markers located from 2kb-5 ´ to 2kb-3 ´ of the MSX1 gene  were obtained from literature review and the NCBI dbSNP da - tabase (http://www.ncbi.nlm.nih.gov/SNP/).,OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
Pairwise linkage disequilibrium (LD) was computed as both D´ and r 2 for all SNPs using the Haploview  program (http://www.broad.mit.edu/mpg/haploview/index.php/)(22-24).,OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
The family-based association test program was used to per - form allelic and genotypic transmission disequilibrium tests  (TDTs) for individual SNPs and the haplotype-based associa - tion test program was used to fabricate sliding windows of hap - lotypes consisting of two and three SNPs (http://www.biostat.,OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
"• Association between MSX1  SNPs and Oral Cleft 524  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.522MAF, heterozygosity, HWE, and LD analyses  The MAF for rs4464513 was lowest (0.295), while the MAFs for rs12532 and rs3821949 showed values of 0.359 and 0.484, re - spectively.",OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
"• Association between MSX1  SNPs and Oral Cleft http://jkms.org   525  http://dx.doi.org/10.3346/jkms.2013.28.4.522alveolus (CLA) results from fusion failure between the medial  nasal process and maxillary process in the primary palate (lip and premaxilla), which takes place during the fourth to the sev - enth week of gestation; cleft palate (CP) results from fusion fail - ure between the palatal processes in the secondary palate, which  develops during the seventh to the twelfth week (20).",Non-OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
• Association between MSX1  SNPs and Oral Cleft 526  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.52225.,Non-OADS,/arxiv_data1/oa_pdf/87/df/jkms-28-522.PMC3617303.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 The Synergistic Apoptotic Interaction of Indole-3-Carbinol and Genistein with TRAIL on Endometrial Cancer Cells Induction of apoptosis in target cells is a key mechanism by which chemotherapy promotes cell killing.",Non-OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"Received: 7 September 2012 Accepted: 28 January 2013 Address for Correspondence: Chi-Heum Cho, MD Department of Obstetrics and Gynecology, Keimyung University, School of Medicine, 56 Dalseong-ro, Jung-gu, Daegu 700-712,  Korea Tel: +82.53-250-7518, Fax: +82.53-250-7599 E-mail: c0035@dsmc.or.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.527 • J Korean Med Sci 2013; 28: 527-533ORIGINAL ARTICLE Oncology & Hematology INTRODUCION Endometrial cancer is the fourth most common gynecologic  malignancy in women in developed countries (1) which arises from the endometrial lining of the uterus.",Non-OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL 528  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.527METERIALS AND METHODS Reagents and cell lines Dulbecco’s modified eagle medium was obtained from GIBCO BRL (Grand Island, NY, USA).",OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL http://jkms.org   529  http://dx.doi.org/10.3346/jkms.2013.28.4.527Statistical analysis The data are presented as mean ± SD.",OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL 530  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.527Effect of combination treatment on cell cycle progression Flow cytometric analysis of cell cycle was performed to exam - ine the mechanism of inhibition of cell growth following I3C, Genistein and TRAIL treatment.",OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL http://jkms.org   531  http://dx.doi.org/10.3346/jkms.2013.28.4.527of a synergistic effect of I3C, Genistein and TRAIL in endome - trial cancer.",Non-OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL 532  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.527over, the combination treatment enhanced the activation of  caspase-8 and suppressed the expression level of Flip.",Non-OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"• Synergistic Effect of I3C, Genistein and TRAIL http://jkms.org   533  http://dx.doi.org/10.3346/jkms.2013.28.4.527cell lines is overcome by co-treatment with cytotoxic drugs.",Non-OADS,/arxiv_data1/oa_pdf/67/f7/jkms-28-527.PMC3617304.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Correlation of Immunohistochemical Markers and BRAF Mutation Status with Histological Variants of Papillary Thyroid Carcinoma in the Korean Population Several pathologic characteristics are associated with an adverse clinical outcome in papillary thyroid carcinoma (PTC), including the histological variant.",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"Key Words:  Thyroid Carcinoma, Papillary; Histological Variant; Immunohistochemistry;  PTEN; S100A4Hye Sook Min, Chul Lee,   and Kyeong Cheon Jung Department of Pathology, Seoul National University  College of Medicine, Seoul, Korea  Received: 27 September 2012 Accepted: 28 January 2013 Address for Correspondence: Hye Sook Min, MD Department of Pathology, Seoul National UniversityCollege of Medicine, 103 Daehak-ro, Jongno-gu,   Seoul 1 10-799, Korea Tel: +82.2-2072-2828, Fax: +82.2-765-5600 E-mail: lilloa@snuh.orghttp://dx.doi.org/10.3346/jkms.2013.28.4.534 • J Korean Med Sci 2013; 28: 534-541ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION  Histological grading, determined by marked nuclear atypia, tu - mor necrosis and vascular invasion, is a significant and inde - pendent parameter predicting papillary thyroid carcinoma  (PTC) mortality, as demonstrated in multivariate analyses (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  http://jkms.org   535  http://dx.doi.org/10.3346/jkms.2013.28.4.534them, we selected 407 patients who have single PTC and un - derwent lymph node (LN) dissection that harbor more than 2  lymph nodes.",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  536  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.534tistical significance.,Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  http://jkms.org   537  http://dx.doi.org/10.3346/jkms.2013.28.4.534BRAF mutation study  The BRAF (V600E) mutation was detected in 70.2% (179/255) of patients, while other types of BRAF alterations were not found (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  538  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.534PTC (6, 17).",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  http://jkms.org   539  http://dx.doi.org/10.3346/jkms.2013.28.4.534Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  540  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.534with that of the Western population (5), this suggests that the  higher BRAF mutation rate in the Korean population is not due to a higher frequency of TCV .",Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
• Characteristics of Histological Variant of Papillary Thyroid Carcinoma  http://jkms.org   541  http://dx.doi.org/10.3346/jkms.2013.28.4.53425.,Non-OADS,/arxiv_data1/oa_pdf/a8/3d/jkms-28-534.PMC3617305.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Immunophenotypic Characterization and Quantification of Neoplastic Bone Marrow Plasma Cells by Multiparametric Flow Cytometry and Its Clinical Significance in Korean Myeloma Patients  Multiparametric flow cytometry (MFC) allows discrimination between normal and neoplastic plasma cells (NeoPCs) within the bone marrow plasma cell (BMPC) compartment.",Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
"Key Words:  Multiple Myeloma; Flow Cytometry; Immunophenotyping; Neoplastic Cells;  Plasma CellsYoung-Uk Cho,1 Chan-Jeoung Park,1  Seo-Jin Park,1 Hyun-Sook Chi,1  Seongsoo Jang,1 Sang Hyuk Park,1 Eul-Ju Seo,1 Dok Hyun Yoon,2 Jung-Hee Lee,2 and Cheolwon Suh2 1Department of Laboratory Medicine and  2Department of Internal Medicine, University of  Ulsan, College of Medicine and Asan Medical  Center, Seoul, Korea Received: 18 October 2012 Accepted: 18 January 2013 Address for Correspondence: Chan-Jeoung Park, MD Department of Laboratory Medicine, University of Ulsan, College of Medicine and Asan Medical Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82.2-3010-4508, Fax: +82.2-478-0884 E-mail: cjpark@amc.seoul.kr  This study was supported by a grant from the Asan Institute for  Life Sciences (2008-179).http://dx.doi.org/10.3346/jkms.2013.28.4.542 • J Korean Med Sci 2013; 28: 542-549ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION The widespread use of multiparametric flow cytometry (MFC)  and the increased availability of reagents for the surface and in - tracellular staining of specific antigens have provided insights into the pathophysiology of plasma cell myeloma (PCM) that have improved our diagnostic and prognostic capabilities (1-3).",Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
"• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells http://jkms.org   543  http://dx.doi.org/10.3346/jkms.2013.28.4.542MATERIALS AND METHODS Patients and samples Diagnostic bone marrow (BM) samples were analyzed from 109 patients with PCM (n = 76) or reactive plasmacytosis (n =  33) between November, 2008 and April, 2010, at the Asan Medi - cal Center (Seoul, Korea).",OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
"• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells 544  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.542labeling index, BMPC count (determined by LM), cell type of  plasma cells (plasmablastic vs plasmacytic), and cytogenetics.",OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells http://jkms.org   545  http://dx.doi.org/10.3346/jkms.2013.28.4.542board waived the requirement for informed consent.,Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells 546  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.542Table 2.,Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells http://jkms.org   547  http://dx.doi.org/10.3346/jkms.2013.28.4.542tients with other combinations (CD56+/CD27+ or CD56-/CD27-)  demonstrated intermediate survival times (Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
"• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells 548  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.542gested, including ISS stage, cytogenetics, fluorescence in situ  hybridization, LD, IgA isotype, plasmablastic histology, and la - beling index (18).",OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
• Flow Cytometric Characterization and Quantification of Neoplastic Plasma Cells http://jkms.org   549  http://dx.doi.org/10.3346/jkms.2013.28.4.542rated into the routine evaluation and diagnosis of all PCM pa - tients in the near future.,Non-OADS,/arxiv_data1/oa_pdf/46/97/jkms-28-542.PMC3617306.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Clinical Implication of Microscopic Anthracotic Pigment in Mediastinal Staging of Non-Small Cell Lung Cancer by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Microscopic anthracotic pigment (MAP) is frequently observed in endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) specimen in non-small cell lung cancer, but its clinical interpretation is not well-known.",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
"Key Words:  Lung Cancer; Staging; Endobronchial Ultrasound; Anthracotic PigmentYoung Sik Park,1 Jinwoo Lee,1  Jin Chul Pang,2 Doo Hyun Chung,3  Sang-Min Lee,1 Jae-Joon Yim,1  Seok-Chul Yang,1 Chul-Gyu Yoo,1  Young Whan Kim,1 and Sung Koo Han1 1Division of Pulmonary and Critical Care Medicine,  Department of Internal Medicine and Lung Institute,  2Department of Nuclear Medicine, and 3Department  of Pathology, Seoul National University College of  Medicine, Seoul, Korea Received: 26 November 2012 Accepted: 6 February 2013 Address for Correspondence: Young Sik Park, MD Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National  University College of Medicine, 101 Daehak-ro, Jongno-gu,  Seoul 1 10-744, KoreaTel: +82.2-2072-7214, Fax: +82.2-762-9662E-mail: mdyspark@gmail.comhttp://dx.doi.org/10.3346/jkms.2013.28.4.550 • J Korean Med Sci 2013; 28: 550-554ORIGINAL ARTICLE Oncology & Hematology INTRODUCTION The introduction of endobronchial ultrasound-guided trans - bronchial needle aspiration (EBUS-TBNA) was a great advance  in diagnostic bronchoscopy, especially in mediastinal staging of non-small cell lung cancer (1-5).",Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
• Microscopic Anthracotic Pigment in EBUS-TBNA Specimens http://jkms.org   551  http://dx.doi.org/10.3346/jkms.2013.28.4.550recruited.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
• Microscopic Anthracotic Pigment in EBUS-TBNA Specimens 552  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.550lowed by adenocarcinoma (42.9%).,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
• Microscopic Anthracotic Pigment in EBUS-TBNA Specimens http://jkms.org   553  http://dx.doi.org/10.3346/jkms.2013.28.4.550DISCUSSION This present study showed the clinical implication of MAP in  mediastinal staging of non-small cell lung cancer.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
Available at http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf [accessed on 26 October 2011].,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
• Microscopic Anthracotic Pigment in EBUS-TBNA Specimens 554  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.550the forthcoming seventh edition of the TNM classification for lung can - cer.,Non-OADS,/arxiv_data1/oa_pdf/5d/a3/jkms-28-550.PMC3617307.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Elevation of Morning Blood Pressure in Sodium Resistant Subjects by High Sodium Diet The present study evaluated the response of blood pressure (BP) by dietary sodium in sodium resistant (SR) subjects.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"Key Words:  Sodium; Hypertension; Sodium ResistanceMoo-Yong Rhee,1 Chi-Yeon Lim,2  Sung-Joon Shin,3 Sang-Woo Oh,4  Yong-Soon Park,5 Jong-Wook Kim,6  Hye-Kyoung Park,6 Cho-il Kim,7  Cheol-Young Park,8  and Sun-Woong Kim9 1Cardiovascular Center, 2Clinical Trial Center,  3Division of Nephrology, and 4Department of Family  Medicine, Dongguk University Ilsan Hospital,  Goyang; 5Department of Food and Nutrition,  Hanyang University, Seoul; 6Nutrition Policy Office,  Food Safety Bureau, Korea Food and Drug  Administration, Cheongwon; 7Department of Food  & Nutrition Industry, Korea Health Industry Development Institute, Cheongwon;  8Department of  Endocrinology and Metabolism, Sungkyunkwan University School of Medicine, Kangbuk Samsung Hospital, Seoul;  9Department of Statistics, Survey  Research Center, Dongguk University, Seoul, Korea Received: 6 September 2012 Accepted: 25 January 2013 Address for Correspondence:  Moo-Yong Rhee, MD Cardiovascular Center, Dongguk University Ilsan Hospital,   27 Dongguk-ro, Ilsandong-gu, Goyang 410-773, KoreaTel: +82.31-961-7125, Fax: +82.31-961-7786   E-mail: mooyong_rhee@dumc.or.kr  This research was supported by a grant (08082KFDA999) from  the Korea Food and Drug Administration in 2009.http://dx.doi.org/10.3346/jkms.2013.28.4.555 • J Korean Med Sci 2013; 28: 555-563ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION High sodium intake is a well-known and important environ - mental factor for the development of hypertension and cardio - vascular events.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"• High Sodium Diet in Sodium Resistant Subjects 556  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.5553 hypertension (BP ≥ 160/100 mmHg) at the time of entry into  the study, secondary hypertension, angina pectoris, myocardial infarction, congestive cardiac failure, stroke, diabetes mellitus, or chronic kidney disease (estimated glomerular filtration rate by the Modification of Diet in Renal Disease equation < 60 mL/  min/1.73 m 2) were excluded.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"• High Sodium Diet in Sodium Resistant Subjects http://jkms.org   557  http://dx.doi.org/10.3346/jkms.2013.28.4.555P= 0.032) and significant lowering of daytime DBP (from 84.8 ±   2.0 to 83.4 ± 1.9 mmHg, P= 0.048) after HSD in hypertensive  subjects with SR (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"• High Sodium Diet in Sodium Resistant Subjects 558  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.555elevation of morning BP and nighttime BP decline (13-16), ad - dressing changes of circadian BP variation as the worsening  mechanism of high sodium intake for the adverse cardiovascu -lar events.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"• High Sodium Diet in Sodium Resistant Subjects http://jkms.org   559  http://dx.doi.org/10.3346/jkms.2013.28.4.555evation was contributed by the elevation of morning DBP in  hypertensive subjects with SR, but not by hypertensive subjects with SS.",Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
• High Sodium Diet in Sodium Resistant Subjects 560  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.555sodium intake directed at the general population rather than SS  individuals (23).,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
• High Sodium Diet in Sodium Resistant Subjects http://jkms.org   561  http://dx.doi.org/10.3346/jkms.2013.28.4.555the effects of dietary patterns on blood pressure: DASH Collaborative Re - search Group.,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
• High Sodium Diet in Sodium Resistant Subjects 562  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.555Supplement Table 1.,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
• High Sodium Diet in Sodium Resistant Subjects http://jkms.org   563  http://dx.doi.org/10.3346/jkms.2013.28.4.555Supplement Table 3.,Non-OADS,/arxiv_data1/oa_pdf/7e/0a/jkms-28-555.PMC3617308.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Impact of Home-Based Exercise Training with Wireless Monitoring on Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Recent studies have suggested a favorable effect of cardiac rehabilitation (CR) on patients with cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
"Key Words:  Acute Coronary Syndrome; Cardiac Rehabilitation; Exercise Capacity; Quality  of LifeYoung-Hwa Lee,1 Seung-Ho Hur,1  Jihyun Sohn,1 Ho-Myung Lee,1  Nam-Hee Park,2 Yun-Kyeong Cho,1  Hyoung-Seob Park,1 Hyuck-Jun Yoon,1  Hyungseop Kim,1 Chang-Wook Nam,1  Yoon-Nyun Kim,1 and Kwon-Bae Kim1 Departments of 1Internal Medicine, 2Thoracic and  Cardiovascular Surgery, Keimyung University   College of Medicine, Daegu, KoreaReceived: 24 September 2012 Accepted: 6 February 2013 Address for Correspondence: Seung-Ho Hur, MD Division of Cardiology, Department of Internal Medicine, Keimyung University College of Medicine, Dongsan Medical Center, 216 Dalseong-ro, Jung-gu, Daegu 700-712, KoreaTel: +82.53-250-7949, Fax: +82.53-250-7034E-mail: shur@dsmc.or.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.564 • J Korean Med Sci 2013; 28: 564-568ORIGINAL ARTICLE Cardiovascular Disorders INTRODUCTION The importance of cardiac rehabilitation (CR) recently has been  stressed among the approaches for proper cardiac disease man - agement including diet control, medications, percutaneous coronary intervention (PCI) or coronary artery bypass graft (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
"• Impact of Home-Based Exercise Training in ACS Patients http://jkms.org   565  http://dx.doi.org/10.3346/jkms.2013.28.4.564gram, which consisted of educational rehabilitation and exer - cise training.",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
"• Impact of Home-Based Exercise Training in ACS Patients 566  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.564 Paired t-tests were used to compare the changes in exercise  capacity, and QOL between baseline and after week 12 in each  group.",OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
"• Impact of Home-Based Exercise Training in ACS Patients http://jkms.org   567  http://dx.doi.org/10.3346/jkms.2013.28.4.564by a CR program even in patients with acute myocardial infarc - tion (4, 14, 15).",Non-OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
• Impact of Home-Based Exercise Training in ACS Patients 568  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.56412.,Non-OADS,/arxiv_data1/oa_pdf/f4/e5/jkms-28-564.PMC3617309.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Relationship between Bone Mineral Density and Moderate to Severe Chronic Kidney Disease among General Population in Korea Recent studies in Western countries have reported a significant association between glomerular filtration rate (GFR) and bone mineral density (BMD) in the absence of dialysis among the general population.",Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
"Key Words:  Glomerular Filtration Rate; Bone Density; Osteoporosis; Renal Insufficiency;  KNHANESJun-Pyo Myong, Hyoung-Ryoul Kim,  Jung-Wan Koo, and Chung Yill Park Department of Occupational and Environmental Medicine, Center for Occupational and  Environmental Medicine, Seoul St. Mary’s Hospital,  The Catholic University of Korea, Seoul, Korea Received: 29 August 2012 Accepted: 25 January 2013 Address for Correspondence: Jung-Wan Koo, MD Department of Preventive Medicine and Center for Occupational and Environmental Medicine, College of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu,   Seoul 137-701, Korea Tel: +82.2-2258-6268, Fax: +82.2-2258-6678 E-mail: jwkoo@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.569 • J Korean Med Sci 2013; 28: 569-574ORIGINAL ARTICLE Nephrology INTRODUCTION End-stage renal disease (ESRD) is a well-established risk factor  for reduced bone mineral density (BMD) and osteoporosis as well as for hip fracture (1-3).",Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
"• Bone Mineral Density and Chronic Kidney Disease 570  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.569able for a total of 3,467 individuals.",Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
• Bone Mineral Density and Chronic Kidney Disease http://jkms.org   571  http://dx.doi.org/10.3346/jkms.2013.28.4.569males and females with MS-CKD were more likely to have lower  BMD and calcium intake.,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
• Bone Mineral Density and Chronic Kidney Disease 572  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.569from secondary hyperparathyroidism.,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
"• Bone Mineral Density and Chronic Kidney Disease http://jkms.org   573  http://dx.doi.org/10.3346/jkms.2013.28.4.569pital in Ireland, there may have been a selection bias in that  older subjects or those with more co-morbid diseases related to osteoporosis or kidney disease had been referred to the hospi - tal for DXA and assessments of renal function (24).",Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
• Bone Mineral Density and Chronic Kidney Disease 574  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.5692011; 26: 392-8.,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
Available at http://knhanes.cdc.,Non-OADS,/arxiv_data1/oa_pdf/3b/2a/jkms-28-569.PMC3617310.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Characteristic Phenotypes in Korean Crohn’s Disease Patients Who Underwent Intestinal Surgery for the Treatment There are no previous large scale studies which have evaluated the phenotypes and clinical characteristics of Korean Crohn’s disease patients who underwent intestinal resection.",Non-OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
"Key Words:  Crohn’s Disease; Phenotypes; Intestinal SurgerySeung Hyuk Baik,1,8 Kyu Joo Park,2,8  Kang Young Lee,1,8 Yong Beom Cho,3,8  Gyu-Seog Choi,4,8 Kil Yeon Lee,5,8  Sang Nam Yoon,6,8 and Chang Sik Yu7,8 1Section of Colon and Rectal Surgery, Department  of Surgery, Yonsei University College of Medicine,  Seoul; 2Department of Surgery, Seoul National  University College of Medicine, Seoul; 3Department  of Surgery, Sungkyunkwan University School of Medicine, Seoul;  4Department of Surgery,  Kyungpook National University School of Medicine, Daegu;  5Department of Surgery, Kyung Hee  University School of Medicine, Seoul; 6Department  of Surgery, Hansol Hospital, Seoul; 7Section of Colon  and Rectal Surgery, Department of Surgery, University of Ulsan, College of Medicine and Asan Medical Center, Seoul;  8IBD Study Group, Korean  Society of Coloproctology, Korea Received: 3 September 2012 Accepted: 30 January 2013 Address for Correspondence: Chang Sik Yu, MD Section of Colon and Rectal Surgery, Department of Surgery, University of Ulsan, College of Medicine and Asan Medical  Center, 88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Korea  Tel: +82.2-3101-3494, Fax: +82.2-3101-6701 E-mail: csyu@amc.seoul.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.575 • J Korean Med Sci 2013; 28: 575-579ORIGINAL ARTICLE Gastroenterology & Hepatology INTRODUCTION Crohn’s disease (CD) is a chronic inflammatory disease that in - volves the entire gastrointestinal tract from the mouth to the  anus.",Non-OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
• Phenotypes in Crohn’s Disease Patients 576  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.575Coloproctology.,Non-OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
• Phenotypes in Crohn’s Disease Patients http://jkms.org   577  http://dx.doi.org/10.3346/jkms.2013.28.4.575and a total proctocolectomy with an ileal J-pouch anal anasto - mosis was performed in 0.4% of the patients.,Non-OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
"• Phenotypes in Crohn’s Disease Patients 578  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.575 In the present study, the phenotypes were not different in the  comparison between the first 10 yr and the second 10 yr. Throug - hout the 20-yr study period, the environmental situation has  been changing according to developing socioeconomic status.",Non-OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
"• Phenotypes in Crohn’s Disease Patients http://jkms.org   579  http://dx.doi.org/10.3346/jkms.2013.28.4.575MA, Cilissen M, Engels LG, Van Deursen C, Hameeteman WH, Wolters  FL, Russel MG, et al.",OADS,/arxiv_data1/oa_pdf/29/c7/jkms-28-575.PMC3617311.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Association between Maternal Characteristics and Neonatal Birth Weight in a Korean Population Living in the Seoul Metropolitan Area, Korea: A Birth Cohort Study (COCOA) Previous studies suggest that maternal characteristics may be associated with neonatal outcomes.",Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
"Received: 2 July 2012 Accepted: 25 January 2013 Address for Correspondence:  Soo-Jong Hong, MD Department of Pediatrics, Childhood Asthma Atopy Center, Research Center for Standardization of Allergic Diseases, Asan Medical Center, University of Ulsan College of Medicine,   88 Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, KoreaTel: +82.2-3010-3379, Fax: +82.2-473-3725E-mail: sjhong@amc.seoul.kr *This research was supported by a grant (2009-E33033-00)  from the research fund of the Korea Centers for Disease Control and Prevention.http://dx.doi.org/10.3346/jkms.2013.28.4.580 • J Korean Med Sci 2013; 28: 580-585ORIGINAL ARTICLE Pediatrics",Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
"• Maternal Characteristics and Neonatal Birth Weight http://jkms.org   581  http://dx.doi.org/10.3346/jkms.2013.28.4.580INTRODUCTION Birth weight (BW) has long been recognized as a good surro - gate marker for fetal well-being (1) as well as a key determinant  of neonatal mortality, morbidity, subsequent growth and de - velopment, and an early onset of adulthood disease (2).",Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
• Maternal Characteristics and Neonatal Birth Weight 582  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.580jobless (full-time homemaker).,Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
"• Maternal Characteristics and Neonatal Birth Weight http://jkms.org   583  http://dx.doi.org/10.3346/jkms.2013.28.4.580DISCUSSION The aim of this large prospective hospital-based birth cohort  study was to determine the effect of maternal characteristics such as maternal age, prepregnancy BMI, smoking, parity, and allergy on BW in a Korean population living in the Seoul metro - politan area, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
"• Maternal Characteristics and Neonatal Birth Weight 584  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.580roids affect the insulin-like growth factor system, and may thus  result in fetal growth restriction (31).",Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
• Maternal Characteristics and Neonatal Birth Weight http://jkms.org   585  http://dx.doi.org/10.3346/jkms.2013.28.4.5808.,Non-OADS,/arxiv_data1/oa_pdf/f8/95/jkms-28-580.PMC3617312.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Evaluation of Immunogenicity and Safety of the New Tetanus-Reduced Diphtheria (Td) Vaccines (GC1107) in Healthy Korean Adolescents: A Phase II, Double-Blind, Randomized, Multicenter Clinical Trial This phase II clinical trial was conducted to compare the immunogenicity and safety of a newly developed tetanus-reduced diphtheria (Td) vaccine (GC1 107-T5.0 and GC1 107-T7.5) and control vaccine.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"Key Words:  Tetanus-Reduced Diphtheria (Td) Vaccine; Immunogenicity; SafetyJung-Woo Rhim,1 Kyung-Yil Lee,1  Sang-Yong Kim,1 Jong-Hyun Kim,1  Hyun-Hee Kim,1 Hwang Min Kim,2  Young-Youn Choi,3 Sang-Hyuk Ma,4  Dong-Ho Kim,5 Dong Ho Ahn,6  and Jin-Han Kang1 1Department of Pediatrics, The Catholic University  of Korea, Seoul; 2Department of Pediatrics, Yonsei  University, Wonju College of Medicine, Wonju;  3Department of Pediatrics, Chonnam National  University Hospital, Gwangju; 4Department of  Pediatrics, Changwon Fatima Hospital, Changwon;  5Department of Pediatrics, Korea Cancer Center  Hospital, Seoul; 6Research Center, Green Cross  Corporation, Yongin, KoreaReceived: 22 October 2012 Accepted: 31 January 2013 Address for Correspondence: Jin-Han Kang, MD Department of Pediatrics, The Catholic University of Korea, Seoul St. Mary’s Hospital, 641 Banpo-ro, Seocho-gu,   Seoul 137-701, KoreaTel: +82.2-2258-6183, Fax: +82.2-537-4544E-mail: kjhan@catholic.ac.kr This study was supported by Seoul St. Mary’s Hospital grant  (XC1 1MDMS0089K), that was underwritten by the Green Cross  Corporation, Yongin, Republic of Korea (201 1).http://dx.doi.org/10.3346/jkms.2013.28.4.586 • J Korean Med Sci 2013; 28: 586-592ORIGINAL ARTICLE Pediatrics INTRODUCTION Diphtheria is a toxin-mediated respiratory disease caused by  Corynebacterium diphtheriae  with a high mortality rate and a  range of symptoms through a systemic blood-borne infection (1).",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"• Evaluation of Immunogenicity and Safety of the New Td Vaccines http://jkms.org   587  http://dx.doi.org/10.3346/jkms.2013.28.4.586has led to the recommendation of combined Tetanus, Diphthe - ria and Pertussis (Tdap) vaccinations to adolescents and adults  in epidemic areas with a minimum 5-yr vaccination interval.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"• Evaluation of Immunogenicity and Safety of the New Td Vaccines 588  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.586swelling with a diameter ≥ 30 mm, or an axillary temperature  ≥ 39.0°C.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"• Evaluation of Immunogenicity and Safety of the New Td Vaccines http://jkms.org   589  http://dx.doi.org/10.3346/jkms.2013.28.4.586223 Subjects were enrolled n=146  Vaccinated, Safety analysis population GC1107-T5.0 GC1107-T7.5 SK-Td pure® 49 49 48 n=145 Immunogenicity analysis population GC1107-T5.0 GC1107-T7.5 SK-Td pure® 49 48 48 n=130  Completed the vaccination schedule  GC1107-T5.0 GC1107-T7.5 SK-Td pure® 44 42 4477 screening failure Discontinued: n=1 Not performed blood sampling GC1107-T5.0 GC1107-T7.5 Td pure® 0 1 0 Discontinued: n=15 GC1107-T5.0 GC1107-T7.5 Td pure® Did not meet eligibility criteria review 2 1 1 Randomization error 3 4 3 Unbinding 0 1 0 Fig.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"• Evaluation of Immunogenicity and Safety of the New Td Vaccines 590  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.586In Group GC1107-T7.5, 29 subjects experienced pain, (59.2%,  29 cases), 17 subjects experienced induration, (34.7%, 17 cas - es), 12 subjects experienced redness (24.5%, 12 cases) and 10 subjects experienced swelling (20.4%, 10 cases).",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"• Evaluation of Immunogenicity and Safety of the New Td Vaccines http://jkms.org   591  http://dx.doi.org/10.3346/jkms.2013.28.4.586national competitiveness will be strengthened, which will con - tribute to better public welfare.",Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
• Evaluation of Immunogenicity and Safety of the New Td Vaccines 592  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.586nancial support of this clinical trial from the Green Cross Co.,Non-OADS,/arxiv_data1/oa_pdf/00/9e/jkms-28-586.PMC3617313.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Alpha Internexin Expression Related with Molecular Characteristics in Adult Glioblastoma and Oligodendroglioma Alpha-internexin (INA) is a proneuronal gene-encoding neurofilament interacting protein.",Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
"Key Words:  Glioblastoma; Oligodendroglioma; Alpha-internexin, humans; 1p/19q  Codeletion; EGFR protein, Human Ja Hee Suh,1 Chul-Kee Park,2  and Sung-Hye Park1 1Departments of Pathology and 2Neurosurgery,  Seoul National University Hospital, Seoul, Korea Received: 16 April 2012 Accepted: 18 January 2013 Address for Correspondence: Sung-Hye Park, MD Department of Pathology, Seoul National University Hospital,  101 Daehak-ro, Jongno-gu, Seoul 1 10-744, KoreaTel: +82.2-2072-3090, Fax: +82.2-743-5530E-mail: shparknp@snu.ac.kr This research was supported by a grant of the Korean Health  Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A1 12005).http://dx.doi.org/10.3346/jkms.2013.28.4.593 • J Korean Med Sci 2013; 28: 593-601ORIGINAL ARTICLE Neuroscience INTRODUCTION Gliomas, which include astrocytic tumors, oligodendrogliomas,  mixed oligoastrocytomas, and ependymomas, are the most common primary malignancy of the central nervous system (CNS) and account for 78% of cases (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma 594  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.59311).,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma http://jkms.org   595  http://dx.doi.org/10.3346/jkms.2013.28.4.593determined using Fisher’s exact test or Pearson’s chi square  test.,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma 596  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.593Fig.,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma http://jkms.org   597  http://dx.doi.org/10.3346/jkms.2013.28.4.59310%).,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma 598  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.593Table 4.,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma http://jkms.org   599  http://dx.doi.org/10.3346/jkms.2013.28.4.593Table 5.,Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
"• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma 600  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.593ical teratoid-rhabdoid tumors, indicating that these primitive  tumors usually exhibit neuronal differentiation (24).",Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
"• Alpha Internexin in Adult Glioblastoma and Oligodendroglioma http://jkms.org   601  http://dx.doi.org/10.3346/jkms.2013.28.4.593Yates A, Burger PC, Scheithauer BW, et al.",Non-OADS,/arxiv_data1/oa_pdf/46/31/jkms-28-593.PMC3617314.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Risk Factors for Suicidal Ideation of the General Population The aim of this study was to investigate risk factors of suicide ideation in general population.",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
"Key Words:  General Population; Risk Factor; Suicide IdeaSeung-Min Bae,1 Yu Jin Lee,1  In Hee Cho,1 Seog Ju Kim,2  Jeong Soo Im,3 and Seong-Jin Cho1 1Department of Psychiatry, Gachon University Gil  Medical Center, Incheon; 2Department of Medicine,  Seoul National University College of Medicine,  Seoul; 3Department of Preventive Medicine, Gachon  University, Incheon, Korea Received: 20 October 2012 Accepted: 30 January 2013 Address for Correspondence: Yu Jin Lee, MD Department of Psychiatry, Gachon University Gil Medical Center,21 Namdong-daero 774-beon-gil, Namdong-gu, Incheon   405-760, KoreaTel: +82.32-468-9932, Fax: +82.32-468-9962 E-mail: leeyj1203@gmail.com This work was supported by the Gachon University Gil Medical  Center (Grant number: 2012-01).http://dx.doi.org/10.3346/jkms.2013.28.4.602 • J Korean Med Sci 2013; 28: 602-607ORIGINAL ARTICLE Psychiatry & Psychology INTRODUCTION Recently, suicide is a major mental health issue in Korea (1).",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
"• Risk Factors for Suicidal Ideation http://jkms.org   603  http://dx.doi.org/10.3346/jkms.2013.28.4.602graphic information, the Center for Epidemiologic Study De - pression Scale (CES-D), the Beck Scale for Suicide Ideation  (BSI), the Spielberger State-Trait Anger Expression Inventory (STAXI), the Barratt Impulsiveness Scale (BIS) and questions on sleep duration on weekdays.",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
• Risk Factors for Suicidal Ideation 604  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.602use to describe their emotions when they feel angry.,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
• Risk Factors for Suicidal Ideation http://jkms.org   605  http://dx.doi.org/10.3346/jkms.2013.28.4.602ation and associated factors in a community population in an  urban area of Korea.,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
"• Risk Factors for Suicidal Ideation 606  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.602 In spite of several limitations, the current study is meaning - ful, because it assessed risk factors for high suicide idea in a ge - neral urban population using representative samples randomly  recruited from city districts and matched equally in terms of gender and age group.",Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
Available at http://titania.Sourceoecd.Org/vl=1337221/cl=19/nw=1/rpsv/health2007/2-7.Htm [accessed on 11 April 2009].,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
• Risk Factors for Suicidal Ideation http://jkms.org   607  http://dx.doi.org/10.3346/jkms.2013.28.4.602history of suicide and personality.,Non-OADS,/arxiv_data1/oa_pdf/f8/6b/jkms-28-602.PMC3617315.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Chlorogenic Acid Decreases Retinal Vascular Hyperpermeability in Diabetic Rat Model To evaluate the effect of chlorogenic acid (CGA), a polyphenol abundant in coffee, on retinal vascular leakage in the rat model of diabetic retinopathy, Sprague-Dawley rats were divided into four groups: controls, streptozotocin-induced diabetic rats, and diabetic rats treated with 10 and 20 mg/kg chlorogenic acid intraperitoneally daily for 14 days, respectively.",Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
"http://dx.doi.org/10.3346/jkms.2013.28.4.608 • J Korean Med Sci 2013; 28: 608-613ORIGINAL ARTICLE Ophthalmology INTRODUCTION Diabetic retinopathy causes breakdown of the blood-retinal  barrier (BRB), resulting in vascular leakage and subsequent macular edema, which is a major cause of visual loss in diabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
"• Chlorogenic Acid in Diabetic Retinopathy Rat Model http://jkms.org   609  http://dx.doi.org/10.3346/jkms.2013.28.4.608Korea), and levels of > 250 mg/dL were considered diabetic.",Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
"Quantification of the densitome - try was performed by the NIH Image program (developed by  Wayne Rasband, National Institutes of Health, Bethesda, MD; available at http://rsb.info.nih.gov/ij/index.html).",OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
• Chlorogenic Acid in Diabetic Retinopathy Rat Model 610  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.608flat-mounted.,Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
• Chlorogenic Acid in Diabetic Retinopathy Rat Model http://jkms.org   61 1  http://dx.doi.org/10.3346/jkms.2013.28.4.608ONL Claudin-5 ZO-1 OccludinControl STZ STZ + CGA10 STZ + CGA20 GCL IPL INL OPL Fig.,Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
"• Chlorogenic Acid in Diabetic Retinopathy Rat Model 612  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.608claudin-5 was variable (2, 24, 25).",Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
• Chlorogenic Acid in Diabetic Retinopathy Rat Model http://jkms.org   613  http://dx.doi.org/10.3346/jkms.2013.28.4.60813.,Non-OADS,/arxiv_data1/oa_pdf/51/72/jkms-28-608.PMC3617316.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Clinical Characteristics of 75 Patients with Leukemia Cutis Leukemia cutis (LC) is defined as a neoplastic leukocytic infiltration of the skin.",Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
"Key Words:  Clinical Characteristics; Leukemia Cutis; PrognosisYeon Soo Kang,1 Hei Sung Kim,2  Hyun Jeong Park,3 Jun Young Lee,1  Hyung Ok Kim,1 Baik Kee Cho,3  and Young Min Park1 Department of Dermatology, 1Seoul St. Mary’s  Hospital, Seoul; 2Incheon St. Mary’s Hospital,  Incheon; 3Yeouido St. Mary’s Hospital, College of  Medicine, The Catholic University of Korea, Seoul,  Korea Received: 31 August 2012 Accepted: 24 January 2013 Address for Correspondence: Young Min Park, MD Department of Dermatology, Seoul St. Mary’s Hospital, College  of Medicine, The Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea Tel: +82.2-2258-6223, Fax: +82.2-594-3255  E-mail: yymmpark6301@hotmail.comhttp://dx.doi.org/10.3346/jkms.2013.28.4.614 • J Korean Med Sci 2013; 28: 614-619ORIGINAL ARTICLE Dermatology INTRODUCTION Leukemia cutis (LC) was first described by Biesiadecki (1) in  1876 and was defined as the cutaneous infiltration of malignant hematopoietic cells causing specific and non-specific skin erup - tions.",Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
"• Clinical Characteristics of 75 Patients with Leukemia Cutis http://jkms.org   615  http://dx.doi.org/10.3346/jkms.2013.28.4.614leukemia (ALL; L1, L2, L3), acute granulocytic leukemia (AGL;  AML M1, M2, M3), acute myelomonocytic leukemia (AMML; M4), acute monocytic leukemia (AMoL; M5), acute erythro - genic leukemia (AEL; M6), or acute megakaryocytic leukemia (AMLK; M7).",Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
• Clinical Characteristics of 75 Patients with Leukemia Cutis 616  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.614leukemia.,Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
• Clinical Characteristics of 75 Patients with Leukemia Cutis http://jkms.org   617  http://dx.doi.org/10.3346/jkms.2013.28.4.614Table 3.,Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
• Clinical Characteristics of 75 Patients with Leukemia Cutis 618  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.614Table 5.,Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
• Clinical Characteristics of 75 Patients with Leukemia Cutis http://jkms.org   619  http://dx.doi.org/10.3346/jkms.2013.28.4.614clinical characteristics and predilection sites according to the  type of leukemia.,Non-OADS,/arxiv_data1/oa_pdf/28/85/jkms-28-614.PMC3617317.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 A Case of Fulminant Sclerosing Peritonitis Presented Like Acute Culture-Negative Peritonitis and Successfully Treated with Corticosteroid Therapy Sclerosing peritonitis is an uncommon complication of peritoneal dialysis.",Non-OADS,/arxiv_data1/oa_pdf/ef/14/jkms-28-620.PMC3617318.pdf
"Key Words:  Peritonitis; Peritoneal Sclerosis; Peritoneal Dialysis; SteroidsJi Yun Jung and Jong Tae Cho Department of Internal Medicine, Dankook  University College of Medicine, Cheonan, Korea Received: 16 August 2012 Accepted: 30 October 2012 Address for Correspondence: Jong Tae Cho, MD Department of Internal Medicine, Dankook University College of Medicine, 201 Manghyang-ro, Dongnam-gu, Cheonan   330-715, Korea Tel: +82.41-550-3925, Fax: +82.41-556-3256 E-mail: jtcho@dankook.ac.krhttp://dx.doi.org/10.3346/jkms.2013.28.4.620 • J Korean Med Sci 2013; 28: 620-623CASE REPORT Nephrology INTRODUCTION Sclerosing peritonitis (SP) is a rare form of peritoneal inflam - mation which involves both the visceral and the parietal surfac - es of the abdominal cavity.",Non-OADS,/arxiv_data1/oa_pdf/ef/14/jkms-28-620.PMC3617318.pdf
"• Case of Fulminant Sclerosing Peritonitis  http://jkms.org   621  http://dx.doi.org/10.3346/jkms.2013.28.4.620were all negative for bacteria, fungi, and mycobacteria.",Non-OADS,/arxiv_data1/oa_pdf/ef/14/jkms-28-620.PMC3617318.pdf
• Case of Fulminant Sclerosing Peritonitis  622  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.620toneal sclerosis (EPS) (1).,Non-OADS,/arxiv_data1/oa_pdf/ef/14/jkms-28-620.PMC3617318.pdf
• Case of Fulminant Sclerosing Peritonitis  http://jkms.org   623  http://dx.doi.org/10.3346/jkms.2013.28.4.620of sclerosing peritonitis in patients on chronic ambulatory peritoneal di - alysis.,Non-OADS,/arxiv_data1/oa_pdf/ef/14/jkms-28-620.PMC3617318.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Spontaneous Healing of Gastric Perforation after Endoscopic Ligation for Gastric Varices  Endoscopic variceal ligation (EVL) can be performed as an optional therapy for gastric variceal bleeding if endoscopic sclerotherapy (ES) is not readily available or if practitioners lack experience.",Non-OADS,/arxiv_data1/oa_pdf/dc/01/jkms-28-624.PMC3617319.pdf
"Received: 27 September 2012 Accepted: 1 1 January 2013 Address for Correspondence: Kwang An Kwon, MD Division of Gastroenterology and Hepatology, Department of Internal Medicine, Gachon University Gil Medical Center, 21  Namdong-daero 774 beon-gil, Namdong-gu, Incheon 405-760,  Korea Tel: +82.32-460-3778, Fax: +82.32-460-3408E-mail: toptom@gilhospital.comhttp://dx.doi.org/10.3346/jkms.2013.28.4.624 • J Korean Med Sci 2013; 28: 624-627CASE REPORT Gastroenterology & Hepatology INTRODUCTION Treatment of variceal bleeding has improved; however, variceal  bleeding is still the most fatal complication of liver cirrhosis (1-3).",Non-OADS,/arxiv_data1/oa_pdf/dc/01/jkms-28-624.PMC3617319.pdf
• Spontaneous Healing of Gastric Perforation http://jkms.org   625  http://dx.doi.org/10.3346/jkms.2013.28.4.624non-bleeding esophageal varix and a nodular shaped gastric  varix with stigmata at the fundus of the stomach.,Non-OADS,/arxiv_data1/oa_pdf/dc/01/jkms-28-624.PMC3617319.pdf
"• Spontaneous Healing of Gastric Perforation 626  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.624 There are few reports of gastric perforation after EVL of gas - tric varices; in fact, only three cases have been reported (7, 8).",Non-OADS,/arxiv_data1/oa_pdf/dc/01/jkms-28-624.PMC3617319.pdf
• Spontaneous Healing of Gastric Perforation http://jkms.org   627  http://dx.doi.org/10.3346/jkms.2013.28.4.624gastrointestinal bleeding in patients with cirrhosis.,Non-OADS,/arxiv_data1/oa_pdf/dc/01/jkms-28-624.PMC3617319.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Pulsatile Tinnitus Caused by a Dilated Mastoid Emissary Vein Although pulsatile tinnitus can be audible, objective demonstration of this heartbeat-synchronous sound has rarely been successful.",Non-OADS,/arxiv_data1/oa_pdf/80/91/jkms-28-628.PMC3617320.pdf
"Key Words:  Pulsatile Tinnitus; Mastoid VeinSeung-Hwan Lee,1 Sam Soo Kim,2  Kun-Yong Sung,3 and Eui-Cheol Nam4 Departments of 1Neurology, 2Radiology, 3Plastic and  Reconstructive Surgery, and 4Otolaryngology, School  of Medicine, Kangwon National University,  Chuncheon, Korea Received: 26 September 2012 Accepted: 1 1 January 2013 Address for Correspondence: Eui-Cheol Nam, MD Department of Otolaryngology, School of Medicine, Kangwon  National University, 1 Kangwondaehak-gil, Chuncheon   200-701, KoreaTel: +82.33-258-231 1, Fax: +82.33-255-8809Email: birdynec@kangwon.ac.kr This work was supported by the Basic Science Research Program  through the National Research Foundation (NRF) of Korea and  funded by the Ministry of Education, Science, and Technology  (201 1-0006602).http://dx.doi.org/10.3346/jkms.2013.28.4.628 • J Korean Med Sci 2013; 28: 628-630CASE REPORT Otorhinolaryngology INTRODUCTION Tinnitus is a perception of sound in the ear without correspond - ing external sound.",Non-OADS,/arxiv_data1/oa_pdf/80/91/jkms-28-628.PMC3617320.pdf
"• Pulsatile Tinnitus by a Dilated Mastoid Vein http://jkms.org   629  http://dx.doi.org/10.3346/jkms.2013.28.4.628ternal jugular vein and the right, with the left being slightly larg - er (Fig.",Non-OADS,/arxiv_data1/oa_pdf/80/91/jkms-28-628.PMC3617320.pdf
"• Pulsatile Tinnitus by a Dilated Mastoid Vein 630  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.628and the flow velocity in the left MEV was relatively high at 0.5  m/s, whereas flow in the right MEV (around the location of the presumed opening) was not detected at all.",Non-OADS,/arxiv_data1/oa_pdf/80/91/jkms-28-628.PMC3617320.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Fibrocartilaginous Intramedullary Bone Forming Tumor of the Distal Femur Mimicking Osteosarcoma Fibrocartilaginous dysplasia (FCD) has occasionally led to a misdiagnosis and wrong decision which can significantly alter the outcome of the patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
"Key Words:  Fibrocartilaginous Dysplasia; Osteosarcoma; Orthopaedic Oncologist;  DiagnosisSang-Heon Song,1 Hanna Lee,2  Hae-Ryong Song,2 Myo-Jong Kim,3  and Jong-Hoon Park3 1Department of Orthopaedic Surgery,  Soonchunhyang University Bucheon Hospital,  Bucheon; 2Institute for rare diseases and  Department of Orthopaedic Surgery, Korea University Medical Center, Guro Hospital, Seoul;  3Department of Orthopaedic Surgery, Korea  University Medical Center, Anam Hospital, Seoul, Korea Received: 1 1 September 2012 Accepted: 1 1 January 2013 Address for Correspondence: Jong-Hoon Park, MD Department of Orthopaedic Surgery, Korea University Medical Center, Anam Hospital, 145 Anam-ro, Seongbuk-gu,   Seoul 136-705, Korea Tel: +82.2-920-6609, Fax: +82.2-924-2471 E-mail: pjh1964@hanmail.net This study was supported by a grant from the Korea Healthcare  Technology R&D Project, Ministry for Health, Welfare & Family  Affairs, Republic of Korea (A1 10416).http://dx.doi.org/10.3346/jkms.2013.28.4.631 • J Korean Med Sci 2013; 28: 631-635CASE REPORT Musculoskeletal Disorders INTRODUCTION Osteosarcoma is the most common malignant tumor of the  bone (1).",Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
• Fibrocartilaginous Tumor Mimicking Osteosarcoma 632  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.631Fig.,Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
• Fibrocartilaginous Tumor Mimicking Osteosarcoma http://jkms.org   633  http://dx.doi.org/10.3346/jkms.2013.28.4.631mild increased uptake in the left distal femur.,Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
"• Fibrocartilaginous Tumor Mimicking Osteosarcoma 634  http://jkms.org  http://dx.doi.org/10.3346/jkms.2013.28.4.631 Thirty-six months after initial visit, radiologic findings from  the plain radiographs (Fig.",Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
• Fibrocartilaginous Tumor Mimicking Osteosarcoma http://jkms.org   635  http://dx.doi.org/10.3346/jkms.2013.28.4.631tral osteosarcoma: a diagnostic dilemma.,Non-OADS,/arxiv_data1/oa_pdf/8c/a6/jkms-28-631.PMC3617321.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Lung Cancer Incidence by Smoking Status in Korean Men: 16-Years of Observations in the Seoul Male Cancer Cohort Study The relative risk (RR) of smoking and mortality of lung cancer in British doctors was previously reported to have increased throughout a 40-yr period.",Non-OADS,/arxiv_data1/oa_pdf/b3/75/jkms-28-636.PMC3617322.pdf
"Key Words:  Cancer Incidence; Cigarette Smoking; Cohort Study; Lung Neoplasm Jong-Myon Bae,1 Zhong-Min Li,2  Myung-Hee Shin,3 Dong-Hyun Kim,4  Moo-Song Lee,5 and Yoon-Ok Ahn6 1Department of Preventive Medicine, Jeju National  University School of Medicine, Jeju, Korea;  2Department of Epidemiology & Statistics, Jilin  University School of Public Health Science,  Changchun, China; 3Department of Social &  Preventive Medicine, Sungkyunkwan University School of Medicine, Suwon;  4Department of Social  Medicine, Hallym University College of Medicine, Chuncheon;  5Department of Preventive Medicine,  University of Ulsan College of Medicine, Seoul;  6Department of Preventive Medicine, Seoul National  University College of Medicine, Seoul, Korea Received: 15 December 2012 Accepted: 15 February 2013 Address for Correspondence: Jong-Myon Bae, MD Department of Preventive Medicine,Jeju National University School of Medicine, 102 Jejudaehak-ro, Jeju 690-756, Korea Tel: +82.64-764-3856, Fax: +82.64-725-2593 E-mail: jmbae@jejunu.ac.kr This study was supported by the 2013 scientific promotion  program funded by Jeju National University (2013-0144).http://dx.doi.org/10.3346/jkms.2013.28.4.636 • J Korean Med Sci 2013; 28: 636-637BRIEF COMMUNICATION Oncology & Hematology Lung cancer has been the leading cause of cancer deaths for 25  years in the Korean population (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/b3/75/jkms-28-636.PMC3617322.pdf
"• Smoking and Lung Cancer Risk in Korean Men  http://jkms.org   637  http://dx.doi.org/10.3346/jkms.2013.28.4.636come this issue as follows: 1) the male British doctors that smok - ed cigarettes reported smoking the same amount at the begin - ning and half way through the study (4), and 2) the carcinogen - ic effect of smoking was presented after 20- to 25 yr (8).",Non-OADS,/arxiv_data1/oa_pdf/b3/75/jkms-28-636.PMC3617322.pdf
Available at http://stat.mw.go.kr/ front/customer/custBoardView.jsp?menuId=28&bbsSeq=15&nttSeq=12177&nPage=192&searchKey=&searchWord [accessed on 19 January 2013].Table 1.,OADS,/arxiv_data1/oa_pdf/b3/75/jkms-28-636.PMC3617322.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 Letter to the Editor Anaphylactic Cardiovascular Collapse during Anesthesia: The Kounis Acute Hypersensitivity Syndrome Seems to be the Most Likely Cause Nicholas Kounis, and George Kounis Department of Medical Sciences, Patras Highest Institute of Education and Technology, Patras, Greecehttp://dx.doi.org/10.3346/jkms.2013.28.4.638 • J Korean Med Sci 2013; 28: 638-639CORRESPONDENCE With have read with a great interest the article published in J  Korean Med Sci [1] concerning a 16-yr-old patient who devel - oped severe anaphylactic reaction with cardiovascular collapse during anesthesia for incision and drainage of post operative femur fracture infection.",Non-OADS,/arxiv_data1/oa_pdf/58/7a/jkms-28-638.PMC3617323.pdf
"Correspondence: To the Editor http://jkms.org   639  http://dx.doi.org/10.3346/jkms.2013.28.4.638 Dexamethasone which was given to this patient, has also  been implicated as causative agent for anaphylaxis in some oc - casions and this should be taken into consideration when treat - ing such sensitized individuals.",Non-OADS,/arxiv_data1/oa_pdf/58/7a/jkms-28-638.PMC3617323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357 The Author Response Suspected Anaphylactic Reaction Associated with Microemulsion Propofol during Anesthesia Induction Se Jin Lee  Department of Anesthesiology and Pain Medicine, Soonchunhyang University Seoul Hospital, Seoul, Koreahttp://dx.doi.org/10.3346/jkms.2013.28.4.640 • J Korean Med Sci 2013; 28: 640-641CORRESPONDENCE To the Editor:  We prepared a case report entitled ‘Suspected Anaphylactic Re - action Associated with a Microemulsion of Propofol during An - esthesia Induction’ (1).",Non-OADS,/arxiv_data1/oa_pdf/a7/bf/jkms-28-640.PMC3617324.pdf
Correspondence: The Author Response http://jkms.org   641  http://dx.doi.org/10.3346/jkms.2013.28.4.6408.,Non-OADS,/arxiv_data1/oa_pdf/a7/bf/jkms-28-640.PMC3617324.pdf
This paper is available on line at http://www.mcponline.org 846 Molecular & Cellular Proteomics 12.4,Non-OADS,/arxiv_data1/oa_pdf/ce/d8/zjw846.PMC3617331.pdf
This paper is available on line at http://www.mcponline.org 856 Molecular & Cellular Proteomics 12.4,Non-OADS,/arxiv_data1/oa_pdf/0c/8b/zjw856.PMC3617332.pdf
This paper is available on line at http://www.mcponline.org 956 Molecular & Cellular Proteomics 12.4,Non-OADS,/arxiv_data1/oa_pdf/6b/99/zjw956.PMC3617342.pdf
Trans R Soc Trop Med Hyg 101:714 –721Centre National de Référence de la Leptospirose (2010) Rapport d'activité —années 2006 à 2010. http://www.pasteur.fr/ip/ resource/filecenter/document/ 01s-00004h-07l/ra-cnr-lepto- 2010.pdf .,Non-OADS,/arxiv_data1/oa_pdf/82/a7/114_2013_Article_1033.PMC3617346.pdf
Surveillance & Response May 2006: Inform ’Action 13. http://www.spc.int/phs/index.php?option=com_docman&task=doc_ download&gid=606&Itemid=102 .,OADS,/arxiv_data1/oa_pdf/82/a7/114_2013_Article_1033.PMC3617346.pdf
http://www.spc.int/phs /PPHSN/Surveillance/ WallisandFutuna/Lepto_Futuna_mars2008(2)-ENG.pdf .,Non-OADS,/arxiv_data1/oa_pdf/82/a7/114_2013_Article_1033.PMC3617346.pdf
London: National Institute for Health and Clinical Excellence .http://www.nice.org.uk/nicemedia/pdf/ Final_FAD_with_updated_audit_advice_sent_to_C&Cs_250506.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ad/96/11019_2011_Article_9376.PMC3617347.pdf
Report of threshold workshop .http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/ad/96/11019_2011_Article_9376.PMC3617347.pdf
http://www.phgfoundation.org/news/4765/ .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.src.riken.jp/english/pro ject/person/index.html .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
"Financial times, ft.com .http://www.ft.com/cms/s/0/7f7c8190-8793-11df- 9f37-00144feabdc0.html#axzz1KdFszze1 .",Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://conventions.coe.int/Treaty/en/Tre aties/Html/164.htm .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
https://wcd.coe.int/wcd/ ViewDoc.jsp?id=977859 .,OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.scribd.com/full/47667236?access_key=key- 2axeq5u99rj6dxgi9jt8 .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
Forskning.no .http://www.forskning.no/artikler/ 2009/februar/209050 .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.guardian.co.uk/sc ience/2006/aug/22/medicineand health.lifeandhealth .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.huntbiosciences.com/ .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.bioethics.ie /index.php/hum an-biolo gical-material- for-research .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.catholiceducation.org/articles/medical_eth ics/me0006.html .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.ntnu.,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.ntnu.no/hunt/ biosciences .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.ntnu.,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.forskningsradet.no/en/Home_page/1177315753906 .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.ukbiobank.ac.uk/docs/EGF 20082.pdf .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.ukbio bank.ac.uk/ .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
BBC News 7 July 2010. http://www.bbc.co.uk/news/10544498 .,Non-OADS,/arxiv_data1/oa_pdf/62/74/11019_2011_Article_9353.PMC3617351.pdf
http://www.csulb.edu/ *jvancamp/ 452_r5.html .,Non-OADS,/arxiv_data1/oa_pdf/3c/e2/11019_2011_Article_9358.PMC3617352.pdf
"Philosophy, Ethics, and Human- ities in Medicine 5: 15. http://www.peh-med.com/content/5/1/15 .",Non-OADS,/arxiv_data1/oa_pdf/3c/e2/11019_2011_Article_9358.PMC3617352.pdf
http://pd.sparknotes.com/ shakespeare/romeojuliet/section1.html (*section26.html).,Non-OADS,/arxiv_data1/oa_pdf/3c/e2/11019_2011_Article_9358.PMC3617352.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/61/cf/srep01558.PMC3617427.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sun, H.F., Jami, E., Harpaz, S. & Mizrahi, I.",Non-OADS,/arxiv_data1/oa_pdf/61/cf/srep01558.PMC3617427.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Petro, E.J.",Non-OADS,/arxiv_data1/oa_pdf/f9/bf/srep01609.PMC3617429.pdf
"ACTA Physica sinica 54, 534 (2005) (in Chinese, an English revised version is available at: http://arxiv.org/abs/nlin.CD/0603016).",Non-OADS,/arxiv_data1/oa_pdf/7b/c4/srep01585.PMC3617432.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Ke, D. Unifying Complexity and Information.",Non-OADS,/arxiv_data1/oa_pdf/7b/c4/srep01585.PMC3617432.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Paz-Silva, G.A.",Non-OADS,/arxiv_data1/oa_pdf/1b/15/srep01530.PMC3617433.pdf
TumorHPD web server is freely accessible at http://crdd.osdd.net/raghava/tumorhpd/.,OADS,/arxiv_data1/oa_pdf/ee/26/srep01607.PMC3617442.pdf
TumorHPD is accessible from URL http://crdd.osdd.net/raghava/tumorhpd/.,OADS,/arxiv_data1/oa_pdf/ee/26/srep01607.PMC3617442.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sharma, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/26/srep01607.PMC3617442.pdf
"The approach incorporates profiling li- braries such as the Prestwick Chemical Library (PCL) which  consists of 1200 off-patent and known biologically active  compounds along with the diverse Molecular Libraries Small  Molecule Repository (MLSMR, http://mlsmr.glpg.com/ML-SMR_HomePage/) library of greater than 350K compounds.",OADS,/arxiv_data1/oa_pdf/3d/36/TOMICROJ-7-34.PMC3617545.pdf
http://www.nickbostrom.com/papers/smart-policy.pdf .,Non-OADS,/arxiv_data1/oa_pdf/71/7b/11098_2011_Article_9778.PMC3617590.pdf
http://www.nytimes.com/2011/05/29/magazine/could-conjoined-twins-share-a-mind.html .,Non-OADS,/arxiv_data1/oa_pdf/71/7b/11098_2011_Article_9778.PMC3617590.pdf
http://andromeda.rutgers.edu/ *jlynch/Texts/jenyns.html .,Non-OADS,/arxiv_data1/oa_pdf/71/7b/11098_2011_Article_9778.PMC3617590.pdf
"The ﬁrst one is a global land Table 1 Global land cover datasets and their main characteristics Code Map Producer Number of land cover classesSpatial resolutionData acquisition yearSource AVHRR Advanced Very High Resolution Radiometer(AVHRR) Land Cover ClassiﬁcationUniversity of Maryland, Department of Geography14 1 km 1981–1994 http://glcf.umiacs.umd.edu/data /landcover/ MODIS MODerate resolution Imaging Spectroradiometer (MODIS) Land Cover ClassiﬁcationBoston University, Department of Geography19 1 km 2001 http://duckwater.bu.edu/lc/mod 12q1.html GLC2000 Global land cover 2000 (v1.1) European Commission Joint Research Center24 1 km 2000 http://bioval.jrc.ec.europa.eu/ products/glc2000/glc2000.php GlobCover GlobCover Land Cover product v2.2European Space Agency 23 global and 47 regional300 m 2005–2006 http://ionia1.esrin.esa.int/GeoJournal (2011) 76:525–538 527 123",Non-OADS,/arxiv_data1/oa_pdf/28/d2/10708_2010_Article_9364.PMC3617592.pdf
http://sedac.ciesin.org/gpw/docs/gpw3_ documentation_ﬁnal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/28/d2/10708_2010_Article_9364.PMC3617592.pdf
http://na.unep.net/globalpop/africa/ .,Non-OADS,/arxiv_data1/oa_pdf/28/d2/10708_2010_Article_9364.PMC3617592.pdf
Charcot diagnosed himself as having ‘pronounced The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution- NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/>.,Non-OADS,/arxiv_data1/oa_pdf/9b/73/S0032247411000222a.PMC3617608.pdf
"Please see http://www.globalhealthaction.net/index.php/ gha/article/view/25010 This paper is part of the thematic cluster Global Health Beyond 2015 - more papers from this cluster can be found at http://www.globalhealthaction.net Received: 11 March 2013; Revised: 13 March 2013; Accepted: 14 March 2013; Published: 3 April 2013 The best-understood of the impacts of climate change on human health can already be estimated statistically, in some cases even documented, wheresignificant change has occurred (1).",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"The observational evidence of the human health impacts of variations in climate conditions is now very substantial,particularly in relation to heat and cold exposure (10, 17).The health impacts of heat have been a concern since the19th century /C1particularly among European colonial staff, military personnel, and other working people (18) /C1andTord Kjellstrom and Anthony J. McMichael 2 (page number not for citation purpose)Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Baseline /C301961/C11990.Climate change threats to population health and well-being Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"1) Malaria 2) Dengue3) Schistosomiasis4) Coastal flooding5) Burden of disease from changes in effectiveness of water and sanitation infrastructure 6) Diarrhoeal disease (temperature driven) 7) Direct impacts of temperature on work ability 8) The direct impacts of heat on mortality9) Malnutrition10) Health effects of economic damages from climate change The following impacts were also identified as important and may be added to the project: .Impacts on outdoor air pollution .Health co-benefits and harms from mitigation and adaptation policiesTord Kjellstrom and Anthony J. McMichael 4 (page number not for citation purpose)Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"The health sector also needs to develop knowledge andClimate change threats to population health and well-being Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Improved quality household energy sources and more efficient use of suchTord Kjellstrom and Anthony J. McMichael 6 (page number not for citation purpose)Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Currency /C30millions of USD PPP; GHG /C30greenhouse gases.Climate change threats to population health and well-being Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Barcelona: Fundacion DARA International; 2012, 320 p. http://daraint.org/climate-vulnerability-monitor/climate-vulnerability-monitor-2012/ 7.",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
Available from: http://www.ipcc.ch/pdf/supporting- material/expert-meeting-ts-scenarios.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Aviat Space Environ Med 2010; 81: 107/C111.Tord Kjellstrom and Anthony J. McMichael 8 (page number not for citation purpose)Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"Am Econ Rev 2009; 99: 198 /C1204.Climate change threats to population health and well-being Citation: Glob Health Action 2013, 6: 20816 - http://dx.doi.org/10.3402/gha.v6i0.20816 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/b5/98/GHA-6-20816.PMC3617647.pdf
"(2011) http://eu-cancer.iarc.fr/cancer-11-melanoma-of- skin.html,en.",Non-OADS,/arxiv_data1/oa_pdf/38/71/514.PMC3617713.pdf
In http://www.schneiderkreuznach.com.,Non-OADS,/arxiv_data1/oa_pdf/38/71/514.PMC3617713.pdf
"“TeraView receives MHRA approval to conduct in-vivo cancer imaging trials,”  http://www.teraview.com/news/terahertz-news/Ter aView-receives-in-vivo- trials-approval.html  20.",Non-OADS,/arxiv_data1/oa_pdf/c3/54/559.PMC3617718.pdf
"F. Jesse, Z. J. Miao, L. Zhao, Y. Chen, a nd Y. Y. Lv, “OSA2012-11 imag e sequences and data,”  http://jesse.org/OSA2012-11/  15.",OADS,/arxiv_data1/oa_pdf/6d/34/614.PMC3617722.pdf
"Corning Incorporated, “Corning® ClearCurve®  Multimode Optical Fiber Product information,”  http://www.corning.com/assets/0/433/573/5 83/9F39014A-1475-4F63-A9 A5-946B2DD39D69.pdf  16.",Non-OADS,/arxiv_data1/oa_pdf/6d/34/614.PMC3617722.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ad/f7/ert004.PMC3617820.pdf
"1485–1496, 2013 doi:10.1093/jxb/ert005 Advance Access publication 1 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a7/90/ert005.PMC3617821.pdf
"1575–1585, 2013 doi:10.1093/jxb/ert008 Advance Access publication 5 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ac/c3/ert008.PMC3617822.pdf
"1497–1507, 2013 doi:10.1093/jxb/ert010 Advance Access publication 1 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4d/7f/ert010.PMC3617823.pdf
"1521–1536, 2013 doi:10.1093/jxb/ert013 Advance Access publication 4 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/50/71/ert013.PMC3617824.pdf
"The raw data were pre-processed by the  Fastx-toolkit pipeline (http://hannonlab.cshl.edu/fastx_toolkit/) to  remove low quality reads, reads smaller than 18 nt, trim adaptor sequences, and contamination formed by adaptor–adaptor ligation.",OADS,/arxiv_data1/oa_pdf/50/71/ert013.PMC3617824.pdf
Precursors of known miRNAs and novel miRNA  candidates were identified by extracting 200 nt of the sequence  ﬂanking the contig sequences matching the known miRNAs and unannotated small RNAs by analysing their secondary structural features using the MIREAP pipeline (https://source-forge.net/projects/mireap/).,OADS,/arxiv_data1/oa_pdf/50/71/ert013.PMC3617824.pdf
"All primers (Supplementary Table S1 available at JXB online) were designed  according to the miRNA mature sequence and cDNAs sequences using Primer Premier 5 (http://www.premierbiosoft.com/crm/jsp/ com/pbi/crm/clientside/ProductList.jsp) and synthesized com- mercially (Genscript Bioscience, Nanjing).",OADS,/arxiv_data1/oa_pdf/50/71/ert013.PMC3617824.pdf
Small RNA regulation during cotton somatic embryogenesis | 1525 searches against the repeat database (http://www.girinst.org/ server/RepBase/).,OADS,/arxiv_data1/oa_pdf/50/71/ert013.PMC3617824.pdf
"1587–1601, 2013 doi:10.1093/jxb/ert014 Advance Access publication 4 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/65/82/ert014.PMC3617825.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/17/ert016.PMC3617826.pdf
"The obtained data were analysed by DICHROWEB  (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml), which is an online server for predicting secondary structures of proteins (Whitmore and Wallace, 2004).",OADS,/arxiv_data1/oa_pdf/2d/17/ert016.PMC3617826.pdf
"After the digital images were taken, the intensities of the AtHIRD11 bands were determined by NIH-Image software (http://rsbweb.nih.gov/nih-image/).",OADS,/arxiv_data1/oa_pdf/2d/17/ert016.PMC3617826.pdf
(C) Composition of  secondary structures in AtHIRD11 as predicted by DICHROWEB (http://dichroweb.cryst.bbk.ac.uk/html/home.shtml).,OADS,/arxiv_data1/oa_pdf/2d/17/ert016.PMC3617826.pdf
"1625–1636, 2013 doi:10.1093/jxb/ert017 Advance Access publication 4 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/8d/ert017.PMC3617827.pdf
The fitting protocol used here was based  on an Excel workbook on the PhysEcol website (http://www.else-vierdirect.com/companion.jsp?ISBN=9780123744609) that accom-panies Landsberg and Sands (2011).,OADS,/arxiv_data1/oa_pdf/99/8d/ert017.PMC3617827.pdf
"1537–1551, 2013 doi:10.1093/jxb/ert018 Advance Access publication 5 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/57/ert018.PMC3617828.pdf
The phylogenetic  tree was constructed in ClustalW2- Phylogeny (http://www.ebi.,OADS,/arxiv_data1/oa_pdf/07/57/ert018.PMC3617828.pdf
The calculated tree file was viewed in TreeView version 1.6.6 software (http://taxonomy.zoology.gla.ac.uk/rod/treeview.html).,OADS,/arxiv_data1/oa_pdf/07/57/ert018.PMC3617828.pdf
"1553–1564, 2013 doi:10.1093/jxb/ert020 Advance Access publication 1 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/9c/ert020.PMC3617829.pdf
A search for post-translational  modification sites was performed and the molecular weights and iso-electric points (pI) were calculated with ExPASy (http://www.expasy.org/).,OADS,/arxiv_data1/oa_pdf/27/9c/ert020.PMC3617829.pdf
"The nuclear localization signal was localized using NucPred (http://www.sbc.su.se/~maccallr/nucpred/) and MEME used to search for conserved motifs (Bailey et al., 2009).",OADS,/arxiv_data1/oa_pdf/27/9c/ert020.PMC3617829.pdf
"The coiled-coil and  polymerization state were predicted using MARCOIL (Delorenzi and Speed, 2002) and Multicoil2 (http://groups.csail.mit.edu/cb/multicoil2/cgi-bin/multicoil2.cgi), respectively.",OADS,/arxiv_data1/oa_pdf/27/9c/ert020.PMC3617829.pdf
"1603–1613, 2013 doi:10.1093/jxb/ert022 Advance Access publication 4 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4e/20/ert022.PMC3617830.pdf
"1565–1573, 2013 doi:10.1093/jxb/ert031 Advance Access publication 11 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bc/fb/ert031.PMC3617834.pdf
"1703–1713, 2013 doi:10.1093/jxb/ert032 Advance Access publication 11 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/53/ert032.PMC3617835.pdf
These  were linked to injury type (Image J; National Institutes of Health;  http://rsbweb.nih.gov/ij/download.html) discriminating dark green (non-injured) leaf area from both light green (chlorotic) and beige-brown (necrotic) area.,OADS,/arxiv_data1/oa_pdf/20/53/ert032.PMC3617835.pdf
"1715–1729, 2013 doi:10.1093/jxb/ert036 Advance Access publication 11 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2a/64/ert036.PMC3617836.pdf
"1731–1743, 2013 doi:10.1093/jxb/ert037 Advance Access publication 11 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/b4/ert037.PMC3617837.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/18/ert040.PMC3617838.pdf
"The ltp3-1 (SALK_095248) and myb96-2 (SAIL_815_G17) mutants were obtained from The Arabidopsis Information Resource (TAIR, http://arabidopsis.org).",OADS,/arxiv_data1/oa_pdf/e2/18/ert040.PMC3617838.pdf
"1745–1753, 2013 doi:10.1093/jxb/ert041 Advance Access publication 5 February, 2013 This paper is available online free of all access charges (see http://jxb.oxfordjournals.org/open_access.html for further details) This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which  permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/ert041.PMC3617839.pdf
"(2009, 2012) and avail- able from the WGIN website (http://www.wgin.org.uk/) was utilized.",Non-OADS,/arxiv_data1/oa_pdf/ea/87/ert041.PMC3617839.pdf
26 The Joint Committee on Guidelines for the Management of Stroke: Japanese Guidelines for the Man- agement of Stroke 2009. http://www.jsts.gr.jp/jss08.html.,Non-OADS,/arxiv_data1/oa_pdf/e6/38/cee-0003-0014.PMC3617882.pdf
"http://www.cancerresearchuk.org/cancer -info/cancerstats/   types/breast/ , last viewed on 01/07/2012.",Non-OADS,/arxiv_data1/oa_pdf/24/78/crg-0007-0106.PMC3617893.pdf
"This article is available online at http://www.jlr.org Journal of Lipid Research Volume 54, 2013 571Copyright © 2013 by the American Society for Biochemistry and Molecular Biology, Inc.(Sia) modiﬁ  cations, thereby preparing large-scale gan gliosides  and permitting the exploration of unknown functions.",Non-OADS,/arxiv_data1/oa_pdf/2c/ee/571.PMC3617933.pdf
This article is available online at http://www.jlr.orgdominant factor in the development of atherosclerosis or  macrophage polarization in mice.,Non-OADS,/arxiv_data1/oa_pdf/57/e9/806.PMC3617954.pdf
e-mail: ptontonoz@mednet.ucla.edu     The online version of this article (available at http://www.jlr.org)  contains supplementary data in the form of one table.,Non-OADS,/arxiv_data1/oa_pdf/57/e9/806.PMC3617954.pdf
"Copyright © 2013 S. Karger AG, Basel   Introduction   The Montreal Cognitive Assessment (MoCA; http://www.mocatest.o rg) is a cognitive- screening test which was recently introduced to detect patients  with mild cognitive impair- ment (MCI).",Non-OADS,/arxiv_data1/oa_pdf/31/dc/dee-0003-0025.PMC3617974.pdf
"Key words: Bioavailability, drug delivery systems, nanocapsule, self-microemulsifying drug delivery system, tacrolimusAbstract Figure 1: Structure of tacrolimus (http://www.zerenex‑molecular.com/ api.asp) Access this article online Quick Response Code:Website:  www.jpionline.org DOI:  10.4103/2230-973X.106981",Non-OADS,/arxiv_data1/oa_pdf/c6/36/IJPI-2-169.PMC3618632.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/c6/36/IJPI-2-169.PMC3618632.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/c6/36/IJPI-2-169.PMC3618632.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/0d/4a/IJPI-2-183.PMC3618634.pdf
Available from: http://www.fda.gov/Drugs/ Guidance compliance Regulatory Information/Guidance/ ucm070 246.pdf [Last accessed on 2011 Jun 19].,Non-OADS,/arxiv_data1/oa_pdf/a4/81/IJPI-2-189.PMC3618635.pdf
Available from: http://www.ema.europa.eu/pdfs/ human/qwp/060496en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a4/81/IJPI-2-189.PMC3618635.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/79/17/IJMPO-33-195.PMC3618640.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/9e/02/IJMPO-33-203.PMC3618641.pdf
Summary Report 2009. http://www.who.int/hpvcentre/en/.,OADS,/arxiv_data1/oa_pdf/de/cb/IJMPO-33-210.PMC3618642.pdf
Available from: http://www.asccp.org/ConsensusGuidelines/ tabid/7436/Default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Available from: http://www.sign.ac.uk/guidelines/fulltext/99/index.html.,Non-OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.,Non-OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Available from: http://www.cancer.org/Healthy/FindCancerEarly/CancerScreeningGuidelines/american-cancer-society-guidelines-for-the-early-detection-of-cancer.,Non-OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Available from: http://icmr.nic.in/guide/cancer/CcMG.pdf [Last accessed on 2012 Jan].,Non-OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Available from: http://www2.cochrane.org/reviews/en/ab007406.html.,OADS,/arxiv_data1/oa_pdf/ab/e9/IJMPO-33-216.PMC3618643.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/8c/a4/IJMPO-33-221.PMC3618644.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/8c/a4/IJMPO-33-221.PMC3618644.pdf
Available from: http://www.hhs.gov/ohrp/ policy/gina.pdf [Last cited on 2012 Apr 30].,OADS,/arxiv_data1/oa_pdf/e6/b8/IJMPO-33-250.PMC3618651.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/31/84/IJMPO-33-253b.PMC3618653.pdf
"To viewthis ﬁle please visit the journal online (http://dx.doi.org/ 10.1136/annrheumdis-2012-201381) 1Department of Immunology, Erasmus MC, Rotterdam, The Netherlands 2Department of Gastroenterology, LUMS,Leiden, The Netherlands Correspondence to Zana Brkic, Department of Immunology, Erasmus MC,Dr Molewaterplein 50,3015 GE Rotterdam, The Netherlands; z.brkic@erasmusmc.nl Received 19 January 2012 Accepted 19 May 2012 Published Online First 26 June 2012ABSTRACT Objective To determine the prevalence of upregulation of interferon (IFN) type I inducible genes, the so called‘IFN type I signature ’, in CD14 monocytes in 69 patients with primary Sjögren ’s syndrome (pSS) and 44 healthy controls (HC) and correlate it with disease manifestationsand expression of B cell activating factor (BAFF).Methods Expression of IFI44L, IFI44, IFIT3, LY6E and MX1 was measured using real time quantitative PCR inmonocytes.",Non-OADS,/arxiv_data1/oa_pdf/9a/b9/annrheumdis-2012-201381.PMC3618683.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9a/b9/annrheumdis-2012-201381.PMC3618683.pdf
doi:10.1136/annrheumdis-2012-201469 665Published Online First 7 June 2012 Open Access Scan to access more free contentonline (http://dx.doi.org/10.1136/annrheumdis-2012-201469),Non-OADS,/arxiv_data1/oa_pdf/2d/89/annrheumdis-2012-201469.PMC3618684.pdf
See: http://creativecommons.org/ licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/2d/89/annrheumdis-2012-201469.PMC3618684.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/ 10.1136/gutjnl-2011-301917).,Non-OADS,/arxiv_data1/oa_pdf/56/d4/gutjnl-2011-301917.PMC3618685.pdf
http://statline.cbs.nl/StatWeb/default.aspx (accessed 14 Mar 2012).,OADS,/arxiv_data1/oa_pdf/56/d4/gutjnl-2011-301917.PMC3618685.pdf
http://cijfersoverkanker.nl/ (accessed 14 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/56/d4/gutjnl-2011-301917.PMC3618685.pdf
http://www.nza.nl/regelgeving/ tarieven/ (accessed 14 Mar 2012).,Non-OADS,/arxiv_data1/oa_pdf/56/d4/gutjnl-2011-301917.PMC3618685.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/56/d4/gutjnl-2011-301917.PMC3618685.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/ 10.1136/gutjnl-2011-301083).,Non-OADS,/arxiv_data1/oa_pdf/f8/73/gutjnl-2011-301083.PMC3618686.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/f8/73/gutjnl-2011-301083.PMC3618686.pdf
To view these ﬁles please visit the journal online (http://dx.doi.org/ 10.1136/gutjnl-2012-302240).,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/gutjnl-2012-302240.PMC3618687.pdf
http://crs.cph.ntu.edu.tw/main.php (accessed 20 Feb 2011).,OADS,/arxiv_data1/oa_pdf/a4/7d/gutjnl-2012-302240.PMC3618687.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/a4/7d/gutjnl-2012-302240.PMC3618687.pdf
"SOM Toolbox for Matlab 5, Report A57, (Accessed 15 February 2007, http://www.cis.hut.fi/projects/somtoolbox/ ).",OADS,/arxiv_data1/oa_pdf/cf/7d/11270_2013_Article_1503.PMC3618885.pdf
"Composti organici volatili (COV) desorbiti con CS2, Edizione 02/2003, http://www.radiello.com/ italiano/cov_chim_it.htm .",Non-OADS,/arxiv_data1/oa_pdf/cf/7d/11270_2013_Article_1503.PMC3618885.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/bc/26/ehs458.PMC3618888.pdf
"publicity available at the R archive network site ( http://cran.r-project.org/ was used to calculate the SHR and cuminc).10–12 Results Long-term effect of individual risk factors Among the 7174 men in the study, 2417 (33.7%) experienced a ﬁrst CHD event and 1335 (18.6%) a ﬁrst stroke over the 35-year follow-up.",OADS,/arxiv_data1/oa_pdf/bc/26/ehs458.PMC3618888.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Journal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently reproduced o r disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/ff/5b/ehs469.PMC3618889.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided that the original authorship is properly and fully attributed; the Jour nal, Learned Society and Oxford University Press are attributed as the original place of publication with correct citation details given; if an article is subsequently repro duced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated.",Non-OADS,/arxiv_data1/oa_pdf/22/0c/eht035.PMC3618890.pdf
"To view a copy of this license, v isit http://creativecommons.org/ licenses/by-nc-sa/3.0/Valsartan and cilnidipine combination therapy S Takai et al 348 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/0b/35/hr2012187a.PMC3619050.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Role of carbonyl stress in Dahl S rats XC h e n et al 367 Hypertension Research",Non-OADS,/arxiv_data1/oa_pdf/6e/cd/hr2012204a.PMC3619051.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)MIC-1 functions in the chemoresistance of PC cells BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2012.484 1091,Non-OADS,/arxiv_data1/oa_pdf/4e/ab/bjc2012484a.PMC3619053.pdf
"The SNPs within each gene were selected using the Pupasuite software (http://pupasuite.bioinfo.cipf.es/index.jsf – version 2.0.0, bioinfo 2008), the CIPF SNP database (dbSNP) generated by the National Centre for Biotechnology Information (http:// www.ncbi.nlm.nih.gov/SNP) and by review of the medical literature, using the following criteria: (1) The polymorphism had some degree of likelihood to alter the structure or the expression of the gene in a biologically relevant manner (i.e., affecting ESE sequences, 30-UTR or promoter region); (2) The minor allele frequency was above 10% (with the only exception of rs2305948, rs6877011 and rs307822); and (3) The genetic polymorphism was established and well documented.",Non-OADS,/arxiv_data1/oa_pdf/59/cf/bjc2012501a.PMC3619056.pdf
All polymorphisms were examined for deviation from Hardy– Weinberg equilibrium using the Powermarker v. 3.25 package (http://statgen.ncsu.edu/powermarker).,OADS,/arxiv_data1/oa_pdf/59/cf/bjc2012501a.PMC3619056.pdf
http://riskfactor.cancer.gov/diet/usualintakes/pop/.,Non-OADS,/arxiv_data1/oa_pdf/e3/98/bjc2012584a.PMC3619057.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Flavonoids and risk of pancreatic cancer 1172 www.bjcancer.com | DOI:10.1038/bjc.2012.584,Non-OADS,/arxiv_data1/oa_pdf/e3/98/bjc2012584a.PMC3619057.pdf
"R Foundation for Statistical Computing: Vienna, Austria (2011) ISBN 3-900051-07-0, URL: http://www.R-project.org/.",Non-OADS,/arxiv_data1/oa_pdf/e9/8b/bjc2012599a.PMC3619058.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Short-term psychological impact of BRCA1/2 test result 1020 www.bjcancer.com | DOI:10.1038/bjc.2012.599,Non-OADS,/arxiv_data1/oa_pdf/e9/8b/bjc2012599a.PMC3619058.pdf
"OS, JM and TRJE acknowledge the support of Cancer Research UK (http://info.cancerresearchuk.org/cancerstats/).REFERENCES Acharyya S, Oskarsson T, Vanharanta S, Malladi S, Kim J, Morris PG, Manova-Todorova K, Leversha M, Hogg N, Seshan VE, Norton L, Brogi E,Massague J (2012) A CXCL1 paracrine network links cancerchemoresistance and metastasis.",Non-OADS,/arxiv_data1/oa_pdf/81/55/bjc201324a.PMC3619061.pdf
Available at: http://www.factsandcomparisons.com (Last consulted on 16 January2013).,Non-OADS,/arxiv_data1/oa_pdf/23/30/bjc201348a.PMC3619066.pdf
Available at: http://www.arizonacert.,Non-OADS,/arxiv_data1/oa_pdf/23/30/bjc201348a.PMC3619066.pdf
Cancer Research UK (2010a) Bowel (colorectal) cancer – UK incidence statistics http://info.cancerresearchuk.org/cancerstats/types/bowel/incidence/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/70/bjc201349a.PMC3619067.pdf
Cancer Research UK (2010b) Bowel (colorectal) cancer – UK mortality statistics http://info.cancerresearchuk.org/cancerstats/types/bowel/ mortality/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/0b/70/bjc201349a.PMC3619067.pdf
National Cancer Intelligence Unit (2009) Colorectal cancer survival by stage http://www.ncin.org.uk/publications/data_briefings/colorectal_cancer_survival_by_stage.aspx.,Non-OADS,/arxiv_data1/oa_pdf/0b/70/bjc201349a.PMC3619067.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER ING1b induces growth-inhibitory microRNA203 1148 www.bjcancer.com | DOI:10.1038/bjc.2013.50,Non-OADS,/arxiv_data1/oa_pdf/ad/68/bjc201350a.PMC3619068.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Apical MUC1 expression in H. pylori gastritis 1118 www.bjcancer.com | DOI:10.1038/bjc.2013.54,Non-OADS,/arxiv_data1/oa_pdf/ab/79/bjc201354a.PMC3619071.pdf
"Images were analysed using ImageJ software v1.42q (National Institutes of Health, http://rsb.info.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/18/e3/bjc201358a.PMC3619075.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Fecal microbiota in Hodgkin lymphoma survivors BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.60 1167,Non-OADS,/arxiv_data1/oa_pdf/80/03/bjc201360a.PMC3619077.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER AVADO (bevacizumab þdocetaxel in mBC) biomarkers 1060 www.bjcancer.com | DOI:10.1038/bjc.2013.69,Non-OADS,/arxiv_data1/oa_pdf/20/b2/bjc201369a.PMC3619079.pdf
http://www.nice.org.uk/guidance/qualitystandards/breastcancer/Staging.jsp.,Non-OADS,/arxiv_data1/oa_pdf/6b/9d/bjc20136a.PMC3619080.pdf
Organized Breast Cancer Screening Programs in Canada—Report on Program Performance in 2005 and 2006http://www.phac-aspc.gc.ca/cd-mc/publications/cancer/obcsp-podcs05/1-eng.php.,Non-OADS,/arxiv_data1/oa_pdf/6b/9d/bjc20136a.PMC3619080.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Breast cancer survival by stage at diagnosis in six countries BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.6 1207,Non-OADS,/arxiv_data1/oa_pdf/6b/9d/bjc20136a.PMC3619080.pdf
"[online] Available at http://www.cancerresearchuk.org/cancer-info/cancerstats/ incidence/projections/selected-cancers/ (accessed 12 November 2012).Mistry M, Parkin DM, Ahmad AS, Sasiei P (2011) Cancer incidence in the United Kingdom: projections to the year 2030.",Non-OADS,/arxiv_data1/oa_pdf/18/7c/bjc201371a.PMC3619081.pdf
[online] Available at http://www.ncin.org.uk/ cancer_information_tools/ukcis.aspx (accessed 20 August 2012).,Non-OADS,/arxiv_data1/oa_pdf/18/7c/bjc201371a.PMC3619081.pdf
[online] Available at http://www.ons.gov.uk/ ons/publications/re-reference-tables.html?edition=tcm%3A77-229866 (accessed 20 August 2012).BRITISH JOURNAL OF CANCER Letter to the Editor 1214 www.bjcancer.com | DOI:10.1038/bjc.2013.71,Non-OADS,/arxiv_data1/oa_pdf/18/7c/bjc201371a.PMC3619081.pdf
http://surveillance.cancer.gov/delay/canques.html (accessed 21 January 2013).,Non-OADS,/arxiv_data1/oa_pdf/9b/41/bjc201372a.PMC3619082.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)NSAID use and the risk of HNC BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.73 1181,Non-OADS,/arxiv_data1/oa_pdf/20/a1/bjc201373a.PMC3619083.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Smoking and HAART use on KS Risk BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.75 1177,Non-OADS,/arxiv_data1/oa_pdf/75/ac/bjc201375a.PMC3619085.pdf
"4      http://www.jcancer .org 296  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(4): 296-303.  doi: 10.7150/ jca.5788  Research Paper   The Anti -inflammatory Role of Endometase/Matrilysin -2  in Human Prostate Cancer Cells   Zahraa I. Khamis1, Diego A.R.",Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
"4    http://www.jcancer .org 297  of physiological processes like embryo implantation,  bone remodeling, cell prolif eration, migration, and  apoptosis [3, 4] .",Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
4    http://www.jcancer .org 298  tory Cytokines and Receptors (PAHS -011C) were  purchased from SuperArray Biosciences and cDNA  was synthesized according to manufacturer instru c- tions.,OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
"4    http://www.jcancer .org 299  CXCL5, CXCL2, and CXCL1).",Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
4    http://www.jcancer .org 300    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
4    http://www.jcancer .org 301  Discussion   MMPs are considered important regulators of  inflammatory disease [8].,Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
4    http://www.jcancer .org 302  molecular mechanisms that govern this MMP in t u- morigene sis.,Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
4    http://www.jcancer .org 303  36.,Non-OADS,/arxiv_data1/oa_pdf/a4/e7/jcav04p0296.PMC3619090.pdf
"4      http://www.jcancer .org 304  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(4): 304-314. doi: 10.7150/ jca.4192  Research Paper   Impact of Age at Diagnosis on Outcomes in Men with  Castrate -Resistant Prostate Cancer (CRPC)   Michael R Humphreys1, Kimberly A Fernandes2, Srikala S Sridhar3   1.",Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
"4    http://www.jcancer .org 305  stage, tumor grade, prostate- specific antigen (PSA)  level) and patient -specific factors (e.g.",Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 306  less likely to have undergone definitive local therapy.,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
"4    http://www.jcancer .org 307  Median LDH  (IU/L)  236  244  223  208  223   Median ALP  (IU/L)  161  149  144  123  144   Median Hgb  (g/L)  124  120  120  115  120   Chemotherapy †         Docetaxel  11 (37%)  30 (26%)  29 (20%)  5 (15%)  75 (23%)    Mitoxantrone  6 (20%)  27 (23%)  47 (33%)  12 (35%)  92 (29%)    Docetaxel and Mitoxantrone  8 (27%)  37 (32%)  29 (20%)  0 (0%)  74 (23%)    None  5 (17%)  20 (17%)  37 (26%)  17 (50%)  79 (25%)    Other  0 (0%)  2 (2%)  0 (0%)  0 (0%)  2 (<1%)   Abbreviations: PSA, prostate specific antigen; Dx , diagnosis; RT, radiotherapy; CCI, Charleston comorbidity index, CRPC, castration resistant prostate cancer;  ADT, androgen deprivation therapy; ECOG, Eastern Cooperative Oncology Group; LDH, lactose dehydrogenase; ALP, alkaline phosphatase; Hgb, hemoglobi n  (†, meets p<0.05 statistical significance  per Fisher’s Exact Test or Chi -squared  test) .",Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 308  Table 2a .,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 309  Table 4 .,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 310    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 311    Figure 4 .,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 312  Table 5 .,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 313  producing.,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
4    http://www.jcancer .org 314  7.,Non-OADS,/arxiv_data1/oa_pdf/3e/31/jcav04p0304.PMC3619091.pdf
"4      http://www.jcancer .org 315  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(4): 315-319. doi: 10.7150/ jca.5956  Research Paper   Synergistic Effect between Sphingosine -1-Phosphate and  Chemotherapy Drugs against Human Brain -  metastasized Breast Cancer MDA -MB-361 cells   Ahlam Sultan1, Binbing Ling1, Huihua Zhang2, Baohua Ma3, Deborah Michel1, Jane Alcorn1, and Jian  Yang1  1.",Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
"4    http://www.jcancer .org 316  lates with its intracellular function (1 1, 12).",Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
4    http://www.jcancer .org 317    Fig 1 .,Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
4    http://www.jcancer .org 318  creased the cytotoxicity of cyclophos phamide but  decreased the cytotoxicity of docetaxel and doxorub i- cin against the MDA -MB-361 cells (Fig.,Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
"4    http://www.jcancer .org 319  their cytotoxicity against MDA -MB-361 cells by a l- most 2 -fold, 3 -fold and 10 -fold, respectively.",Non-OADS,/arxiv_data1/oa_pdf/bd/2a/jcav04p0315.PMC3619092.pdf
All specimens were ordered by a clinician and dete r-  Ivyspring    International Publisher     http://www.jcancer .org,Non-OADS,/arxiv_data1/oa_pdf/3d/25/jcav04p0320.PMC3619093.pdf
"Author  KRAS mutant/Total   (percentage)  BRAF mutant   (percentage)  Concomitant   BRAF and KRAS mutations   VanCutsem [5] 397/1,063 (37.4%)  60/999 (6.0%)  1/999 (0.1%)   Lamy [6] 450/1077 (41.8%)  26/397 (6.5%)  0/397 (0%)   Price [7] 90/315 (28.8%)  33/315(10.6%)  0/315 (0%)   Maughan [8] 565/1294 (43.7%)  102/1189 (8.5%)  0/1189 (0%)   Li [9] 63/200 (31.5%)  14/200 (6.5%)  0/200 (0%)   Bokemeyer [10] 136/315 (43.2%)  11/309  (3.6%)  0/309 (0%)   DeRoock [11] 299/747 (40.0%)  36/761 (4.7%)  0/761 (0%)   Total  2116/5287 (40.0%)  297/4323 (6.9%)  1/4323 (0.02%)     http://www.jcancer .org",Non-OADS,/arxiv_data1/oa_pdf/3d/25/jcav04p0320.PMC3619093.pdf
http://www.jcancer .org,Non-OADS,/arxiv_data1/oa_pdf/3d/25/jcav04p0320.PMC3619093.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2a/86/ijbsv09p0322.PMC3619094.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
Sequence and phylogenetic analyses   Sequence similarity and analysis for conserved  domains  were performed using NCBI BLAST pr o- grams (http://blast.ncbi.nlm.nih.gov/Blast.cgi).,OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
ExPASy Proteomics Se rver (http://cn.expasy.org/  tools/pi_tool.html) was used to compute  the isoele c- tric point s and molecular weight s of deduced protein  sequences.,OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
"The signal peptide was predicated by   SignalP 3.0  (http://www.cbs.dtu.dk/service/   SignalP/ ), and  transmembrane hel ices were analyzed  using TMHMM v.2.0 (http://www.cbs.dtu.dk/   services/TMHMM -2.0/) [33].",OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
NetNGlyc  1.0 Server (http://www.cbs.dtu.dk/services/   NetNGlyc/)  was used to analyze the N-glycosylation sites [35].,OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
"http://www.ijbs.com /v09p0331s1.pdf   Acknowledgements   This work was supported in part by the National  Basic Research Program of China (2009CB125903), Natural Science Foundation of Chongqing (CSTC, 2013jjB80005, JJA80020), the Program for Changjiang Scholars and Innovative Research Team in Uni versity  (IRT0976), and the Earmarked Fund for Modern Agro -industry (Citrus) Technology Research System  of China.",Non-OADS,/arxiv_data1/oa_pdf/1b/0f/ijbsv09p0331.PMC3619095.pdf
"9      http://www.ijbs.com  303  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  BBiioollooggiiccaall  SScciieenncceess   2013; 9(3):303-312. doi: 10.7150/ ijbs.6214   Research Paper   Development of a miR -26 Companion Diagnostic Test  for Adjuvant Interferon -alpha Therapy in Hepatocellular  Carcinoma   Junfang Ji1,, Lei Yu1,2, Zhipeng Yu1, Marshonna Forgues1, Takahiro Uenishi3, Shoji Kubo3, Kenichi  Wakasa3, Jian Zhou2, Jia Fan2, Zhao -You Tang2, Shijun Fu4, Hongguang Zhu4, Jason Gang Jin4, Hui -Chuan  Sun2, and Xin Wei Wang1,  1.",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
"9    http://www.ijbs.com  304  incidence and mortality have risen in most industr i- alized countries, including the United States, in the  past decade (2).",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
9    http://www.ijbs.com  305  and patients were older in Cohort 3 compared to C o- hort 1 and 2.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
"9      http://www.ijbs.com  306  An optimized eight -gene multiplex RT reaction  was performed in 30 µl containing 1× RT Buffer, 2 nM  dNTPs,  250 units  of MultiScribe Reverse Transcript a- se, 9.3 units of RNase Inhibitor, 15.2  µl of eight RT  primers (1.9 µl for each)  and 120 ng of total RNAs  using microRNA reverse transcription kit.",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
"9    http://www.ijbs.com  307  RNU48 showed a disconcordant expression pattern  between singleplexing and multiplexing (data not  shown), suggesting that this probe was not suitable  for multiplexing.",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
9      http://www.ijbs.com  308    Fig 1.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
9    http://www.ijbs.com  309    Fig 2.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
9      http://www.ijbs.com  310    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
"9      http://www.ijbs.com  311  Discussion   HCC is a heterogeneous disease, which repre- sents by its clinical presentation and tumor biology.",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
9    http://www.ijbs.com  312  w i t h  I F N α  to  th o s e  w h o  do  n o t  h a v e  i m p r o v e d  s u r- vival from this type of therapy so that they could gain  a chance for other treatment modalities.,Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
"Supplementary Material   Additional File 1:  Supplementary Figures 1-3, Sup- plementary Tables 1 -3.   http://www.biolsci.org/v0 9p0303s1.pdf   Acknowledgements   We thank Karen Yarrick for bibliographic assis- tance and the NIH Fellows Editorial Board for editing the manuscript.",Non-OADS,/arxiv_data1/oa_pdf/53/fb/ijbsv09p0303.PMC3619096.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/) .,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"Facilitated with  different behavioral repertoires (e.g., removal, burial,  and cannibalism), honey bees, ants, and termites have  evolved complex systems of corpse management   Ivyspring    International Publisher     http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"However, Visscher  [6] suggested that a     http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"1B), a common undertaking strategy in various ant species, is distinguished from other nest cleaning b e- haviors as corpses are transported more rapidly and    http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"Similarly, when fungal infe c- tion occurred,  R. flavipes  workers also aggregated and  actively recruited fellow workers to cope with the    http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"Illustrate d by Zhou, X.       http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
The study of    http://www.ijbs.com,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
http://www.ijbs.com,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
"2010, 20(3): 249- 252.    http://www.ijbs.com",Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
2012; 83(5): 1269- 1278.     http://www.ijbs.com,Non-OADS,/arxiv_data1/oa_pdf/1f/dc/ijbsv09p0313.PMC3619097.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
E xpre s-  Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
"( a) Cells w ere treated with propofol of different c oncentration s. Total cell extracts were prepared and subjected to  western -blot analysis in order to detect the active phosphorylated forms of p 38 MAPK , ERK1/2 and JNK; ( b) Cells w ere treated with 10  µM SB203580, SP600125, or PD98059 for 30 min and challenged with 100 µM propofol  for another 8 h then  incubat ed with H2O2 for 24  h. Total cell extracts were prepared and subjected to western blot analysis for detection of the levels of HO -1.    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
Maines   [37] found that there is a low expression of HO -1 in-   http://www.medsci.org,OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
"The protein  s a m p l e s  ( 2 0  μ g )  w e r e  l o a d e d  o n  a  12% of  SDS-polyacrylamide gel for electrophoresis, and  transferred onto PVDF transfer membranes (Mill i- pore, Billerica, MA, USA) at 0.8 mA/cm2 for 2 h.    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
2001 ; 11: 297-305.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
2011;23(3) :229- 235.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/cc/b1/ijmsv10p0599.PMC3619098.pdf
Adenovirus vectors   Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
"Microinjections of the viral vectors  (Ad-SYN -EGFP -WPRE, 1 μl of 5x10 6 ifu;  AAV2 -CBA -EGFP -WPRE, 1 µl of 1.0 x 109 gc;  AAV2 -CBA -AT2R -WPRE,  1 µl of 5.0 x 108 gc) were  performed as previously described [5], using the fo l- lowing stereotaxic coordinate s. PVN (bilateral inje c- tions): 1.9 mm posterior to bregma, ± 0.2 mm lateral to the midline, and 7.8 mm ventral to the skull surface;    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
Our i n vivo  studies using a viral microinjection technique in rats  demonstrated that 3' addition of the WPRE increased EGFP expression for at least one month with no loss of    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
"Neuroendocrinology 1992, 55(5):563 -573.    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
2008 Sep;22(9):3175- 85.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/05/06/ijmsv10p0607.PMC3619099.pdf
"10       http://www.medsci.org  617  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(5):617-623.  doi: 10.7150/ ijms.5773  Research Paper   The Prognostic Value of Abdominal Aortic  Calcification  in Peritoneal Dialysis Patients   Hye Eun Yoon1,2, Bo Geun Park1,  Hyeon Seok Hwang1,  Sungjin Chung1, Cheol Whee Park1, Chul Woo  Yang1, Yong -Soo Kim1, and Seok Joon Shin1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
10     http://www.medsci.org  618   The prognostic impact of vascular calcification  in peritoneal dialysis (PD) patients has been demo n- strated in previous reports (5 -8).,Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
"10     http://www.medsci.org  619  velocity (E) to peak early diastolic mitral annular v e- locity (E/E’ ratio), that is an estimate of left ventric u- lar filling pressure (LVFP), was also calculated (21) .",Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
10     http://www.medsci.org  620  Echocardiographic Measurements   Table 3 shows the comparison of echocardi o- graphic measurements between the low -ACI group  and the high- ACI group.,OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
10     http://www.medsci.org  621        Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
"10     http://www.medsci.org  622  tion (25), and increased arterial stiffness is associated  with vascular calcification and diastolic dysfunction  (15, 17) .",Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
10     http://www.medsci.org  623  dialysis patients: outcome of the calcification outcome in renal disease  (CORD) study.,Non-OADS,/arxiv_data1/oa_pdf/b1/69/ijmsv10p0617.PMC3619100.pdf
Web site:  http://www.HealthInformaticsLab.org/ffzhou/ .,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
It has   Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
"All the recruited CHF patients, including  both in-  and out -patients, visited the cardiovascular  department of the Xiangya Hospital in the Central  South University in China between October 2009 and    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
"All the basal characteristics of the three  groups of samples were summarized as Mean±Stdev,    http://www.medsci.org",OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
Variable  A (n=60)  B (n=61)  P-value   NYHA  2.77±0.67  2.75±0.67  9.93E -01  Age (yr old)  58.37±5.88  58.75±6.07  7.22E -01  SBP (mmHG)  104.72±10.93  103.57±10.36  5.56E -01  DBP (mmHG)  75.68±9.05  75.26±8.77  7.95E -01  Ang_II (pg/ml)  94.25±6.02  94.05±6.26  8.58E -01  hs_CRP (mg/l)  8.07±1.04  8.02±1.04  7.79E -01  LVESVI  54.43±4.05  54.21±3.78  7.58E -01  LVEF  35.73±3.00  35.80±3.21  9.02E -01  NT_proBNP (pg/l)  4312.40±292.66  4314.26±294.60  9.72E -01      http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
Variable  sA0 sA7 sA0 vs sA7  sA15  sA0 vs sA15   Ang_II (pg/ml)  94.83±6.13  93.40±6.12  2.67E -12 70.62±5.59  1.73E -33  hs_CRP (mg/l)  8.11±1.04  7.91±1.03  1.42E -03 5.77±0.94  1.33E -34  LVESVI  54.27±4.09  53.25±3.81  6.95E -10 47.08±3.80  3.08E -30  LVEF  36.85±2.78  37.62±2.68  2.32E -04 41.62±2.38  4.43E -29  NT_proBNP (pg/l)  4318.57±298.86  4103.65±419.12  5.96E -06 3111.80±409.03  1.24E -31  Variable  tA0 tA7 tA0 vs tA7  tA15  tA0 vs tA15   Ang_II (pg/ml)  93.10±5.75  92.00±5.80  5.39E -06 71.10±8.37  5.01E -12  hs_CRP (mg/l)  8.00±1.07  7.82±1.06  1.47E -04 5.54±0.98  4.08E -19  LVESVI  54.75±4.05  53.60±3.99  4.51E -06 47.40±3.97  8.63E -17  LVEF  33.50±2.04  34.30±2.41  5.80E -05 38.60±2.82  2.17E -16  NT_proBNP (pg/l)  4300.05±287.04  3211.80±295.34  1.92E -20 2149.60±259.82  3.27E -15  Variable  sB0 sB7 sB0 vs sB7  sB15  sB0 vs sB15   Ang_II (pg/ml)  94.56±6.39  93.34±6.48  5.50E -11 47.51±6.98  9.63E -38  hs_CRP (mg/l)  8.07±1.04  7.66±1.04  2.16E -11 3.11±0.63  1.15E -33  LVESVI  53.95±3.85  52.78±3.81  6.04E -14 40.56±3.27  8.10E -35  LVEF  36.90±3.09  37.54±3.09  8.64E -07 46.37±2.46  3.74E -25  NT_proBNP  (pg/l)  4321.17±301.67  3935.17±401.83  8.22E -17 2065.41±371.46  7.89E -37  Variable  tB0 tB7 tB0 vs tB7  tB15  tB0 vs tB15   Ang_II (pg/ml)  93.00±6.01  91.90±5.97  1.99E -04 48.00±8.57  6.23E -16  hs_CRP (mg/l)  7.93±1.06  7.77±1.00  4.88E -04 3.26±0.89  1.87E -11  LVESVI  54.75±3.65  53.25±3.39  3.92E -07 40.85±3.77  9.82E -18  LVEF  33.55±2.14  34.45±2.46  2.98E -04 42.55±2.87  2.97E -13  NT_proBNP (pg/l)  4300.10±286.65  3210.80±294.84  1.70E -20 1390.60±238.24  9.96E -20        http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
"The same differences were a lso observed in  the test datasets tA7, tB7, tA15 and tB15 in Table 5.    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
Variable  sA7 vs sB7  tA7vs tB7  sA15 vs sB15  tA15 vs tB15  2*(sA15 -sA0) vs (sB15 -sB0) 2*(tA15 -tA0) vs (tB15 -tB0)  Ang_II (pg/ml)  9.67E -01 9.57E -01 7.97E -27 1.78E -10 3.31E -01 7.71E -01  hs_CRP (mg/l)  2.87E -01 8.85E -01 3.39E -23 3.42E -09 1.39E -01 5.02E -01  LVESVI  5.81E -01 7.67E -01 3.28E -12 4.44E -06 6.55E -02 2.15E -01  LVEF  8.91E -01 8.47E -01 2.22E -13 8.76E -05 8.80E -01 4.04E -02  NT_proBNP (pg/l)  6.87E -02 9.92E -01 1.82E -19 1.04E -11 8.26E -02 1.45E -13      http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
History:  http://www.acupuncture.ca.gov/about_us/history.shtml .,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
2001.      http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/c9/ijmsv10p0624.PMC3619101.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
"High levels of NGF and NTRK1 in pancreatic  cancers and the perineurium of pancreatic nerves are  closely correlated with perineural invasion [10] , tu- mor aggressivene ss, and unfavorable prognosis, and   Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
Extracellular ATP -dependent suppression of    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
2009; 28: 1960 -70.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/3f/5f/ijmsv10p0634.PMC3619102.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
"It is well  known that hepatic steatosis plays an important role  in hepatic inflammatory necrosis and fibrosis deve l- opment  in patients with chronic hepatitis C (CHC),   Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
88  0.385       http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
"CHB patients are more likely to develop h e- patic steatosis as their BMI and WHR increase, su g- gesting that increased BMI and WHR may promote    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
Lancet  2011; 377: 529- 532.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/23/bd/ijmsv10p0641.PMC3619103.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
Al t- hough effective vaccine exists for preventing HBV   Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
"There were no differences in age, gender, HBV DNA, alanine aminotransferase (ALT) levels, ultrasound findings/presence of cirrhosis, and p eri- ods from the initial administration of ETV or LAM to    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
Attention should be paid to these features in clinical    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
2008; 23:  571-579.      http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/01/e6/ijmsv10p0647.PMC3619113.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
The secreated CRP cir- culating in the Peri pheral blood is part of the soluble   Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
Tumor grade was    http://www.medsci.org,OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
The number of male and f e-   http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
High serum CRP was obviously assoc i- ated with tumor number in HCC with an estimated    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
Wolfgang Sie ghart et al [ 31] argued    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
2007;27:1091- 7.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
2012;  56:  1299 -304.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/d4/fe/ijmsv10p0653.PMC3619114.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
"In h u- mans , however , no adverse effects on the reprodu c-  Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
"2.6 Serum Genistein Measurement   12-hours after  the last genistein injection , blood    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
"Uterine luminal   Circumference  (C)  (µm) Myometrial  Thickness ( µm) Endometrial   Thickness ( µm)  Control  1763.50 ± 80.58 *  98.63 ± 5.68*  219.77 ± 10.12*   0.5G  1504.61 ± 68.89*  67.74 ± 7.43*  269.82 ± 12.84*   5.0G  1681.02 ± 91.51*  93.14 ± 6.99*  375.93 ± 20.49†   10G 2697.83 ± 102.32*  110.65 ± 5.41†, *  382.12 ± 18.75†   25G 2820.28 ± 87.66* , † 173.42 ± 8.75†  331.08 ± 15.21†   50G 8215.57 ± 125.45† 181.04 ± 10.25†, *  344.74 ± 19.06†   100G  10280.74 ± 100.22* , † 204.59 ± 9.43†, *  340.54 ± 14.21†   E 7380.28 ± 89.65 † 148.30 ± 7.11†  367.35 ± 10.54†   P 1617.33 ± 72.25*  107.61 ± 5.69*  256.16 ± 9.16*   DMSO  1744.87 ± 85.28*  88.94 ± 8.92*  211.48 ± 13.09*           http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
Ex- cessive fluid in the uterus may cause adverse effects  on multiple reproductive processes which include    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
These levels were rarely achieved follo w- ing normal  dietary exposure to soy isoflavone even in  the population who traditionally consumed high    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
2008; 19(2): 223-234.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/6b/56/ijmsv10p0665.PMC3619115.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
"microRNAs (miRNAs ) are short, highly con- served small non -coding RNA molecules of about 22  nucleotides in length  that regulate gene expression by   binding to the 3’ untranslated region (3’ -UTR) of the   Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
2011;  17(2):211- 5.    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/9a/93/ijmsv10p0676.PMC3619116.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
Ivyspring    International Publisher     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
"Stained cells were a n- alyzed on a FACSCalibur cytometer (BD Biosciences,    http://www.medsci.org",OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
"GSTP1 mRNA expression in HCC patients was  significantly lower than in CHB patients (median,  0.04; range, 0.005 –0.33 vs. median, 0.06; range,    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
"Therefore, our result suggests that decreased GSTP1 expression takes part in the development of HCC    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
"Abbreviations   AFP, alpha fetoprotein ; ALT, alanine am i- notransferase; AST, aspartate aminotransferase; CHB, chronic hepatitis B; ELISA, enzyme -linked -  immunosorbent -assay; GSH, reduc ed glutathione  hormone; GST, glutathione -S-transferases; GSTP1,    http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
Oncol Rep. 2013; 29:875- 84.     http://www.medsci.org,OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
2010; 53:508- 18.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/c9/3c/ijmsv10p0683.PMC3619117.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
"To date, approximately 19   Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
Protein (50 µg    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
Scale bars represent  100 μ m.         http://www.medsci.org,OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
Scale bars represent 100 μ m.    http://www.medsci.org,OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
Our results are consistent with previous    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/e0/66/ijmsv10p0691.PMC3619118.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by-nc -nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
"Non- canonical pathways are diverse and grouped into  several categories, such as the planar cell polarity   Ivyspring    International Publisher     http://www.medsci.org",Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
PCR  reactions were performed using a touchdown prot o-   http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
A great si g- nificant decrease of ty rosinase and TRP1 mRNA were  detected in AdWnt5a -infected cells rather than control    http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
*p< 0.05.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
2003 ;162:899-908.     http://www.medsci.org,Non-OADS,/arxiv_data1/oa_pdf/bb/63/ijmsv10p0699.PMC3619119.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3f/3d/srep01619.PMC3619133.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/3d/srep01619.PMC3619133.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/f7/srep01621.PMC3619134.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kumar, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/f7/srep01621.PMC3619134.pdf
33. http://www.swpc.noaa.gov.,Non-OADS,/arxiv_data1/oa_pdf/aa/eb/srep01611.PMC3619135.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0 How to cite this article: Zhu, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/aa/eb/srep01611.PMC3619135.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6e/bd/srep01614.PMC3619136.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Liang, Z. et al.",Non-OADS,/arxiv_data1/oa_pdf/6e/bd/srep01614.PMC3619136.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/84/srep01617.PMC3619137.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Choi, D.H. et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/84/srep01617.PMC3619137.pdf
IMD World Competitiveness Yearbook 2007 (http://www.imd.org/).,Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
12. http://www.transparency.org/research/cpi/overview.,Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
World Bank http://data.worldbank.org/indicator.,Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
35. http://www.oecd.org/gov/43926778.pdf.36.,Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
http://www.ecb.europa.eu/pub/pdf/scpwps/ecbwp1406.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Podobnik, B., Baaquie, B.E., Bishop, S., Njavro, D. & Li, B.",Non-OADS,/arxiv_data1/oa_pdf/01/54/srep01612.PMC3619138.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/55/e3/srep01616.PMC3619140.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Liu, X.-W. et al.",Non-OADS,/arxiv_data1/oa_pdf/55/e3/srep01616.PMC3619140.pdf
The contribution from the Extremadura group is coordinated in the frame of the Iberoamerican Network of Pharmacogenetics (http://www.ribef.org).,Non-OADS,/arxiv_data1/oa_pdf/7e/24/tpj201157a.PMC3619141.pdf
"This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works3.0Unported License.Toviewacopy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Appendix .",Non-OADS,/arxiv_data1/oa_pdf/7e/24/tpj201157a.PMC3619141.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Levitas, V.I.",Non-OADS,/arxiv_data1/oa_pdf/0a/5b/srep01615.PMC3619142.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.License: This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.,Non-OADS,/arxiv_data1/oa_pdf/de/36/srep01613.PMC3619147.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Cannistraci, C.V., Alanis-Lobato, G. & Ravasi, T. From link-prediction in brain connectomes and protein interactomes to thelocal-community-paradigm in complex networks.",Non-OADS,/arxiv_data1/oa_pdf/de/36/srep01613.PMC3619147.pdf
"Galit Yovel 1,2 * and Winrich A. Freiwald 2 * Addresses: 1 School of Psychological Sciences & Sagol School of Neuroscience, Tel Aviv University, Ramat Aviv, Tel Aviv, 69987 Israel; 2 Laboratory of Neural Systems, The Rockefeller University, 1230 York Avenue, New York, NY 10065, USA * Corresponding author: Galit Yovel (gality@post.tau.ac.il) and Winrich A. Freiwald (wfreiwald@rockefeller.edu) F1000Prime Reports 2013, 5:10 (doi:10.12703/P5-10) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/10 Abstract Primate societies are based on face recognition.,Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"However, in contrast to the human brain, no face area has been found dorsal to area MT in the macaque brain, no circular arrangements of face- and body-areas have been Page 2 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Page 3 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Correspondence between human and monkey face areas based on relative and absolute anatomical location and connectivity Scenario 1 Posterior-anterior axis Species Dorso-Ventral Axisdorsal MF AF Macaque pSTS aSTS Human ventral PL ML AL AM Macaque OFA pFFA mFFA AFP Human Scenario 2 Posterior-anterior axis Species Dorso-Ventral Axisdorsal mSTS aSTS Macaque pSTS aSTS Human ventral vV4 TF AMTS Macaque OFA FFA AFP Human Scenario 3 Posterior-anterior axis Species Dorso-Ventral Axisdorsal – Macaque STS-FA(s) Human ventral PL-ML/MF-AL/AF-AM Macaque OFA - FFA - AFP Human Three scenarios indicating putative correspondences between macaque and human face areas along the posterior-anterior and dorso-ventral anatomi cal axis Page 4 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Page 5 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Page 6 of 8 (page number not for citation purposes) F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Weiner KS, Grill-Spector K: Not one extrastriate body area: using anatomical landmarks, hMT+, and visual field maps to Page 7 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Page 8 of 8 (page number not for citation purposes)F1000Prime Reports 2013, 5:10 http://f1000.com/prime/reports/b/5/10",Non-OADS,/arxiv_data1/oa_pdf/41/52/biolrep-05-10.PMC3619156.pdf
"Anderson Cancer Center, Houston, TX * Corresponding author: Scott Kopetz (SKopetz@mdanderson.org) F1000Prime Reports 2013, 5:11 (doi:10.12703/P5-11) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/m/5/11 Abstract Activating mutations of the BRAF oncogene are present in approximately 5-10% of all human malignancies and lead to constitutive activation of the mitogen activated protein kinase (MAPK)pathway.,Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"However, even though theseminal phase 1 study with vemurafenib showed acomplete or partial response in all three patients withpapillary thyroid cancer [47], to date, no clinical trials have been reported detailing the effects of BRAF inhibitor Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:11 http://f1000.com/prime/reports/m/5/11",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"Advanced solid tumors with RAS mutationsTo determine the maximum tolerated dose safety and tolerability of RAF265 in combination with theMEK inhibitor MEK162; todetermine initial anti-tumorefficacy in two separatepatient populations RO5185426 [56] Hofmann-LaRoche II Unresectable or metastatic papillary thyroid cancer harboring a BRAF mutationand resistant to radioactiveiodine therapyTo study the safety and efficacy of RO5185426 as a single agent therapy GSK2118436 [57] GlaxoSmithKline II Advanced stage/metastatic NSCLC with a V600E BRAF mutation that progressed after platinum chemotherapyTo assess the efficacy, safety, and tolerability of GSK2118436 as a single-agent therapy Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:11 http://f1000.com/prime/reports/m/5/11",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, Hogg D, Lorigan P, Lebbe C,Jouary T, Schadendorf D, Ribas A, O ’Day SJ, Sosman JA, Kirkwood JM, Eggermont AMM, Dreno B, Nolop K, Li J, Nelson B, Hou J, Lee RJ, Flaherty KT, McArthur GA: Improved survival with vemurafenib Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:11 http://f1000.com/prime/reports/m/5/11",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"Prahallad A, Sun C, Huang S, Di Nicolantonio F, Salazar R, Zecchin D, Beijersbergen RL, Bardelli A, Bernards R: Unresponsiveness of Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:11 http://f1000.com/prime/reports/m/5/11",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"Available from: www.clinicaltrials.gov/NCT01336634 Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:11 http://f1000.com/prime/reports/m/5/11",Non-OADS,/arxiv_data1/oa_pdf/b0/e5/medrep-05-11.PMC3619157.pdf
"* Corresponding author: Karla M. Neugebauer (neugebau@mpi-cbg.de) F1000Prime Reports 2013, 5:9 (doi:10.12703/P5-9) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/9 Abstract Splicing is the removal of intron sequences from pre-mRNA by the spliceosome.,Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"The average co-transcriptional Page 2 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:9 http://f1000.com/prime/reports/b/5/9",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"Page 3 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:9 http://f1000.com/prime/reports/b/5/9",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"Page 4 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:9 http://f1000.com/prime/reports/b/5/9",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"Page 5 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:9 http://f1000.com/prime/reports/b/5/9",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"Page 6 of 6 (page number not for citation purposes)F1000Prime Reports 2013, 5:9 http://f1000.com/prime/reports/b/5/9",Non-OADS,/arxiv_data1/oa_pdf/99/c2/biolrep-05-09.PMC3619158.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)IF1and apoptotic mitochondria D Faccenda et al 697 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/15/96/cdd2012163a.PMC3619234.pdf
"The number of GFP-labelled hemocytes at or in contactwith the wound margin was quantiﬁed 1 h post-ablation, with wound area measuredfrom wideﬁeld images of transmitted laser light (channel D) in NIH ImageJ (http://rsbweb.nih.gov/ij/index.html).",OADS,/arxiv_data1/oa_pdf/68/51/cdd2012166a.PMC3619236.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)SCAR drives phagosome processing and migration IR Evans et al 720 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/68/51/cdd2012166a.PMC3619236.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Li, J.F.",Non-OADS,/arxiv_data1/oa_pdf/37/bd/srep01623.PMC3619251.pdf
"Cell lines were chosen based on the presence of known mutations in the MDA-MB-231 cell line (COSMIC Database: http://www.sanger.ac.uk/perl/genetics/CGP/ cosmic?action=sample&id=905960&display=mutation) and their distinct transcriptional profiles (Neve et al, 2006).",OADS,/arxiv_data1/oa_pdf/30/be/bjc201392a.PMC3619252.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)CTC isolation using dielectrophoretic cell sorting BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.92 1367,Non-OADS,/arxiv_data1/oa_pdf/30/be/bjc201392a.PMC3619252.pdf
Supplementary Information accompanies the paper on British Journal of Cancer website (http://www.nature.com/bjc)In vivo RAF transduction as a biomarker for sorafenib efficacy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.64 1305,Non-OADS,/arxiv_data1/oa_pdf/0e/a7/bjc201364a.PMC3619253.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)ER stress mesothelioma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.66 1347,Non-OADS,/arxiv_data1/oa_pdf/33/45/bjc201366a.PMC3619254.pdf
"PBS liposomes purchased from Clodronate Liposomes Organisa- tion (http://www.clodronateliposomes.org, Vrije Universiteit, The Netherlands).",OADS,/arxiv_data1/oa_pdf/8b/0c/bjc201393a.PMC3619255.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Macrophage activation augments cancer immunotherapy BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.93 1297,Non-OADS,/arxiv_data1/oa_pdf/8b/0c/bjc201393a.PMC3619255.pdf
Website: http://www.ons.gov.uk/ ons/rel/census/census-2001-key-statistics/local-authorities-in-england-and-wales/local-authorities-ks24–migration.xls (accessed on 1 March2011).,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/bjc201389a.PMC3619259.pdf
Available at: http://www.palliativecarefunding.org.uk/PCFRFinal%20Report.pdf (accessed:18 February 2013).,Non-OADS,/arxiv_data1/oa_pdf/fc/e0/bjc201389a.PMC3619259.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Overexpression of YWHAZ in gastric carcinoma BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.65 1331,Non-OADS,/arxiv_data1/oa_pdf/40/da/bjc201365a.PMC3619260.pdf
Amplicons were designed using the EpiDesigner programme (http://www.EpiDesigner.com; Supplementary Table 2).,Non-OADS,/arxiv_data1/oa_pdf/48/d0/bjc2013104a.PMC3619261.pdf
Gene annotation was performed using the Mar 2006 (NCBI/26/hg18) assembly at the UCSC database (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/48/d0/bjc2013104a.PMC3619261.pdf
"Oncomine analysis (http://www.oncomine.org) demon- strated downregulation of NDN transcript in multiple tumour types including bladder (Sanchez-Carbayo et al, 2006), colorectal (Sabates-Bellver et al , 2007; Skrzypczak et al , 2010), ovarian, oesophageal (Kim et al, 2010) and breast (Richardson et al, 2006) compared with the normal tissue (Figure 3).",Non-OADS,/arxiv_data1/oa_pdf/48/d0/bjc2013104a.PMC3619261.pdf
org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Necdin is hypermethylated and downregulated in cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.104 1377,Non-OADS,/arxiv_data1/oa_pdf/48/d0/bjc2013104a.PMC3619261.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Adjuvant chemotherapy for gastric cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.86 1251,Non-OADS,/arxiv_data1/oa_pdf/00/39/bjc201386a.PMC3619263.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Surgical–pathological factors and early cervical cancer BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.78 1357,Non-OADS,/arxiv_data1/oa_pdf/71/88/bjc201378a.PMC3619265.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)Human-selective DMXAA analogues BRITISH JOURNAL OF CANCER www.bjcancer.com | DOI:10.1038/bjc.2013.101 1315,Non-OADS,/arxiv_data1/oa_pdf/ad/3a/bjc2013101a.PMC3619269.pdf
"In brief, 252 tag SNPs for 22 genes located at the chromosome 9p21.3 region (19.9–32.8 Mb) were genotyped at the NCI Core Genotyping Facility (Advanced Technology Center, Gaithersburg, MD; http://snp500cancer.nci.nih.gov) using a cus- tom-designed iSelect Infinium assay (Illumina, www.illumina.com).",OADS,/arxiv_data1/oa_pdf/2e/d5/bjc20137a.PMC3619272.pdf
Supplementary Information accompanies this paper on British Journal of Cancer website (http://www.nature.com/bjc)BRITISH JOURNAL OF CANCER Genetic variants in 9p21.3 and multiple tumours 1386 www.bjcancer.com | DOI:10.1038/bjc.2013.7,Non-OADS,/arxiv_data1/oa_pdf/2e/d5/bjc20137a.PMC3619272.pdf
"Questionnaires (in Danish) can be seen at the ‘Childhood malignancies – symptoms and DI’ project homepage: http://www.cap.au.dk/childhoodcancer REFERENCES Ansell P, Johnston T, Simpson J, Crouch S, Roman E, Picton S (2010) Brain tumor signs and symptoms: analysis of primary health care records fromthe UKCCS.",Non-OADS,/arxiv_data1/oa_pdf/ce/e3/bjc201388a.PMC3619273.pdf
Available at: http://www.who.int/classifications/icd/en/.,OADS,/arxiv_data1/oa_pdf/ce/e3/bjc201388a.PMC3619273.pdf
"Several major US proton centers led by the Massachusetts General Hospital and University of Pennsylvania have recently launched a phase III randomised trial of IMRT vsPBT for localised low and low-intermediate risk prostate cancer (http://clinicaltrials.gov/ct2/ show/NCT01617161), with patient-reported quality of life out- comes, as well as other clinical, physical, biological, and economic end points (including assessing cost-effectiveness under current and future conditions for alternative treatment delivery and pricing scenarios).",Non-OADS,/arxiv_data1/oa_pdf/56/b4/bjc2013100a.PMC3619274.pdf
Available from: http://www.ncbi.nlm.nih.gov/books/NBK97147/.,Non-OADS,/arxiv_data1/oa_pdf/56/b4/bjc2013100a.PMC3619274.pdf
The statistical tests were implemented in the web-based tool SNPstats (http://bioinfo.iconcologia.net/SNPstats) (30).,OADS,/arxiv_data1/oa_pdf/df/8c/ERC-38-59.PMC3619450.pdf
The high-resolution images together with annotation of the presence or absence of aparticular protein target in adipocytes are publically avail-able through the HPA (http://www.proteinatlas.org).,Non-OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
This combined reaction list resulted in an updated version of our HMRdatabase that is available at http://www.metabolicatlas.org.,OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
iAdipocytes1809 contains 6160 reactions and 4550 metabolites in 8 differentcompartments (2497 unique metabolites) (Supplementary Table S3) and it is available in the Systems Biology Mark-up Language (SBML) format at http://www.metabolicatlas.org.There are 1809 genes in the model and 80% of the reactions are associated with one or more genes.,OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
Data availability The annotation of the presence or absence of protein targets in adipocytes together with the high-resolution images is publicallyavailable through the HPA (http://www.proteinatlas.org).,OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
"GEM for adipocytes, iAdipocytes1809 and HMR database is publically available in the Systems Biology Mark-up Language (SBML) format at Human Metabolic Atlas (http://www.metabolicatlas.org).",OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
Gene expression from SATof subjects from the SOS Sib Pair Study is publically available in Gene Expression Omnibus (GEO) database with the accession number GSE27916 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=phadhqigowykote&acc=GSE27916.,OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
To view a copy ofthis licence visit http://creativecommons.org/licenses/by- nc-sa/3.0/.Human adipocyte metabolism at the genome scale A Mardinoglu et al 16Molecular Systems Biology 2013 &2013 EMBO and Macmillan Publishers Limited,Non-OADS,/arxiv_data1/oa_pdf/fa/e8/msb20135.PMC3619940.pdf
"The raw data are available from the BioDaredatabase, http://www.biodare.ed.ac.uk, for speciﬁc experimentalIDs see Supplementary Table 7.",OADS,/arxiv_data1/oa_pdf/95/a0/msb20137.PMC3619941.pdf
"Computational methods Sensitivity analysis and period estimation for simulations wereperformed in the Time Series Sensitivity Analysis MATLAB package,described in Rand (2008) and freely available from http://www2.war-wick.ac.uk/fac/sci/systemsbiology/software/.",OADS,/arxiv_data1/oa_pdf/95/a0/msb20137.PMC3619941.pdf
"Inference was performed using the functions lm(R Development Core Team, 2011) and lmer (Bates and Maechler, 2011) implemented in the open source statistical programming environment R, freely availablefrom http://www.R-project.org/.",OADS,/arxiv_data1/oa_pdf/95/a0/msb20137.PMC3619941.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by-nc-sa/3.0/.Temperature compensation by cryptochromes PD Gould et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 13,Non-OADS,/arxiv_data1/oa_pdf/95/a0/msb20137.PMC3619941.pdf
"Raw MRM data and method ﬁles are available at http://www.peptideatlas.org/ PASS/PASS00189 for absolute quantiﬁcation, and http://www.peptideatlas.org/PASS/PASS00188 for relative quantiﬁcation acrosscell lines.",OADS,/arxiv_data1/oa_pdf/6a/24/msb20134.PMC3619942.pdf
Raw shotgun MS data are available at http://www.peptideatlas.org/ PASS/PASS00190.,OADS,/arxiv_data1/oa_pdf/6a/24/msb20134.PMC3619942.pdf
To view a copy ofthis licence visit http://creativecommons.org/licenses/by- nc-sa/3.0/.Stoichiometry of the human nuclear pore complex A Ori et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 11,Non-OADS,/arxiv_data1/oa_pdf/6a/24/msb20134.PMC3619942.pdf
Fluorescence quantiﬁcation and analysis All ﬁles generated by the microscope software (Resolve3D softWoRx-Acquire Version: 4.0.0 Release 16) were processed and analyzed withImageJ 1.45s (US National Institutes of Health; http://imagej.nih.gov/ij/download.html).,OADS,/arxiv_data1/oa_pdf/c4/b1/msb20133.PMC3619943.pdf
To view a copy of this licence visit http://creativecommons.org/licenses/by- nc-sa/3.0/.Analysis of protein interactions in single cells D Moreno et al &2013 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2013 13,Non-OADS,/arxiv_data1/oa_pdf/c4/b1/msb20133.PMC3619943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.European Journal of Cardio-Thoracic Surgery 43 (2013) 946 –951 ORIGINAL ARTICLE doi:10.1093/ejcts/ezs484 Advance Access publication 6 September 2012",Non-OADS,/arxiv_data1/oa_pdf/5a/6a/ezs484.PMC3619944.pdf
"In utero , the female germ cells undergo an estimated 22 cell divisions beforeThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/ad/dys236.PMC3619950.pdf
Available from: http://www.cdc.,Non-OADS,/arxiv_data1/oa_pdf/f8/ad/dys236.PMC3619950.pdf
"Available from: http://www.nytimes.com/2009/04/05/magazine/05wwln-lede-t.html?_r=0 (31January 2013, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/f8/ad/dys236.PMC3619950.pdf
"Introduction Progress towards the Millennium Development Goals (MDGs) has been uneven.1–5Inequalities in maternal and child health are especially large.6,7Few of the poorest women in developing countries receive professional care during delivery, whereas most weal- thier women do.8The link between socio-economic disadvantage and health disadvantage has seriousconsequences: one third of global childhood deaths are attributable to inequalities in socio-economic mor- tality within countries.9Effective interventions are known,10,11but rarely reach those who need them most.12–19Even ‘basic’ interventions that are thought to favour the poor, such as oral rehydration therapy and immunisation, tend to predominantly reach those who are more economically comfortable.12–14Little is known about how to reduce socio-economic inequalities inThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/af/dyt012.PMC3619953.pdf
"Monitoring the status of children and women 2012; Available from http://www.childinfo.org/delivery_ care_countrydata.php (2 April 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/38/af/dyt012.PMC3619953.pdf
Geneva: World Health Organization; http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/38/af/dyt012.PMC3619953.pdf
"www.landesbioscience.com Small GTPases 1Small GTPases 4:1, 1–2; January/February/March 2013; © 2013 Landes Bioscience EDITOR’S CAORNER EDITOR’S PREVIEW In this issue of Small GTPases Elaine L. Ellerton Landes Bioscience; Austin, TX USA Correspondence to: Elaine L. Ellerton; Email: elaine@landesbioscience.com Submitted: 01/09/13 Accepted: 01/09/13 http://dx.doi.org/10.4161/sgtp.23610UpScaling Production of Myristoylated Arf6   pp.",Non-OADS,/arxiv_data1/oa_pdf/e8/60/sgtp-4-1.PMC3620095.pdf
"J Biol Chem 2012; 287:19550–63; PMID:22511774; http://dx.doi.org/10.1074/jbc.M112.351908Keywords:  Rab32, Rab38, BLOC-2,  AP-1, AP-3, melanosome, lysosome-relat - ed organelle, intracellular traffic Submitted: 07/09/12Revised: 09/21/12Accepted: 09/24/12http://dx.doi.org/10.4161/sgtp.22349 *Correspondence to: Santiago M. Di Pietro;   Email: santiago.dipietro@colostate.eduLysosome-related organelles (LROs)  exist in specialized cells to serve spe - cific functions and typically co-exist with conventional lysosomes.",OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mol Biol Cell  2005; 16:5356-72; PMID:16162817; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mol Biol Cell  2006; 17:4027-38; PMID:16837549; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mol Biol Cell  2007; 18:768-80; PMID:17182842; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol  2004; 164:1065-76; PMID:15051738; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Curr Opin Cell Biol  2009; 21:552-9; PMID:19497727; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 2006; 175:271-81; PMID:17043139;  http://dx.doi.org/10.1083/jcb.200606050 24.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Biochim Biophys Acta  2003; 1651:68-75; PMID:14499590; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Am J Physiol Lung Cell Mol Physiol  2011; 301:L461-77; PMID:21764986; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mamm Genome 2004; 15:307-14; PMID:15112108;  http://dx.doi.org/10.1007/s00335-004-2337-9 28.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Physiol Rev  2011; 91:119-49; PMID:21248164; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Nat Rev Mol Cell Biol 2001; 2:107-17; PMID:11252952; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Nat Rev Mol Cell Biol 2009; 10:513- 25; PMID:19603039; http://dx.doi.org/10.1038/ nrm2728References 1.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Nat Rev Mol Cell Biol 2007; 8:786-97; PMID:17878918;  http://dx.doi.org/10.1038/nrm2258 2.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Sci 2008; 121:3995- 9; PMID:19056669; http://dx.doi.org/10.1242/ jcs.040667 3.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Curr  Opin Genet Dev 2003; 13:284-9; PMID:12787791;  http://dx.doi.org/10.1016/S0959-437X(03)00059-5 4.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Annu Rev Genomics Hum Genet 2008; 9:359- 86; PMID:18544035; http://dx.doi.org/10.1146/ annurev.genom.9.081307.164303 5.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
FASEB J 2000;  14:1265-78; PMID:10877819; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Curr Opin Cell Biol 2007; 19:394- 401; PMID:17628466; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Blood 2006;  107:4857-64; PMID:16507770; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Immunity 2002; 16:697-706; PMID:12049721;  http://dx.doi.org/10.1016/S1074-7613(02)00311-4 9.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Dev Cell 2006; 10:343-54; PMID:16516837;  http://dx.doi.org/10.1016/j.devcel.2006.01.012 12.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 2001; 152:809- 24; PMID:11266471; http://dx.doi.org/10.1083/ jcb.152.4.809 13.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol  2003; 161:521-33; PMID:12732614; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Expert Rev Dermatol 2011; 6:97- 108; PMID:21572549; http://dx.doi.org/10.1586/ edm.10.70 15.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
"J Biochem 2012; 151:343-51; PMID:22323658;  http://dx.doi.org/10.1093/jb/mvs009transport machinery uncovered in mela - nocytes also functions in the biogenesis of  other LROs, such as platelet dense gran - ules and lamellar bodies.",OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Thromb Haemost 2008; 6:2143-51;  PMID:18983523; http://dx.doi.org/10.1111/j.1538- 7836.2008.03178.x 51.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Am J Pathol 2008; 173:1265-74; PMID:18832574;  http://dx.doi.org/10.2353/ajpath.2008.080056 52.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mol Biol Cell 2007; 18:3914-27;  PMID:17671165; http://dx.doi.org/10.1091/mbc.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Mol Biol Cell 2009; 20:2900-8; PMID:19403694;  http://dx.doi.org/10.1091/mbc.E08-12-1161 54.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Biol Chem  2011; 286:7507-21; PMID:21187289; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Proc Natl Acad Sci USA 2003; 100:1146- 50; PMID:12538872; http://dx.doi.org/10.1073/ pnas.0237292100 56.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Curr Biol 2010; 20:R943- 52; PMID:21056839; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Cell Logist 2011; 1:111-7; PMID:21922076;  http://dx.doi.org/10.4161/cl.1.3.1727941.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
BMC Cell Biol 2005; 6:33; PMID:16159387; http://dx.doi.org/10.1186/1471- 2121-6-33.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 2009; 187:247- 64; PMID:19841138; http://dx.doi.org/10.1083/ jcb.200907122 43.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Invest  Dermatol 2007; 127:1471-8; PMID:17301833;  http://dx.doi.org/10.1038/sj.jid.5700737 44.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Proc Natl Acad Sci USA 2003; 100:8770- 5; PMID:12847290; http://dx.doi.org/10.1073/ pnas.1532040100 45.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Biol Chem 2010;  285:7794-804; PMID:20048159; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Bioessays 2004; 26:616-28; PMID:15170859;  http://dx.doi.org/10.1002/bies.20042 49.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Curr Opin Cell Biol  2004; 16:458-64; PMID:15261680; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J  Biol Chem 2012; 287:19550-63; PMID:22511774;  http://dx.doi.org/10.1074/jbc.M112.351908 32.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Annu Rev  Cell Dev Biol 2004; 20:153-91; PMID:15473838;  http://dx.doi.org/10.1146/annurev.cell - bio.20.010403.104543 33.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Annu Rev Biochem 2003; 72:395-447; PMID:12651740; http://dx.doi.org/10.1146/ annurev.biochem.72.121801.161800 34.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Annu Rev  Cell Dev Biol 2001; 17:517-68; PMID:11687498;  http://dx.doi.org/10.1146/annurev.cellbio.17.1.517 35.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Science 1998; 280:431-4;  PMID:9545220; http://dx.doi.org/10.1126/sci - ence.280.5362.431 36.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
EMBO  J 1997; 16:917-28; PMID:9118953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
Cell 1998; 93:423-32; PMID:9590176;  http://dx.doi.org/10.1016/S0092-8674(00)81170-8 38.,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 1996; 133:749-60; PMID:8666661; http://dx.doi.org/10.1083/ jcb.133.4.749 39.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 1997; 137:835- 45; PMID:9151686; http://dx.doi.org/10.1083/ jcb.137.4.835 40.,Non-OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
J Cell Biol 2006; 175:571-8;  PMID:17116749; http://dx.doi.org/10.1083/ jcb.200607164,OADS,/arxiv_data1/oa_pdf/75/dc/sgtp-4-16.PMC3620096.pdf
"J Cell Sci 2012; 125:2457–65; PMID:22366457; http://dx.doi.org/10.1242/jcs.100966Keywords:  Dictyostelium , RacGEFs,  Zizimins, Dock proteins, Rho small  GTPases Abbreviations:  cAMP, cyclic adenosine  monophosphate; Dock, dedicator of  cytokinesis; GEF, guanine nucleotide exchange factor; DHR, Dock-homology region; PH, Plekstrin homology.",OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
"PIP 2,  phosphatidylinositol-(4,5)-bisphosphate; PIP 3, phosphatidylinositol-(3,4,5)-tri - sphosphate Submitted: 08/01/12Revised: 09/04/12Accepted: 09/05/12http://dx.doi.org/10.4161/sgtp.20287 *Correspondence to: Douwe Veltman and Robin  S.B.",Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Annu Rev Cell Dev Biol 2005; 21:247-69; PMID:16212495; http://dx.doi.org/10.1146/annurev.cellbio.21.020604.150721 3.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Eur J Cell Biol 2006; 85:947-59; PMID:16762450; http://dx.doi.org/10.1016/j.ejcb.2006.04.011 4.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Cell Sci 2012; 125:2457-65; PMID:22366457; http://dx.doi.org/10.1242/jcs.100966 5.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Nat Cell Biol 2005; 7:797-807; PMID:16025104; http://dx.doi.org/10.1038/ncb1280 6.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Methods Enzymol 2006; 406:41-57; PMID:16472648; http://dx.doi.org/10.1016/S0076-6879(06)06004-6 7.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Cell Sci 2005; 118:4937-46; PMID:16254241; http://dx.doi.org/10.1242/jcs.02671 8.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Biochem J 2001; 354:73-8; PMID:11171081; http://dx.doi.org/10.1042/0264-6021:3540073 9.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Nat Cell Biol 2002; 4:639-47; PMID:12172552; http://dx.doi.org/10.1038/ncb835 11.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Biol Chem 1996; 271:19017-20; PMID:8702569; http://dx.doi.org/10.1074/jbc.271.32.19017 12.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
"Biol Lett 2010; 6:342-5; PMID:20031978; http://dx.doi.org/10.1098/rsbl.2009.0948mutations in Zir3 have resulted in an  immunodeficiency syndrome,34 and an  autosomal-recessive form of hyper-IgE syn - drome,35,36 presenting with eosinophilia  (increased eosinophil count in peripheral blood), increased serum IgE levels and recurrent pneumonia, skin abscesses and viral infections.",Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
N Engl J Med 2009; 361:2046-55; PMID:19776401; http://dx.doi.org/10.1056/NEJMoa0905506 37.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Am J Hum Genet 2011; 89:328-33; PMID:21820096; http://dx.doi.org/10.1016/j.ajhg.2011.07.009 39.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Psychiatr Genet 2007; 17:274-86; PMID:17728666; http://dx.doi.org/10.1097/YPG.0b013e328133f352 40.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Biol Chem 2011; 286:25211-23; PMID:21532034; http://dx.doi.org/10.1074/jbc.M111.235028 41.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Cell 2003; 112:673-84; PMID:12628187; http://dx.doi.org/10.1016/S0092-8674(03)00155-7 42.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Biol Psychiatry 2010; 68:320-8; PMID:20346443; http://dx.doi.org/10.1016/j.bio - psych.2010.02.002 43.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Biochem J 2012; 442:413-22; PMID:22115042; http://dx.doi.org/10.1042/BJ20100993 44.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Curr Biol 2008; 18:1456-65; PMID:18835169; http://dx.doi.org/10.1016/j.cub.2008.08.053 45.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Neuron 2006; 51:727-39; PMID:16982419; http://dx.doi.org/10.1016/j.neu - ron.2006.07.02025.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Exp Cell Res 2007; 313:791-804; PMID:17196961; http://dx.doi.org/10.1016/j.yexcr.2006.11.017 26.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Neurosci Res 2009; 87:1794-805; PMID:19156867; http://dx.doi.org/10.1002/jnr.21997 27.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Nature 2005; 435:43-57; PMID:15875012; http://dx.doi.org/10.1038/nature03481 28.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Encyclopedia of Life Sciences  2007;  In Press; http://dx.doi.org/ 10.1002/9780470015902.a0006038 29.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Trends Mol Med 2006; 12:415-24; PMID:16890490; http://dx.doi.org/10.1016/j.molmed.2006.07.003 30.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Semin Cell Dev Biol 2011; 22:105-13; PMID:21093602; http://dx.doi.org/10.1016/j.semcdb.2010.11.002 31.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
EMBO J 2002; 21:4539-49; PMID:12198156; http://dx.doi.org/10.1093/emboj/cdf449 33.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Eur J Immunol 2011; 41:3423-35; PMID:21969276; http://dx.doi.org/10.1002/eji.201141759 35.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
"J Allergy Clin Immunol 2009; 124:1289-302, e4; PMID:20004785; http://dx.doi.org/10.1016/j.jaci.2009.10.03813.",OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Cell Sci 2011; 124:1373-82; PMID:21502134; http://dx.doi.org/10.1242/jcs.064592 14.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Dev Comp Immunol 2012; 38:160-8; PMID:22634526; http://dx.doi.org/10.1016/j.dci.2012.05.004 15.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Cell Biol 2006; 174:647-52; PMID:16943182; http://dx.doi.org/10.1083/jcb.200602142 16.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
J Biol Chem 2009; 284:27-35; PMID:19004829; http://dx.doi.org/10.1074/jbc.M808010200 18.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Science 2009; 324:384-7; PMID:19325080; http://dx.doi.org/10.1126/sci - ence.1170179 19.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Mol Biol Cell 2009; 20:699-707; PMID:19037099; http://dx.doi.org/10.1091/mbc.E08-09-0899 21.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Curr Biol 2008; 18:1456-65; PMID:18835169; http://dx.doi.org/10.1016/j.cub.2008.08.053 22.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
FEBS Lett 2005; 579:1039-46; PMID:15710388; http://dx.doi.org/10.1016/j.febslet.2005.01.006 23.,OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Immun Ageing 2012; 9:2; PMID:22494997; http://dx.doi.org/10.1186/1742-4933-9-2 24.,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
Blood 2012; 119:4451-61; PMID:22461490; http://dx.doi.org/10.1182/blood-2012-01-407098,Non-OADS,/arxiv_data1/oa_pdf/fb/e8/sgtp-4-22.PMC3620097.pdf
"EMBO J 2012; 31:2908–21; PMID:22588079; http://dx.doi.org/10.1038/emboj.2012.130Keywords:  RhoG, Rac1, Cdc42,  microRNA miR-124, ELMO/Dock180,  GEF, axonal branching, dendritic branching, cytoskeletal reorganization Submitted: 20/01/12Revised: 11/14/12Accepted: 11/16/12http://dx.doi.org/10.4161/sgtp.22922 *Correspondence to: Stefan Schumacher;   Email: stefan.schumacher@uni-ulm.deRhoG is a member of the Rho family  of small GTPases sharing highest  sequence similarity with Rac and Cdc42.",OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Cell Biol 2007; 178:1279-93; PMID:17875742; http://dx.doi.org/10.1083/jcb.200612053 5.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Immunity 2011; 35:208-22; PMID:21820331; http://dx.doi.org/10.1016/j.immuni.2011.06.003 6.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Cell Biol 2006; 175:453-63; PMID:17074883; http://dx.doi.org/10.1083/jcb.200605144 7.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Cell Sci 2009; 122:696-705; PMID:19208761; http://dx.doi.org/10.1242/jcs.040345 8.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Cell Biol 2010; 190:461-77; PMID:20679435; http://dx.doi.org/10.1083/jcb.201005141 9.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Mol Cell Biol 2000; 20:7378-87; PMID:10982854; http://dx.doi.org/10.1128/MCB.20.19.7378-7387.2000 10.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Curr Biol 2002; 12:307-12; PMID:11864571; http://dx.doi.org/10.1016/S0960-9822(02)00658-9 11.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nature 2003; 424:461-4; PMID:12879077; http://dx.doi.org/10.1038/nature01817 12.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nat Genet 2005; 37:495-500; PMID:15806104; http://dx.doi.org/10.1038/ng1536 13.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Cell 2005; 120:15-20; PMID:15652477; http://dx.doi.org/10.1016/j.cell.2004.12.035 14.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
EMBO J 2012; 31:2908-21; PMID:22588079; http://dx.doi.org/10.1038/emboj.2012.130 15.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
EMBO J 2007; 26:2371-86; PMID:17431398; http://dx.doi.org/10.1038/sj.emboj.7601680 16.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Cell Sci 2008; 121:1981-9; PMID:18505794; http://dx.doi.org/10.1242/jcs.025130 17.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Neurosci 2010; 30:14759-72; PMID:21048135; http://dx.doi.org/10.1523/JNEUROSCI.4036-10.2010expression of different gene products at  the same time.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
"Oncogene 2003; 22:330-42; PMID:12545154; http://dx.doi.org/10.1038/sj.onc.1206116 3. deBakker CD, Haney LB, Kinchen JM, Grimsley  C, Lu M, Klingele D, et al.",OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Curr Biol 2004; 14:2208-16; PMID:15620647; http://dx.doi.org/10.1016/j.cub.2004.12.029was done by constructing a series of con - centric circles with gradually increasing  radius around the neuronal cell body and then counting how many times the den - drites intersect the circumference of these concentric circles.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nature 2006; 439:283-9; PMID:16421561; http://dx.doi.org/10.1038/nature04367 29.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nat Cell Biol 2009; 11:705-16; PMID:19465924; http://dx.doi.org/10.1038/ncb1876 30.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Mol Cell 2007; 27:435-48; PMID:17679093; http://dx.doi.org/10.1016/j.mol - cel.2007.07.01524.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Development 2010; 137:4101-10; PMID:21062867; http://dx.doi.org/10.1242/dev.048637 25.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nature 2009; 461:99-103; PMID:19693013; http://dx.doi.org/10.1038/nature08242 26.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Nature 2002; 416:442-7; PMID:11919635; http://dx.doi.org/10.1038/416442a 27.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
J Biol Chem 2011; 286:37615-24; PMID:21900250; http://dx.doi.org/10.1074/jbc.M111.268029 19.,OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
Annu Rev Neurosci 1993; 16:129-58; PMID:8460888; http://dx.doi.org/10.1146/annurev.ne.16.030193.001021 22.,Non-OADS,/arxiv_data1/oa_pdf/a1/72/sgtp-4-42.PMC3620101.pdf
"Neuron 2012; 73:911–24; PMID:22405202; http://dx.doi.org/10.1016/j.neuron.2011.12.030Keywords:  RhoA, cortical mal - formations, Double Cortex, SBH,  Cobblestones, microtubules, actin Submitted: 10/19/12Revised: 11/28/12Accepted: 12/03/12http://dx.doi.org/10.4161/sgtp.23093 Correspondence to: Silvia Cappello;   Email: silvia.cappello@helmholtz-muenchen.deRho-GTPases have been found to be  crucial for cytoskeleton remodelling  and cell polarity, as well as key players in directed cell migration in various tis - sues and organs, therefore, becoming good candidates for involvement in neu - ronal migration disorders.",OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Annu  Rev Neurosci 2001; 24:1041-70; PMID:11520927; http://dx.doi.org/10.1146/annurev.neuro.24.1.1041 8.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Mol Neurobiol 2009; 40:1-14; PMID:19330467; http://dx.doi.org/10.1007/s12035-009-8065-0 10.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Mol Cell Neurosci 2008; 38:15-42; PMID:18372191; http://dx.doi.org/10.1016/j.mcn.2008.01.012 11.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Nat Neurosci 2006; 9:1099-107; PMID:16892058; http://dx.doi.org/10.1038/nn1744 12.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Dev Biol 2009; 325:162-70; PMID:19007770; http://dx.doi.org/10.1016/j.ydbio.2008.10.023 13.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Trends Neurosci 2002; 25:191-9; PMID:11998687; http://dx.doi.org/10.1016/S0166-2236(00)02118-4 15.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
J Neurosci 2011; 31:5120-30; PMID:21451048; http://dx.doi.org/10.1523/JNEUROSCI.4807-10.2011 16.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Neuron 2012; 73:911-24; PMID:22405202; http://dx.doi.org/10.1016/j.neuron.2011.12.030 18.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Nat Cell Biol 2011; 13:203-14; PMID:21336301; http://dx.doi.org/10.1038/ncb2163 19.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
J Child Neurol 2005; 20:280-6; PMID:15921227; http://dx.doi.org/10.1177/08830738050200040301 20.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Nat Cell Biol 2011; 13:989-95; PMID:21785421; http://dx.doi.org/10.1038/ncb2292 21.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
"J Neurosci 2012; 32:12619-29; PMID:22956851; http://dx.doi.org/10.1523/JNEUROSCI.1063-12.2012faster migration observed, presumably  together with the aberration in some radial glial endfeet, is likely to be responsible for the formation of basal cobblestones in a cell-autonomous way.",Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Eur J Neurosci 1999; 11:3937-44; PMID:10583482; http://dx.doi.org/10.1046/j.1460-9568.1999.00818.x 3.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Neuron 2001; 32:591-604; PMID:11719201; http://dx.doi.org/10.1016/S0896-6273(01)00504-9 4.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Annu Rev Cell Dev Biol 2004; 20:593-618; PMID:15473853; http://dx.doi.org/10.1146/annurev.cellbio.20.082503.103047 5.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Science 1997; 278:474-6; PMID:9334308; http://dx.doi.org/10.1126/science.278.5337.474 6.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Cold Spring Harb Perspect Biol 2010; 2:a001834; PMID:20182622; http://dx.doi.org/10.1101/cshperspect.a001834of the development of different types of  heterotopias.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Mol Cell Biol 2008; 28:1480-8; PMID:18086886; http://dx.doi.org/10.1128/MCB.00651-07 28.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Curr Biol 1998; 8:983-6; PMID:9742403; http://dx.doi.org/10.1016/S0960-9822(98)70402-625.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
J Biol Chem 2008; 283:14469-78; PMID:18378689; http://dx.doi.org/10.1074/jbc.M708919200 26.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
J Neurosci 2008; 28:5817-26; PMID:18509043; http://dx.doi.org/10.1523/JNEUROSCI.0853-08.200822.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
PLoS One 2011; 6:e25465; PMID:21980468; http://dx.doi.org/10.1371/journal.pone.0025465 23.,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
Neuron 2003; 40:501-14; PMID:14642275; http://dx.doi.org/10.1016/S0896-6273(03)00666-4 24.,OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
J Cell Biol 1999; 147:1109-22; PMID:10579729; http://dx.doi.org/10.1083/jcb.147.5.1109,Non-OADS,/arxiv_data1/oa_pdf/d6/6d/sgtp-4-51.PMC3620103.pdf
"It is effective to investigate such a mechanism in the spontaneous lesion of Received: 31 August 2012, Accepted: 21 September 2012 *Corresponding author: M Imaoka (e-mail: imaoka.masako.hf@ daiichisankyo.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/bd/07/tox-26-001.PMC3620208.pdf
co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/ad/14/tox-26-011.PMC3620209.pdf
"Comprehen - sive toxicity studies and the measurement of DNA adducts, oxidative stress and enzymatic activities have been demon -Received: 13 September 2012, Accepted: 6 November 2012 *Corresponding author: T Umemura (e-mail: umemura@nihs.go.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/a1/09/tox-26-019.PMC3620210.pdf
com) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/17/12/tox-26-029.PMC3620211.pdf
"Various activities of BDs have previously been reported, some of Received: 10 October 2012, Accepted: 5 December 2012 *Corresponding author: N Mizukawa (e-mail: mizukawa@ md.okayama-u.ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/bc/be/tox-26-035.PMC3620212.pdf
"This evidence suggests that systemic analysis of this model may be useful for addressing the factors that predict the activa - tion of CDC, including complement regulators in vivo .Received: 27 September 2012, Accepted: 10 December 2012 *Corresponding author:C Kato (e-mail: katoce@chugai-pharm.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/18/cc/tox-26-041.PMC3620213.pdf
"In the biopsy samples of the mesen - Received: 9 July 2012, Accepted: 26 September 2012 *Corresponding author: M Suzuki (e-mail: msuzuki@ark.ocn.ne.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc-nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/98/12/tox-26-051.PMC3620214.pdf
a4@asubio.co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/2c/7f/tox-26-055.PMC3620215.pdf
ac.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/db/d1/tox-26-061.PMC3620216.pdf
"), according to the previously defined histopathological terminology and diag - nostic criteria (goRENI, http://www.goreni.org/; Leininger and Jokinen, 1990).",Non-OADS,/arxiv_data1/oa_pdf/db/d1/tox-26-061.PMC3620216.pdf
http://www.goreni.org/.,Non-OADS,/arxiv_data1/oa_pdf/db/d1/tox-26-061.PMC3620216.pdf
"The mass was clinically confirmed to have rapidly de - veloped in the cervical region from 19 weeks of age until 21  Received: 25 October 2012, Accepted: 3 December 2012 *Corresponding authors: Y Li (e-mail: l-iyinghua@hanmail.net ) and  B-H Kang (e-mail: bkang51@chemon.co.kr) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/98/0a/tox-26-067.PMC3620217.pdf
co.jp) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/67/e9/tox-26-073.PMC3620218.pdf
"tw), Y-H Wang (e-mail: 129180@mail.tku.edu.tw) ©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.Fig.",Non-OADS,/arxiv_data1/oa_pdf/fe/4a/tox-26-079.PMC3620219.pdf
"The selected placentas were embedded in paraffin, sectioned at a thickness of 4-µm, and  Received: 28 October 2012, Accepted: 17 December 2012 *Corresponding author: S Furukawa (e-mail: furukawa@nis - sanchem.co.jp)©2013 The Japanese Society of Toxicologic Pathology This is an open-access article distributed under the terms of the Cre - ative Commons Attribution Non-Commercial No Derivatives (by-nc- nd) License <http://creativecommons.org/licenses/by-nc-nd/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/9a/45/tox-26-083.PMC3620220.pdf
This article is distributed under the terms of an Attribution–Noncommercial–Share  Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"After six months it is available under a Cre - ative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20121416/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1038/ni.195 5 Barber, D.L., E.J.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"203:2461– 2472. http://dx.doi.org/10.1084/jem.2006146 2 Fife, B.T., K.E.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/ni.179 0 Frebel, H., V. Nindl, R.A. Schuepbach, T. Braunschweiler, K. Richter, J.  Vogel, C.A.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"209:2485– 2499. http://dx.doi.org/10.1084/jem.2012101 5 Freeman, G.J., A.J.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.192.7.102 7 Ganusov, V.V., and R.J. De Boer.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1128/JVI.01128­0 8 Grakoui, A., S.K.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1126/science.285.5425.22 1 Ha, S.J., S.N.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.2007194 9 Harris, T.H., E.J.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/j.chom.2008.12.00 7 Iwai, Y., M. Ishida, Y. Tanaka, T. Okazaki, T. Honjo, and N. Minato.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1073/   pnas.19246109 9 Junt, T., E.A.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/nature0628 7 Kaufmann, D.E., D.G.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/   ni151 5 Keir, M.E., M.J. Butte, G.J.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1146/annurev.immunol.26.021607.09033 1 Kim, P.S., and R. Ahmed.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1016/j.coi.2010.02.00 5 Krutzik, P.O., and G.P.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1002/cyto.a.1007 2 Li, Q., P.J.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1126/science.116867 6 McCausland, M.M., and S. Crotty.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/j.jviromet.2007.08.02 5 McGavern, D.B., U. Christen, and M.B.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
http://dx.doi.org/10.1038/ni84 3determinant of lymphocytic choriomeningitis virus persistence and im ­ munosuppression.,Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1034/j.1600 ­065X   .2002.18913. x Brahmer, J.R., S.S. Tykodi, L.Q.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1172/JCI3438 8 Brooks, D.G., L. Teyton, M.B.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1128/JVI.79.16.10514­10527.200 5 Brooks, D.G., D.B.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1172/JCI2685 6 Brooks, D.G., M.J. Trifilo, K.H.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1038/nm149 2 Brooks, D.G., A.M. Lee, H. Elsaesser, D.B.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.2007194 8 Chemnitz, J.M., R.V.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1038/nri274 6 Curran, M.A., W. Montalvo, H. Yagita, and J.P. Allison.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1073/   pnas.091517410 7 Day, C.L., D.E.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1038/nature0511 5 Dong, H., G. Zhu, K. Tamada, and L. Chen.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/7093 2 Dustin, M.L.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1038/ni144 3 Sims, D.W., E.J.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/nature0651 8 Stinchcombe, J.C., G. Bossi, S. Booth, and G.M.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/S1074 ­  7613(01)00234­ 5 Sullivan, B.M., S.F.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi   .org/10.1056/NEJMoa120069 0 Velu, V., K. Titanji, B. Zhu, S. Husain, A. Pladevega, L. Lai, T.H.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/nature0766 2 Viswanathan, G.M., S.V.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/4483 1 Waite, J.C., I. Leiner, P. Lauer, C.S.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1371/journal.ppat.100132 6 Wherry, E.J.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1128/   JVI.77.8.4911­4927.200 3 Wherry, E.J., S.J.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/   j.immuni.2007.09.00 6 Wilson, E.B., Y. Kidani, H. Elsaesser, J. Barnard, L. Raff, C.L.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/   j.chom.2012.03.00 9 Yokosuka, T., M. Takamatsu, W. Kobayashi­Imanishi, A. Hashimoto­ Tane, M. Azuma, and T. Saito.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.2011274 1 Zajac, A.J., J.N.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.188.12.220 5 Zinselmeyer, B.H., J. Dempster, D.L.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/S0076­6879(09)05416­ 0Mempel, T.R., M.J. Pittet, K. Khazaie, W. Weninger, R. Weissleder,  H. von Boehmer, and U.H.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/   j.immuni.2006.04.01 5 Monks, C.R., B.A.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/2576 4 Moskophidis, D., F. Lechner, H. Pircher, and R.M.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/362758a 0 Mueller, S.N., and R. Ahmed.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1016/S1074 ­  7613(00)80470­ 7 Oxenius, A., M.F.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/   10.1016/j.cell.2011.01.01 1 Pircher, H., K. Bürki, R. Lang, H. Hengartner, and R.M.",OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1038/   342559a 0 Quigley, M., F. Pereyra, B. Nilsson, F. Porichis, C. Fonseca, Q. Eichbaum,  B. Julg, J.L.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"http://dx.doi.org/10.1084/jem.2011148 5 Sevilla, N., S. Kunz, A. Holz, H. Lewicki, D. Homann, H. Yamada, K.P.",Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
http://dx.doi.org/10.1084/jem.192.9.124 9,Non-OADS,/arxiv_data1/oa_pdf/23/11/JEM_20121416.PMC3620347.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Un - ported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
"http://creativecommons.org/ 	 licenses/by/3.0 	(accessed 	February 	28,	 2013).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
http://dx.doi.org/10.1083/jcb.20080403 7 	 3.,Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
"http://www.wellcome.ac.uk/ 	 stellent/groups/corporatesite/@policy_ 	 communications/documents/web_document/WTVM055715.pdf 	(accessed	 February	28,	2013).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
"http://news.bis.gov.uk/ 	 Press-Releases/Consumers-given-more-copyright-freedom-68542.aspx 	(accessed	 February	28,	2013).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
"LIBLICENSE 	entry,	 August	 5,	2012.	 http://listserv.crl.edu/ wa.exe?A2=LIBLICENSE-L;17e4abd4.1208	 	 (accessed	February	28,	2013).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
"http://opencitations.wordpress.com/ 	 2012/07/16/open-citations-extension- 	 project/ 	(accessed 	February 	28,	2013).",Non-OADS,/arxiv_data1/oa_pdf/ee/58/JEM_20130457.PMC3620348.pdf
This article is distributed under the terms of  an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the  first six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.4161/onci.2024 9 Fuentes, R., R. Allman, and M.D.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/   10.1016/S0169-5002(97)00049- 4 Fukuda, M., U. Rutishauser, and R.L.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/   10.1038/leu.2009.26 2 Gocht, A., G. Rutter, and B. Kniep.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1007/s00418005028 4 Groffen, J., and N. Heisterkamp.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/S0950-3536   (97)80002- 9 Kaur, P., N. Feldhahn, B. Zhang, D. Trageser, M. Müschen, V. Pertz, J.  Groffen, and N. Heisterkamp.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"6:67.  http://dx.doi.org/10.1186/1476-4598-6-6 7 Kiefel, M.J., B. Beisner, S. Bennett, I.D.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10   .1021/jm950611 f Klein, A., M. Krishna, N.M. Varki, and A. Varki.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1073/pnas.91.16.778 2 Kniep, B., E. Kniep, N. Ozkucur, S. Barz, M. Bachmann, F .",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1002/ijc.2178 8 Krishna, M., and A. Varki.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1084/   jem.185.11.199 7 Lanctot, P.M., F.H.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/   j.cbpa.2007.05.03 2 Lee, H.J., J.E.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1002/cncr.2569 0 Malisan, F., L. Franchi, B. Tomassini, N. Ventura, I. Condò, M.R.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1084/jem.2002096 0 Moorman, A.V.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/j.blre.2012.01.00 1 Mukherjee, K., A.K.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/   10.1002/jcb.2186 7 Parameswaran, R., M. Müschen, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-10-030 0 Parameswaran, R., M. Y u, M. Lim, J. Groffen, and N. Heisterkamp.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/   leu.2011.7 6Submitted: 6 July 2012 Accepted: 6 February 2013 REFERENCES Arming, S., D. Wipfler, J. Mayr, A. Merling, U. Vilas, R. Schauer, R.  Schwartz-Albiez, and R. Vlasak.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1093/glycob/cwq15 3 Banaszynski, L.A., M.A.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/nm.175 4 Birklé, S., S. Ren, A. Slominski, G. Zeng, L. Gao, and R.K. Yu.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
http://dx.doi   .org/10.1046/j.1471-4159.1999.0720954.,Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
http://dx.doi.org/10.1046/j.1471-4159.2000.740547.,Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1093/neuonc/nor10 8 Cariappa, A., H. Takematsu, H. Liu, S. Diaz, K. Haider, C. Boboila, G.  Kalloo, M. Connole, H.N.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1084/jem.2008139 9 Chen, H.Y., and A. Varki.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1074/jbc.M51237920 0 Chowdhury, S., and C. Mandal.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"4:361– 374. http://dx.doi.org/10.1002/biot.20080025 3 Chowdhury, S., S. Bandyopadhyay, C. Mandal, S. Chandra, and C. Mandal.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"8:40.  http://dx.doi.org/10.1186/1471-2407-8-4 0 Duy, C., C. Hurtz, S. Shojaee, L. Cerchietti, H. Geng, S. Swaminathan,  L. Klemm, S.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/   nature0988 3 Erdmann, M., D. Wipfler, A. Merling, Y .",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/   10.1007/s10719-006-9000- 5 Fahr, C., and R. Schauer.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
http://dx.doi   .org/10.1046/j.1523-1747.2001.01237.,Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1158/1535-7163.MCT-10-006 9 Fei, F., S. Stoddart, M. Müschen, Y.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
http://dx.doi   .org/10.1038/leu.2009.30 2,Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/leu.2012.5 4 Park, E., E.J.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1182/blood-2011-04-35123 9 Pasternak, G., A. Hochhaus, B. Schultheis, and R. Hehlmann.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1007/s00432005022 8 Pui, C.H., L.L.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/S0140-6736   (08)60457- 2 Ravindranath, M.H., H.H.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi   .org/10.1038/nrc156 7 Ren, S., J.N.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1096/fj.99-1028co m Rivera, G.K., Y. Zhou, M.L.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/leu.2009.26 1Satake, H., H.Y.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1074/jbc.M21056520 0 Schauer, R. 2009.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/   j.sbi.2009.06.00 3 Schauer, R., G.V.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1007/   978-1-4419-7877-6_2 8 Schrappe, M., S.P.",Non-OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1056/NEJMoa111016 9 Soneoka, Y., P.M. Cannon, E.E.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1093/nar/23.4.62 8 Varki, A., F. Hooshmand, S. Diaz, N.M. Varki, and S.M.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/   0092-8674(91)90408- Q Varki, N.M., and A. Varki.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1038/labinvest.370065 6 Vater, M., B. Kniep, H.J.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10.1016/S0165-2478(97)00116- 8 Wipfler, D., G.V.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
"http://dx.doi.org/10   .1093/glycob/cwr05 0 Yanagisawa, M., and R.K. Yu.",OADS,/arxiv_data1/oa_pdf/7b/d7/JEM_20121482.PMC3620349.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20112061/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1126/science.107595 8 Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"8:351– 358. http://dx.doi.org/10.1038/ni144 4 Atarashi, K., T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose,  G. Cheng, S. Yamasaki, T. Saito, Y. Ohba, et al.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1126/science.119846 9 Bautista, J.L., C.W.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/ni.173 9 Bennett, C.L., J. Christie, F. Ramsdell, M.E.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/8371 3 Brunkow, M.E., E.W.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/8378 4 Burchill, M.A., J. Yang, C. Vogtenhuber, B.R.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/   10.1038/ni131 8 Igarashi, H., S.C. Gregory, T. Yokota, N. Sakaguchi, and P.W.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.1016/S1074-7613(02)00366- 7 Jiang, W., W.J.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/375151a 0 Jordan, M.S., A. Boesteanu, A.J.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/8630 2 Kawahata, K., Y. Misaki, M. Yamauchi, S. Tsunekawa, K. Setoguchi, J.  Miyazaki, and K. Yamamoto.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"4:337– 342. http://dx.doi.org/10.1038/ni90 9 Kumanogoh, A., X. Wang, I. Lee, C. Watanabe, M. Kamanaka, W. Shi, K.  Yoshida, T. Sato, S. Habu, M. Itoh, et al.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2010232 7 Li, J., J.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10   .1016/j.immuni.2007.11.02 1 Lio, C.W., L.F. Dodson, C.M.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.4049/jimmunol.100001 9 Liston, A., and A.Y.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/j.coi.2007.02.00 5 Liston, A., K.M.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/j.it.2006.03.00 4 Lomada, D., B. Liu, L. Coghlan, Y. Hu, and E.R.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"65:139– 243. http://dx.doi.org/10.1016/S0065-2776(08)60743- 9 Martorell, J., I. Rojo, R. Vilella, E. Martinez-Caceres, and J. Vives.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10   .1016/j.immuni.2007.11.02 2 Ciofani, M., and J.C. Zúñiga-Pflücker.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-11-279 1 Coquet, J.M., S. Middendorp, G. van der Horst, J.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.1016/j.immuni.2012.09.00 9 Derbinski, J., J. Gäbler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn,  L. Peltonen, J. Walter, and B. Kyewski.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2005047 1 Dorner, B.G., M.B.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.02 7 Eldering, E., C.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.1093/nar/gng15 3 Fontenot, J.D., M.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/ni90 4 Fontenot, J.D., J.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2005078 4 Fontenot, J.D., J.P. Rasmussen, M.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/ni126 3 Gallegos, A.M., and M.J. Bevan.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2004145 7 Gravestein, L.A., W. van Ewijk, F. Ossendorp, and J. Borst.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10   .1084/jem.184.2.67 5 Gray, D., J. Abramson, C. Benoist, and D. Mathis.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2007079 5 Hendriks, J., L.A. Gravestein, K. Tesselaar, R.A. van Lier, T.N.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.1084/jem.2003091 6 Hendriks, J., Y. Xiao, J.W.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1093/intimm/6.3.47 7 Hori, S., T. Nomura, and S. Sakaguchi.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
http://dx.doi.org/10.1126/science.107949 0,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/j.immuni   .2009.04.01 0 Soares, H., H. Waechter, N. Glaichenhaus, E. Mougneau, H. Yagita, O.  Mizenina, D. Dudziak, M.C.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1084/jem.2007017 6 Spence, P.J., and E.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/ni116 0 Taylor, S.R., D.R.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/0092-8674(88)90156- 0 van Santen, H.M., C. Benoist, and D. Mathis.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.1084/jem.2004102 2 Van Vliet, E., M. Melis, and W. Van Ewijk.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1002/eji.183014060 8 Vang, K.B., J. Yang, A.J.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"184:4074– 4077. http://dx.doi.org/10.4049/jimmunol.090393 3 von Boehmer, H. 2004.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"436:1181– 1185. http://dx.doi.org/10.1038/nature0388 6 Wildin, R.S., F. Ramsdell, J. Peake, F. Faravelli, J.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
http://dx.doi.org/10.1084/jem.2008004 6double-positive thymocytes reflects competing effects on Bcl-2 expres - sion and can be regulated by the intensity of CD28 costimulation.,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
http://dx.doi.org/10   .1111/j.1600-065X.2009.00774.,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
http://dx.doi.org/   10.1038/icb.2010.,Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1093/intimm/10.4.51 7 Ouyang, W ., O. Beckett, Q. Ma, and M.O.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/   10.1016/j.immuni.2010.04.01 2 Pacholczyk, R., H. Ignatowicz, P .",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.05.01 6 Peperzak, V., E.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi   .org/10.4049/jimmunol.100015 9 Peperzak, V., Y. Xiao, E.A.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/   10.1172/JCI4017 8 Proietto, A.I., S. van Dommelen, P. Zhou, A. Rizzitelli, A. D’Amico,  R.J. Steptoe, S.H.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1073/   pnas.081026810 5 Ribot, J., P. Romagnoli, and J.P. van Meerwijk.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.1038/ni.171 7 Romagnoli, P., D. Hudrisier, and J.P. van Meerwijk.",Non-OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
"http://dx.doi.org/10.4049/jimmunol.090066 5 Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. T oda.",OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
http://dx.doi.org/10   .1016/j.cell.2008.05.00 9,OADS,/arxiv_data1/oa_pdf/ef/b0/JEM_20112061.PMC3620350.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
Online supplemental material is avail - able at http://www.jem.org/cgi/content/full/jem.20122126/DC1.,Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/   10.1128/MCB.22.12.4053-4061.200 2 Bourguignon, L.Y ., E. Gilad, A. Brightman, F .",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1074/jbc.M50773420 0 Brancaccio, M., E. Hirsch, A. Notte, G. Selvetella, G. Lembo, and G. Tarone.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/j.cardiores.2005.12.01 5 Burridge, K., and K. Wennerberg.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00003- 0 Clerk, A., and P.H.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1196/   annals.1302.01 9 Frey, N., and E.N.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1146/   annurev.physiol.65.092101.14224 3 Frey, N., H.A.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10   .1016/S0076-6879(06)06031- 9 Guilluy, C., V. Swaminathan, R. Garcia-Mata, E.T.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"13:722– 727. http://dx.doi.org/10.1038/ncb225 4 Hall, A.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"279:509– 514. http://dx.doi.org/10.1126/science.279.5350.50 9 Heineke, J., and J.D.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1038/nrm198 3 Herroeder, S., P .",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.02.01 0 Hill, J.A., and E.N.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1056/NEJMra07213 9 Ito, H., Y. Hirata, S. Adachi, M. Tanaka, M. Tsujino, A. Koike, A. Nogami,  F. Murumo, and M. Hiroe.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/   10.1172/JCI11657 9 Lammerding, J., R.D.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi   .org/10.1196/annals.1302.00 5 Laser, M., C.D.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1074/jbc.M00612420 0 Luber, C.A., J. Cox, H. Lauterbach, B. Fancke, M. Selbach, J. Tschopp, S.  Akira, M. Wiegand, H. Hochrein, M. O’Keeffe, and M. Mann.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/j.immuni   .2010.01.01 3 Miyamoto, S., D.P.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/   10.1007/s12265-010-9192- 8 Olson, E.N., and A. Nordheim.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1038/nrm289 0Riobo, N.A., and D.R.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/j.tips.2005.01.00 7 Rockman, H.A., W.J.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1038/415206 a Rossman, K.L., C.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1038/nrm158 7 Sadoshima, J., and S. Izumo.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1146/annurev.physiol.59.1.55 1 Sadoshima, J., Y. Xu, H.S.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1016/   0092-8674(93)90541- W Takefuji, M., A. Wirth, M. Lukasova, S. Takefuji, T. Boettger, T. Braun,  T. Althoff, S. Offermanns, and N. Wettschureck.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi   .org/10.1161/CIRCULATIONAHA.112.10925 6 Torsoni, A.S., S.S. Constancio, W. Nadruz Jr., S.K.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1161/01.RES.0000081595.25297   .1B Wang, N., J.D.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1038/   nrm259 4 Xiang, S.Y., D. Vanhoutte, D.P.",Non-OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
"http://dx.doi.org/10.1172/JCI4437 1 Yutao, X., W. Geru, B. Xiaojun, G. Tao, and M. Aiqun.",OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
http://dx.doi.org/10.1016/j.ejheart.2005.05.01 4,OADS,/arxiv_data1/oa_pdf/7e/57/JEM_20122126.PMC3620351.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.1182/blood-2004-03-079 1 Choi, B.K., T. Asai, D.S.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1016/j.cyto.2006.04.00 8 Choi, B.K., Y.H.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.4049/jimmunol.080045 9 Collins, P.L., S. Chang, M. Henderson, M. Soutto, G.M.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.4049/jimmunol.100012 4 Curran, M.A., and J.P. Allison.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
http://dx.doi.org/10.1158/0008-5472.,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1371/ journal.pone.001949 9 DeBenedette, M.A., A. Shahinian, T.W.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi   .org/10.4049/jimmunol.080116 2 Dubrot, J., F. Milheiro, C. Alfaro, A. Palazón, I. Martinez-Forero, J.L.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1007/s00262-010-0846- 9 Futagawa, T., H. Akiba, T. Kodama, K. Takeda, Y. Hosoda, H. Yagita, and  K. Okumura.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.1093/intimm/14.3.27 5Ebi3/, T-bet/, OT-II, Pmel, and CD4-Cre mice were obtained from The  Jackson Laboratory.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1371/journal.pone.001100 3 Lucas, S., N. Ghilardi, J. Li, and F.J. de Sauvage.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
222:277– 286. http://dx.doi.org/10.1111/j.1600-065X.2008.00621.,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1126/science.117833 4 Owaki, T., M. Asakawa, N. Morishima, I. Mizoguchi, F. Fukai, K. Takeda,  J. Mizuguchi, and T. Yoshimoto.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1084/jem.2009191 8 Qui, H.Z., A.T. Hagymasi, S. Bandyopadhyay, M.C.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.4049/   jimmunol.110124 4 Rao, R.R., Q. Li, K. Odunsi, and P.A.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.10.01 0 Rutishauser, R.L., and S.M.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi   .org/10.1038/nm110 7 Shuai, K., G.R.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1126/science   .769098 9 Shuford, W.W., K. Klussman, D.D.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1084/jem.186.1.4 7 Siebler, J., S. Wirtz, C. Frenzel, M. Schuchmann, A.W.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.1038/nm1202-79 6 Sun, Y., X. Lin, H.M. Chen, Q. Wu, S.K.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/   10.1097/CJI.0b013e318209e7e c Herrero, C., X. Hu, W.P.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1093/intimm/dxm13 9 Hurtado, J.C., Y.J.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1016/j.immuni.2011.02.02 1 Intlekofer, A.M., A. Banerjee, N. Takemoto, S.M.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi   .org/10.1126/science.115980 6 Johnston, J.A., C.M.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.4049/jimmunol.100268 1 Kocak, E., K. Lute, X. Chang, K.F.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-05-212 8 Kwon, B.S., J.C. Hurtado, Z.H.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi   .org/10.1016/j.imlet.2005.06.00 1 Lee, S.C., S.A. Ju, H.N.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"73:5144– 5151. http://dx.doi.org/10.1128/IAI.73.8.5144-5151.200 5 Li, B., J. Lin, M. Vanroey, M. Jure-Kunkel, and K. Jooss.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1016/j.clim.2007.07.00 5 Lin, G.H., B.J.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1002/1521-4141(200212)32:12<3617::AID-   IMMU3617>3.0.CO;2- MWang, C., G.H.",Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
http://dx.doi.org/10.1111/j.1600-065X.2009.00765.,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
"http://dx.doi.org/10.1084/jem.2009192 1 Zhao, D.M., S. Yu, X. Zhou, J.S.",OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
http://dx.doi.org/10.4049/jimmunol.090119 9,Non-OADS,/arxiv_data1/oa_pdf/2d/52/JEM_20121190.PMC3620352.pdf
This article is distributed under the terms of an   Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first   six months after the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.05.01 0 De Smedt, M., K. Reynvoet, T. Kerre, T. Taghon, B. Verhasselt, B.  Vandekerckhove, G. Leclercq, and J.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1182/   blood-2005-02-049 6 Dik, W.A., K. Pike-Overzet, F. Weerkamp, D. de Ridder, E.F. de Haas,  M.R.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10   .1084/jem.2004252 4 Dontje, W., R. Schotte, T. Cupedo, M. Nagasawa, F. Scheeren, R. Gimeno,  H. Spits, and B. Blom.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1182/blood-2005-05-209 0 Garbe, A.I., and H. von Boehmer.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.it.2007.01.00 4 Garbe, A.I., A. Krueger, F. Gounari, J.C. Zúñiga-Pflücker, and H. von  Boehmer.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"203:1579– 1590. http://dx.doi.org/10.1084/jem.2006047 4 García-Peydró, M., V.G.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1182/blood-2002-10-326 1 Gordon, J., S. Xiao, B. Hughes III, D.M.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"7:69. http://dx.doi.org/10.1186/1471-213X-7-6 9 Haks, M.C., J.M.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.immuni   .2005.04.00 3 Hayes, S.M., L. Li, and P.E.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi   .org/10.1016/j.immuni.2005.03.01 4 Heinzel, K., C. Benz, V.C.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1084/jem.2008013 4 Jiang, R., Y. Lan, H.D.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"12:1046– 1057. http://dx.doi.org/10.1101/gad.12.7.104 6 Klinakis, A., C. Lobry, O. Abdel-Wahab, P. Oh, H. Haeno, S. Buonamici,   I. van De Walle, S. Cathelin, T. Trimarchi, E. Araldi, et al.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1038/nature0999 9 Koch, U., and F. Radtke.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/S0070-2153(10)92013- 9 Koch, U., E. Fiorini, R. Benedito, V. Besseyrias, K. Schuster-Gossler, M.  Pierres, N.R.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
http://dx.doi.org/10.1084/jem.2008082 9and EGFP+ cells were sorted.,OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1126/scisignal.2100jc 2 Artavanis-Tsakonas, S., M.D.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"284:770– 776. http://dx.doi.org/10.1126/science.284.5415.77 0 Beatus, P., J. Lundkvist, C. Oberg, and U. Lendahl.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/   j.cell.2009.03.02 5 Blom, B., and H. Spits.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1146/annurev   .immunol.24.021605.09061 2 Ciofani, M., and J.C. Zúñiga-Pflücker.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi   .org/10.1016/j.cell.2009.03.04 5 Kreslavsky, T., M. Gleimer, and H. von Boehmer.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.coi.2009.12.00 6 Li, K., Y. Li, W. Wu, W.R. Gordon, D.W. Chang, M. Lu, S. Scoggin,  T. Fu, L. Vien, G. Histen, et al.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1074/ jbc.M80017020 0 Lobry, C., P. Oh, and I. Aifantis.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1084/jem.2011185 5 Mancini, S.J., N. Mantei, A. Dumortier, U. Suter, H.R.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"105:2340– 2342. http://dx.doi.org/10.1182/blood-2004-08-320 7 Petrie, H.T., and J.C. Zúñiga-Pflücker.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1146/annurev.immunol   .23.021704.11571 5 Plum, J., M. De Smedt, G. Leclercq, T .",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1007/s00281-008-0135- 2 Radtke, F ., A. Wilson, G. Stark, M. Bauer, J. van Meerwijk, H.R.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi   .org/10.1016/S1074-7613(00)80054- 0 Radtke, F., N. Fasnacht, and H.R.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/   j.immuni.2010.01.00 4 Shi, J., M. Fallahi, J.L.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1182/blood-   2011-04-34672 6 Suliman, S., J. Tan, K. Xu, P.C.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1371/journal.pone.002493 7 Taghon, T., and E.V.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1007/   s00281-008-0134- 3 Taghon, T., M. De Smedt, F. Stolz, M. Cnockaert, J.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.immuni.2005.11.01 2 Taghon, T., I.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1182/blood-2008-07-16890 6 Taghon, T., E. Waegemans, and I.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1007/82_2012_23 0 Timmermans, F., I. Velghe, L. Vanwalleghem, M. De Smedt, S. Van  Coppernolle, T. Taghon, H.D.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/   10.1182/blood-2010-06-29004 9 Vermijlen, D., M. Brouwer, C. Donner, C. Liesnard, M. Tackoen, M. Van  Rysselberge, N. Twité, M. Goldman, A. Marchant, and F. Willems.",Non-OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1084/jem.2009034 8 Wang, T., C.M.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/j.cellsig.2007.07.01 9 Washburn, T., E. Schweighoffer, T. Gridley, D. Chang, B.J.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)81929- 7 Wilson, A., H.R.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1084/jem.194.7.100 3 Wolfer, A., A. Wilson, M. Nemir, H.R.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1016/S1074-   7613(02)00330- 8 Xu, J., L.T.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
"http://dx.doi.org/10.1101/gad.179370 9 Yashiro-Ohtani, Y., T. Ohtani, and W.S.",OADS,/arxiv_data1/oa_pdf/91/7f/JEM_20121798.PMC3620353.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
Online supplemental material is available at  http://www.jem.org/cgi/content/full/jem.20122609/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10   .1038/ni87 8 Benz, C., V.C.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1084/jem.2007216 8 Bhandoola, A., and A. Sambandam.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/nri177 8 Bhandoola, A., H. von Boehmer, H.T.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"26:678– 689. http://dx.doi.org/10.1016/j.immuni.2007.05.00 9 Bosco, N., C. Engdahl, A. Bénard, J. Rolink, R. Ceredig, and A.G. Rolink.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"38:3520– 3529. http://dx.doi.org/10.1002/eji.20083866 8 Branda, C.S., and S.M.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00399- X Bruno, L., B. Rocha, A. Rolink, H. von Boehmer, and H.R.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1002/   eji.183025071 3 Burtrum, D.B., S. Kim, E.C.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/   nri93 7 Chang, Y.F., J.S.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/ni114 1 Corcoran, L., I. Ferrero, D. Vremec, K. Lucas, J. Waithman, M. O’Keeffe, L. Wu,  A. Wilson, and K. Shortman.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/   10.1038/ni.225 5 Luche, H., O. Weber, T. Nageswara Rao, C. Blum, and H.J.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1002/eji.20063674 5 Luche, H., L. Ardouin, P .",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1002/eji   .20114172 8 Luo, M.J., and R. Reed.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1182/blood-2008-02-14263 8 Martin, C.H., I. Aifantis, M.L.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/   ni965 Martin, D.I., and E. Whitelaw.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1002/bies.95018111 1 Montoliu, L., S. Chávez, and M. Vidal.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1023/A:100899573028 5 Moore, M.J., and N.J. Proudfoot.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/j.cell.2009.02.00 1 Petrie, H.T., and P .W .",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1084/jem   .2005099 0 Porritt, H.E., L.L.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/   10.1016/j.immuni.2004.05.00 4 Prinz, I., A. Sansoni, A. Kissenpfennig, L. Ardouin, M. Malissen, and B.  Malissen.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
http://dx.doi.org/   10.1111/j.1600-065X.2010.00964.,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1182/blood-2009-07-   23082 1 Schlenner, S.M., V. Madan, K. Busch, A. Tietz, C. Läufle, C. Costa, C.  Blum, H.J.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
http://dx.doi.org/10.1016/j.immuni.2010.03.00 5Natl.,OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1073/   pnas.96.25.1449 3 Dejbakhsh-Jones, S., M.E.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1073/   pnas.13155979 8 Dudley, E.C., M. Girardi, M.J. Owen, and A.C. Hayday.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/S0960-9822(95)00131- X Fehling, H.J., A. Krotkova, C. Saint-Ruf, and H. von Boehmer.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1038/375795a 0 Feyerabend, T.B., G. Terszowski, A. Tietz, C. Blum, H. Luche, A. Gossler,  N.W.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.10.01 6 García-Ojeda, M.E., S. Dejbakhsh-Jones, D. Chatterjea-Matthes, A.  Mukhopadhyay, A. BitMansour, I.L.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/ni77 8 Hadjantonakis, A.K., M.E.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/nrg112 6 Havran, W.L., and J.P. Allison.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1038/344068a 0 Havran, W .L., and J.M.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.4049/jimmunol   .090273 3 Hayday , A.C. 2009.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/j.immuni.2009   .08.00 6 Hayday, A.C., and D.J.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1038/ni143 6 Hayday, A.C., H. Saito, S.D.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1016/0092-8674(85)90140- 0 Hennet, T., F.K.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/0022-1759(93)90370- M Krueger, A., and H. von Boehmer.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1016/j.immuni.2006.12.00 4 Krueger, A., S. Willenzon, M. Lyszkiewicz, E. Kremmer, and R. Förster.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1182/blood-2009-07-23572 1 Lee, S.Y., J. Stadanlick, D.J.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
http://dx.doi.org/10.1111/j.0105- 2896.2009.00879. x,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1182/blood-2008-08-17368 2 Shen, H.Q., M. Lu, T. Ikawa, K. Masuda, K. Ohmura, N. Minato, Y .",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1371/journal.pone.004659 0 Shimshek, D.R., J. Kim, M.R.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1002/gene.1002 3 Shortman, K., and W .R.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1111/j.0105-2896.2009   .00870. xShortman, K., and S.H.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10   .1038/nri199 6 Srinivas, S., T. Watanabe, C.S.",Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi   .org/10.1038/nri163 6 Wilson, A., and H.R.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.1016/j.smim.2005   .05.00 1 Y ui, M.A., N. Feng, and E.V .",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
"http://dx.doi.org/10.4049/jimmunol.100067 9 Zlotoff, D.A., and A. Bhandoola.",OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
http://dx.doi   .org/10.1111/j.1749-6632.2010.05881.,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
http://dx.doi   .org/10.1182/blood-2009-08-23778 4,Non-OADS,/arxiv_data1/oa_pdf/ef/aa/JEM_20122609.PMC3620354.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
Online supplemental material is  available at http://www.jem.org/cgi/content/full/jem.20122005/DC 1.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/j.conb.2009.08.00 7 Harding, H.P., I. Novoa, Y. Zhang, H. Zeng, R. Wek, M. Schapira, and D.  Ron.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1016/S1097-2765(00)00108- 8 Harding, H.P., M. Calfon, F. Urano, I. Novoa, and D. Ron.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1146/annurev.cellbio.18.011402.16062 4 Jesuraj, N.J., P.K.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/jnr.2275 2 Kirschner, D.A., L. Wrabetz, and M.L.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/jnr.1025 5 Kojima, E., A. Takeuchi, M. Haneda, A. Yagi, T. Hasegawa, K. Yamaki,  K. Takeda, S. Akira, K. Shimokata, and K. Isobe.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"17:1573– 1575. http://dx.doi.org/10.1096/fj.02-0462co m Kubo, T., T. Yamashita, A. Yamaguchi, K. Hosokawa, and M. Tohyama.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/   10.1046/j.1471-4159.2002.01060.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/ng0993-3 5 Le, N., R. Nagarajan, J.Y .",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10   .1073/pnas.040783610 2 Leblanc, S.E., R. Srinivasan, C. Ferri, G.M.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1111/j.1471-4159.2005.03056.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10   .1038/nn.227 3 Lin, J.H., H. Li, D. Yasumura, H.R.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.2353/ajpath.2008.08044 9 Madorsky, I., K. Opalach, A. Waber, J.D.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/j.nbd.2009.01.00 2 Mager, G.M., R.M.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1074/jbc.M10427120 0 Arthur-Farraj, P.J., M. Latouche, D.K.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1016/j.neuron.2012.06.02 1 Back, S.H., D. Scheuner, J. Han, B.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/j.cmet.2009.06.00 2 Barbosa-Tessmann, I.P., C. Chen, C. Zhong, S.M.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1074/jbc.274.44.3113 9 Berger, P., A. Niemann, and U. Suter.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/glia.2038 6 Bosse, F., K. Hasenpusch-Theil, P. Küry, and H.W.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1111/ j.1471-4159.2005.03635.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1126/science.110190 2 Colby, J., R. Nicholson, K.M.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1006/nbdi.2000.032 3 D’Antonio, M., D. Michalovich, M. Paterson, A. Droggiti, A. Woodhoo,  R. Mirsky, and K.R.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/glia.2030 9 D’Antonio, M., M.L.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/jnr.2206 6 Feltri, M.L., M. D’antonio, A. Quattrini, R. Numerato, M. Arona, S.  Previtali, S.Y.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10   .1046/j.1460-9568.1999.00568.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1016/j.nbd.2006.09.01 8 Fukuda, S., M. Sumii, Y. Masuda, M. Takahashi, N. Koike, J. Teishima, H.  Yasumoto, T. Itamoto, T. Asahara, K. Dohi, and K. Kamiya.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1006/bbrc.2000.411 1 Giambonini-Brugnoli, G., J. Buchstaller, L. Sommer, U. Suter, and N.  Mantei.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1016/j.nbd.2004.10.02 3 Giese, K.P., R. Martini, G. Lemke, P. Soriano, and M. Schachner.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1016/0092-8674(92)90591- Y,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"30:11388– 11397. http://dx.doi.org/10.1523/JNEUROSCI.1356-10.201 0 Ron, D., and P. Walter.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/nrm219 9 Rutkowski, D.T., S.M.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1371/journal.pbio.004037 4 Saporta, M.A., B.R.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1093/   brain/aws14 0 Saxena, S., E. Cabuy, and P. Caroni.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/nn.229 7 Scherer, S.S., and L. Wrabetz.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1002/glia.2075 1 Scheuner, D., B.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/S1097-2765(01)00265- 9 Southwood, C.M., J. Garbern, W. Jiang, and A. Gow.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)01045- 0 Svaren, J., and D. Meijer.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1002/glia.2076 7 Tabas, I., and D. Ron.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/ncb0311-18 4 Taveggia, C., G. Zanazzi, A. Petrylak, H. Yano, J. Rosenbluth, S. Einheber,  X. Xu, R.M.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"47:681– 694. http://dx.doi.org/10.1016/j.neuron.2005.08.01 7 Ten Asbroek, A.L., F. Van Ruissen, J.M.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1002/jnr.2096 6 Topilko, P., S. Schneider-Maunoury, G. Levi, A. Baron-Van Evercooren,  A.B.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/371796a 0 Tsang, K.Y., D. Chan, D. Cheslett, W.C. Chan, C.L.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1371/journal.pbio.005004 4 Tsaytler, P., H.P.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1126/science.120139 6 van der Knaap, M.S., J.C. Pronk, and G.C.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1016/   S1474-4422(06)70440- 9by promoting protein synthesis and oxidation in the stressed endoplas - mic reticulum.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1101/   gad.125070 4 Miller, L.J., A. Patzko, R.A. Lewis, and M.E.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1111/j.1529-8027.2012.00398.,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1016/S0896-6273(01)00282- 3 Nagarajan, R., N. Le, H. Mahoney, T. Araki, and J. Milbrandt.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1186/gb-2005-6-9-r8 1 Nodari, A., D. Zambroni, A. Quattrini, F.A.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1083/jcb.20061001 4 Novoa, I., H. Zeng, H.P.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1083/jcb.153.5.101 1 Novoa, I., Y. Zhang, H. Zeng, R. Jungreis, H.P.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi   .org/10.1093/emboj/cdg11 2 Oda, Y., T. Okada, H. Yoshida, R.J. Kaufman, K. Nagata, and K. Mori.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1083/jcb.20050705 7 Oh-hashi, K., H. Koga, S. Ikeda, K. Shimada, Y. Hirata, and K. Kiuchi.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1016/   j.bbrc.2009.07.04 7 Ohoka, N., S. Yoshii, T. Hattori, K. Onozaki, and H. Hayashi.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1083/jcb.20080301 3 Patzig, J., O. Jahn, S. Tenzer, S.P.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"31:16369– 16386. http://dx.doi.org/10.1523/JNEUROSCI.4016-11.201 1 Pennuto, M., E. Tinelli, M. Malaguti, U. Del Carro, M. D’Antonio, D.  Ron, A. Quattrini, M.L.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1101/gad.111620 3 Wei, M.C., W.X.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1083/jcb.148.5.102 1 Wrabetz, L., M.L.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.3819-05.200 6 Yum, S.W., K.A.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1006/nbdi.2002.054 5 Zeng, L., M. Lu, K. Mori, S. Luo, A.S. Lee, Y. Zhu, and J.Y.",OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
"http://dx.doi.org/10.1038/sj.emboj.760010 6 Zinszner, H., M. Kuroda, X. Wang, N. Batchvarova, R.T. Lightfoot, H.  Remotti, J.L.",Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
http://dx.doi.org/10.1101/gad   .12.7.98 2,Non-OADS,/arxiv_data1/oa_pdf/47/2d/JEM_20122005.PMC3620355.pdf
This article is distributed under the terms of an Attribution–   Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
Online supplemental material  is available at http://www.jem.org/cgi/content/full/jem.20122824/DC1.,Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi   .org/10.1128/JVI.01762-0 8 Diskin, R., J.F.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1126/science.121378 2 Gray, E.S., M.C.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"The 2010 Filtered Web Alignment (excluding   4 SIV sequences; Los Alamos HIV Database, http://www.hiv.lanl.gov/) was  used to determine the frequency of NLGS in Env.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1128/JVI.02036-0 8 Saunders, C.J., R.A. McCaffrey, I. Zharkikh, Z. Kraft, S.E.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1128/JVI.79.14.9069-9080.200 5 Scheid, J.F., H. Mouquet, B. Ueberheide, R. Diskin, F. Klein, T.Y.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi   .org/10.1126/science.120722 7 Schief, W.R., Y.E.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi   .org/10.1016/j.vaccine.2009.10.02 8 Stamatatos, L. 2012.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10 .1016/   j.coi.2012.04.00 6 Waisman, A., M. Kraus, J. Seagal, S. Ghosh, D. Melamed, J.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1084/jem.2006202 4 Wakabayashi, C., T. Adachi, J. Wienands, and T. Tsubata.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1126/science.107696 3 West, A.P.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1126/   science.118765 9 Wu, X., T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N.S.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1126/science.120753 2 Wyatt, R., N. Sullivan, M. Thali, H. Repke, D. Ho, J. Robinson, M. Posner,  and J. Sodroski.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1016/j.bbrc.2009.09.02 9 Zhou, T., I. Georgiev, X. Wu, Z.Y.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
http://dx.doi.org/10.1126/science.119281 9decline and high viral load during acute infection.,Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"85:4828– 4840. http://dx.doi.org/10.1128/JVI.00198-1 1 Gray, G.E., M. Allen, Z. Moodie, G. Churchyard, L.G.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1016/   S1473-3099(11)70098- 6 Hoot, S., A.T. McGuire, K.W.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1371/journal.ppat.100310 6 Horikawa, K., S.W.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1084/jem.2006192 3 Huang, P.S., Y.E.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/   10.1371/journal.pone.002410 9 Kwong, P.D., and J.R. Mascola.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.08.01 2 Li, Y., S.A. Migueles, B. Welcher, K. Svehla, A. Phogat, M.K.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1038/nm162 4 Li, Y., S. O’Dell, L.M.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1128/   JVI.00754-1 1 Ly, A., and L. Stamatatos.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1128/JVI.74.15.6769-6776.200 0 Lynch, R.M., L. Tran, M.K.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1128/JVI.00734-1 2 Mascola, J.R., and D.C. Montefiori.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1146/   annurev-immunol-030409-10125 6 Mikell, I., D.N.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.1371/journal   .ppat.100125 1 Ota, T., C. Doyle-Cooper, A.B.",Non-OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
"http://dx.doi.org/10.4049/jimmunol.120216 5 Sather, D.N., J. Armann, L.K.",OADS,/arxiv_data1/oa_pdf/dc/fd/JEM_20122824.PMC3620356.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1016/S0960-894X(02)00647- 9 Breitman, T.R., S.J.",OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/   10.1038/343177a 0 Du, C., R.L.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/   10.1146/annurev-biochem-052110-12001 2 Guillemin, M.C., E. Raffoux, D. Vitoux, S. Kogan, H. Soilihi, V. Lallemand- Breitenbach, J. Zhu, A. Janin, M.T.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1084/jem.2002112 9 Hu, J., Y.F.",OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1038/nature0701 6 Johnstone, R.W.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi   .org/10.1038/nrd77 2 Kastner, P., H.J.",OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/   10.1182/blood.V97.5.131 4 Lallemand-Breitenbach, V., and H. de Thé.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1101/csh - perspect.a00066 1 Lallemand-Breitenbach, V., M.-C. Guillemin, A. Janin, M.-T. Daniel, L.  Degos, S.C. Kogan, J.M.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1158/2159- 8290.CD-11-008 7 Altucci, L., A. Rossin, O. Hirsch, A. Nebbioso, D. Vitoux, E. Wilhelm, F .",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
http://dx.doi.org/10.1158/0008- 5472.CAN-04-356 9,Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi   .org/10.1016/j.toxlet.2011.02.01 2 Melnick, A., and J.D.",OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1016/0145-2126(85)90039- 6 Zhou, J., L. Pérès, N. Honoré, R. Nasr, J. Zhu, and H. de Thé.",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1073/   pnas.060332410 3 Zhu, J., M. Gianni, E. Kopf, N. Honoré, M. Chelbi-Alix, M. Koken, F .",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
"http://dx.doi.org/10.1073/   pnas.96.26.1480 7 Zhu, J., J. Zhou, L. Peres, F .",Non-OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
http://dx.doi.org/10.1016/   j.ccr.2005.01.00 5,OADS,/arxiv_data1/oa_pdf/68/2f/JEM_20122337.PMC3620357.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.192.2.28 1 de Jong, A., E.C.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/   10.1016/j.chembiol.2007.09.01 0 de Jong, A., V. Peña-Cruz, T.Y.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/ni.195 6 de la Salle, H., S. Mariotti, C. Angenieux, M. Gilleron, L.F. Garcia-Alles, D.  Malm, T. Berg, S. Paoletti, B. Maître, L. Mourey, et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"310:1321– 1324. http://dx.doi.org/10.1126/science.111530 1 De Libero, G., A.P.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1016/j.immuni   .2005.04.01 3 Dzionek, A., A. Fuchs, P. Schmidt, S. Cremer, M. Zysk, S. Miltenyi, D.W.  Buck, and J. Schmitz.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1371/journal.pbio.100022 8 Gilleron, M., S. Stenger, Z. Mazorra, F. Wittke, S. Mariotti, G. Böhmer,  J. Prandi, L. Mori, G. Puzo, and G. De Libero.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.2003109 7 Grant, E.P., M. Degano, J.P. Rosat, S. Stenger, R.L.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/   10.1084/jem.189.1.19 5 Gurcha, S.S., A.R.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10   .1042/BJ2002010 7 Haig, N.A., Z. Guan, D. Li, A. McMichael, C.R.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1074/jbc   .M111.26794 8 Holst, J., A.L.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/   nprot.2006.6 1 Huang, S., T.Y.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi   .org/10.1016/j.coi.2009.05.02 2 Kasmar, A.G., I. van Rhijn, T.Y.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
208:1741– 1747. http://dx.doi.org/10.1084/jem.2011066 513.6 (clone IM1330; Beckman Coulter) for an additional 20 min at 4°C.,Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.4049/jimmunol.100361 5 Altman, J.D., P.A.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/   10.1038/372691a 0 Beckman, E.M., A. Melián, S.M.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/ni.214 3 Brigl, M., L. Bry, S.C. Kent, J.E.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/   10.1038/ni100 2 Brigl, M., R.V.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.2010255 5 Briken, V., R.M.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1126/science.278.5343.162 6 Layre, E., L. Sweet, S. Hong, C.A.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1016/   j.chembiol.2011.10.01 3 Lee, P.T., K. Benlagha, L. Teyton, and A. Bendelac.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.2001190 8 Li, D., L. Wang, L. Yu, E.C.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1093/intimm/dxs08 2 Matsuda, J.L., O.V.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.192.5.74 1 Matsunaga, I., A. Bhatt, D.C. Young, T.Y.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/   10.1084/jem.2004142 9 Moody, D.B., B.B.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10   .1126/science.278.5336.28 3 Moody, D.B., T. Ulrichs, W. Mühlecker, D.C. Young, S.S. Gurcha, E.  Grant, J.P. Rosat, M.B.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/3500911 9 Moody, D.B., V. Briken, T.Y.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1126/science.108935 3 Pellicci, D.G., A.J.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10   .1038/ni.207 6 Porcelli, S., M.B.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/341447a 0 Porcelli, S., C.T.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/360593a 0 Prigozy, T.I., O. Naidenko, P. Qasba, D. Elewaut, L. Brossay, A. Khurana,  T. Natori, Y. Koezuka, A. Kulkarni, and M. Kronenberg.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1126/science.291.5504.66 4 Roura-Mir, C., M. Catálfamo, T.Y.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1194/jlr.M01036 3 Scharf, L., N.S.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1016/j.immuni.2010.11.02 6 Sirakova, T.D., V .S.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10   .1128/IAI.71.7.3794-3801.200 3 Sugita, M., N. van Der Wel, R.A. Rogers, P .J.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1194/jlr.M00198 2 Van Rhijn, I., D.C. Young, A.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1084/jem.2008248 0 van Summeren, R.P., D.B.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1021/ja060499 i Weller, S., M.C.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1182/blood-2004-01-034 6 Yakimchuk, K., C. Roura-Mir, K.G.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi   .org/10.1002/eji.20104080 8 Y oung, M.H., and L. Gapin.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1002/   eji.20114140 8 Zeissig, S., K. Murata, L. Sweet, J. Publicover, Z. Hu, A. Kaser, E. Bosse, J.  Iqbal, M.M.",Non-OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
"http://dx.doi.org/10.1038/nm.281 1 Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. Sagiv,  K. Hudspeth, Y.P.",OADS,/arxiv_data1/oa_pdf/ba/a0/JEM_20120624.PMC3620358.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi   .org/10.1126/science.107595 8 Aschenbrenner, K., L.M.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"8:351– 358. http://dx.doi.org/10.1038/ni144 4 Bettelli, E., Y.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1038/nature0475 3 Boursalian, T.E., J. Golob, D.M.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
http://dx.doi.org/10.1038/ni104 9and warrants a rethinking of the role of the medulla in T cell  development.,Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"373:531– 536. http://dx.doi.org/10.1038/373531a 0 Carlson, C.M., B.T.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1038/nature0488 2 Choi, Y.I., J.S.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1016/j.immuni   .2008.10.00 8 Gaspal, F.M., D. Withers, M. Saini, V. Bekiaris, F.M.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi   .org/10.1084/jem.2010148 4 Gubbels Bupp, M.R., B. Edwards, C. Guo, D. Wei, G. Chen, B. Wong,  E. Masteller, and S.L.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1038/   icb.2008.8 7 Heino, M., P. Peterson, N. Sillanpää, S. Guérin, L. Wu, G. Anderson, H.S.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"30:1884– 1893. http://dx.doi.org/10.1002/1521-4141(200007)30:7<1884::AID-   IMMU1884>3.0.CO;2- P Hinterberger, M., M. Aichinger, O. Prazeres da Costa, D. Voehringer, R.  Hoffmann, and L. Klein.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1038/ni.187 4 Hinterberger, M., G. Wirnsberger, and L. Klein.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi   .org/10.1016/j.immuni.2005.12.01 1 Li, J., Y .",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/   10.1073/pnas.070888410 4 Lio, C.W., and C.S.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10   .1016/j.immuni.2007.11.02 1 Lio, C.W., L.F. Dodson, C.M.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi   .org/10.4049/jimmunol.100001 9 Liston, A., K.M.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1038/nature0228 4 McCaughtry, T.M., M.S.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/   10.1084/jem.2007060 1 Proietto, A.I., S. van Dommelen, P. Zhou, A. Rizzitelli, A. D’Amico,  R.J. Steptoe, S.H.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10   .1073/pnas.081026810 5 Roberts, N.A., A.J.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1016/j.immuni.2012.01.01 6 Rossi, S.W., M.Y.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1084/jem.2006249 7 Spence, P.J., and E.A.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"184:4074– 4077. http://dx.doi.org/10.4049/jimmunol.090393 3 Weih, F., D. Carrasco, S.K.",Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
"http://dx.doi.org/10.1016/S1074-   7613(00)80649- 4 Yu, W., H. Nagaoka, M. Jankovic, Z. Misulovin, H. Suh, A. Rolink, F.  Melchers, E. Meffre, and M.C.",OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
http://dx.doi.org/   10.1038/2328 7,Non-OADS,/arxiv_data1/oa_pdf/26/60/JEM_20122070.PMC3620359.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/9066 7 Akdis, M. 2006.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1016/j.coi   .2006.06.00 3 Bakocević, N., T. Worbs, A. Davalos-Misslitz, and R. Förster.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.4049/jimmunol.090227 7 Bang, B.R., E. Chun, E.J.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"43:275– 280. http://dx.doi.org/10.3858/emm.2011.43.5.02 8 Beaty, S.R., C.E.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1084/jem.2007071 9 Bilyk, N., and P.G.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1084/jem.177.6.177 3 Blumenthal, R.L., D.E.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1067/mai.2001.11284 5 Braedel, S., M. Radsak, H. Einsele, J.P .",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1111/j.1365- 2141  .2004.04922. x Chen, W., W. Jin, N. Hardegen, K.J.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1084/jem.2003015 2 Coombes, J.L., K.R.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"204:1757– 1764. http://dx.doi.org/10.1084/jem.2007059 0 Cose, S., C. Brammer, K.M.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
36:1423– 1433. http://dx.doi.org/10.1002/eji.20053553 9Real-time qPCR.,OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/nm.194 6 Harp, J.R., and T.M.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1371/journal.pone.001097 3 Hawrylowicz, C.M., and A. O’Garra.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/nri158 9 Hintzen, G., L. Ohl, M.L.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1084/jem   .177.2.39 7 Josefowicz, S.Z., R.E.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/nature1077 2 Kamada, N., T. Hisamatsu, S. Okamoto, T. Sato, K. Matsuoka, K. Arai, T.  Nakai, A. Hasegawa, N. Inoue, N. Watanabe, et al.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"4:5. http://dx.doi.org/10.1186/1476-7961-4- 5 Kheradmand, F., A.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"183:1983– 1989. http://dx.doi.org/10.4049/jimmunol.090108 9 Larché, M. 2007.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"132:1007– 1014. http://dx.doi.org/10.1378/chest.06-243 4 Lekkerkerker, A.N., J. Aarbiou, T. van Es, and R.A. Janssen.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.2174/13816121280243039 6 Lipscomb, M.F., A.M. Pollard, and J.L.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1016/j.immuni.2009.08.00 7 Mambula, S.S., K. Sau, P. Henneke, D.T.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1074/ jbc.M20168320 0 Mucida, D., N. Kutchukhidze, A. Erazo, M. Russo, J.J. Lafaille, and M.A.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10   .1172/JCI2448 7 Mucida, D., Y.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1126/science.114569 7 Nakano, H., M.E.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/mi.2011.4 7 Neveu, W.A., J.B. Allard, O. Dienz, M.J. Wargo, G. Ciliberto, L.A.  Whittaker, and M. Rincon.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"183:1732– 1738. http://dx.doi.org/10.4049/jimmunol.080292 3Curotto de Lafaille, M.A., N. Kutchukhidze, S. Shen, Y. Ding, H. Yee, and  J.J. Lafaille.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1016/j.immuni.2008.05.01 0 de Heer, H.J., H. Hammad, T. Soullié, D. Hijdra, N. Vos, M.A.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10   .1084/jem.2004003 5 Denning, T.L., Y.C.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/ni151 1 Denning, T.L., B.A.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.4049/jimmunol.100270 1 Doganci, A., T. Eigenbrod, N. Krug, G.T.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1016/j.coi.2007.07.01 7 Duan, W., T. So, and M. Croft.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1016/j.jaci.2010.09.02 1 Duan, W ., T. So, A.K.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1165/rcmb.2011-0070O C Fütterer, A., K. Mink, A. Luz, M.H.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1016/S1074-7613(00)80588- 9 Gajewska, B.U., D. Alvarez, M. Vidric, S. Goncharova, M.R.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi   .org/10.1016/j.immuni.2011.01.01 6 Halwani, R., S. Al-Muhsen, H. Al-Jahdali, and Q. Hamid.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1165/rcmb.2010-0027T R Hamann, A., K. Klugewitz, F. Austrup, and D. Jablonski-Westrich.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
http://dx.doi.org/10.1002/1521- 4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2- L,Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1046/j.1365- 2567.1996.459542. x Sun, C.M., J.A.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1084/jem.2007060 2 Thepen, T., C. McMenamin, B. Girn, G. Kraal, and P.G.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
http://dx.doi.org/   10.1111/j.1365-2222.1992.tb00137.,Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/   10.1038/ni154 9 Trompette, A., S. Divanovic, A. Visintin, C. Blanchard, R.S.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1016/j.coi.2006   .09.00 7 Upham, J.W., D.H. Strickland, N. Bilyk, B.W.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1002/cyto.a.2006 4 Wikstrom, M.E., E. Batanero, S.R.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/10.1038/icb.2010.1 8 Willart, M.A., K. Deswarte, P. Pouliot, H. Braun, R. Beyaert, B.N.",OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
"http://dx.doi.org/   10.1084/jem.2011269 1 Zasłona, Z., J. Wilhelm, L. Cakarova, L.M.",Non-OADS,/arxiv_data1/oa_pdf/35/12/JEM_20121849.PMC3620360.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1002/ddr.112 9 Contant, C.F ., A.B.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.0268-10.201 0 Dettbarn, C.L., and L.J.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1016/j.acthis.2007.01.00 4 Fagan, K.A., B.W.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1172/JCI386 2 Ferré, S., M. Karcz-Kubicha, B.T.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"83:263– 276. http://dx.doi.org/10.1016/j.pneurobio.2007.07.00 5 Fulton, R.L., and C.E.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1080/01926230131705248 6 Gomes, I., B.A.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/   10.1007/s00109010021 9 Graham, D.B., C.M.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1172/JCI3272 9 Grommes, J., and O. Soehnlein.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.2119/molmed   .2010.0013 8 Haskó, G., D.Z.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/01.CCM.0000206467   .19509.C 6 Hawkins, R.A., R.L.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1074/jbc.271.27   .1638 4 Henson, P.M., and Z.G.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
56:1053– 1061. http://dx.doi.org/10.1172/JCI10815 2We gratefully acknowledge Dr. Susan E. Lewis for critically reading and editing  the manuscript.,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/01.CCM.0000057843.47705.E 8 Abraham, E., A. Carmody, R. Shenkar, and J. Arcaroli.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi   .org/10.1038/sj.jcbfm.960003 9 Angers, S., A. Salahpour, E. Joly, S. Hilairet, D. Chelsky, M. Dennis, and  M. Bouvier.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/00003246-200204000-0001 0 Baker, A.J., R.J. Moulton, V.H.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.3171/   jns.1993.79.3.036 9 Baughman, R.P., K.L.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/   00006123-199704000-0000 9 Bronchard, R., P. Albaladejo, G. Brezac, A. Geffroy, P.F.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/00000542-200402000-0000 9 Brown, R.M., J.R. Duncan, M.R.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1017/S146114571100126 X Chen, J.F., Z. Huang, J. Ma, J. Zhu, R. Moratalla, D. Standaert, M.A.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/   10.1210/jc.2009-077 8 Ciruela, F., M. Escriche, M.M.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10   .1074/jbc.274.45.3189 1 Ozawa, S., H. Kamiya, and K. Tsuzuki.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
61:2015– 2024. http://dx.doi.org/10.1111/j.1471-4159.1993.tb07437.,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
http://dx.doi.org/   10.1111/j.1471-4159.2005.03071.,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1152/ajplung.00277.201 1 Reutershan, J., and K. Ley.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1186/cc288 1 Reutershan, J., R.E.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1016/S0163-7258(01)00160- 7 Rocheville, M., D.C. Lange, U. Kumar, R. Sasi, R.C.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi   .org/10.1074/jbc.275.11.786 2 Said, S.I., H.I.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"12:226.  http://dx.doi.org/10.1186/cc699 0 Schröder, H., D.F.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi   .org/10.1016/j.neuropharm.2008.12.01 0 Sharma, A.K., V.E.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/   10.1016/j.jtcvs.2009.08.03 3 Shen, L., J.Z.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
http://dx.doi.org/10.1111/   j.1745-7254.2007.00511.,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1042/BJ2003040 5 Jin, W., L. Zhu, Q. Guan, G. Chen, Q.F.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.3181/0807-RM-23 2 Jordan, B.A., and L.A. Devi.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1016/j.tips.2011.09.00 3 Keita, M., P. Bessette, M. Pelmus, Y. Ainmelk, and A. Aris.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"3:3. http://dx.doi   .org/10.1186/1757-2215-3- 3 Lee, W.J., R.A. Hawkins, J.R. Viña, and D.R.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
http://dx.doi.org/10.1016/j.neuroscience.,OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1016/j.expneurol.2008   .09.01 2 Liu, X.C., Y.G.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1097/00005373-198311000-0000 2 Magalhães, M.A., F. Zhu, H. Sarantis, S.D.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1189/jlb.020712 6 Mascia, L., I. Mastromauro, and S. Viberti.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.4049/jimmunol.090323 8 Nishi, A., F. Liu, S. Matsuyama, M. Hamada, H. Higashi, A.C. Nairn, and  P. Greengard.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi   .org/10.1371/journal.pbio.003017 4 Tomkins, O., I. Shelef, I. Kaizerman, A. Eliushin, Z. Afawi, A. Misk, M.  Gidon, A. Cohen, D. Zumsteg, and A. Friedman.",Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1136/jnnp.2007.12642 5 Tsai, S., and S.J.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1016/S0140-6736(07)60604- 7Xu, T., J. Qiao, L. Zhao, G. Wang, G. He, K. Li, Y. Tian, M. Gao, J. Wang,  H. Wang, and C. Dong.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
"http://dx.doi.org/10.1164/rccm .200511-   1751O C Yu, L., Z. Huang, J. Mariani, Y. Wang, M. Moskowitz, and J.F.",OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
http://dx.doi.org/10.1213/ANE.0b013e3181fc011 2,Non-OADS,/arxiv_data1/oa_pdf/98/b3/JEM_20122196.PMC3620361.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"After six months it is  available under a Creative Commons License (Attribution–Noncommercial–Share  Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/ by-nc-sa/3.0/).The Journal of Experimental Medicine",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
Online supplemental material is available at http://www.jem.org/   cgi/content/full/jem.20120153/DC1.,Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"The predicted gene accor - dance in at least two algorithms were retained and used for KEGG pathway  annotation, which was obtained from the “has_pathway.list” file down - loaded from KEGG ftp (ftp://ftp.genome.jp/pub/kegg/).",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
All statistical analyses were performed using R/Bioconductor  software (http://www.bioconductor.org).,OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"361:1437– 1447. http://dx.doi.org/10.1056/NEJMoa090128 2 Jia, H.L., Q.H.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-06-102 5 Landgraf, P., M. Rusu, R. Sheridan, A. Sewer, N. Iovino, A. Aravin, S.  Pfeffer, A.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/j.cell.2007.04.04 0 Li, Y., B. Tian, J. Yang, L. Zhao, X. Wu, S.L.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1007/s00432-004-0564- 9 Li, S., H. Fu, Y. Wang, Y.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/   10.1002/hep.2275 7 Liang, L., C.M.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/hep.2390 4 Lois, C., E.J.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1126/science.106708 1 Ma, L., J. Teruya-Feldstein, and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1038/nature0617 4 Nevins, J.R., and A. Potti.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1038/nrg213 7 Park, S.M., A.B.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1101/gad.164060 8 Polyak, K., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1038/nrc262 0 Stewart, S.A., I. Ben-Porath, V .J.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1038/ng112 7 Sun, F.X., Z.Y.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1023/A:102644232129 5 Sun, B.S., Q.Z.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/hep.2253 1 Tan, H.X., Q. Wang, L.Z.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1007/s12032-009-9264- 2 Tavazoie, S.F., C. Alarcón, T. Oskarsson, D. Padua, Q. Wang, P.D.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1038/nature0648 7 Thiery, J.P., H. Acloque, R.Y.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/j.cell.2009.11.00 7 Thomson, J.M., J. Parker, C.M.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1038/nmeth70 4Author contributions: Z.-H. Tao, J.-L. Wan, and W.-Z.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"431:350– 355. http://dx.doi.org/10.1038/nature0287 1 Bartel, D.P.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00045- 5 Bartel, D.P.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/j.cell.2009.01.00 2 Bracken, C.P., P.A.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1158/0008-5472.CAN-08-194 2 Budhu, A., H.L.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/hep.2216 0 Castellano, G., G. Malaponte, M.C.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1158/1078-0432.CCR-08-087 0 Chaffer, C.L., and R.A. Weinberg.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1126/science.120354 3 Charafe-Jauffret, E., C. Ginestier, and D. Birnbaum.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"9:202. http://dx.doi.org/   10.1186/1471-2407-9-20 2 Cummins, J.M., Y.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/   10.1038/ncb203 9 Fidler, I.J.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10   .1038/nrc109 8 Gregory, P.A., A.G. Bert, E.L. Paterson, S.C. Barry, A. Tsykin, G. Farshid,  M.A.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi   .org/10.1038/ncb172 2 Gupta, G.P., and J. Massagué.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/j.cell.2006.11.00 1 He, H., K. Jazdzewski, W. Li, S. Liyanarachchi, R. Nagy, S. Volinia,  G.A.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
http://dx.doi.org/10.1111/ j.1872-034X.2009.00502.,Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1093/bioinformatics/btm53 1 Ji, J., J. Shi, A. Budhu, Z. Yu, M. Forgues, S. Roessler, S. Ambs, Y. Chen,  P.S.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10   .1002/hep.2280 6 Ventura, A., and T. Jacks.",Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/j.cell.2009.02.00 5 Voorhoeve, P .M., C. le Sage, M. Schrier, A.J.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10   .1016/j.cell.2006.02.03 7 Watanabe, T., A. Takeda, K. Mise, T. Okuno, T. Suzuki, N. Minami, and H.  Imai.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1016/   j.febslet.2004.11.06 7 Wong, C.C., C.M.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1053/   j.gastro.2010.10.00 6 Xue, Y.H., X.F.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/hep.2394 2 Yang, J., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"14:818– 829. http://dx.doi.org/10.1016/j.devcel.2008.05.00 9Yang, B.W., Y. Liang, J.L.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1097/MEG.0b013e3283050a6 7 Yao, J., L. Liang, S. Huang, J. Ding, N. Tan, Y. Zhao, M. Yan, C. Ge, Z.  Zhang, T. Chen, et al.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/hep.2300 8 Zhou, J., and W. Wang.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"http://dx.doi.org/10.1002/   jso.2194 1 Zhu, X.D., J.B. Zhang, P.Y.",OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
http://dx.doi.org/10.1200/   JCO.2007.15.652 1,Non-OADS,/arxiv_data1/oa_pdf/bf/6a/JEM_20120153.PMC3620363.pdf
"Youdim1,2* 1Technion Rappaort Faculty of Medicine, Eve Topf and NPF Centers of Excellence for Neurodegenerative Diseases Haifa,  Haifa 30196, Israel, 2Department of Systems Biology, Yonsei University, Seoul 120-749, Korea http://dx.doi.org/10.5607/en.2013.22.1.1 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
"Key words:  brain selective MAO inhibition, multi-target drugs, neuroprotective and neurorestorative drugs, antidepressant activity This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
2 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Moussa B.H.,Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
"3 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Neuroprotective and Neurorestorative Drugs MULTI TARGET NEUROPROTECTIVE ANTI ALZHEIMER DRUGS,  LADOS  TIGIL AND M30, AS A DERIVATIVE OF RASAGILINE The cardinal features of Alzheimer’s disease (AD) are progressive  memory deterioration and disordered cognitive function  resulting from a loss of cholinergic transmission in cortical  brain regions innervated by neurones arising in the nucleus  basalis of Meynert [21].",Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
4 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Moussa B.H.,Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
5 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Neuroprotective and Neurorestorative Drugs up-regulated by M30 treatment in a brain-region-dependent  manner.,Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
6 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Moussa B.H.,OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
7 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Neuroprotective and Neurorestorative Drugs REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
8 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Moussa B.H.,OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
9 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Neuroprotective and Neurorestorative Drugs Neurosci 13:374-379.,Non-OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
10 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.1Moussa B.H.,OADS,/arxiv_data1/oa_pdf/d5/95/en-22-1.PMC3620452.pdf
"Oxidative stress occurs when an imbalance is formed  between production of reactive oxygen species (ROS) and cellular Role of Oxidative Stress in Parkinson’s Disease Onyou Hwang * Department of Biochemistry and Molecular Biology, University of Ulsan College of Medicine, Seoul 138-736, Koreahttp://dx.doi.org/10.5607/en.2013.22.1.11 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
"Key words:  Parkinson’s disease, dopamine, oxidative stress, neuroinflammation, MMP-3, NQO1 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
12 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Onyou Hwang antioxidant activity.,OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
"13 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Oxidative Stress in PD Because DAergic neurons are intrinsically more ROS-generating  and vulnerable as described above, any event that triggers  further oxidative stress can be harmful to the cell.",Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
14 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Onyou Hwang 3 is induced by free radicals and the cytokines in these cells  [58].,Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
"15 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Oxidative Stress in PD Wentworth P Jr, Lerner RA, Kelly JW (2006) Elevated levels  of oxidized cholesterol metabolites in Lewy body disease  brains accelerate alpha-synuclein fibrilization.",Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
"16 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Onyou Hwang Perry RH, Jaros E, Hersheson JS, Betts J, Klopstock T, Taylor  RW , Turnbull DM (2006) High levels of mitochondrial DNA  deletions in substantia nigra neurons in aging and Parkinson  disease.",OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
17 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.11Oxidative Stress in PD novel signaling proteinase from apoptotic neuronal cells that  activates microglia.,Non-OADS,/arxiv_data1/oa_pdf/3c/77/en-22-11.PMC3620453.pdf
"Carabobo 2001, Venezuelahttp://dx.doi.org/10.5607/en.2013.22.1.18 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"Key words:  experimental psychosis, ketamine, NMDA, haloperidol, social interaction test Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"19 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.18Implications for the Treatment of Schizophrenia MATERIALS AND METHODS Animals Male Sprague-Dawley rats (weight, 150-200 g) were placed in  separate cages with food and water provided ad libitum , and  room temperature of 22oC.",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"20 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.18Ezequiel Uribe, et al.",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"21 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.18Implications for the Treatment of Schizophrenia In our study, memantine was administered at 10 mg ㆍkg-1 after  ketamine treatment and memantine treatment resulted in a greater  reversal of social isolation than that of the placebo or haloperidol  (0.25 mgㆍkg-1).",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"22 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.18Ezequiel Uribe, et al.",Non-OADS,/arxiv_data1/oa_pdf/31/72/en-22-18.PMC3620454.pdf
"Sulfite oxidase  deficiency is a hereditary disorder and can show the importance Curcumin, the Main Part of Turmeric,   Prevents Learning and Memory Changes   Induced by Sodium Metabisulfite,   a Preservative Agent, in Rats Ali Noorafshan1,2, Reza Asadi-Golshan1,2, Saied Karbalay-Doust1,2*,  Mohammad Amin Abdollahifar1,2 and Ali Rashidiani-Rashidabadi1,2 1Histomorphometry and Stereology Research Centre, 2Anatomy Department, School of Medicine,  Shiraz University of Medical Sciences, Shiraz, Iran http://dx.doi.org/10.5607/en.2013.22.1.23 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"Key words:  curcumin, sulfite, learning, memory, rats Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"24 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.23Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"26 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.23Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"28 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.23Ali Noorafshan, et al.",OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"30 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.23Ali Noorafshan, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/d5/en-22-23.PMC3620455.pdf
"However, none of the known AD AAD-2004 Attenuates Progressive Neuronal Loss  in the Brain of Tg-betaCTF99/B6 Mouse Model of  Alzheimer Disease In-Sun Baek1, Tae-Kyung Kim2,3, Ji-Seon Seo2, Kang-Woo Lee1,3, Young Ae Lee4,  Jaeyoung Cho4, Byoung Joo Gwag4,5 and Pyung-Lim Han1,2,3* Departments of 1Chemistry and Nano Science, 2Brain and Cognitive Sciences, and 3Brain Disease Research Institute,  Ewha Womans University, Seoul 120-750, 4GNT Pharma Co. Ltd., Yongin 446-901, 5Department of Neuroscience,  Ajou University School of Medicine, Suwon 443-749, Koreahttp://dx.doi.org/10.5607/en.2013.22.1.31 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"Key words:  Alzheimer’s disease, neuronal loss, neuritic atrophy, neuroprotection, small molecule Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"32 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31In-Sun Baek, et al.",OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"33 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31Neuroprotective Effect of AAD-2004 in a Murine AD Model Western blots For the Western blot analysis, the hippocampus was homoge - nized in ice-cold lysis buffer (50 mM Tris [pH 8.0], 150 mM NaCl,  1% NP-40, 0.1% SDS, 0.5% sodium deoxycholate) containing  1 mM phenylmethylsulfonyl fluoride, and protease inhibitor  (CompleteTM; Roche, Mannheim, Germany).",Non-OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"34 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31In-Sun Baek, et al.",OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
35 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31Neuroprotective Effect of AAD-2004 in a Murine AD Model were reversed to the levels of the non-transgenic control in mice  treated with AAD-2004 (Fig.,Non-OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"36 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31In-Sun Baek, et al.",OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
37 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.31Neuroprotective Effect of AAD-2004 in a Murine AD Model Alzheimer’s disease therapeutics.,Non-OADS,/arxiv_data1/oa_pdf/66/26/en-22-31.PMC3620456.pdf
"However, the most important environmental factor that regulates PINK1 Deficiency Enhances Inflammatory  Cytokine Release from Acutely   Prepared Brain Slices  Jun Kim1, Ji-Won Byun1, Insup Choi1, Beomsue Kim1,  Hey-Kyeong Jeong1, Ilo Jou1,2,3 and Eunhye Joe1,2,3,4* 1Neuroscience Graduate Program, 2Department of Pharmacology, 3Chronic Inflammatory Disease Research Center,  4National Research Lab of Brain Inflammation, Ajou University School of Medicine, Suwon 442-721, Koreahttp://dx.doi.org/10.5607/en.2013.22.1.38 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
"Key words:  Parkinson’s disease, PINK1, inflammation Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
39 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38PINK1 and Brain Inflammation neuronal function and survival is glia (astrocytes and microglia).,OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
"40 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38Jun Kim, et al.",OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
41 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38PINK1 and Brain Inflammation KO slices (Fig.,Non-OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
"42 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38Jun Kim, et al.",OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
43 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38PINK1 and Brain Inflammation 131.,Non-OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
"44 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.38Jun Kim, et al.",OADS,/arxiv_data1/oa_pdf/ab/31/en-22-38.PMC3620457.pdf
"From the previous studies, it is Effects of Serotonin on Erythropoietin Expression  in Mouse Hippocampus Miyeon Choi and Hyeon Son * Department of Biochemistry and Molecular Biology, Hanyang University College of Medicine, Seoul 133-791, Koreahttp://dx.doi.org/10.5607/en.2013.22.1.45 Exp Neurobiol.",OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
"Key words:  erythropoietin, depression, hippocampus Copyright © Experimental Neurobiology 2013. www.enjournal.orgThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
46 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.45Miyeon Choi and Hyeon Son speculated that there might be a link between actions of EPO and  5-HT in the brain.,OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
47 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.45EPO Induction by 5-HT  0.25 µl/min with an injection cannula protruding 0.5 mm beyond  the guide cannula.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
48 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.45Miyeon Choi and Hyeon Son 5-HT in the absence of bFGF for 4 days (Fig.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
49 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.45EPO Induction by 5-HT  animal model of depression.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
50 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.45Miyeon Choi and Hyeon Son Lett 586:2360-2365.,Non-OADS,/arxiv_data1/oa_pdf/7e/55/en-22-45.PMC3620458.pdf
"Indeed, It  is still unclear whether TRPV1 signaling is a prevalent mode to TRPV1 Activation in Primary Cortical   Neurons Induces Calcium-Dependent  Programmed Cell Death Juhyun Song1, Jun Hong Lee1, Sung Ho Lee1, Kyung Ah Park1,  Won Taek Lee1* and Jong Eun Lee1,2* 1Department of Anatomy, 2BK21 Project for Medical Sciences, Yonsei University College of Medicine, Seoul 120-752, Koreahttp://dx.doi.org/10.5607/en.2013.22.1.51 Exp Neurobiol.",Non-OADS,/arxiv_data1/oa_pdf/5b/62/en-22-51.PMC3620459.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/62/en-22-51.PMC3620459.pdf
"52 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.51Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/5b/62/en-22-51.PMC3620459.pdf
"54 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.51Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/5b/62/en-22-51.PMC3620459.pdf
"56 www.enjournal.org http://dx.doi.org/10.5607/en.2013.22.1.51Juhyun Song, et al.",OADS,/arxiv_data1/oa_pdf/5b/62/en-22-51.PMC3620459.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1625 | DOI: 10.1038/srep01625 6,Non-OADS,/arxiv_data1/oa_pdf/b7/20/srep01625.PMC3620655.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Luo, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/b7/20/srep01625.PMC3620655.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fontana, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/97/srep01634.PMC3620663.pdf
The integrative network algo-rithm developed here could help elucidate the biological and clinicalsignificance of epigenetic changes associated with common diseases.Methods The protein interaction network .We downloaded the Human Protein Reference Database ( HPRD ) interaction network from Pathway Commons http://www.pathwaycommons.org44 (13th June 2012).,OADS,/arxiv_data1/oa_pdf/b1/3d/srep01630.PMC3620664.pdf
"Availability .We have implemented the EpiMod algorithm as an executable R-script which is freely available on request, or from http://code.google.com/p/epimods/.",OADS,/arxiv_data1/oa_pdf/b1/3d/srep01630.PMC3620664.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b1/3d/srep01630.PMC3620664.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: West, J., Beck, S., Wang, X.",Non-OADS,/arxiv_data1/oa_pdf/b1/3d/srep01630.PMC3620664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Denisov, D., Dang, M.T., Struth, B., Wegdam, G. & Schall, P. Resolving structural modifications of colloidal glasses by combining x-ray scattering and rheology.",Non-OADS,/arxiv_data1/oa_pdf/04/20/srep01631.PMC3620665.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3a/90/srep01628.PMC3620666.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ye, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/3a/90/srep01628.PMC3620666.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c7/28/srep01629.PMC3620667.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Guzman, J.R. et al.",Non-OADS,/arxiv_data1/oa_pdf/c7/28/srep01629.PMC3620667.pdf
Sequence processing and statistical analysis .The initial processing of the sequences was carried out with the package QIIME (http://qiime.org/).,OADS,/arxiv_data1/oa_pdf/11/bf/srep01624.PMC3620669.pdf
"The sequences with similarity greater than or equal to 97% were grouped into operational taxonomic units (OTUs), and the taxonomic classification was performed using the RDP (Ribosomal Database Project:http://rdp.cme.msu.edu/classifier/classifier.jsp) classification threshold of 80%.",OADS,/arxiv_data1/oa_pdf/11/bf/srep01624.PMC3620669.pdf
All these analyses were performed with the statistical software PAST (http://folk.uio.no/ohammer/past/ ).,OADS,/arxiv_data1/oa_pdf/11/bf/srep01624.PMC3620669.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/bf/srep01624.PMC3620669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Carlos, C., Torres, T.T.",Non-OADS,/arxiv_data1/oa_pdf/11/bf/srep01624.PMC3620669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Schropp, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/00/67/srep01633.PMC3620670.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (NC-BY) (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any mediu m, provided the original work is properly cited.the present study suggest a link between protein oxidation and neuronal/glial cell death in vivo , and also demonstrate impaired proteostasis in this widely used murine model ofMS.",Non-OADS,/arxiv_data1/oa_pdf/0b/ff/an005e111.PMC3620690.pdf
"Thenotion that most cell death occurs early in the disease is sup-ported by the ﬁnding that calpain activity, a marker of bothnecrosis and apoptosis (Guyton et al., 2005), is elevated inacute EAE, but not in chronic EAE (Supplementary Figure S1at http://www.asnneuro.org/an/005/an005e111add.htm).",Non-OADS,/arxiv_data1/oa_pdf/0b/ff/an005e111.PMC3620690.pdf
"C/circlecopyrt2013 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (NC-BY) (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/ff/an005e111.PMC3620690.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f1/d3/srep01635.PMC3620844.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Hara, K.Y., Wada, T., Kino, K., Asahi, T. & Sawamura, N. Construction of photoenergetic mitochondria in cultured mammalian cells.",Non-OADS,/arxiv_data1/oa_pdf/f1/d3/srep01635.PMC3620844.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/09/3d/srep01632.PMC3620900.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Avdoshenko, S.M., Koskinen, P., Sevinçli, H., Popov, A.A. & Rocha, C.G.",Non-OADS,/arxiv_data1/oa_pdf/09/3d/srep01632.PMC3620900.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/22/5a/srep01583.PMC3620901.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Zhao, J., Lee, S.H., Huss, M. & Holme, P. The Network Organization of Cancer-associated Protein Complexes in Human Tissues.",Non-OADS,/arxiv_data1/oa_pdf/22/5a/srep01583.PMC3620901.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d2/e2/srep01626.PMC3620902.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Delpini, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/d2/e2/srep01626.PMC3620902.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d4/b6/srep01620.PMC3621091.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Bachnoff, N., Cohen-Kutner, M., Trus, M. & Atlas, D. Intra-membrane Signaling Between the Voltage-Gated Ca21-Channel and Cysteine Residues of Syntaxin 1A Coordinates Synchronous Release.",Non-OADS,/arxiv_data1/oa_pdf/d4/b6/srep01620.PMC3621091.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5c/d8/srep01622.PMC3621141.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Liu, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/5c/d8/srep01622.PMC3621141.pdf
"Furthermore, we  have set up a web-accesible MySQL database named the CPR PTM  Resource containing all identified phosphoproteins making it easy  to search for identified phosphorylation sites on any given protein of interest: http://cpr1.sund.ku.dk/cgi-bin/PTM.pl.",OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
All networks are available in flat file format and in Cyto - scape session format as a user-friendly community resource from  http://cpr1.sund.ku.dk/cgi-bin/PTM.pl (see Supplementary Data 2).,OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
The network is available as a  Cytoscape session file including accession numbers and protein names for  all proteins in the network at http://cpr1.sund.ku.dk/cgi-bin/PTm.pl.,OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
Phosphoproteins were identified using the Mascot search  algorithm (http://www.matrixscience.com) by searching all MS/MS spectra against  a concatenated forward/reversed version of rat and mouse International Protein  Index v.3.37 protein sequence database supplemented with protein sequences of  common observed contaminants such as human keratins and porcine trypsin.,OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
All rights reserved.produced using Servier Medical Art (http://www.servier.com).,Non-OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
"To search   for over-represented motifs, we used sequence windows of  ± 6 residues adjacent  to all serine and threonine phosphorylation sites and matched these against ten  known linear protein kinase motifs (http://www.phosida.com) representing PKA,  AKT, PKD, CAMK2, CHEK, CK2, PLK, CDK, ERK and ATM/ATR kinases, as   well as proline-directed substrate sites.",OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
The CPR PTM Resource (http://cpr1.sund.ku.dk/cgi-bin/ PTM.pl) is a web-based data repository that integrates all of the high-confidence  in-vivo  post-translational modifications sites such as site-specific phosphorylation  that we have identified by MS-based proteomics in different tissue samples from  various species.,OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
"For each modified site in a protein, we list matching kinase motifs and use the Reflect (http://reflect.cbs.dtu.dk/index.html) service to add additional information  about the modified proteins.",OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
Reprints and permission  information is available online at http://npg.nature.,Non-OADS,/arxiv_data1/oa_pdf/36/fd/ncomms1871.PMC3621391.pdf
References 1. WHO The World Malaria Report 2011. http://www.who.int/malaria/world_ malaria_report_2011/9789241564403_eng.pdf (2011).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
9. WHO The World Malaria Report 2008. http://www.who.int/malaria/ publications/atoz/9789241563697/en/index.html (2008).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://www.mara.,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://www.dcp2.org/file/26/wp11.pdf (2008).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://www.who.int/malaria/publications/atoz/ incidence_estimations2.pdf (2010).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://ipti.lshtm.ac.uk/ (2011).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://www.cpc.noaa.,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
http://www.ornl.gov/sci/landscan/ (2011).,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Cairns, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/a7/3b/ncomms1879.PMC3621394.pdf
"Rambaut, A. Tracer v1.5 Available from http://tree.bio.ed.ac.uk/software/tracer/  (2007).",OADS,/arxiv_data1/oa_pdf/9e/dd/ncomms1881.PMC3621396.pdf
All  co-authors contributed to drafting of initial manuscript and revision of  manuscripts and  responding to review comments in their specific areas of expertise.Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/dd/ncomms1881.PMC3621396.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  MacDonald, G.M.",Non-OADS,/arxiv_data1/oa_pdf/9e/dd/ncomms1881.PMC3621396.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Cao, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/ee/90/ncomms1882.PMC3621397.pdf
All rights reserved.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/66/38/ncomms1883.PMC3621399.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/How to cite this article:  Zeil, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/66/38/ncomms1883.PMC3621399.pdf
Preprint at http://arxiv.org/abs/1112.2524  (2011).,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/ncomms1885.PMC3621402.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/5e/ncomms1885.PMC3621402.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Lemoult, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/5e/ncomms1885.PMC3621402.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7e/7f/ncomms1886.PMC3621406.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Visconti, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/7e/7f/ncomms1886.PMC3621406.pdf
25. http://www.openmx-square.org.26.,Non-OADS,/arxiv_data1/oa_pdf/55/9e/ncomms1887.PMC3621408.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/55/9e/ncomms1887.PMC3621408.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Bals, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/55/9e/ncomms1887.PMC3621408.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Noonan, F.P .",Non-OADS,/arxiv_data1/oa_pdf/31/bb/ncomms1893.PMC3621412.pdf
"are  the inventors of this pending patent.Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Baker, W .J.",Non-OADS,/arxiv_data1/oa_pdf/ac/b2/ncomms1895.PMC3621415.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications.,Non-OADS,/arxiv_data1/oa_pdf/2c/8c/ncomms1897.PMC3621417.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Pálsson, G.K. et al.",Non-OADS,/arxiv_data1/oa_pdf/2c/8c/ncomms1897.PMC3621417.pdf
BLAST with A. mellifera fem - and csd-coding sequences was   carried out on Hymenoptera genome sequences available at the Hymenoptera  Genome Database (http://hymenopteragenome.org/) and the ‘ Ant Genomics  Database’ (http://www.antgenomes.org/) websites.,OADS,/arxiv_data1/oa_pdf/d4/03/ncomms1898.PMC3621418.pdf
Intron/exon maps were  drawn using FancyGene (http://host13.bioinfo3.ifom-ieo-campus.it/fancygene/).,OADS,/arxiv_data1/oa_pdf/d4/03/ncomms1898.PMC3621418.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d4/03/ncomms1898.PMC3621418.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Schmieder, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/d4/03/ncomms1898.PMC3621418.pdf
"Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  We declare that the authors have no competing interests  as defined by Nature Publishing Group, or other interests that might be perceived to  influence the results and/or discussion reported in this article.",Non-OADS,/arxiv_data1/oa_pdf/04/bc/ncomms1899.PMC3621420.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Di Marco, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/04/bc/ncomms1899.PMC3621420.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/a0/ncomms1900.PMC3621422.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  McMahon, A. C. et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/a0/ncomms1900.PMC3621422.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d5/3a/ncomms1901.PMC3621426.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Wanamaker, A. D. et al.",Non-OADS,/arxiv_data1/oa_pdf/d5/3a/ncomms1901.PMC3621426.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fe/29/ncomms1911.PMC3621428.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Engel, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/29/ncomms1911.PMC3621428.pdf
Additional information     Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications     Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/c7/ncomms1914.PMC3621430.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Bonmassar, G.  et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/c7/ncomms1914.PMC3621430.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/7d/c7/ncomms1914.PMC3621430.pdf
Additional information     Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications     Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/be/ncomms1922.PMC3621432.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Morioka, E.  et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/be/ncomms1922.PMC3621432.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/5b/be/ncomms1922.PMC3621432.pdf
Th e reference CYP sequences were downloaded  from  http://drnelson.uthsc.edu/P450seqs.dbs.html .,OADS,/arxiv_data1/oa_pdf/92/c0/ncomms1923.PMC3621433.pdf
"All of the data generated in this project, including those related to genome assembly, gene prediction, gene functional annotations and transcriptomic data, may be downloaded from our interactive web portal at  http://www.herbalgenomics.org/galu .",OADS,/arxiv_data1/oa_pdf/92/c0/ncomms1923.PMC3621433.pdf
Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications    Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/c0/ncomms1923.PMC3621433.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Chen, S.  et al.",Non-OADS,/arxiv_data1/oa_pdf/92/c0/ncomms1923.PMC3621433.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/92/c0/ncomms1923.PMC3621433.pdf
Development of genetic markers linked to CRb DNA markers for fine mapping of CRb were designed on the basis of genome sequencing information from the B. rapa Genome Sequencing Project (BrGSP: http://www.brassica- rapa.org/BRGP/index.jsp; Mun et al.,OADS,/arxiv_data1/oa_pdf/5c/29/63_116.PMC3621437.pdf
2008) and Brassica database (BRAD: http://brassicadb.org/brad/; Wang et al.,OADS,/arxiv_data1/oa_pdf/5c/29/63_116.PMC3621437.pdf
"To estimate candidate genes for CRb, we inspected pro- tein homologies within the chromosomal regions deter-mined by fine mapping ana lysis using a BLASTX search against protein sequences in  GenBank (http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/5c/29/63_116.PMC3621437.pdf
Positions of markers were de- termined on the basis of the B. rapa  genome sequence of chromosome R3 from the Brassica  database (BRAD: http://brassicadb.org/brad/).,OADS,/arxiv_data1/oa_pdf/5c/29/63_116.PMC3621437.pdf
Approximately 2.1 million SNPs  for the domesticated apple are now available on Genome Database for Rosaceae (GDR;http://www.rosaceae.org/).,OADS,/arxiv_data1/oa_pdf/b4/56/63_125.PMC3621438.pdf
"Concurrently, Argentina and Italy sequenced the mito- chondria (http://www.mitoch ondrialgenome.org/) and chloroplast genomes (NCBI accession number: NC_007898)(Kahlau et al.",OADS,/arxiv_data1/oa_pdf/47/34/63_14.PMC3621439.pdf
"The SBM con-tigs were merged with the BA C-by-BAC contigs; together, these contigs cover 81 % of the previously registered tomatoESTs (http://www.kazusa.or.jp/to mato/).",OADS,/arxiv_data1/oa_pdf/47/34/63_14.PMC3621439.pdf
"Based on ITAG Release 2.3 (http://solgenomics.net/organism/Solanum _lycopersicum/genome), there are 34,727 of these predictedgenes in the reference genome; based on RNA sequencingdata 30,855 genes out of thes e predicted genes correspond to transcribed genes.",OADS,/arxiv_data1/oa_pdf/47/34/63_14.PMC3621439.pdf
"Com-bining detailed phenotyping of  cultivated tomatoes (for example, http://www.phenome- networks.com/home; http:// solgenomics.net/search/pheno types) with genome sequenc- ing facilitates association of  DNA sequences to agronomi- cally important traits.",Non-OADS,/arxiv_data1/oa_pdf/47/34/63_14.PMC3621439.pdf
"Therefore, the RFLP markershave been replaced by PCR-based cleaved amplified poly-morphic sequence (CAPS) mark ers (http://solgenomics.net), which are more convenient to handle than RFLP markers be-cause their use requires less DNA and simpler laboratory ex- periments.",Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"2005, http://solgenomics.ne t).",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
2011: http://tomatoma.nbrp.jp).,Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
The ILs are av ailable from the Tomato Ge- netics Resource Center (TGRC: http://tgrc.ucdavis.edu) and the NBRP for tomato (Saito et al.,OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"1999), NR in NCBI (http://www.ncbi.nlm.",Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
2000; http://www.pdb.org) databases and domain searches against the Pfam database (Punta et al.,OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"2005; http://solgenomics.net) is recognized as one of the databases for molecular geneticsand genomics in Solanaceae, e. g., tomato, potato, pepper, eggplant, tobacco, petunia and so  on.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"Among the tomato databases for DNA markers, the Solanaceae Coordinated Agricultural Project (SolCAP:http://solcap.msu.edu), which focuses on translating ge- nomic advances to tomato and potato breeding, has provided 62,576 SNPs and experimentally validated data on 96 SNPsfor 85 tomato cultivars (Hamilton et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"The Tomato Mapping Resource Database (http://www.tomatomap.net)releases genotyping data of 52 indel, 102 RFLP, 205 SNPand 94 SSR markers for 102 to mato lines including 9 wild species.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"In the Tomato SNPs database (http://www-plb.ucdavis.edu/labs/maloof/tomatosnp/), 12,568 and 5,004SNPs detected by in silico  analyses between S. lycopersicum and  S. habrochaites  and between  S. lycopersicum  and S. pennellii are are available, of which 220 and 196 SNPs have been experimentally verified, respectively.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
The Ve gMarks (http://vegmarks.nivot.,Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"The MiBASE (http://www.pgb.kazusa.or.jp/mibase/), a databasespecific to Micro-Tom resources, also provides 1935 SNPcandidates between Micro-Tom and either five lines and 409EST-SSRs found by in silico  analyses.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"A portal website for tomato genomics, Ka zusa T omato Genomics  Database (KaTomicsDB: http://www.kazusa.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"The first is the Tomato Marker Database(http://marker.kazusa.or.jp/to mato/), which mainly provides information on 8,297 SNP and 21,100 SSR markers, i.e., primer sequences and DNA fragments including markerloci, genetic linkage maps of the provided DNA markers andgenotyping data of the SNPs for 42 lines (Hirakawa et al.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"Thesecond is the Tomato Functional SNP Database (http://plant1.kazusa.or.jp/tomato/), which provides the genes with SNPs annotated by similarity s earches against the databases of KOG (Tatusov et al.",OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
2000; http://www.pdb.org).,Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
"The enhancing capacity of th e NGSs will enable genotyp- ing by sequencing (GBS), in which a huge number of SNPs can be genotyped by re-sequenc ing of multiple lines in a sin- gle experiment against reference genome sequences (DaveyTable  2.Databases for tomato genetics, genomics and breeding available from the World Wide Web Categories Database Names URLs Portal sites Kazusa Tomato Genomics Database (KaT omicsDB) http://www.kazusa.or.jp/tomato/ Plant Genome DataBase Ja pan (PGDBj) http://pgdbj.jp SOL Genomics Network (SGN) http://solgenomics.net/ eusol (eusol) http://www.eu-sol.net/Lat-SOL network (Lat-SOL) http://cnia.inta.gov.ar/lat-sol/ Plants Database http://plants.usda.gov/ PURDUE University http://www.hort .purdue.edu/rhodcv/hort410/tomat/ Solaneceae Genomics Resource http ://solanaceae.plantbiology.msu.edu/ Genome databases PlantGDB http://www.plantgdb.org/SlGDB/A Tomato Integrated Database (TOMATOMICS ) http://bioinf.mind.meiji.ac.jp/tomatomics/ International Solanaceae Genome Project http://sol.kribb.re.kr/tomatogenome/ Italian SOLAnaceae genomics  resource (ISOL) http://b iosrv.cab.unina.it/isola/ Tomato SBM Database http://www.kazusa.or.jp/tomato_sbm/ DNA marker databases Tomato Marker Database http://marker.kazusa.or.jp/tomato/ A DNA marker database for vegetables (V egMarks) http://vegmarks.nivot.affrc.go.jp/ Tomato Mapping Resource Database http://www.tomatomap.net/Solanaceae Coordinated Agricultural Pr oject (SolCAP) http ://solcap.msu.edu/ dbSNP (Short Genetic Variations) (dbSNP) http://www.nc bi.nlm.nih.gov/snp/?term=Solanum+lycopersicum&SITE=   NcbiHome&submit=Go Tomato SNP http://www-plb.ucdavi s.edu/labs/maloof/tomatosnp/ EST databases Micro-Tom Database (MiBASE) http:/ /www.kazusa.or.jp/jsol/microtom/ Kazusa Full-length Tomato cDNA Database (KafTom) http://www.pgb.kazusa.or.jp/kaftom/ Solaneceae EST Database (SolEST) ht tp://biosrv.cab.unina.it/solestdb/ A Comparative Omics Databa se for Plant Trichome  (TrichOME)http://www.planttrichome.org/tricho medb/estbyspecies_detail.jsp?species=   Solanum%20lycopersicum DFCI Tomato Gene Index (DFCI) h ttp://compbio.dfci.harvard.edu/cg i-bin/tgi/gimain.pl?gudb=tomato Gene expression databases PLEXdb (TomPLEX) http://www.ple xdb.org/plex.php?database=Tomato TIGR Solanaceae Genomics Resource (S GED) http://www.jcvi.org/potato/ Tomato Functional Genomics Database http://ted.bti.cornell.edu/ Plant Transcription Factor Database (PlantTFDB ) http://planttfdb.cbi.pku.edu.cn/index.php?sp=Sly Metabolome databases Kazusa Plant Pathway Viewer  (KaPPA-View4 SOL) http://kpv.kazusa.or.jp/kpv4-sol/ MassBase http://webs2.k azusa.or.jp/massbase/ Plant material databases EU-SOL BreeDB database (Br eeDB) https://www.eu-sol.wur.nl/ The ECPGR Tomato Database http://doc uments.plant.wur.nl/cgn/pgr/tomato/ Tomato Genetics Resource Center  (TGRC) http://tgrc.ucdavis.edu/ TOMATOMA http://tomatoma.nbrp.jp/Tomato Mutant Database http://z amir.sgn.cornell.edu/mutants/ Tomato Mutant DB (LycoTILL) ht tp://www.agrobios.it/tilling/ Others Tomato Functional SNP Database http://plant1.kazusa.or.jp/tomato/ GMO Detection method Database (GMDD) http://gmdd.shgmo.org/event/view/113 Solanaceae Source http://www.nhm.ac.uk/research-c uration/research/projects/solanaceaesource/ The Tomato Genetics Cooperat ive http://tgc.ifas.ufl.edu/ JSOL http://www.kazusa.or.jp/jsol/",Non-OADS,/arxiv_data1/oa_pdf/ea/a6/63_21.PMC3621441.pdf
We have covered more than 80% of the tomatometabolome when we evaluated the coverage by comparingphysicochemical properties of the detected metabolites andthose in the LycoCyc database (http://solgenomics.net/tools/ solcyc/) (Mazourek et al.,OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
"Genomic- and post-genomic resources in tomatoes The Expressed Sequence Tag (EST) database for the to- mato has many sequences co rresponding to 40,000 Uni- Genes (http://www.sgn.cornell.edu) (Mueller et al.",OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
"TOMATOMICS, which is the integrated omics database for tomato plants, is constructed from the latest UniGene set (K TU4) that is made up of 125,883 ESTs from 9 cDNA libraries and other publiclyavailable 196,912 ESTs fro m Sol Genomics Network (SGN), resulting in 58,083 UniGenes (http://bioinf.mind.",OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
"1.To-date coverage of the tomato metabolome using the MS-based  metabolomics platform in PRIMe (Platform for RIKEN Metabolomics, http://prime.psc.riken.jp/).",Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
"Omics-related research approaches for improvement of tomato fruit quality and yield In this section, we will intr oduce application examples of omics approaches to improv e agronomically and economi- cally important traits as we ll as metabolite composition in the tomato.Table  1.Omics databases intr oduced in the article species database URL reference Arabidopsis AraNet http://www.functionalnet.org/aranet/ (Lee et al.",Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
2010) CYPedia http://www-ibmp.u-strasbg.fr/~CYPedia/ (Ehlting et al.,Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
2008) VirtualPlant http://virtualplant.bio .nyu.edu/cgi-bin/vpweb/ (Katari et al.,Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
2010) rice OryzaExpress http://riceball.lab .nig.ac.jp/oryzaexpress/ (Hamada et al.,Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
2009) tomato TOMATOMICS http://bioinf.mind.meiji.ac.jp/tomatomics/Arabidopsis and six crop species PlaNet http://aranet.mpimp-g olm.mpg.de (Mutwil et al.,Non-OADS,/arxiv_data1/oa_pdf/af/ca/63_31.PMC3621443.pdf
A comprehensive data-base including the majority of the tomato genome sequenceand a large number of expre ssed sequence tags (ESTs) is presented through the Solanaceae Genomics Network(SGN) website (http://solgenomics.net/) (Bombarely et al.,OADS,/arxiv_data1/oa_pdf/5a/f9/63_42.PMC3621444.pdf
"Because the TILLING plat- form has been closely linked to the Micro-Tom mutant data-base TOMATOMA (http://tomato.nbrp.jp/indexEn.html),additional mutant populations will become beneficial re- sources for both forward- and reverse genetic studies and provide opportunities to obtai n more novel mutants and al-lelic variations of target gene s. Also, the mutant screening of several genes involved in import ant traits is currently under- way.",Non-OADS,/arxiv_data1/oa_pdf/5a/f9/63_42.PMC3621444.pdf
"http://statgen.ncs u.edu/qtlcart/WQTLCart.htm Winfield,  M.O., C.  Lu, I.D.",OADS,/arxiv_data1/oa_pdf/09/be/63_58.PMC3621446.pdf
"Similarity searcheswere performed against the NCBI non-redundant database (http://www.ncbi.nlm.nih.gov; National Center for Bio-technology Information, Beth esda, MD, USA) and the TAIR database (http://www.arabidop sis.org) using the default BLAST parameters.",OADS,/arxiv_data1/oa_pdf/02/23/63_68.PMC3621447.pdf
Protein a lignment was carried using Jalview multiple alignment e ditor (http://www.jalview.,OADS,/arxiv_data1/oa_pdf/02/23/63_68.PMC3621447.pdf
The theoretical isoelectric point (pI) and the molecular weight of the putative protein we re calculated using an on- line version of the ExPASy pI  program (http://web.expasy.,Non-OADS,/arxiv_data1/oa_pdf/02/23/63_68.PMC3621447.pdf
Prediction of  subcellular localization was performed using the ChloroP 1.1 (http://www.cbs.dtu.dk/ services/ChloroP/) and Targ etP (http://www.cbs.dtu.dk/ services/TargetP/) prediction servers.,OADS,/arxiv_data1/oa_pdf/02/23/63_68.PMC3621447.pdf
"Although the three residues of the TM of the 13-bp deletion allele were changed, the domain predicti on database (http://www.ebi.",Non-OADS,/arxiv_data1/oa_pdf/aa/da/63_77.PMC3621448.pdf
"Even though th e production of European pear (P. communis  L.) cultivar ‘La France’ has been increasing in Japan, it is still less than 9%  of the total pear production in Japan (Statistical Yearbook of Ministry of Agriculture,Forestry and Fisheries, Japa n 2011, http://www.maff.go.jp/ e/tokei/kikaku/nenji_e/85nenji/ index.html).",Non-OADS,/arxiv_data1/oa_pdf/3a/88/63_86.PMC3621449.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Poddubny, A. N.  et al.",Non-OADS,/arxiv_data1/oa_pdf/82/bb/ncomms1924.PMC3621451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/82/bb/ncomms1924.PMC3621451.pdf
Additional information     Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications     Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/65/32/ncomms1925.PMC3621452.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Wang, Y .",Non-OADS,/arxiv_data1/oa_pdf/65/32/ncomms1925.PMC3621452.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/65/32/ncomms1925.PMC3621452.pdf
Additional information     Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications     Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5f/6f/ncomms1930.PMC3621454.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Huang, W .",Non-OADS,/arxiv_data1/oa_pdf/5f/6f/ncomms1930.PMC3621454.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/",Non-OADS,/arxiv_data1/oa_pdf/5f/6f/ncomms1930.PMC3621454.pdf
Additional information     Supplementary Information   accompanies this paper at  http://www.nature.com/ naturecommunications     Competing fi  nancial interests:   Th e authors declare no competing fi  nancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/ncomms1932.PMC3621455.pdf
"Reprints and permission   information is available online at  http://npg.nature.com/ reprintsandpermissions/     How to cite this article:   Park, C.-J.",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/ncomms1932.PMC3621455.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/ncomms1932.PMC3621455.pdf
Additional information Supplementary Information  accompanies this paper at http://www.nature.com/ naturecommunications Competing financial interests:  The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ef/25/ncomms1933.PMC3621463.pdf
"Reprints and permission  information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article:  Lee, J.C. et al.",Non-OADS,/arxiv_data1/oa_pdf/ef/25/ncomms1933.PMC3621463.pdf
Journal of Histochemistry & Cytochemistry 61(4) 306 –312 © The Author(s) 2013 Reprints and permission:   sagepub.com/journalsPermissions.nav DOI: 10.1369/0022155413476868 http://jhc.sagepub.com The murine cell line NIH 3T3 has been used as a model  system in a multitude of different studies since its first description in 1963.,Non-OADS,/arxiv_data1/oa_pdf/0d/ff/10.1369_0022155413476868.PMC3621507.pdf
Supplementary material for this article is available on the Journal of  Histochemistry & Cytochemistry Web site at http://jhc.sagepub.com/supplemental.,Non-OADS,/arxiv_data1/oa_pdf/0d/ff/10.1369_0022155413476868.PMC3621507.pdf
"As NIH 3T3  has been used in thousands of published studies (http://www.ncbi.nlm.nih.gov/pubmed), its molecular cytogenetic characterization seems to be overdue.",Non-OADS,/arxiv_data1/oa_pdf/0d/ff/10.1369_0022155413476868.PMC3621507.pdf
Characterization of NIH 3T3 309 the UCSC Genome Browsers (http://www.ensembl.org/ Mus_musculus/Location/Synteny; http://genome.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/0d/ff/10.1369_0022155413476868.PMC3621507.pdf
http://www.fish.uniklinikum-jena.de/mFISH.html.,Non-OADS,/arxiv_data1/oa_pdf/0d/ff/10.1369_0022155413476868.PMC3621507.pdf
"See: http://creativecommons.org/licenses/ by-nc/3.0/ REFERENCES 1 Pottinger A, Pervolaris A, Howes D. The end of life.",Non-OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
Aboriginal Peoples –Data T able 2010. http://www12.statcan.ca/census-recensement/2006/dp-pd/hlt/97-558/pages/page.cfm?,OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
"Cancer CareOntario, 2011. http://www.cancercare.on.ca/cms/One.aspx?portalId=1377&pageId=10397 (accessed 18 August 2011).",Non-OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
"NIHConsensus and State-of-the-Science Statements, 2004 http://consensus.nih.gov/2004/2004EndOfLifeCareSOS024PDF .pdf(accessed 9 August 2011).",OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
Caregiver Resilience and the Quest for Balance: A Report on Findings from Focus Groups.Healthy Balance Research Program 2004. http://www.acewh.dal.ca/eng/reports/T eamQ-web.pdf (accessed 9 August 2011).,Non-OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
"A Cultural Competence Guide for Primary Health Care Professionals in Nova Scotia.Primary Health Care Section, Nova Scotia: Department ofHealth, 2005. http://www.healthteamnovascotia.ca/cultural_competence/Cultural_Competence_guide_for_Primary_Health_Care_Professionals.pdf (accessed 9 August2011).",Non-OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
"The Saskatchewan Institute of Public Policy , Briefing Notes, 2004 http://www.uregina.ca/sipp/documents/pdf/BN6_Aboriginal%20Persons%20with%20Disabilities.pdf (accessed 23 March 2006).",Non-OADS,/arxiv_data1/oa_pdf/57/07/bmjspcare-2011-000122.PMC3621524.pdf
"Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/ntr/nts206Original investigatiOn readiness to Quit smoking and Quit attempts among  australian Mental Health inpatients Emily Stockings BPsyc (Hons)1,2,3, Jenny Bowman PhD1,2,3, Kathleen McElwaine BPsyc (Hons)1,2,3,4,   Amanda Baker PhD1,2,5, Margarett Terry MPsych (Clin)6, Richard Clancy MMedSc (Clin Epid)1,5,6,   Kate Bartlem BPsyc (Hons)1,2,3, Paula Wye PhD1,2,3,4, Paula Bridge BPsyc (Hons)1, Jenny Knight MMedSc1,4,  John Wiggers PhD1,2,3,4 1University of Newcastle, Callaghan, NSW, Australia; 2Hunter Medical Research Institute, Level 3 John Hunter Hospital, New  Lambton Heights, NSW, Australia; 3University of Newcastle Priority Research Centre for Health Behaviour, Newcastle, NSW,  Australia; 4Hunter New England Population Health, Wallsend, NSW, Australia; 5Priority Research Centre for Translational  Neuroscience and Mental Health, Mater Hospital, Waratah, NSW, Australia; 6Mental Health and Substance Use Service, Mater  Hospital, Waratah, NSW, Australia Corresponding Author: Emily Stockings, B.Psyc.",Non-OADS,/arxiv_data1/oa_pdf/15/74/nts206.PMC3621580.pdf
"NPCs provide an  *Correspondence to: Naoko Imamoto; Email: nimamoto@riken.jp Submitted: 10/30/12; Revised: 01/17/13; Accepted: 01/26/13http://dx.doi.org/10.4161/nucl.23796in metazoans with “open” mitosis, cells undergo structural  chan ges involving the complete disassembly of the nuclear  envelope (N e).",OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2010; 123:1973-8; PMID:20519579; http://dx.doi.org/10.1242/jcs.019042.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Biophys Biochem Cytol 1955; 1:257-70; PMID:13242591; http://dx.doi.org/10.1083/jcb.1.3.257.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2000; 148:635-51; PMID:10684247; http://dx.doi.org/10.1083/jcb.148.4.635.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2002; 158:915-27; PMID:12196509; http://dx.doi.org/10.1083/jcb.200206106.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Annu Rev Cell Dev Biol 1999; 15:607-60; PMID:10611974; http://dx.doi.org/10.1146/annurev.cellbio.15.1.607.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Microbiol Mol Biol Rev 2001; 65:570-94; PMID:11729264; http://dx.doi.org/10.1128/MMBR.65.4.570-594.2001.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nucleus 2012; 3:422-8; PMID:22895094; http://dx.doi.org/10.4161/nucl.21713.9.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Genes Dev 2002; 16:533-47; PMID:11877373; http://dx.doi.org/10.1101/gad.960502.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000547; PMID:20826548; http://dx.doi.org/10.1101/cshperspect.a000547.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Annu Rev Cell Dev Biol 2010; 26:421-44; PMID:20507227; http://dx.doi.org/10.1146/annurev-cellbio-100109-104037.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2012; 149:1035-47; PMID:22632968; http://dx.doi.org/10.1016/j.cell.2012.03.046.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Science 2002; 298:406-9; PMID:12169658; http://dx.doi.org/10.1126/sci - ence.1075119.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2005; 171:799-810; PMID:16330710; http://dx.doi.org/10.1083/jcb.200506083.16.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2003; 115:825-36; PMID:14697201; http://dx.doi.org/10.1016/S0092-8674(03)00985-1.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Rev Mol Cell Biol 2005; 6:21-31; PMID:15688064; http://dx.doi.org/10.1038/nrm1550.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Annu Rev Genomics Hum Genet 2006; 7:369-405; PMID:16824021; http://dx.doi.org/10.1146/annurev.genom.7.080505.115732.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000760; PMID:20182615; http://dx.doi.org/10.1101/cshperspect.a000760.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2011; 144:539-50; PMID:21335236; http://dx.doi.org/10.1016/j.cell.2011.01.012.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2002; 108:97-107; PMID:11792324; http://dx.doi.org/10.1016/S0092-8674(01)00628-6.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1997; 138:1193-206; PMID:9298976; http://dx.doi.org/10.1083/jcb.138.6.1193.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Biochemistry 2000; 39:6483-8; PMID:10828963; http://dx.doi.org/10.1021/bi992908b.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2011; 22:1058-69; PMID:21289085; http://dx.doi.org/10.1091/mbc.E10-07-0641.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nucleus 2012; 3:187-99; PMID:22555603; http://dx.doi.org/10.4161/nucl.19595.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Am J Hum Genet 2003; 72:1013-7; PMID:12618959; http://dx.doi.org/10.1086/373938.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2007; 120:520-30; PMID:17251381; http://dx.doi.org/10.1242/jcs.03355.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1996; 135:1715-25; PMID:8991085; http://dx.doi.org/10.1083/jcb.135.6.1715.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Biol Chem 2010; 285:33281-93; PMID:20576617; http://dx.doi.org/10.1074/jbc.M110.102368.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Biol Chem 2004; 279:13265-71; PMID:14718546; http://dx.doi.org/10.1074/jbc.M308854200.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2011; 22:3306-17; PMID:21795390; http://dx.doi.org/10.1091/mbc.E11-03-0199.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Biol Chem 2000; 275:4840-7; PMID:10671519; http://dx.doi.org/10.1074/jbc.275.7.4840.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
EMBO J 2001; 20:4399-407; PMID:11500367; http://dx.doi.org/10.1093/emboj/20.16.4399.40.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2001; 153:621-6; PMID:11331311; http://dx.doi.org/10.1083/jcb.153.3.621.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2003; 116:2237-46; PMID:12697839; http://dx.doi.org/10.1242/jcs.00432.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Science 2011; 334:1706-10; PMID:22116031; http://dx.doi.org/10.1126/science.1211222.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1997; 137:1001-16; PMID:9166402; http://dx.doi.org/10.1083/jcb.137.5.1001.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Cell Biol 2001; 3:848-51; PMID:11533666; http://dx.doi.org/10.1038/ncb0901-848.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Genes Dev 2011; 25:2579-93; PMID:22155925; http://dx.doi.org/10.1101/gad.179515.111.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1993; 122:295-306; PMID:8391536; http://dx.doi.org/10.1083/jcb.122.2.295.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2000; 151:1155-68; PMID:11121432; http://dx.doi.org/10.1083/jcb.151.6.1155.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2001; 154:71-84; PMID:11448991; http://dx.doi.org/10.1083/jcb.200101089.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000554; PMID:20452940; http://dx.doi.org/10.1101/cshper-spect.a000554.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1997; 137:1199-210; PMID:9182656; http://dx.doi.org/10.1083/jcb.137.6.1199.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2009; 186:183-91; PMID:19620630; http://dx.doi.org/10.1083/jcb.200901106.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Cell Biol 2007; 9:1160-6; PMID:17828249; http://dx.doi.org/10.1038/ncb1636.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Rev Mol Cell Biol 2008; 9:464-77; PMID:18478030; http://dx.doi.org/10.1038/nrm2410.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nature 2003; 424:689-94; PMID:12894213; http://dx.doi.org/10.1038/nature01898.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell Cycle 2005; 4:1161-5; PMID:16082212; http://dx.doi.org/10.4161/cc.4.9.1979.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2009; 20:4043-58; PMID:19641022; http://dx.doi.org/10.1091/mbc.E09-02-0152.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell Div 2010; 5:5; PMID:20181052; http://dx.doi.org/10.1186/1747-1028-5-5.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Rev Mol Cell Biol 2007; 8:798-812; PMID:17848966; http://dx.doi.org/10.1038/nrm2257.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Science 2006; 311:1887-93; PMID:16543417; http://dx.doi.org/10.1126/science.1122771.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell Mol Life Sci 2010; 67:2215-30; PMID:20372967; http://dx.doi.org/10.1007/s00018-010-0325-7.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2008; 132:771-82; PMID:18329364; http://dx.doi.org/10.1016/j.cell.2008.01.029.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Biochem Soc T rans 2008; 36:1339-43; PMID:19021552; http://dx.doi.org/10.1042/BST0361339.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Rev Mol Cell Biol 2012; 14:13-24; PMID:23212477; http://dx.doi.org/10.1038/nrm3488.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1992; 119:17-25; PMID:1527167; http://dx.doi.org/10.1083/jcb.119.1.17.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2001; 154:61-70; PMID:11448990; http://dx.doi.org/10.1083/jcb.200101025.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1990; 111:2247-59; PMID:2277059; http://dx.doi.org/10.1083/jcb.111.6.2247.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2001; 154:61-70; PMID:11448990; http://dx.doi.org/10.1083/jcb.200101025.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2010; 191:505-21; PMID:20974814; http://dx.doi.org/10.1083/jcb.201007098.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Struct Mol Biol 2007; 14:138-46; PMID:17220896; http://dx.doi.org/10.1038/nsmb1194.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Genes Cells 2002; 7:435-46; PMID:11952839; http://dx.doi.org/10.1046/j.1365-2443.2002.00529.x.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Biochem Biophys Res Commun 2003; 305:327-32; PMID:12745078; http://dx.doi.org/10.1016/S0006-291X(03)00772-1.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Genes Cells 2004; 9:1083-91; PMID:15507119; http://dx.doi.org/10.1111/j.1365-2443.2004.00791.x.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Curr Biol 2006; 16:1748-56; PMID:16950114; http://dx.doi.org/10.1016/j.cub.2006.06.067.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
EMBO Rep 2007; 8:165-72; PMID:17235358; http://dx.doi.org/10.1038/sj.embor.7400889.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Curr Biol 2007; 17:1657-62; PMID:17825564; http://dx.doi.org/10.1016/j.cub.2007.08.041.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2009; 20:5260-75; PMID:19864462; http://dx.doi.org/10.1091/mbc.E09-05-0377.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2010; 191:923-31; PMID:21098116; http://dx.doi.org/10.1083/jcb.201007124.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Curr Biol 2006; 16:1757-63; PMID:16950115; http://dx.doi.org/10.1016/j.cub.2006.07.071.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
EMBO J 2005; 24:3519-31; PMID:16193066; http://dx.doi.org/10.1038/sj.emboj.7600825.85.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
"Cell 2012; 150:1084-1084, e1; PMID:22939630; http://dx.doi.org/10.1016/j.cell.2012.08.003.",OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cold Spring Harb Perspect Biol 2010; 2:a000562; PMID:20630994; http://dx.doi.org/10.1101/cshperspect.a000562.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1971; 51:405-18; PMID:5165267; http://dx.doi.org/10.1083/jcb.51.2.405.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2010; 141:1030-41; PMID:20550937; http://dx.doi.org/10.1016/j.cell.2010.04.036.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nucleus 2011; 2:113-8; PMID:21738834; http://dx.doi.org/10.4161/nucl.2.2.15446.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Science 2006; 312:440-3; PMID:16627745; http://dx.doi.org/10.1126/sci-ence.1124196.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Chromosoma 2010; 119:469-77; PMID:20721671; http://dx.doi.org/10.1007/s00412-010-0289-2.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nat Struct Mol Biol 2010; 17:1065-71; PMID:20711190; http://dx.doi.org/10.1038/nsmb.1878.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2011; 194:27-37; PMID:21727197; http://dx.doi.org/10.1083/jcb.201012154.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
FEBS Lett 2010; 584:3292-8; PMID:20624389; http://dx.doi.org/10.1016/j.febslet.2010.07.008.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2008; 180:857-65; PMID:18316408; http://dx.doi.org/10.1083/jcb.200707026.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 1988; 106:1-12; PMID:3339085; http://dx.doi.org/10.1083/jcb.106.1.1.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2003; 113:195-206; PMID:12705868; http://dx.doi.org/10.1016/S0092-8674(03)00235-6.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2011; 194:425-40; PMID:21825076; http://dx.doi.org/10.1083/jcb.201012063.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2008; 19:3982-96; PMID:18596237; http://dx.doi.org/10.1091/mbc.E08-01-0012.70.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Int Rev Cytol 2007; 261:1-46; PMID:17560279; http://dx.doi.org/10.1016/S0074-7696(07)61001-8.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Biol Chem 2003; 278:6969-75; PMID:12493765; http://dx.doi.org/10.1074/jbc.M208811200.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2002; 158:475-85; PMID:12163470; http://dx.doi.org/10.1083/jcb.200202019.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2003; 116:3811-23; PMID:12902403; http://dx.doi.org/10.1242/jcs.00682.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2012; 150:122-35; PMID:22770216; http://dx.doi.org/10.1016/j.cell.2012.04.043.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Nature 2007; 449:611-5; PMID:17851530; http://dx.doi.org/10.1038/nature06170.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Structure 2012; 20:998-1006; PMID:22632834; http://dx.doi.org/10.1016/j.str.2012.03.025.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Mol Biol 2010; 395:578-86; PMID:19913035; http://dx.doi.org/10.1016/j.jmb.2009.11.010.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Science 2006; 314:815-7; PMID:17082456; http://dx.doi.org/10.1126/science.1132516.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2007; 129:83-96; PMID:17418788; http://dx.doi.org/10.1016/j.cell.2007.01.044.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Annu Rev Biochem 2011; 80:613-43; PMID:21495847; http://dx.doi.org/10.1146/annurev-biochem-060109-151030.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Exp Cell Res 2009; 315:1181-9; PMID:19210986; http://dx.doi.org/10.1016/j.yexcr.2008.12.024.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Biol 2007; 178:785-98; PMID:17724119; http://dx.doi.org/10.1083/jcb.200704108.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2008; 121:2540-54; PMID:18628300; http://dx.doi.org/10.1242/jcs.033597.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2004; 117:6117-28; PMID:15546916; http://dx.doi.org/10.1242/jcs.01529.121.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Cell 2008; 135:1017-27; PMID:19070573; http://dx.doi.org/10.1016/j.cell.2008.10.022.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
FEBS Lett 2007; 581:4910-6; PMID:17900573; http://dx.doi.org/10.1016/j.febs-let.2007.09.021.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2006; 119:4442-51; PMID:17074834; http://dx.doi.org/10.1242/jcs.03207.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Genes Dev 2008; 22:3409-21; PMID:19141474; http://dx.doi.org/10.1101/gad.1735208.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Pathol 2012; 226:735-45; PMID:22025297; http://dx.doi.org/10.1002/path.3033.115.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
J Cell Sci 2012; 125:4214-8; PMID:22718353; http://dx.doi.org/10.1242/jcs.105809.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Dev Biol 2009; 327:399-409; PMID:19146848; http://dx.doi.org/10.1016/j.ydbio.2008.12.024.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2005; 16:2382-94; PMID:15703211; http://dx.doi.org/10.1091/mbc.E04-10-0857.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Biol Cell 2008; 19:1753-62; PMID:18256286; http://dx.doi.org/10.1091/mbc.E07-08-0820.,Non-OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Cell 2005; 17:83-92; PMID:15629719; http://dx.doi.org/10.1016/j.mol-cel.2004.12.010.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Mol Cell 2006; 22:93-103; PMID:16600873; http://dx.doi.org/10.1016/j.molcel.2006.02.015.,OADS,/arxiv_data1/oa_pdf/7a/9b/nucl-4-105.PMC3621742.pdf
Bioarchitecture 2012; 2:200-3;  PMid:23267413; http://dx.doi.or g/10.4161/bioa.22726 dNA methylation changes during aging and is  likely to be inv olved in aging-related processes  with subsequent phenotype changes and  increased susceptibility to certain diseases.,Non-OADS,/arxiv_data1/oa_pdf/e1/6b/nucl-4-83.PMC3621747.pdf
Epigenetics 2013;  8:28-33; PM id:23257959; http://dx.doi.or g/10.4161/ epi.23366,Non-OADS,/arxiv_data1/oa_pdf/e1/6b/nucl-4-83.PMC3621747.pdf
"www.landesbioscience.com  Nucleus  89Nucleus 4:2, 89–91; March/Apr il 2013; © 2013 Landes Bioscience CoMM eNtAry CoMM eNtAry Keywords:  sea urchin, development,  specification, gene regulatory networks,  computational embryology Submitted: 01/18/13Accepted: 02/12/13http://dx.doi.org/10.4161/nucl.23986 *Correspondence to: Zhiping Weng;   Email: zhiping.weng@umassmed.eduEric Davidson at Caltech has spent  several decades investigating the  molecular basis of animal development using the sea urchin embryo as an experi - mental system 1,2 although his scholarship  extends to all of embryology as embodied in several editions of his landmark book.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Science 1969; 165:349-57;  PMID:5789433; http://dx.doi.org/10.1126/sci - ence.165.3891.349.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
FASEB J 2009; 23:2019-21; PMID:19567373; http://dx.doi.org/10.1096/fj.09-0702.,Non-OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Int J  Biostat 2010; 6:7; PMID:20305706; http://dx.doi.org/10.2202/1557-4679.1203.6.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Nano Commun Netw 2010; 1:173-80; PMID:22110566; http://dx.doi.org/10.1016/j.nan - com.2010.09.002.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Synth Lect Data Mining Knowl Disc 2012; 3:1-159; http://dx.doi.org/10.2200/S00433ED1V01Y201207DMK005.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Genome Res 2012; 22:577-91; PMID:22110045; http://dx.doi.org/10.1101/gr.133009.111.References 1.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Dev Biol 200  6; 300:9-14; PMID:17113576; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
Dev Biol  2011; 358:285-94; PMID:21723860; http://dx.doi.org/10.1016/j.ydbio.2011.06.021.,OADS,/arxiv_data1/oa_pdf/b6/08/nucl-4-89.PMC3621749.pdf
"Cell 2012; 149:832-46; PMID:22579286; http://dx.doi.org/10.1016/j.cell.2012.03.032Keywords:  nuclear envelope, nuclear  lamina, nuclear pore complex, Wnt sig - naling, neuromuscular junctions, RNA  export Submitted: 03/05/13Accepted: 03/08/13http://dx.doi.org/10.4161/nucl.24237 Correspondence to: Caterina Strambio-De-Castilla;  Email: caterina.strambio@umassmed.eduThe nuclear envelope forms a cocoon  that surrounds the cellular genome  keeping it out of harm’s way and can be utilized by the cell as a means of func - tionally regulating chromatin structure and gene expression.",OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Cell 2012; 149:832-46; PMID:22579286; http://dx.doi.org/10.1016/j.cell.2012.03.032.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Sci 2010; 123:1973-8; PMID:20519579; http://dx.doi.org/10.1242/jcs.019042.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Sci  2012; 125:2087-93; PMID:22669459; http://dx.doi.org/10.1242/jcs.087288.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Struct Biol 2012; 177:24-31; PMID:22126840; http://dx.doi.org/10.1016/j.jsb.2011.11.007.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Genome Biol 2011; 12:222; PMID:21639948; http://dx.doi.org/10.1186/gb-2011-12-5-222.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nat Rev Mol Cell Biol 2011; 12:695-708; PMID:21971041; http://dx.doi.org/10.1038/nrm3207.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Clin Invest 2009; 119:1825-36; PMID:19587457; http://dx.doi.org/10.1172/JCI37679.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 2001; 154:71-84; PMID:11448991; http://dx.doi.org/10.1083/jcb.200101089.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nat Rev Mol Cell Biol 2010; 11:490-501; PMID:20571586; http://dx.doi.org/10.1038/nrm2928.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Trends Cell Biol 2012; 22:465-73; PMID:22771046; http://dx.doi.org/10.1016/j.tcb.2012.05.007.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 1993; 123:275-84; PMID:7691829; http://dx.doi.org/10.1083/jcb.123.2.275.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 1994; 125:955-69; PMID:8195299; http://dx.doi.org/10.1083/jcb.125.5.955.14.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nature 2010; 467:600-3; PMID:20811366; http://dx.doi.org/10.1038/nature09285.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Microbiol Mol Biol Rev 2001; 65:570-94; PMID:11729264; http://dx.doi.org/10.1128/MMBR.65.4.570-594.2001.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nature 1949; 163:280; PMID:18112254; http://dx.doi.org/10.1038/163280a0.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Biophys Biochem Cytol 1956; 2(Suppl):439-44; PMID:13357583; http://dx.doi.org/10.1083/jcb.2.4.439.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Mol Biol Cell 2005; 16:5610-20; PMID:16195343; http://dx.doi.org/10.1091/mbc.E05-08-0715.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Cell 1992; 69:605-13; PMID:1586943; http://dx.doi.org/10.1016/0092-8674(92)90224-Z.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 1966; 31:55-77; PMID:5971975; http://dx.doi.org/10.1083/jcb.31.1.55.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 1995; 129:1205-16; PMID:7775568; http://dx.doi.org/10.1083/jcb.129.5.1205.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Exp Cell Res 2008; 314:1708-20; PMID:18374333; http://dx.doi.org/10.1016/j.yexcr.2008.02.003.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nature 2011; 475:333-41; PMID:21776079; http://dx.doi.org/10.1038/nature10318.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Trends Neurosci 2010; 33:173-82; PMID:20303187; http://dx.doi.org/10.1016/j.tins.2010.01.005.27.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Science 2005; 309:1514-8; PMID:16141059; http://dx.doi.org/10.1126/sci - ence.1111443.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Cell Biol Int Rep 1988; 12:729-36; PMID:3197122; http://dx.doi.org/10.1016/0309-1651(88)90086-0.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Nucleus 2012; 3:526-39; PMID:22929056; http://dx.doi.org/10.4161/nucl.21979.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Rev Med Virol 2010; 20:214-30; PMID:20069615; http://dx.doi.org/10.1002/rmv.643.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Virol 2009; 83:408-19; PMID:18922868; http://dx.doi.org/10.1128/JVI.01568-08.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Virol 2008; 82:3109-24; PMID:18160444; http://dx.doi.org/10.1128/JVI.02124-07.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Virol 2005; 79:13047-59; PMID:16189007; http://dx.doi.org/10.1128/JVI.79.20.13047-13059.2005.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Virol 2008; 82:8392-9; PMID:18562518; http://dx.doi.org/10.1128/JVI.00951-08.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Cold Spring Harb Perspect Biol 2012; 4:4; PMID:22510459; http://dx.doi.org/10.1101/cshperspect.a008045.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Science 2005; 310:1344-7; PMID:16311339; http://dx.doi.org/10.1126/sci - ence.1117051.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Trends Cell Biol 2012; 22:509-14; PMID:22858153; http://dx.doi.org/10.1016/j.tcb.2012.07.003.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell  Biol 1963; 19:391-414; PMID:14086764; http://dx.doi.org/10.1083/jcb.19.2.391.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
PLoS One 2012; 7:e35172; PMID:22523574; http://dx.doi.org/10.1371/journal.pone.0035172.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Science 2011; 331:1616-20; PMID:21310966; http://dx.doi.org/10.1126/sci - ence.1201847.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Struct Biol 2011; 176:268-78; PMID:21907806; http://dx.doi.org/10.1016/j.jsb.2011.08.013.40.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Cold Spring Harb Symp Quant Biol 1956; 21:257-69; PMID:13433596; http://dx.doi.org/10.1101/SQB.1956.021.01.021.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
Int Rev Cytol 1992; 133:43-120; PMID:1374369; http://dx.doi.org/10.1016/S0074-7696(08)61858-6.,OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
PLoS Biol 2004; 2:e380; PMID:15523559; http://dx.doi.org/10.1371/journal.pbio.0020380.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
J Cell Biol 2011; 193:963-72; PMID:21670211; http://dx.doi.org/10.1083/jcb.201102042.,Non-OADS,/arxiv_data1/oa_pdf/4a/ba/nucl-4-95.PMC3621751.pdf
"Additional information Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.. Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Palmer, M.J. et al.",Non-OADS,/arxiv_data1/oa_pdf/b9/ff/ncomms2648.PMC3621900.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2648 8 NATURE COMMUNICATIONS | 4:1634 | DOI: 10.1038/ncomms2648 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/b9/ff/ncomms2648.PMC3621900.pdf
"Lever presses, the light stimulus presentation,the reward delivery, and data collection were controlled by a PC running Whisker control software (Cardinal and Aitken, http://www.whiskercontrol.com ).",Non-OADS,/arxiv_data1/oa_pdf/aa/02/213_2012_Article_2949.PMC3622002.pdf
http://pest.ceris.purdue.edu/map.php?,Non-OADS,/arxiv_data1/oa_pdf/66/91/248_2013_Article_218.PMC3622004.pdf
http://www.biology.ualberta.ca/bsc/ejournal/sgsbws_21/ sgsbws_21.html .,Non-OADS,/arxiv_data1/oa_pdf/66/91/248_2013_Article_218.PMC3622004.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b5/95/srep01641.PMC3622076.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Bando, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/b5/95/srep01641.PMC3622076.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c0/b2/srep01646.PMC3622077.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yan, Z.X., Cai, M. & Shen, P.K.",Non-OADS,/arxiv_data1/oa_pdf/c0/b2/srep01646.PMC3622077.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7e/cf/srep01638.PMC3622078.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Freedman, K.J., Haq, S.R., Edel, J.B., Jemth, P. & Kim, M.J.",Non-OADS,/arxiv_data1/oa_pdf/7e/cf/srep01638.PMC3622078.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f4/a7/srep01642.PMC3622079.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Chen, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/f4/a7/srep01642.PMC3622079.pdf
The map was generated using GeoMapApp version 2 (http://www.geomapapp.org/).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1643 | DOI: 10.1038/srep01643 2,Non-OADS,/arxiv_data1/oa_pdf/12/a9/srep01643.PMC3622080.pdf
Thetemperature data set was from MODIS Land Product Subsets (http://daac.ornl.gov/ MODIS/MODIS-menu/).,OADS,/arxiv_data1/oa_pdf/12/a9/srep01643.PMC3622080.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/a9/srep01643.PMC3622080.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lin, W., Wang, Y., Gorby, Y., Nealson, K. & Pan, Y.",Non-OADS,/arxiv_data1/oa_pdf/12/a9/srep01643.PMC3622080.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/7e/srep01648.PMC3622081.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Miller, C.R., Wang, D.K., Smart, S. & Diniz da Costa, J.C. Reversible Redox Effect on Gas Permeation of Cobalt Doped Ethoxy Polysiloxane (ES40) Membranes.",Non-OADS,/arxiv_data1/oa_pdf/3b/7e/srep01648.PMC3622081.pdf
"The computation was formalized as the following Integer Linear Programming (ILP) problemminimizeX v[V>xv subject toX v,ufg[Exv§1 for all u[V\ xv[0,1 for all v[V>ð3Þ where the optimal solution was calculated using ’glpsol’ solver (http://www.gnu.org/ software/glpk).",OADS,/arxiv_data1/oa_pdf/c5/53/srep01647.PMC3622082.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c5/53/srep01647.PMC3622082.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Nacher, J.C. & Akutsu, T. Structural controllability of unidirectional bipartite networks.",Non-OADS,/arxiv_data1/oa_pdf/c5/53/srep01647.PMC3622082.pdf
32. http://data.worldbank.org/.,Non-OADS,/arxiv_data1/oa_pdf/43/b9/srep01640.PMC3622083.pdf
"http://www.geonames.org/, Retr.",Non-OADS,/arxiv_data1/oa_pdf/43/b9/srep01640.PMC3622083.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/43/b9/srep01640.PMC3622083.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Zhang, Q., Perra, N., Gonçalves, B., Ciulla, F. & Vespignani, A. Characterizing scientific production and consumption in Physics.",Non-OADS,/arxiv_data1/oa_pdf/43/b9/srep01640.PMC3622083.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2013 |  73  | e50218 | Page 1 of 8Video Article Murine Spinotrapezius Model to Assess the Impact of Arteriolar Ligation on Microvascular Function and Remodeling Alexander Michael Guendel*1, Kyle S. Martin*1, Joshua Cutts2, Patricia L. Foley3, Alexander M. Bailey1, Feilim Mac Gabhann4, Trevor R. Cardinal2, Shayn M. Peirce1 1Department of Biomedical Engineering, University of Virginia 2Department of Biomedical Engineering, California Polytechnic State University 3Office of Animal Welfare, University of Virginia 4Department of Biomedical Engineering & Institute for Computational Medicine, Johns Hopkins University *These authors contributed equally Correspondence to: Shayn M. Peirce at smp6p@virginia.edu URL: http://www.jove.com/video/50218 DOI: doi:10.3791/50218 Keywords: Biomedical Engineering, Issue 73, Medicine, Anatomy, Physiology, Surgery, Immunology, Hematology, Microvessels, Capillaries, Arterioles, Venules, Vascular Diseases, Ischemia, spinotrapezius, peripheral vascular disease, functional vasodilation, arteriolar ligation, vessels, circulation, confocal microscopy, animal model Date Published: 3/3/2013 Citation: Guendel, A.M., Martin, K.S., Cutts, J., Foley, P.L., Bailey, A.M., Mac Gabhann, F., Cardinal, T.R., Peirce, S.M.",Non-OADS,/arxiv_data1/oa_pdf/cc/39/jove-73-50218.PMC3622090.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/50218/ Introduction Animal models of chronic ischemia are valuable tools for investigating the pathophysiology of ischemic diseases, such as peripheral artery disease, coronary artery disease, and cerebrovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/cc/39/jove-73-50218.PMC3622090.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseMarch 2013 |  73  | e4376 | Page 1 of 14Video Article Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction Kazuyuki Nagai1,2, Shintaro Yagi2, Shinji Uemoto2, Rene H. Tolba1 1Institute for Laboratory Animal Science and Experimental Surgery, RWTH-Aachen University 2Department of Hepato-Biliary-Pancreatic Surgery and Transplantation, Graduate School of Medicine, Kyoto University Correspondence to: Kazuyuki Nagai at kaznagai@kuhp.kyoto-u.ac.jp URL: http://www.jove.com/video/4376 DOI: doi:10.3791/4376 Keywords: Medicine, Issue 73, Biomedical Engineering, Anatomy, Physiology, Immunology, Surgery, liver transplantation, liver, hepatic, partial, orthotopic, split, rat, graft, transplantation, microsurgery, procedure, clinical, technique, artery, arterialization, arterialized, anastomosis, reperfusion, rat, animal model Date Published: 3/7/2013 Citation: Nagai, K., Yagi, S., Uemoto, S., Tolba, R.H. Surgical Procedures for a Rat Model of Partial Orthotopic Liver Transplantation with Hepatic Arterial Reconstruction.",Non-OADS,/arxiv_data1/oa_pdf/b5/5e/jove-73-4376.PMC3622100.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4376/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/b5/5e/jove-73-4376.PMC3622100.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2013  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseFebruary 2013 |  72  | e4344 | Page 1 of 6Video Article Rapid Genetic Analysis of Epithelial-Mesenchymal Signaling During Hair Regeneration Wei-Meng Woo*1, Scott X. Atwood*1, Hanson H. Zhen1, Anthony E. Oro1 1Program in Epithelial Biology, Stanford University School of Medicine *These authors contributed equally Correspondence to: Anthony E. Oro at oro@stanford.edu URL: http://www.jove.com/video/4344 DOI: doi:10.3791/4344 Keywords: Genetics, Issue 72, Tissue Engineering, Medicine, Biomedical Engineering, Cellular Biology, Surgery, Epithelial Biology, regeneration, chamber, hair, follicle, dermis, dermal cells, keratinocyte, graft, epithelial, cell culture, lentivirus, knockdown, shRNA-mediated knockdown, overexpression, mice, transgenic mice, animal model Date Published: 2/28/2013 Citation: Woo, W.M., Atwood, S.X., Zhen, H.H., Oro, A.E.",Non-OADS,/arxiv_data1/oa_pdf/d0/43/jove-72-4344.PMC3622109.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/4344/ Protocol 1.,Non-OADS,/arxiv_data1/oa_pdf/d0/43/jove-72-4344.PMC3622109.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lee, T.M.C., Leung, M.K., Lee, T.M.Y., Raine, A.",Non-OADS,/arxiv_data1/oa_pdf/52/98/srep01636.PMC3622132.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Jonsson, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/60/f4/srep01644.PMC3622134.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Fuchs, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/42/0a/srep01637.PMC3622138.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fd/eb/srep01606.PMC3622141.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kim, S.W.",Non-OADS,/arxiv_data1/oa_pdf/fd/eb/srep01606.PMC3622141.pdf
"The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
London: TSO; available at http://www.ofﬁcial-documents.gov.uk/document/cm79/7985/7985.pdf 4.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
"Department for Environment, Food and Rural Affairs (2010) Food 2030. http://sd.defra.gov.uk/2010/01/food-2030/ (accessed April 2011).",Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http://www.scotland.gov.uk/Publications/2010/02/17140721/19 (accessed May 2010).,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http:// tna.europarchive.org/20100929190231/http://www.eatwell.gov.uk/healthydiet/eatwellplate/ (accessed April 2011).,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
"Report to the Food Standards AgencyScotland, 31st March 2011. http://www.foodbase.org.uk// admintools/reportdocuments/418- 1-1141_S14035_Monitoring_ Report_2001-2009_310311ﬁnal.pdf (accessed May 2011).",Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http://www.dh.gov.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
London: TSO; available at http://www.sacn.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
London: TSO; available at http://www.sacn.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http://www.sacn.gov.uk/reports_position_statements/reports/draft_energy_ requirements_report_scientiﬁ c_consultation_-november_2009.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http://tna.europarchive.org/20100929190231/http://www.,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
http://www.noo.org.uk/uploads/doc/vid_11171_ Attitudes.pdf (accessed October 2011).,Non-OADS,/arxiv_data1/oa_pdf/59/50/S1368980012004193a.PMC3622166.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.,Non-OADS,/arxiv_data1/oa_pdf/ac/fd/S0950268812001355a.PMC3622169.pdf
Food poisoning investigation reports (http://www.mhlw.go.jp/topics/syokuchu/04.html).,Non-OADS,/arxiv_data1/oa_pdf/ac/fd/S0950268812001355a.PMC3622169.pdf
"amphetamine induces an acute opioid release in thebrain, speciﬁcally in the ventral striatum, measurable as a The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/2.5/ >.",Non-OADS,/arxiv_data1/oa_pdf/a3/80/S1461145712000818a.PMC3622172.pdf
The virus is also quickly destroyed by pH changes in decomposing carcasses (http://www.cfsph.iastate.edu/Factsheets/pdfs/rift_valley_fever.pdf).,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/MBY-39-139.PMC3622235.pdf
"By main-taining these standards, various harmful pathogens should be destroyed (http://ccpeat.com/literature/com-posttech.pdf).",Non-OADS,/arxiv_data1/oa_pdf/f7/d1/MBY-39-139.PMC3622235.pdf
http://www.solagro.org/site/im_user/034impacts.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/MBY-39-139.PMC3622235.pdf
Annex: http://www.solagro.org/site/im_user/034annexes_sanitaire.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/MBY-39-139.PMC3622235.pdf
http://www.who.int csr/resources/publications/anthrax/whoemc&di986text.pdf.,Non-OADS,/arxiv_data1/oa_pdf/f7/d1/MBY-39-139.PMC3622235.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/ea/evt028.PMC3622293.pdf
Available from: http://arxiv.org/pdf/1212.3076v1.,Non-OADS,/arxiv_data1/oa_pdf/76/ea/evt028.PMC3622293.pdf
Available from: http://www.genomicron.evol- verzone.com/2012/09/encode-spokesperson-40-not-80/ .,Non-OADS,/arxiv_data1/oa_pdf/76/ea/evt028.PMC3622293.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/76/ea/evt028.PMC3622293.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/c2/evt023.PMC3622294.pdf
"(http://genome.ucsc.edu/ENCODE/ , last accessed February 27, 2013) and modENCODE ( Kharchenko et al.",OADS,/arxiv_data1/oa_pdf/48/c2/evt023.PMC3622294.pdf
"2010 )(http://www.modencode.org/ , last accessed February 27, 2013) databases, respectively.",OADS,/arxiv_data1/oa_pdf/48/c2/evt023.PMC3622294.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/67/da/evt021.PMC3622295.pdf
"Materials and Methods Data Full-genome alignments of D. sechellia and D. erecta to D. melanogaster (dm3, BDGP release 5) were downloaded from the UCSC database http://hgdownload.cse.ucsc.edu/ goldenPath/dm3/multiz15way/ (Clark et al.",OADS,/arxiv_data1/oa_pdf/67/da/evt021.PMC3622295.pdf
"2012 ,http://www.hgsc.bcm.tmc.edu/projects/dgrp/ freeze1_July_2010/Illumina/ )w e r eu s e dt oi d e n t i f yp o l y m o r - phisms.",Non-OADS,/arxiv_data1/oa_pdf/67/da/evt021.PMC3622295.pdf
"2009 ) (v. 0.1.11, http://samtools.sourceforge.net/ ) with the default parameters.",Non-OADS,/arxiv_data1/oa_pdf/67/da/evt021.PMC3622295.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/43/11/evt020.PMC3622296.pdf
Protein-coding sequences (CDS) were downloaded from the National Center for Biotechnology Information FTP server (ftp://ftp.ncbi.nih.gov/genomes/ ).,OADS,/arxiv_data1/oa_pdf/43/11/evt020.PMC3622296.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/00/48/evs116.PMC3622297.pdf
"Segmented Regression In symbols, a segmented regression model ( Muggeo 2003 ) comprising one predictor and one change point, can be written as: y¼a1+b1x+error ,forx/C20c, y¼a2+b2x+error ,forx>c: The R package “segmented ”(http://cran.r-project.org/ web/packages/segmented/index.html ;[Muggeo 2008 ]) pro- vides functions to ﬁt segmented regressions with one ormore predictors, including the estimation of change points, and to assess through statistical tests whether differences inslope before and after change points are signiﬁcant.",OADS,/arxiv_data1/oa_pdf/00/48/evs116.PMC3622297.pdf
Supplementary Material Supplementary ﬁgures S1–S9 andtables S1–S10 are available atGenome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/00/48/evs116.PMC3622297.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
All sequences were assembled and analyzed using Geneious version 5.4 created by Biomatters (available from http://www.geneious.,OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
Data Retrieval Data from the 1000 Genomes Project were retrieved from itswebsite ( http://www.1000genomes.org/ ).,OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
Chimpanzee reference sequence was downloaded from the UCSC Genome Browser (UCSC: http://genome.ucsc.edu/ )a n d used as outgroup.,OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
"2011 ), available in UCSC Genome Browser ( http://genome.ucsc.edu/ ) in the Human GRCh37/ hg19 assembly.",OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
"Statistical Analysis The summary statistics of population genetic variation,number of segregating sites ( S), nucleotide diversity ( p)(Nei and Li 1979 ), which is based on average number of pairwise differences between sequences; Watterson’s estimator of thepopulation mutation rate parameter ( y W)(Watterson 1975 ), which is based on the number of segregating sites and sample size, and Tajima’s D(Tajima 1989 ) and Fay and Wu’s H ( Fay a n dW u2 0 0 0 ) , which summarizes information about the spectrum of allele frequencies, were calculated using SLIDER (http://genapps.uchicago.",OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
"2011 ), available through the UCSC Genome Browser ( http://genome.ucsc.",OADS,/arxiv_data1/oa_pdf/e4/05/evt029.PMC3622298.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/2d/evt022.PMC3622299.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/7c/evt019.PMC3622300.pdf
"ncbi.nih.gov ; last accessed February 21, 2013), TraceArchive and Sequence Read Archive (SRA; http://www.ncbi.nlm.nih.",OADS,/arxiv_data1/oa_pdf/d7/7c/evt019.PMC3622300.pdf
"gov/Traces/home/ ; last accessed February 21, 2013), Joint Genome Institute ( www.jgi.doe.gov/ ; last accessed February 21, 2013), Broad Institute ( http://www.broad.mit.edu/ ;l a s t accessed February 21, 2013), University of Tokyo ( http://mer olae.biol.s.u-tokyo.ac.jp/ ; last accessed February 21, 2013), and EMBL ( http://ct.bork.embl.de ; last accessed February 21, 2013).",OADS,/arxiv_data1/oa_pdf/d7/7c/evt019.PMC3622300.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/39/be/evt030.PMC3622302.pdf
Fractional methylation valueswere then averaged across each annotated element.Solenopsis invicta DNA methylation data are available from Gene Expression Omnibus ( http://www.ncbi.nlm.nih.gov/ geo/; GSE39959).,OADS,/arxiv_data1/oa_pdf/39/be/evt030.PMC3622302.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8d/f4/evt031.PMC3622303.pdf
"According to the cumulative GC skew and AT skew, which were calculated using GenSkewApp.jar (downloaded from http://genskew.csb.univie.ac.at , last accessed March 13, 2013), the OriC and Ter site were presumed to be at 0 and 1,414 kb, respectively.",OADS,/arxiv_data1/oa_pdf/8d/f4/evt031.PMC3622303.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/95/a9/evt026.PMC3622304.pdf
Supplementary Material Supplementary ﬁgures S1–S5 andtable S1 are available at Genome Biology and Evolution online ( http://www.gbe.,OADS,/arxiv_data1/oa_pdf/95/a9/evt026.PMC3622304.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
"Genome se- quencing was performed at the IGA Technology Services(http://www.igatechnology.com/ ), Udine, Italy, using an Illumina HiSeq2000 with pair-end sequencing ( Bennett 2004 ), yielding reads with length of 100 bp.",OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
"The raw se- quences were checked with FastQC ( http://www.bioinformat- ics.babraham.ac.uk/projects/fastqc/ ), then the ﬁrst four bases at the 5 0-end were trimmed to remove low-quality bases and a dynamic trimming was applied on reads ends, imposing a min- imum read length of 34 bases and a minimum quality of 20.The trimmed reads were assembled using Abyss v1.3.0(Simpson et al.",OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
2011 and http://scikit-learn.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
"Network parameterswere computed using networkx ( http://networkx.lanl.gov/ ), using Gephi ( Mathieu et al.",OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
See http://www.ncbi.nlm.nih.gov/COG/grace/ ﬁew.cgi for the list of COG codes.Replicon-Dependent Bacterial Genome Evolution GBE Genome Biol.,Non-OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
Supplementary Material Supplementary ﬁgures S1–S3 andtables S1–S6 are available atGenome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/82/35/evt027.PMC3622305.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Electroretinography during embolization of an ophthalmic  arteriovenous fistula David J. Padalino, Vladyslav Melnyk, Geoffrey Allott, Eric M. Deshaies Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, NY , USA E‑mail:  Da vid J. Padalino  ‑ padalind@upsta te.edu; Vladyslav Melnyk  ‑ meln ykv@upstate.edu; Geoffrey Allott  ‑ allottg@upsta te.edu;  *Eric M. Deshaies  ‑ deshaiee@upstate.edu   *Corresponding author Received: 04 February 13    Accepted: 28 February 13  Published: 28 March 13 Abstract Background: Intraoperative neuromonitoring  (IONM) is used for real‑time  evaluation of neuronal tracts and reflexes in the anesthetized patient, when a neurologic exam is not possible.",Non-OADS,/arxiv_data1/oa_pdf/ae/72/SNI-4-40.PMC3622349.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/40/109653 Copyright: © 2013 Padalino DJ.,Non-OADS,/arxiv_data1/oa_pdf/ae/72/SNI-4-40.PMC3622349.pdf
"Surgical Neurology International 2013, 4:40  http://www.surgicalneurologyint.com/content/4/1/40Treatment options for orbital AVFs include open  surgical occlusion and endovascular embolization.",Non-OADS,/arxiv_data1/oa_pdf/ae/72/SNI-4-40.PMC3622349.pdf
"Surgical Neurology International 2013, 4:40  http://www.surgicalneurologyint.com/content/4/1/40next day and worsened with episodes of blood pressure  elevation.",Non-OADS,/arxiv_data1/oa_pdf/ae/72/SNI-4-40.PMC3622349.pdf
"Surgical Neurology International 2013, 4:40  http://www.surgicalneurologyint.com/content/4/1/40for monitoring retina ischemia and hyperemia when  patients are in the prone position, such as spine surgery and posterior fossa cranial surgery, where anterior optic neuropathy puts the patient at risk for blindness.",Non-OADS,/arxiv_data1/oa_pdf/ae/72/SNI-4-40.PMC3622349.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article The effect of weight in the outcomes of meningioma patients Holly Dickinson, Christine Carico, Miriam Nuño, Kristin Nosova, Adam Elramsisy, Chirag G. Patil Department of Neurosurgery, Center for Neurosurgical Outcomes Research, Maxine Dunitz Neurosurgical Institute, Cedars‑Sinai Medical Center 8631 W .",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/45/110023 Copyright: © 2013 Dickinson H. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45bias, with a female to male ratio of almost 3:1 in the  brain and up to 6:1 in the spinal cord.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45patients, 50,356 (70.0%) were female, with median age  of 57.6 years.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45loss, respectively.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45Table 4: Adjusted odds ratio of risk of mortality, 95%  confidence intervals and P values Effect OR 95% CI P value Female 0.85 0.8‑1.0 0.0200 Age in decades 1.47 1.4‑1.5 <0.0001 Admission source: ER 2.25 2.0‑2.6 <0.0001 Hospital procedure count 0.98 0.9‑1.0 <0.0001 Weight loss (men) 6.66 4.7‑9.4 <0.0001 Weight loss (women) 3.92 2.8‑9.4 0.0400 Obesity (women) 0.47 0.3‑0.7 0.0006 Malignant meningioma 1.93 1.6‑2.4 <0.0001 Comorbidities Chronic blood loss anemia 3.15 1.9‑5.1 <0.0001 Coagulopathy 5.63 4.6‑6.9 <0.0001 Peripheral vascular disease 3.69 2.8‑4.9 <0.0001 Renal failure 3.37 2.6‑4.4 <0.0001 *Diabetes was adjusted for and found to be not statistically significant Table 5: Adjusted odds ratio of risk of complications, 95% confidence intervals and  P values Effect Complications odds ratio Women Men OR 95% CI P value OR 95% CI P value Age in decades 1.14 1.1‑1.2 <0.0001 1.10 1.1‑1.1 <0.0001 Admission source: ER 1.43 1.3‑1.6 <0.0001 1.31 1.2‑1.5 <0.0001 Comorbidity score 0.95 0.9‑1.0 0.0351 0.95 0.9‑1.0 0.1600 Hospital procedure count 1.01 1.0‑1.0 <0.0001 1.00 1.0‑1.0 0.1600 Race (white vs. all other) 0.84 0.8‑0.9 <0.0001 0.85 0.8‑0.9 0.0005 Weight loss 8.37 6.7‑10.5 <0.0001 6.13 4.7‑8.1 <0.0001 Obesity 0.8 0.7‑0.9 0.007 1.03 0.8‑1.3 0.8100 Comorbidities Alcohol abuse 1.83 1.2‑2.8 0.007 1.61 1.2‑2.1 0.0003 Deficiency anemia 1.4 1.3‑1.6 <0.0001 2.25 1.9‑2.7 <0.0001 Chronic pulmonary disease 1.18 1.1‑1.3 0.0048 1.22 1.0‑1.4 0.0200 Coagulopathy 4.24 3.6‑5.1 <0.0001 5.46 4.5‑6.7 <0.0001 Diabetes 1.54 1.4‑1.7 <0.0001 0.97 0.8‑1.1 0.7400 Liver disease 1.65 1.0‑2.6 0.0338 1.29 0.8‑2.1 0.3100 Paralysis 2.98 2.7‑3.3 <0.0001 2.38 2.1‑2.7 <0.0001Total charges were similar in women in men by age,  race, admissions source, surgery delay, and number of  procedures as observed in LOS [Table 6].",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45conditions (as opposed to acting in causation of them),  and it is rather these comorbidities ultimately affecting  patient outcomes.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"Surgical Neurology International 2013, 4:45  http://www.surgicalneurologyint.com/content/4/1/45and recently increasing rates of obesity in the US, it  is very likely that NIS data underestimates obesity.",Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
Available from: http://www.cancer.org/Research/CancerFactsFigures/index.,Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
Available from: http://www.cbtrus.,Non-OADS,/arxiv_data1/oa_pdf/af/68/SNI-4-45.PMC3622350.pdf
"This is an Open Access article distributed under the terms of the Creative Com mons Attribution Non-Commercial Lice nse (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reprodu ction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/fc/evt033.PMC3622351.pdf
"Illumina sequencing generated 28,516,837 single- end 76 bp reads, which we aligned to the 454 draft genomeusing Mosaik ( http://bioinformatics.bc.edu/marthlab/Mosaik , last accessed March 15, 2013).",OADS,/arxiv_data1/oa_pdf/29/fc/evt033.PMC3622351.pdf
Supplementary Material Supplementary ﬁgures S1 andS2andtable S1 a r ea v a i l a b l ea t Genome Biology and Evolution online ( http://www.gbe.,Non-OADS,/arxiv_data1/oa_pdf/29/fc/evt033.PMC3622351.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comT echnical Note Ballistics for neurosurgeons: Effects of firearms of customized  cranioplasty implants Johannes Lemcke, Rainer Löser1, Andreas Telm2, Ullrich Meier Department of Neurosurgery, Unfallkrankenhaus Berlin, Berlin, 2Rifle Specialist/Gunsmith, Beeskow , 1Head of Hunting Training Centre, Schloss und Gut  Liebenberg, Germany E‑mail: *Johannes Lemcke ‑ johannes.lemcke@web.de; Rainer Löser ‑ srloeser@gmx.de; Andreas T elm ‑ jtz@schloss‑liebenberg.de ;   Ullrich Meier ‑ ullrich.meier@ukb.de   *Correspondence author Received: 11 December 12   Accepted: 12 March 13  Published: 03 April 13 Abstract Introduction: There are about 33,000 deaths caused by gunshot wounds in the  USA each year.",Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/46/110027 Copyright: © 2013 Lemcke J.,Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
"Surgical Neurology International 2013, 4:46  http://www.surgicalneurologyint.com/content/4/1/46customized computer‑aided designed (CAD) cranioplasty  implants are necessary.",Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
"Surgical Neurology International 2013, 4:46  http://www.surgicalneurologyint.com/content/4/1/46a special cranial situation; namely, terminal ballistics  in customized CAD cranioplasty implants.",Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
"Surgical Neurology International 2013, 4:46  http://www.surgicalneurologyint.com/content/4/1/46found that PEEK‑Optima® material did not provide  any resistance to any ballistic action and that titanium  is more resistant and so may, theoretically, avoid  secondary injuries caused by shrapnel fragments from  the implant.",Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
"Commentary http://www.remington.com/en/pages/news‑and‑resources/ ballistics.aspx C. David Hunt Marquette, MI 49855, USA.",Non-OADS,/arxiv_data1/oa_pdf/83/89/SNI-4-46.PMC3622352.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Pathophysiology of increased cerebrospinal fluid pressure associated  to brain arteriovenous malformations: The hydraulic hypothesis Sandro Rossitti Department of Neurosurgery, University Hospital, Linköping, Sweden E‑mail: *Sandro Rossitti ‑ sandro.rossitti@lio.se   *Corresponding author Received: 25 September 12   Accepted: 28 February 13  Published: 28 March 13 Abstract Background:  Brain arteriovenous malformations (AVMs) produce circulatory and  functional disturbances in adjacent as well as in remote areas of the brain, but their  physiological effect on the cerebrospinal fluid (CSF) pressure is not well known.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/42/109657 Copyright: © 2013 Rossitti S.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***Otherwise intracranial pressure has commonly not been  a major concern in the management of AVM patients,  especially in the adult patient group.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***quantitatively determined by the coordinated action of  the inflow and outflow cerebrovascular resistances.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***arteries, the nidus, and the draining veins.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***(inflow resistance, or Ra) is very low, and the increased  blood pressure in the high‑flow draining vein is transmitted  to the subarachnoid veins and to the CSF , thus increasing  Psv and Pcsf.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***communication was published in abstract form,[68] but the  study was never completed.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***the basic hydraulic model seems to be straightforward in  DAVFs with direct cortical venous drainage with reference  to the pressure transmission at the draining vein, but the  situation is more dramatic since the draining vein of a  DAVF often exhibits more profound pathological changes  than the draining vein of a brain AVM.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***hydrocephalus.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***dilation of the arteriolar resistance vessels in response to  the regional decrease in perfusion pressure close to the  AVM.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***whether the pretreatment level of Pcsf could be a predictive  factor for posttreatment NPPB.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology International 2013, 4:***  http://www.surgicalneurologyint.com/content/4/1/***28.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/SNI-4-42.PMC3622353.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report An infundibulum of thalamoperforator arteries: Importance of  angiographic images for appropriate diagnosis Nancy McLaughlin, Pablo J. Villablanca1, Reza Jahan2, Neil A. Martin Departments of Neurosurgery, 1Radiology, and 2Radiology, Neurointerventional Radiology, David Geffen School of Medicine at UCLA, UCLA Medical Center,  Los Angeles, CA, USA E‑mail: Nancy McLaughlin ‑ nmclaughlin@mednet.ucla.edu; Pablo J. Villablanca ‑ pvillablanca@mednet.ucla.edu; Reza Jahan ‑ rjahan@mednet.ucla.edu;  *Neil A. Martin  ‑ neilmartin@mednet.ucla.edu   *Corresponding author Received: 13 November 12   Accepted: 22 February 13  Published: 30 March 13 Abstract Background:  The identification of infundibula on noninvasive imaging modalities  may be challenging.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/44/109811 Copyright: © 2013 McLaughlin N.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Surgical Neurology International 2013, 4:44  http://www.surgicalneurologyint.com/content/4/1/44diagnosis, and emphasize the importance of catheter  angiography for appropriate diagnosis and management.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Surgical Neurology International 2013, 4:44  http://www.surgicalneurologyint.com/content/4/1/44Both CTA and MRA have become the primary imaging  screening techniques for detection of intracranial  aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Surgical Neurology International 2013, 4:44  http://www.surgicalneurologyint.com/content/4/1/44with the 2D angiography to exclude potential artifacts  resulting from the 3D reconstruction processing.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Surgical Neurology International 2013, 4:44  http://www.surgicalneurologyint.com/content/4/1/4415.",Non-OADS,/arxiv_data1/oa_pdf/d0/ae/SNI-4-44.PMC3622354.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Surgery as a Global health issue Walter D. Johnson Department of Neurosurgery, Loma Linda University, Loma Linda, CA; Adjunct Professor, School of Community and Global Health, Claremont Graduate  University, Claremont, CA E‑mail: *Walter D Johnson ‑ wjohnson@llu.edu   *Corresponding author Received: 12 March 13   Accepted: 12 March 13  Published: 03 April 13 INTRODUCTION Over the past decade, the concept of surgical care as a  population‑based, affordable, and globally relevant issue  has gradually begun to emerge.",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/47/110030 Copyright: © 2013 Johnson WD.,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
"Surgical Neurology International 2013, 4:47  http://www.surgicalneurologyint.com/content/4/1/47Additionally, WHO has made surgical care a  priority.",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
"Surgical Neurology International 2013, 4:47  http://www.surgicalneurologyint.com/content/4/1/47Uganda also has 20 orthopedic surgeons, 3 cardiothoracic  surgeons, 3 pediatric surgeons, 6 neurosurgeons, 3 plastic  surgeons, and 3 urologists, yet this fills only 7.4% of  projected need met [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
"Surgical Neurology International 2013, 4:47  http://www.surgicalneurologyint.com/content/4/1/47the growth of surgical services.",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
It most frequently  changes the volunteer in much more significant and  enduring respects than the volunteer changes the hosting  institution.APPENDIX WHO International  Partnershttp://www.who.int/surgery/collaborations/en GIEESC www.who.int/surgery FIENS www.fiens.org World Medical  Missionhttp://www.samaritanspurse.org/index.php/ WMM/index PAACS www.paacs.net Duke Global Surgery http://surgery.duke.edu/about‑department/ divisions‑and‑programs/duke‑global‑surgery UCSF http://gpas.surgery.ucsf.edu Harvard http://ghsm.hms.harvard.edu American College of  Surgeons Operation  Give Backhttp://www.operationgivingback.facs.org REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://ghsm.hms.harvard.edu/[Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://globalhealth.unc.edu/[Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://gpas.surgery.ucsf.edu/[Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://surgery.duke.edu/about‑department/ divisions‑and‑programs/duke‑global‑surgery [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.lluglobal.com/site/c.msKRL6PNLrF/b.,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/gho/child_health/mortality/causes/en/ index.html [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/gho/maternal_health/en/[Last accessed  on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/healthinfo/statistics/mortality_child_ cause/en/index.html [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/surgery [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/surgery/challenges/esc_pregnancy_more/ en/index.html [Last accessed on 2013 Mar 18].,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
Available from: http://www.who.int/whr/2008/chapter3/en/index.html [Last,Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
"Surgical Neurology International 2013, 4:47  http://www.surgicalneurologyint.com/content/4/1/47accessed on 2013 Mar 18].",Non-OADS,/arxiv_data1/oa_pdf/9f/4b/SNI-4-47.PMC3622355.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Chronic expanding pituitary hematoma without rebleeding after  pituitary apoplexy Masato Hojo, Masanori Goto, Susumu Miyamoto Department of Neurosurgery, Kyoto University Graduate School of Medicine, Kyoto 606‑8507, Japan E‑mail: *Masato Hojo ‑ mhojo@kuhp.kyoto‑u.ac.jp; Masanori Goto ‑ mgoto@kuhp.kyoto‑u.ac.jp; Susumu Miyamoto ‑ miy@kuhp.kyoto‑u.ac.jp   *Correspondence author Received: 19 February 13   Accepted: 05 March 13  Published: 28 March 13 Abstract Background:  Enlargement of intracerebral hematoma without rebleeding in chronic  phase is a rare but well‑known clinical condition, and is well‑described as chronic  expanding intracerebral hematoma.",Non-OADS,/arxiv_data1/oa_pdf/9d/8a/SNI-4-41.PMC3622356.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/41/109654 Copyright: © 2013 Hojo M.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/9d/8a/SNI-4-41.PMC3622356.pdf
"Surgical Neurology International 2013, 4:41  http://www.surgicalneurologyint.com/content/4/1/41neuro‑ophthalmological signs, can be conservatively  treated.",Non-OADS,/arxiv_data1/oa_pdf/9d/8a/SNI-4-41.PMC3622356.pdf
"Surgical Neurology International 2013, 4:41  http://www.surgicalneurologyint.com/content/4/1/41vomiting, visual field defect, and ocular paresis.",Non-OADS,/arxiv_data1/oa_pdf/9d/8a/SNI-4-41.PMC3622356.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Use of stent‑assisted coil embolization for the treatment of  wide‑necked aneurysms: A  systematic review Nancy McLaughlin, David L. McArthur, Neil A. Martin Department of Neurosurgery, David Geffen School of Medicine at UCLA, 757 Westwood Plaza, Suite 6236, Los Angeles, CA, 90095‑7436, USA E‑mail:  Nancy McLaughlin ‑ nmclaughlin@mednet.ucla.edu; David L. McArthur ‑ dmcarthur@mednet.ucla.edu; *Neil A. Martin ‑ neilmartin@mednet.ucla.edu   *Corresponding author Received: 18 September 12   Accepted: 22 Febuary 13  Published: 30 March 13 Abstract Backgroun d: The use of stent‑assisted coiling (SAC) has been shown to be a  treatment option for complex aneurysms.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/43/109810 Copyright: © 2013 McLaughlin N.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43giant aneurysm, important technical limitations in the  GDC technology has prevented complete and durable  aneurysm occlusion.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43complication rates, to begin to define appropriate use,  and to allow comparison with surgical results.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43review [Tables 2 and 3].",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43Table 2: Details of studies included in the review Author/Yr Nb pts/ Nb APts with  SAHAnt circ/ Post circType of  StentIntra‑procedural  eventPost‑procedural  eventImmediate  Angiographic results  of SAC (nb pt)Delayed Angiographic  results (nb A; timing;  result)Delayed  in‑stent  stenosis Sani, 2005 10/10 3 9/1 NF 2T IST: 0 TE: 0ST: 0 TE: 0C: 9/10 10A/6 mo Stable: 10; Recan: 0N/M Wanke,  200525/26 6 8/18 NF 2 IST: 1 TE: 0ST: 0 TE: 1, ASC: 15/26 26A/8mo Stable: 16; CThrombo:  4; Recan: 3 1, AS Kis, 2006 21/25 0 18/7 Leo IST: 1 TE: 1ST: 1 TE: 0C: 14/19 21A/mean 6 mo Stable: 15; Improved: 2 Recan: 3 1, AS Katsaridis,  200644/54 33 N/S NF2 IST: 1 TE: 0ST: 0 TE: 0C: 51/52 18A/after 6 mo Stable: 18; Recan: 00 Weber, 2007 30/31 13 25/6 Enterprise IST: 1 TE: 0ST: 1 TE: 1, SC: 6/28 30A/6 mo Stable: 10; CThrombo:  14 Recan: 62 AS Yavuz, 2007 15/18 1 16/2 SOLO IST: 0 TE: 0ST: 0 TE: 0C: 10/18 18A/6 mo Stable: 10; CThrombo: 7 Recan: 10 Lee, 2007 32/32 4 21/11 NF N/M N/M C: 7/32 32A/mean 6.1 mo Stable: 12; Improved: 13 Recan: 7 6 Biondi, 2007 42/46 5 39/7 NF: 7 NF 2: 17 NF 2T: 20 NF 3: 3IST: 0 TE: 1ST: 0 TE: 0C: 14/40 30 A/mean 9 mo Stable: 15; Improved: 9 Recan: 61 Kim, 2008 127/ 13650 93/43 NF IST: 2 TE: 0ST: 3 TE: 6 AS, and  6 SC: 39/123 77A/mean 13.7 mo* Stable: 17; CThrombo:  40 Recan: 7 1, AS Sedat, 2009 42/42 11 36/6 NF IST: 1 TE: 1TE: 2, S N/M 38A/mean 42 mo C: 27; Recan: 4 1, AS Lubicz, 2009 32/34 2 24/10 Leo: 14 Enterprise:  20IST: 0 TE: 0ST: 0 TE: 0C: 9/34 34/mean 20 mo Stable: 16; Improved: 14 Recan: 0 7  Huang, 2009 21/21 21 21/0 AcoANF 2 or  3: 19 Leo 2IST: 0 TE: 0ST: 0 TE: 0>95: 18 12A/median 5.6 mo Stable: 11; Recan: 1 0 Yun, 2010 11/11 11 11/0 AcoANF IST: 0 TE: 0ST: 0 TE: 0C: 10/11 10A/6 and/or 12 mo Stable: 10; Recan: 01 Yang, 2010 16/16 10 16/0 MCANF: 12 Leo: 4 Enterprise:  1IST: 0 TE: 0ST: 0 TE: 0C: 9/13 13A/mean 5.6 mo Stable: 10; CThromb: 3 Recan: 00 Gao, 2010 71/72 39 57/15 NF IST: 0 TE: 4 (2S)ST: 0 TE: 0C: 43/72 59A/mean 43.2 mo N/M; Recan: 171, S Vendrell,  201149/52 16 52/0 MCANF or EnterpriseIST: 10 (4S) TE: 0ST: 0 TE: 0C: 18/50 48 A/mean 14 mo Stable: 20; CThrombo:  21 Recan: 72, AS Maldonaldo,  201168/76 0 68/8 NF: 1 NF2: 26 NF3: 49IST: 5 (1S) TE: 0ST: 1, S TE: 5, ASC: 24/76 46A/mean 37.09 mo C: 26/46; Recan: 7 (at longest follow‑up)3, AS A: Aneurysm, AcoA: Anterior communicating artery, AS: Asymptomatic, C: Complete occlusion, CThrombo: Complete thrombosis, IST: Intrastent thrombosis, MCA: Middle  cerebral artery, Mo: months, NF: Neuroform, NF 2T: Neuroform 2 Treo, N/M: Not mentioned, Recan: Recanalization, S: Symptomatic, SAC: Stent-assisted coiling,   SAH: Subarachnoid hemorrhage, ST: Stent thrombosis, TE: Thromboemboli",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43criteria for complete occlusion instead of 100% as did the  other studies.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43medical condition of the patient.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43for the interpretation of results presented in reviews,  which are based mostly on small studies, bias should  be carefully considered.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43complications occurring in the setting of SAC.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/43of the discussed results, this would probably not be  recommended given the higher complication rate, more  incomplete occlusion, higher recanalization rate, potential  for stenosis, and absence of long‑term data.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/4335.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology International 2013, 4:43  http://www.surgicalneurologyint.com/content/4/1/4380.",Non-OADS,/arxiv_data1/oa_pdf/61/08/SNI-4-43.PMC3622357.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Fulminant holocord intramedullary tubercular abscess with  enigmatic presentation Kalyan Bommakanti, Rajesh Alugolu, Lakshmana Rao Chittem, Madhusudan Patil1,  Anirrudh Kumar Purohit Departments of Neurosurgery, and 1Microbiology, Nizam’s Institute of Medical Sciences, Punjagutta, Andhra  Pradesh, India E‑mail:  Kal yan Bommakanti  ‑ kal yan98omc@yahoo.co.in; *Rajesh Alugolu  ‑ drarajesh1306@gmail.com;  Lakshmana Rao Chittem  ‑ 86laxman@gmail.com;   Madhusudan Patil  ‑ anushamap@yahoo.com; Anirrudh Kumar Purohit  ‑ akpcpcp@gmail.com.",Non-OADS,/arxiv_data1/oa_pdf/d8/2b/SNI-4-32.PMC3622373.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/32/109506 Copyright: © 2012 Bommakanti K. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/d8/2b/SNI-4-32.PMC3622373.pdf
"Surgical Neurology International 2013, 4:32  http://www.surgicalneurologyint.com/content/4/1/32with chills and rigors for 6  days and sudden onset  of weakness in both the lower limbs, complete loss  of sensations below the level of nipples and urinary  retention for 5  days, prior to presentation to our hospital.",Non-OADS,/arxiv_data1/oa_pdf/d8/2b/SNI-4-32.PMC3622373.pdf
"Surgical Neurology International 2013, 4:32  http://www.surgicalneurologyint.com/content/4/1/32and immunoflorescence staining for tubercular bacilli  were negative.",Non-OADS,/arxiv_data1/oa_pdf/d8/2b/SNI-4-32.PMC3622373.pdf
"Surgical Neurology International 2013, 4:32  http://www.surgicalneurologyint.com/content/4/1/32then exteriorized at the conus.",Non-OADS,/arxiv_data1/oa_pdf/d8/2b/SNI-4-32.PMC3622373.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Awake craniotomy for trapping a giant fusiform aneurysm of the  middle cerebral artery Emiliano Passacantilli, Giulio Anichini, Delia Cannizzaro, Francesca Fusco, Francesca Pedace,  Jacopo Lenzi, Antonio Santoro Department of Neurology and Psychiatry, Neurosurgery, University of Rome, “Sapienza”, Italy E‑mail:  Emiliano Passacantilli ‑ e.passacantilli@gmail.com; *Giulio Anichini ‑ giulioanichini@libero.it; Delia Cannizzaro ‑ deliacannizzaro@libero.it;  Francesca Fusco ‑ francescafusco1982@libero.it; Francesca Pedace ‑ francesca_pedace@yahoo.it; Jacopo Lenzi ‑ jacopole@yahoo.it; Antonio Santoro ‑ santorant@libero.it   *Corresponding author Received: 20 December 12   Accepted: 21 January 13  Published: 28 March 13 Abstract Background: Giant fusiform aneurysms of the distal middle cerebral artery (MCA)  are rare lesions that, because of the absence of an aneurysm neck and the presence  of calcified walls and partial thrombosis, can be difficult to clip without sacrificing the  parent vessel.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/39/109652 Copyright: © 2013 Passacantilli E. This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Surgical Neurology International 2013, 4:39  http://www.surgicalneurologyint.com/content/4/1/39for the surgeon.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Surgical Neurology International 2013, 4:39  http://www.surgicalneurologyint.com/content/4/1/39line, the surgical wound incision line and the pinsites of  the Mayfield head frame.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Surgical Neurology International 2013, 4:39  http://www.surgicalneurologyint.com/content/4/1/39patient reported no fever or history of previous infections,  all preoperative assessments were normal, and the  aneurysms was located on M2 tract, so septic processes  and infectious etiology were excluded.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Surgical Neurology International 2013, 4:39  http://www.surgicalneurologyint.com/content/4/1/39for epilepsy than in the management of a complex  neurovascular problem.",Non-OADS,/arxiv_data1/oa_pdf/07/74/SNI-4-39.PMC3622374.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Targeting thalamic tremor cells in deep brain stimulation for  multiple sclerosis‑induced complex tremor Ersoy Kocabicak1,4, Murat Terzi2, Onur Alptekin3, Yasin Temel4 1Departments of Neurosurgery, and 2Neurology, Ondokuz Mayis University, Samsun, 3Medtronic Inc., Istanbul, Turkey, 4Departments of Neurosurgery and  Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands E‑mail: *Ersoy Kocabicak ‑ ekocabicak@yahoo.com; Murat T erzi ‑ mterzi@omu.edu.tr; Onur Alptekin ‑ onur.alptekin@medtronic.com;  Yasin T emel ‑ y.temel@maastrichtuniversity.nl   *Corresponding author Received: 24 July 12  Accepted: 09 January 13  Published: 22 March 13 Abstract Background: Tremor is an important cause of disability in patients with multiple  sclerosis (MS).",Non-OADS,/arxiv_data1/oa_pdf/2d/d0/SNI-4-31.PMC3622375.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/31/109464 Copyright: © 2013 Kocabicak E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/2d/d0/SNI-4-31.PMC3622375.pdf
"Surgical Neurology International 2013, 4:31  http://www.surgicalneurologyint.com/content/4/1/31magnetic resonance imaging (MRI) showed  periventricular  demyelinating lesions.",Non-OADS,/arxiv_data1/oa_pdf/2d/d0/SNI-4-31.PMC3622375.pdf
"Surgical Neurology International 2012, 4:31  http://www.surgicalneurologyint.com/content/4/1/31Clinical outcome The patient underwent programming of the stimulation  parameters in the next days after surgery.",Non-OADS,/arxiv_data1/oa_pdf/2d/d0/SNI-4-31.PMC3622375.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Open craniotomy for brain abscess: A  forgotten experience?",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/34/109522 Copyright: © 2013 Gadgil N.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34therapy for brain abscess, has been overshadowed by the  advent of stereotactic aspiration, which has become the  treatment of choice in many institutions.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34frontoparietal  (n = 2, 6%).",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34lesion or an ill‑defined area of contrast enhancement  with no definite ring‑enhancing lesion.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34from these sources.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34to the advent of CT‑guided stereotaxis.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/34It is disputed whether the advantages of complete surgical  excision of abscess come at the expense of worsened  outcome.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology International 2013, 4:34  http://www.surgicalneurologyint.com/content/4/1/3418.",Non-OADS,/arxiv_data1/oa_pdf/6c/e2/SNI-4-34.PMC3622376.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Quality and quantity of research publications by Iranian  neurosurgeons: Signs of scientific progress over the past  decades Marjan Alimi1†, Shervin Taslimi1,2†, Seyed Mohammad Ghodsi1,3*, Vafa Rahimi‑Movaghar1* 1Department of Neurosurgery, Sina Trauma and Surgery Research Center, T ehran University of Medical Sciences, 2Department of Epidemiology and Biostatistics,  T ehran University of Medical Sciences, 3Brain and Spinal Cord Injury Repair Research Center (BASIR), T ehran University of Medical Sciences, T ehran, Iran E‑mail:  Marjan Alimi ‑ marjan_809@yahoo.com; Shervin Taslimi ‑ taslimi@razi.tums.ac.ir; *Seyed Mohammad ghodsi ‑ ghodsism@sina.tums.ac.ir;   *Vafa Rahimi‑Movaghar ‑ v_rahimi@sina.tums.ac.ir   *Corresponding author Received: 30 June 12  Accepted: 05 February 13  Published: 28 March 13 Abstract Background:  This is an analysis of papers published by Iranian neurosurgeons  while working in Iran until the year 2010.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/38/109651 Copyright: © 2013 Alimi M.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38INTRODUCTION Neurosurgery is a comparatively young specialty in  the world of medicine and was not on a firm footing  until the early 20th century.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38university affiliated neurosurgeons, 5 of whom were among  the top 20 most prolific practicing neurosurgeons in the  country.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Search strategy For international publications, the PubMed database  was searched and for national publications IranMedex  (http://www.iranmedex.com) was searched using all  possible different spellings for the names of Iranian  neurosurgeons.",OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38anatomical studies) did not have any score assigned.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38achievements, by providing an extensive amount of data  available for research.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38Most publications by Iranian neurosurgeons originated  in the large cities of the country [Figure 1].",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38regression model to evaluate their effect on total numbers  of publications by each author.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38article types for which their LOE could not be evaluated  based on our criteria.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38DISCUSSION About 1196 papers were written in scientific journals in the past 63 years by neurosurgeons practicing in Iran  and most were published in the field of neurosurgery.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38measured by the amount of manuscripts generated as  a contribution to the world of neurosurgery has shown  a significant increase in the past decade.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38would also be a challenge in Iran in smaller medical  centers.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38constitute a considerable fraction of our experienced  neurosurgeons’ publications.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology International 2013, 4:38  http://www.surgicalneurologyint.com/content/4/1/38in neurosurgery:  Trends in globalization, scientific focus, and funding.",Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
Available from:  http://ori.hhs.gov/education/pas.shtml.,Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
Available from: http://www.cebm.net/index.aspx?o=1025.,Non-OADS,/arxiv_data1/oa_pdf/98/b9/SNI-4-38.PMC3622377.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comReview Article Teamwork in skull base surgery: An avenue for improvement  in patient care Nancy McLaughlin, Ricardo L. Carrau1, Daniel F .",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/36/109527 Copyright: © 2013 McLaughlin N.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology International 2013, 4:36  http://www.surgicalneurologyint.com/content/4/1/36INTRODUCTION Skull base surgery, as a subspecialty including open and  endoscopic approaches, continues to evolve, favoring  minimal access approaches in order to reduce surgical  morbidity and mortality, preserve neurological function,  as well as cosmesis.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology International 2013, 4:36  http://www.surgicalneurologyint.com/content/4/1/36had a change in diagnosis, staging, or treatment plan.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology International 2013, 4:36  http://www.surgicalneurologyint.com/content/4/1/36teams caring for patients with skull base pathologies,  the leader should be a member of the surgical team, as  surgeons are best suited to coordinate treatment planning,  perioperative management and posttreatment care.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology International 2013, 4:36  http://www.surgicalneurologyint.com/content/4/1/36are numerous methods to teach teamwork including Crew  Resource Management, team STEPPS, and Observational  Teamwork Assessment for Surgery Systems.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology International 2013, 4:36  http://www.surgicalneurologyint.com/content/4/1/3621.",Non-OADS,/arxiv_data1/oa_pdf/23/b0/SNI-4-36.PMC3622378.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comNeurosurgery Concepts Neurosurgery concepts: Key perspectives on regulatory proteins,  management of ossification of the posterior longitudinal ligament,  and radiosurgery for intracranial lesions Jonathan H. Sherman, Zachary A. Smith1, Jin Mo Cho2, Michael Lim3, Chaim B. Colen4,  Chae- Y ong Kim5, Vincent Yat Wang6, Gabriel Zada7, Gordon Li8, Isaac Yang9 The George Washington University, Washington, D.C, 1Northwestern University, Evanston, IL, U.S, 2Ajou University School of Medicine, Suwon, South Korea,  3Johns Hopkins, Baltimore, Maryland, 4Beaumont Hospital, Grosse Pointe, MI, U.S, 5Seoul National University College of Medicine, Seoul, South Korea,   6UCSF, San Francisco, CA,7Keck School of Medicine at USC, Los Angeles, 8Stanford, 9UCLA, Los Angeles, CA, U.S  E‑mail: Jonathan H. Sherman ‑ jsherman0620@gmail.com; Zachary A. Smith ‑ zsmithmd@gmail.com;Jin Mo Cho ‑ chojinmo@gmail.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/35/109525 Copyright: © 2013 Sherman JH This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Surgical Neurology International 2013, 4:35  http://www.surgicalneurologyint.com/content/4/1/35wide range of human solid tumors including glioblastoma.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Surgical Neurology International 2013, 4:35  http://www.surgicalneurologyint.com/content/4/1/35cranial nerve deficits and cerebrospinal fluid (CSF)  leakage was highest in patients in group B.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Surgical Neurology International 2013, 4:35  http://www.surgicalneurologyint.com/content/4/1/35Perspective:  In this study, the authors use a decision  analytical model to estimate the cost effectiveness of  various treatment strategies for severe TBI.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Surgical Neurology International 2013, 4:35  http://www.surgicalneurologyint.com/content/4/1/35of GBM patients.",Non-OADS,/arxiv_data1/oa_pdf/f2/ab/SNI-4-35.PMC3622379.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial Why physicians might want to learn computer programming Pieter L. Kubben Department of Neurosurgery, Maastricht University Medical Center, The Netherlands E‑mail: *Pieter L. Kubben ‑ pieter@kubben.nl   *Corresponding author Received: 19 February 13  Accepted: 20 February 13  Published: 22 March 13 How long does it take to become a physician?",Non-OADS,/arxiv_data1/oa_pdf/1b/29/SNI-4-30.PMC3622380.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/30/109461 Copyright: © 2013 Kubben PL.,Non-OADS,/arxiv_data1/oa_pdf/1b/29/SNI-4-30.PMC3622380.pdf
"Surgical Neurology International 2013, 4:30  http://www.surgicalneurologyint.com/content/4/1/30Android, which in turn boosted downloads even more.",Non-OADS,/arxiv_data1/oa_pdf/1b/29/SNI-4-30.PMC3622380.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Posttraumatic delayed subdural tension pneumocephalus Volodymyr O. Solomiichuk, Vitaliy O. Lebed, Konstantin I. Drizhdov Neurosurgical Department, Yalta City Hospital, Yalta, Crimea, Ukraine E‑mail: *Volodymyr O. Solomiichuk ‑ solomiichuk@gmail.com; Vitaliy O. Lebed ‑ lebed_vitaliy@ukr.net; Konstantin I. Drizhdov ‑ yaltaneurozav@bigmir.net   *Corresponding author Received: 23 January 13   Accepted: 05 March 13  Published: 25 March 13 Abstract Background: Pneumocephalus is a complication of head injury in 3.9-9.7% of  the cases, it also appears after supratentorial craniotomy in 100% of cases.",Non-OADS,/arxiv_data1/oa_pdf/c8/10/SNI-4-37.PMC3622390.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/37/109537 Copyright: © 2013 Solomiichuk VO.,Non-OADS,/arxiv_data1/oa_pdf/c8/10/SNI-4-37.PMC3622390.pdf
"Surgical Neurology International 2013, 4:37  http://www.surgicalneurologyint.com/content/4/1/37physiological way during Valsalva maneuver, or through  the iatrogenic lumbar drain.",Non-OADS,/arxiv_data1/oa_pdf/c8/10/SNI-4-37.PMC3622390.pdf
"Surgical Neurology International 2013, 4:37  http://www.surgicalneurologyint.com/content/4/1/37Patient underwent a conservative treatment and  observation.",Non-OADS,/arxiv_data1/oa_pdf/c8/10/SNI-4-37.PMC3622390.pdf
"Surgical Neurology InternationalEditor-in-Chief: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comEditorial New Features in Surgical Neurology International  for 2013 James P .",Non-OADS,/arxiv_data1/oa_pdf/34/ea/SNI-4-33.PMC3622391.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/1/33/109510 Copyright: © 2013 Cook JP .,Non-OADS,/arxiv_data1/oa_pdf/34/ea/SNI-4-33.PMC3622391.pdf
"Surgical Neurology International 2013, 4:33  http://www.surgicalneurologyint.com/content/4/1/33Posts > CNS Neurowiki.",Non-OADS,/arxiv_data1/oa_pdf/34/ea/SNI-4-33.PMC3622391.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Nakatani T. Heart transplantation.,Non-OADS,/arxiv_data1/oa_pdf/8f/b5/heartasia-2012-010160.PMC3622429.pdf
"Published by Oxford University Press on behalf of the British Occupational Hygiene Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/9a/mes083.PMC3622438.pdf
Available at http://cesp.vjf.inserm.fr/asthmajem/.,Non-OADS,/arxiv_data1/oa_pdf/c9/9a/mes083.PMC3622438.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Vedre A, Gurm HS, Froehlich JB, et al.",Non-OADS,/arxiv_data1/oa_pdf/07/2f/heartasia-2012-010225.PMC3622494.pdf
"Davis1, Richard G. Dekany1, Mansi M. Kasliwal5, Shrinivas R. Kulkarni1,2, Timothy D. Morton2, Eran O. Ofek6, Sujit Punnadi4 1Caltech Optical Observatories, California Institute of Technology 2Department of Astronomy, California Institute of Technology 3Dunlap Institute for Astronomy and Astrophysics, University of Toronto 4Inter-University Centre for Astronomy & Astrophysics 5Observatories of the Carnegie Institution for Science 6Benoziyo Center for Astrophysics, Weizmann Institute of Science Correspondence to: Christoph Baranec at baranec@astro.caltech.edu URL: http://www.jove.com/video/50021 DOI: doi:10.3791/50021 Keywords: Physics, Issue 72, Astronomy, Mechanical Engineering, Astrophysics, Optics, Adaptive optics, lasers, wavefront sensing, robotics, stars, galaxies, imaging, supernova, telescopes Date Published: 2/12/2013 Citation: Baranec, C., Riddle, R., Law, N.M., Ramaprakash, A., Tendulkar, S.P., Bui, K., Burse, M.P., Chordia, P., Das, H.K., Davis, J.T., Dekany, R.G., Kasliwal, M.M., Kulkarni, S.R., Morton, T.D., Ofek, E.O., Punnadi, S. Bringing the Visible Universe into Focus with Robo-AO.",Non-OADS,/arxiv_data1/oa_pdf/0a/82/jove-72-50021.PMC3622497.pdf
Video Link The video component of this article can be found at http://www.jove.com/video/50021/ Introduction The impact of atmospheric turbulence on astronomical imaging was first recognized centuries ago by Christiaan Huygens4 and Isaac Newton5.,Non-OADS,/arxiv_data1/oa_pdf/0a/82/jove-72-50021.PMC3622497.pdf
Available from: http://www.astro.caltech.edu/ Robo-AO/  (2012).,Non-OADS,/arxiv_data1/oa_pdf/0a/82/jove-72-50021.PMC3622497.pdf
"Proceedings of the British PharmacologicalSociety at http://www.pa2online.org/Vo l2Issue2abst096P.html Falcetti E, Hall SM, Phillips PG, Patel J, Morrell NW, Haworth SG, Clapp LH (2010) Smooth muscle proliferation and role of theprostacyclin (IP) receptor in idiopathic pulmonary arterial hyper-tension.",Non-OADS,/arxiv_data1/oa_pdf/ef/6c/210_2013_Article_846.PMC3622741.pdf
12) is available for download using the link http://www.iaea.org/Publications/ Acknowledgments We wish to thank Dr. M. Chinol and Dr. C. De- Christoforo for their invaluable advice.,Non-OADS,/arxiv_data1/oa_pdf/de/9b/259_2012_Article_2330.PMC3622744.pdf
Europe 2020. http://ec.europa.eu/europe 2020/index_en.htm .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://www.efgcp.be/downloads/icrel_docs/Final_report_ ICREL.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
"Proposal for a Regulation of the Euro- pean Parliament and of the Council on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC.http://ec.europa.eu/health/ﬁle s/clinicaltrials/2012_07/proposal/ 2012_07_proposal_en.pdf .",Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
ENTR/F/2/SF D (2009) 32674. http://ec.europa.eu/health/ ﬁles/clinicaltrials/docs/ 2009_10_09_public-consultation-paper.,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/health/ﬁles/clinicaltrials/ docs/responses_2001-20/medicines_and_healthcare_products_regulatory_agency.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/health/ﬁles/clinicaltrials/docs/ responses_2001-20/danish_ministry_of_health_and_prevention.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/health/ﬁles/clinicaltrials/ctresp_2011- 06/bfarm_pei_2.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
EPF’s response to the Commission public consultation on the Clinical Trials Directive 2001/20/EC.http://ec.europa.eu/health/ﬁles/clinicaltrials/docs/responses_2001- 20/european_patient_forum.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/governan ce/impact/planned_ia/docs/ 47_sanco_clinical_trials_directive_en.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://eur-lex.europa.eu/LexUriServ/ LexUriServ.do?uri=COM:2007:0023:FIN:EN:PDF .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
EFPIA response to public con- sultation paper ENTR/F/2/SF D (2009) 32674. http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/health/ﬁles/clin icaltrials/concept_paper_02-2011.,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/ health/ﬁles/clinicaltrials/ctresp_2011-06/efpia_evm.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/health/ ﬁles/clinicaltrials/docs/responses_2001-20/bpi_german_pharmac eutical_industry_assosciation.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://ec.europa.eu/ health/ﬁles/clinicaltrials/ctresp_2011-06/eortc.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://europa.eu/rapid/pressReleasesAction.,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://www.efpia.eu/sites/www.efpia.eu/ﬁles/efpia_ key_messages_ctr_10.12.2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
10 December 2012. http://www.efpia.eu/sites/www.efpia.eu/ﬁles/efpia_key_messages_ctr_10.12.2012.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
http://www.gpo.gov/fdsys/pkg/FR-2011-07-26/pdf/2011- 18792.pdf .,Non-OADS,/arxiv_data1/oa_pdf/11/68/40290_2013_Article_12.PMC3622747.pdf
We hence tested if the type 2 diabetes CpG-SNPs that exhibit differential DNA methylation and are located in geneintrons or exons are associated with differentially expressed exons assessed by splice index using Gene Array Analyzer (http://GAA.mpi-bn.mpg.de )[17].,OADS,/arxiv_data1/oa_pdf/ac/15/125_2012_Article_2815.PMC3622750.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.1 Clinical and Molecular Hepatology 2013;19:1-16 Review INTRODUCTION  Grayscale ultrasonography (US) and Doppler US are widely  used in the detection and differentiation of focal liver lesions (FLLs) relying on the differences in echogenicity and vascularity  between the FLLs and surrounding liver tissues.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
2 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1throughout the vascular phases of the liver which lead to great  advances in diagnostic accuracy of US.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1of perfluorobutane microbubbles with a phospholipid shell.16 It  provides detailed perfusion features of the FLLs during the vascu - lar phase, as well as late Kupffer phase images.20 Microbubbles are partly removed by metabolism in the liver  (stabilizing shells) and partly eliminated from the lungs (with air or  other gases) during the breathing process.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
4 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1ners.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1CEUS is very useful in the diagnosis of hepatic hemangioma,  since perfusion through lesion can be observed in real time and  is very similar to the perfusion pattern found on CT scans.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"6 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1color- and power Doppler images show the spoke-wheel sign  pathognomonic of classical FNH, with often a feeding vessel being  evident.40 Most cases of classical FNH can be diagnosed using only  a combination of B-mode and color-Doppler ultrasound.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1some cases sinusoids can also cause a prolonged bubble signal.44  The hemorrhagic regions are avascular and do not show enhance - ment in any phase.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"8 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1been included in important guidelines and recommendations, such  as those from the American Association for the Study of Liver Dis - eases (AASLD) in 2005,51 the APASL (Asian Pacific Association for  the Study of the Liver),52 the Japanese Society of Hepatology,53 and  the EFSUMB (European Federation of Societies for Ultrasound in  Medicine and Biology) guidelines in 200454 and 2008.55 However,  CEUS no longer appears in the diagnostic flow chart of nodules in cirrhosis in the AASLD guidelines updated in 2011, 56 for two  quoted reasons: (1)“CEUS may offer false-positive HCC diagnosis in patients with cholangiocarcinoma, and thus has been dropped  from the diagnostic techniques”and (2)“CEUS is not available in  the USA, so these results are not entirely applicable to a North  American population.” This removal was controversial and was  not well received in Europe and Asia.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1HCC, which is due to a decreased PV supply.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
10 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1rized in Tables 3 and 4.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1Metastatic liver cancer Most metastatic liver cancer is hypovascular and is character - ized by hypervascularity in the tumor periphery, where tumor cells  are abundant.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"12 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1encountered when using CEUS to screen the whole liver in terms  of convenience and cost-effective, because repeated injections  of the contrast agent are needed to examine all of the level seg - ments.90 However, the main limitations are the skill of the operator  and the experience of the physician performing CEUS markedly influencing the diagnosis accuracy.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1Conclusions The introduction of second generation UCAs microbubbles has  allowed real-time imaging of FLLs in every phase of enhance - ment, which has dramatically improved the accuracy of US-based  detection and characterization, as well as providing guidance to  therapeutic procedures and evaluation of responses to treatment.",Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"New Health Technology Assessment (nHTA), CEUS(Contrast En - hanced Ultrasonography), nHTA web site, < http://neca.re.kr/nHTA/ application/receipt_list.jsp?cpage=1>, Accessed on Feb. 26, 2013.",OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
14 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.126.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
Guidelines of contrast enhanced ultrasound for the focal liver lesions http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1January 2004.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
16 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.182.,Non-OADS,/arxiv_data1/oa_pdf/83/82/cmh-19-1.PMC3622850.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.17 Clinical and Molecular Hepatology 2013;19:17-25 Review INTRODUCTION  Hepatitis C virus (HCV) is a hepatotropic RNA virus of the genus  Hepacivirus in the Flaviviridae  family, originally cloned in 1989 as  the causative agent of non-A, non-B hepatitis.1,2 It causes acute  and chronic hepatitis in humans and chimpanzees with a high  propensity for chronicity.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
"18 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17with less toxicity and drug resistance—preferably as IFN-free, all  oral combination regimens.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
"HCV virology and life cycle http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17HCV virion and lipoviroparticle The HCV viral particle includes HCV RNA genome, core and the  envelope glycoproteins, E1 and E2.2 HCV RNA genome interacts  with the core protein to form the viral nucleocapsid, in association  with cytosolic lipid droplets (cLD).",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
20 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17The tight junction proteins Claudin 1 and Occludin Two tight junction proteins (CLDN1 and OCLN) identified by  screening cDNA library for cellular factors that enable infection by HCV pseudoparticles were shown to be essential entry factors for  HCV.,OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
"HCV virology and life cycle http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17way is closely related to that of assembled virions.93,94 The virion  is a lipoviroparticle with a lipid composition that resembles VLDL  and LDL with associated apoE and/or apoB, which are essential  for the infectious virus assembly.93-96 Of clinical relevance, histo - logical fatty changes in the liver has been associated with clinical  and therapeutic outcomes97 and HCV genotype 3 was shown to  mediate greater steatosis,98 although its pathogenetic mechanisms  related to HCV life cycle is not clear.",Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
22 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17understanding of the mechanisms of persistence and pathogenesis  of this fascinating virus.,Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
HCV virology and life cycle http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17and assembly of these envelope proteins.,Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
"24 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.17Jones CT, et al.",OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
HCV virology and life cycle http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.1785.,Non-OADS,/arxiv_data1/oa_pdf/ed/b8/cmh-19-17.PMC3622851.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.26 Clinical and Molecular Hepatology 2013;19:26-28 Editorial Chronic hepatitis C (CHC) affects approximately 170 million  people worldwide, and over 3 million individuals are newly in - fected each year.1 Kim et al2 reported that the adjusted prevalence  rate of hepatitis C virus (HCV) infection in the general Korean  population is approximately 0.78%, and the prevalence has been  increasing.3 HCV is an important cause of liver diseases, such as liver cir - rhosis and hepatocellular carcinoma (HCC).",Non-OADS,/arxiv_data1/oa_pdf/fc/74/cmh-19-26.PMC3622852.pdf
"http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.26genotype 1 (80.8% vs. 54.7%, P=0.02), although patients with  genotypes 2 and 3 in a clinical and cohort study had similar SVR  rates.",Non-OADS,/arxiv_data1/oa_pdf/fc/74/cmh-19-26.PMC3622852.pdf
28 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.26wide seroepidemiology of hepatitis C virus infection in South Korea.,Non-OADS,/arxiv_data1/oa_pdf/fc/74/cmh-19-26.PMC3622852.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.29 Clinical and Molecular Hepatology 2013;19:29-35 Original Article INTRODUCTION  Chronic hepatitis B (CHB) affects 400 million individuals world - wide and is a leading cause of liver-related morbidity and mortal -ity.1,2 Studies have demonstrated that the risk of liver disease pro - gression in patients with CHB is associated with elevated hepatitis  B virus (HBV) DNA levels.3 The introduction of oral nucleos(t)ides  analogue (NA) therapy in the last two decades has revolutionized Antiviral efficacies of currently available rescue thera - pies for multidrug-resistant chronic hepatitis B  Mi Sung Park1, Beom Kyung Kim1,2, Kyung Sik Kim3, Ja Kyung Kim1,2, Seung Up Kim1,2,4, Jun Yong Park1,2,4,  Do Young Kim1,2,4, Oidov Baartarkhuu5, Kwang Hyub Han1,2,4,6, Chae Yoon Chon1,2,4, and Sang Hoon Ahn1,2,4,6  1Department of Internal Medicine and 2Institute of Gastroenterology, 3Department of Surgery, Yonsei University College of Medicine;  4Liver Cirrhosis Clinical Research Center, Seoul, Korea; 5Department of Infectious Disease, Health Sciences University, Ulaanbaatar,  Mongolia; 6Brain Korea 21 Project for Medical Science, Seoul, Korea Background/Aims: The incidence of multidrug-resistant (MDR) chronic hepatitis B (CHB) during sequential lamivudine  (LAM) and adefovir dipivoxil (ADV) treatment is increasing.",Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
30 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29the treatment of CHB.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
"Treatment for drug resistant chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29Statistical analyses Continuous variables were compared using a two-tailed Stu - dent’s t-test (and if appropriate, Mann-Whitney test) or a one-way  ANOVA method (and if appropriate, Kruskal-Wallis method).",Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
32 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
"Treatment for drug resistant chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29tance mutations frequently develop in LAM-resistant patients after  switching to ADV monotherapy.14,16,17 Therefore, current interna - tional guidelines recommend initiating combination therapy rather  than switching to ADV monotherapy.",Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
34 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29to have a better virologic response compared to ETV monotherapy  or combination therapy with LAM and ADV.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
Treatment for drug resistant chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.29lution of full-length HBV sequences in chronic hepatitis B patients  with sequential lamivudine and adefovir dipivoxil resistance.,Non-OADS,/arxiv_data1/oa_pdf/87/de/cmh-19-29.PMC3622853.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.36 Clinical and Molecular Hepatology 2013;19:36-44 Original Article Clinical features and outcomes of gastric variceal bleed - ing: retrospective Korean multicenter data Moon Young Kim1,25, Soon Ho Um2,25*, Soon Koo Baik1,25, Yeon Seok Seo2,25, Soo Young Park3,25, Jung Il Lee4,25, Jin Woo  Lee4,25, Gab Jin Cheon5,25, Joo Hyun Sohn6,25, Tae Yeob Kim6,25, Young Suk Lim7,25, Tae Hyo Kim8,25,  Tae Hee Lee9,25,  Sung Jae Park10,25, Seung Ha Park10,25, Jin Dong Kim11,25, Sang Young Han12,25, Chang Soo Choi13,25, Eun Young Cho13,25,  Dong Joon Kim14,25, Jae Seok Hwang15,25, Byoung Kuk Jang15,25, June Sung Lee16,25, Sang Gyune Kim17,25, Young Seok  Kim17,25, So Young Kwon18,25, Won Hyeok Choe18,25, Chang Hyeong Lee19,25, Byung Seok Kim19,25, Jae Young Jang20,25,  Soung Won Jeong20,25, Byung Ho Kim21,25, Jae Jun Shim21,25, Yong Kyun Cho22,25, Moon Soo Koh23,25, and Hyun Woong  Lee24,25  1Department of Internal Medicine and Cell Therapy and Tissue Engineering Center, Yonsei University Wonju College of Medicine, Wonju;  2Department of Internal Medicine, Korea University College of Medicine, Seoul; 3Department of Internal Medicine, Kyungpook National  University College of Medicine, Daegu; 4Department of Internal Medicine, Inha University College of Medicine, Incheon; 5Department  of Internal Medicine, Ulsan University College of Medicine, Gangneung; 6Department of Internal Medicine, Hanyang University Guri  Hospital, Hanyang University College of Medicine, Guri; 7Department of Internal Medicine, Ulsan University College of Medicine, Seoul;  8Department of Internal Medicine, Gyeongsang National University College of Medicine, Jinju; 9Department of Internal Medicine,  Konyang University College of Medicine, Daejeon; 10Department of Internal Medicine, Inje University College of Medicine, Busan;  11Department of Internal Medicine, The Catholic University of Korea, College of Medicine, Seoul; 12Department of Internal Medicine,  Dong-A University College of Medicine, Busan; 13Department of Internal Medicine, Wonkwang University College of Medicine, Iksan;  14Department of Internal Medicine, Hallym University College of Medicine, Chuncheon; 15Department of Internal Medicine, Keimyung  University College of Medicine, Daegu; 16Department of Internal Medicine, Inje University College of Medicine, Goyang; 17Department of  Internal Medicine, Soonchunhyang University Hospital Bucheon, Soonchunhyang University College of Medicine, Bucheon; 18Department  of Internal Medicine, Konkuk University School of Medicine, Seoul; 19Department of Internal Medicine, Catholic University of Daegu  College of Medicine, Daegu; 20Department of Internal Medicine, Soonchunhyang University Hospital Seoul, Soonchunhyang University  College of Medicine; 21Department of Internal Medicine, Kyung Hee University College of Medicine; 22Department of Internal Medicine,  Sungkyunkwan University College of Medicine, Seoul; 23Department of Internal Medicine, Dongguk University College of Medicine,  Goyang; 24Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea; 25Korean Portal Hypertension  Study Group Background/Aims: While gastric variceal bleeding (GVB) is not as prevalent as esophageal variceal bleeding, it is  reportedly more serious, with high failure rates of the initial hemostasis (>30%), and has a worse prognosis than esophageal variceal bleeding.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"Gastric variceal bleeding in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36INTRODUCTION  Gastric varices (GVs) are less common than esophageal varices  (EVs), occurring in approximately 20% of patients with portal  hypertension.1 However, gastric variceal bleeding (GVB) is report - edly more severe, requires more transfusions, and has a higher mortality rate than the bleeding from EVs.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"38 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36(GOVs), either associated with EVs along the lesser curvature  (GOV1) or along the fundus (GOV2), and isolated gastric varices  (IGVs), which are present in isolation in the fundus (IGV1) or at ec - topic sites in the stomach or the first part of the duodenum (IGV2), as determined using the criteria of Sarin et al.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
Gastric variceal bleeding in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36Table 1.,Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"40 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36hemostasis and the type of GV, with failure occurring in 55 (7.1%),  21 (5.5%), 3 (2.5%), and 1 (3.3%) of cases of GOV1, GOV2, IGV1,  and IGV2, respectively ( P=0.207).",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"Gastric variceal bleeding in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36with EIS, TIPS, or balloon tamponade ( P=0.002), although the  outcome did not differ significantly among the EVL, EVO, and  BRTO groups ( P=0.625; Fig.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"42 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36Although the risk of bleeding from a GV is lower than that from  an EV, once bleeding has occurred, the transfusion requirements  and the risk of mortality are greater for GVB.1,18 The mortality from  the first GVB was reported as high as 20% within 6  weeks of the  index bleeding and among the type of GV, GOV2s frequently bled  and were associated with high mortality.1-3 However, in the pres - ent study, the overall mortality rate was half of that, at 10.3%,  and it did not differ between cardiac and fundal varices.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"Gastric variceal bleeding in Korea http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36therapy of GVB, in Korea as we showed in this study, they have  been applied as the primary hemostatic method for GVB in some  centers.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"44 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.36Acknowledgements This study was supported by a grant of the Korea Healthcare  technology R&D Project, Ministry of Health and Welfare, Republic  of Korea.",Non-OADS,/arxiv_data1/oa_pdf/e9/a5/cmh-19-36.PMC3622854.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.45 Clinical and Molecular Hepatology 2013;19:45-50 Original Article INTRODUCTION  Hepatitis C virus (HCV) is a major cause of liver cirrhosis and  hepatocellular carcinoma (HCC) worldwide.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
"46 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.45There are geographic differences in the distribution of HCV  genotypes.3 HCV genotypes 1 to 3 are widely distributed globally,  whereas genotypes 4 to 6 are limited to less-developed regions:  genotype 4 in Egypt and Africa; genotype 5 in South Africa; and  genotype 6 in Southeast Asia, South China, Hong Kong, and  Taiwan.2,4 The geographic distribution is associated with the trans - mission route.",Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
Completed questionnaires and clinical data were collected and  entered into an electronic case report form at the Korean HCV co - hort study group homepage (http://www.hcvcohort.or.kr).,OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
HCV genotype 6 in Korea  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.45RESULTS The prevalence of genotype 6 HCV infection in  Korean patients The prevalence of HCV genotypes in the Korean HCV cohort  is summarized in Table 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
48 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.45cirrhosis in the genotype 6 patients; this might be related to their  younger age.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
"HCV genotype 6 in Korea  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.45but there were no major differences in the clinical features of the  different genotypes or in the development of HCC or liver cirrhosis  between the genotypes.11 In our study, the most common risk factors in patients with gen - otype 6 were acupuncture (n=8, 88.9%), dental procedures (n=7, 77.8%), endoscopy (n=7, 77.8%), tattooing (n=6, 66.7%), IDU  (n=3, 33.3%), and more than three sex partners (n=3, 33.3%).",Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
50 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.45history of exposure to a risk factor did not necessarily indicate the  cause of the HCV infection.,Non-OADS,/arxiv_data1/oa_pdf/5e/58/cmh-19-45.PMC3622855.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.51 Clinical and Molecular Hepatology 2013;19:51-59 Original Article INTRODUCTION  Although vaccination for the prevention of hepatitis B virus  (HBV) infection has been effectively used for over 25 years, HBV  infection is still one of the most important and fatal infectious  liver diseases, with approximately 400 million chronically infected people worldwide.1 The prevalence of chronic HBV infection in  developed countries such as Western Europe and the USA is cur - rently less than 1-2%, however in Asia, Africa, and some Mediter - ranean countries, the prevalence exceeds as high as 10%.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
"52 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51Recently, w ith wide-spread use of cytotoxic chemotherapy or  immunosuppressants such as high-dose corticosteroids and bio - logic agents, reactivation of HBV is becoming an issue.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
Rituximab-induced HBV reactivation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51were used for non-continuous variables.,OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
54 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51Table 3.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
"Rituximab-induced HBV reactivation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51travenous rituximab therapy along with cyclophosphamide, doxo - rubicin, vincristine and prednisolone as an R-CHOP regimen.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
56 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51with lamivudine and experienced HBV reactivation under preemp - tive therapy.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
"Rituximab-induced HBV reactivation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51these six patients, three patients (3/6, 50%) were not assessed  for viral markers of HBV infection and none of the patients were  assessed for liver function.",Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
58 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51had undergone assessment for lamivudine resistance.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
Rituximab-induced HBV reactivation http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.51REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6f/3b/cmh-19-51.PMC3622856.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.60 Clinical and Molecular Hepatology 2013;19:60-69 Original Article High effectiveness of peginterferon alfa-2a plus ribavi - rin therapy in Korean patients with chronic hepatitis C  in clinical practice  Nae-Yun Heo1, Young-Suk Lim2, Han Chu Lee2, Yung Sang Lee2, Kang Mo Kim2, Kwan Soo Byun3, Kwang-Hyub Han4,  Kwan Sik Lee4, Seung Woon Paik5, Seung Kew Yoon6, and Dong Jin Suh2  1Department of Internal Medicine, Haeundae Paik Hospital, Inje University College of Medicine, Busan;  2Department of  Gastroenterology, Liver Center, Asan Medical Center, University of Ulsan College of Medicine; 3Department of Internal Medicine, Korea  University College of Medicine; 4Department of Internal Medicine, Yonsei University College of Medicine; 5Department of Medicine,  Sungkyunkwan University School of Medicine; 6Department of Internal Medicine, The Catholic University of Korea College of Medicine,  Seoul, Korea Background/Aims: Identifying the impact of a patient’s ethnicity on treatment responses in clinical practice may assist  in providing individualized treatment regimens for chronic hepatitis C (CHC).",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"+82-2-485-5782 E-mail; limys@amc.seoul.krAbbreviations:  ANC, absolute neutrophil count; CHC, chronic hepatitis C; cEVR, complete early  virologic response; CI, 95% confidence interval; EVR, early virological response; ETR,  end-of-treatment response; HCV, hepatitis C virus; Hb, hemoglobin; IL28B, interleukin  28B; OR, odds ratio; PCR, polymerase chain reaction; PEG-IFN, peginterferon; RBV, ribavirin; RFMP , restriction fragment mass polymorphism; RNA, ribonucleic acid; SVR, sustained virological response This study has been registered at ClinicalTrials.gov, number NCT01596517  (URL  http://www.clinicaltrials.gov/ct2/show/NCT01596517).",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"Effective hepatitis C therapy in Koreans http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60See Editorial on Page 26 INTRODUCTION  Chronic hepatitis C virus (HCV) infection is one of the major  causes of chronic hepatitis, cirrhosis, and hepatocellular carcino - ma.1,2 The prevalence of HCV infection varies geographically, with  the majority of infected people (about 90 million) originating from  Asian countries.3 Despite the high burden of HCV disease among  Asians, very little is known about the treatment outcomes in these patients because most of the pivotal studies only included small  numbers of Asian patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"62 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60Dose modification and definition of adherence In the Clinical Trial group, if ANC dropped below 750 cells/mm3,  PEG-IFN α-2a was reduced to 135 μg.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"Effective hepatitis C therapy in Koreans http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60assessed: 301, including three patients with HCV genotype 6, did  not meet the enrollment criteria and were excluded.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"64 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60cantly higher EVR and cEVR rates than the Cohort group (EVR:  92.0% vs. 72.2%, P=0.04; cEVR: 92.0% vs. 71.3%, P=0.03;  Table 2).",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
Effective hepatitis C therapy in Koreans http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"66 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60otype 1 patients who achieved EVR and adherence ≥80/80/80,  the SVR rate was not significantly different between the Clinical  Trial and Cohort groups (100% vs. 80.0%, P=0.18).",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
Effective hepatitis C therapy in Koreans http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60ranged between 46% and 52% for genotype 1 patients and be - tween 76% and 80% for genotype 2 or 3 patients.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"68 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60sistant who provides education and support to patients undergo - ing hepatitis C therapy has been suggested to be important.24,37  Unfortunately, we did not have such a physician assistant during  the period of this study, which might have contributed to the low  adherence in our clinical practice cohort patients.",Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
Effective hepatitis C therapy in Koreans http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.60Expanded Access Group.,Non-OADS,/arxiv_data1/oa_pdf/e5/04/cmh-19-60.PMC3622857.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.70 Clinical and Molecular Hepatology 2013;19:70-77 Original Article INTRODUCTION  Hepatocellular carcinoma (HCC) is the seventh most common  carcinoma worldwide, and the third most common cause of  cancer-related mortality.1 Recent advances in treatment modalities have improved the survival rate for patients with HCC.2,3 There have been numerous reports about the relationship  between chronic inflammation and cancer.",Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
CRP and prognosis of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70to cope with an effective host anti-tumor response.,Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
72 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70were obtained from all patients before treatment.,Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
CRP and prognosis of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70Independent Student’s t-test.,Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
"74 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70large tumor size (HR: 1.17, P=0.01) in th multivariate analysis   (Table 2).",OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
CRP and prognosis of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70significantly associated with high serum CRP level in tumor size  over 5 cm group (Table 6).,Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
"76 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70sponse.22,23 In recently, some reports showed that high serum CRP  level were also associated with several other tumor prognostic  factors such as distant metastasis, tumor size, lymph node metas - tasis, vascular invasion and tumor recurrence.11,12,24,25  Chun et al24 reported preoperative high CRP was associated  with the aggressiveness of early recurrent HCC.",Non-OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
CRP and prognosis of HCC http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.70K.,OADS,/arxiv_data1/oa_pdf/31/d5/cmh-19-70.PMC3622858.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.78 Clinical and Molecular Hepatology 2013;19:78-81 Case Report INTRODUCTION  Varices commonly occur in the gastro-esophageal region and  bleeding from gastro-esophageal varices is one of the most seri - ous complications of portal hypertension.",Non-OADS,/arxiv_data1/oa_pdf/82/ea/cmh-19-78.PMC3622859.pdf
A case of variceal bleeding from the jejunum in liver cirrhosis  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.78rate of 18/min and body temperature of 36.8°C.,Non-OADS,/arxiv_data1/oa_pdf/82/ea/cmh-19-78.PMC3622859.pdf
"80 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.78with portal hypertension caused by an obstruction of the portal or  splenic veins, duodenal varices are more prevalent than in patients  with intrahepatic portal hypertension.1 A history of abdominal  surgery appears to predispose the development of ectopic varices in adhesions.",Non-OADS,/arxiv_data1/oa_pdf/82/ea/cmh-19-78.PMC3622859.pdf
"A case of variceal bleeding from the jejunum in liver cirrhosis  http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.78In conclusion, bleeding from ectopic varices must be considered  for patients with portal hypertension and obscure overt GI bleed - ing, and we described a case of variceal bleeding from the jejunum  in a patient with liver cirrhosis who had not previously undergone  abdominal surgery.",Non-OADS,/arxiv_data1/oa_pdf/82/ea/cmh-19-78.PMC3622859.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.82 Clinical and Molecular Hepatology 2013;19:82-86 Case Report INTRODUCTION  Chronic hepatitis B (CHB) is a major health problem worldwide.",Non-OADS,/arxiv_data1/oa_pdf/0c/00/cmh-19-82.PMC3622860.pdf
Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.82CASE REPORT Case 1  A 28-year-old man who received telbivudine therapy for chronic  hepatitis B presented with progressive weakness of both lower  legs and difficulty in ascending stairs over the past 4 months.,Non-OADS,/arxiv_data1/oa_pdf/0c/00/cmh-19-82.PMC3622860.pdf
84 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.82diagnosed with toxic myopathy.,Non-OADS,/arxiv_data1/oa_pdf/0c/00/cmh-19-82.PMC3622860.pdf
"Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.82tured, which leads directly to exhaustion of ATP, resulting in poor  energy supply.18 Nevertheless, at present, the biological mecha - nism of telbivudine-related CK elevations and myopathy is not yet  clear.",Non-OADS,/arxiv_data1/oa_pdf/0c/00/cmh-19-82.PMC3622860.pdf
86 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.82tion 2010;26:159-162.,Non-OADS,/arxiv_data1/oa_pdf/0c/00/cmh-19-82.PMC3622860.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.87 Clinical and Molecular Hepatology 2013;19:87-91 Liver Pathology INTRODUCTION  Reactive lymphoid hyperplasia (RLH) is a rare benign condition  that forms a mass-like lesion characterized by proliferation of non- neoplastic lymphocytes forming follicles and germinal centers.",Non-OADS,/arxiv_data1/oa_pdf/12/50/cmh-19-87.PMC3622861.pdf
88 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.87with germinal centers composed of small or large lymphoid cells  and tingible body macrophages (Fig.,Non-OADS,/arxiv_data1/oa_pdf/12/50/cmh-19-87.PMC3622861.pdf
Reactive lymphoid hyperplasia of the liver   http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.87findings between hepatic RLH and HCC.,Non-OADS,/arxiv_data1/oa_pdf/12/50/cmh-19-87.PMC3622861.pdf
"90 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.87is no reported case that transformed into malignant lymphoma,  which had been initially diagnosed as RLH of the liver up to now.",Non-OADS,/arxiv_data1/oa_pdf/12/50/cmh-19-87.PMC3622861.pdf
Reactive lymphoid hyperplasia of the liver   http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.87raphy and magnetic resonance imaging findings.,Non-OADS,/arxiv_data1/oa_pdf/12/50/cmh-19-87.PMC3622861.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.92 Clinical and Molecular Hepatology 2013;19:92-96 Liver Imaging INTRODUCTION  Hepatocellular carcinoma (HCC) is the fifth most common tumor  in the world, and the incidence of HCC is rapidly increasing.1 The  value of imaging in the diagnosis of HCC is well-established and,  in particular, magnetic resonance imaging (MRI) has been report - ed to be an excellent imaging modality because it offers high tis - sue contrast and allows the use of various tissue-specific contrast  agents.2 Today, several liver-specific MRI contrast media have been in - vestigated with the goal of increasing the diagnostic performance  of liver MRI, especially with respect to lesion detection.3 One  of these contrast media, the gadoxetate disodium (gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid; Gd-EOB-DTPA;  Eovist and Primovist, Bayer-Schering Pharma), is taken up by he - patocytes and then excreted into the bile ducts, 4 with combined  vascular and hepatocyte-selective properties.",Non-OADS,/arxiv_data1/oa_pdf/19/f1/cmh-19-92.PMC3622862.pdf
Hyperintense HCC on MRI http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.92ily history was negative.,Non-OADS,/arxiv_data1/oa_pdf/19/f1/cmh-19-92.PMC3622862.pdf
"94 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.92alanine aminotransferase, alkaline phosphatase, total bilirubin,  and tumor markers including serum α-fetoprotein and protein in - duced by vitamin K antagonist-II (PIVKA-II) were all in the normal range.",OADS,/arxiv_data1/oa_pdf/19/f1/cmh-19-92.PMC3622862.pdf
Hyperintense HCC on MRI http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.92of hepatic segment VII.,Non-OADS,/arxiv_data1/oa_pdf/19/f1/cmh-19-92.PMC3622862.pdf
96 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.92Conflicts of Interest The authors have no conflicts to disclose.,Non-OADS,/arxiv_data1/oa_pdf/19/f1/cmh-19-92.PMC3622862.pdf
"Copyright © 2013 by The Korean Associa tion for the Study of the Liver This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 2287-2728       eISSN 2287-285X http://dx.doi.org/10.3350/cmh .2013.19.1.97 Clinical and Molecular Hepatology 2013;19:97-98 Letter to the Editor To the Editor, We read with great interest the article ‘A case of emphysema - tous hepatitis with spontaneous pneumoperitoneum in a patient  with hilar cholangiocarcinoma’ by Jung Ho Kim et al.1 The authors described fatal case of emphysematous hepatitis  caused by C. perfringens , but did not mention the hemolysis or  disseminated intravascular coagulopathy (DIC) during hospital course.",Non-OADS,/arxiv_data1/oa_pdf/9e/d1/cmh-19-97.PMC3622863.pdf
98 Clin Mol Hepatol Volume _19  Number _1  March 2013 http://www.e-cmh.org http://dx.doi.org/10.3350/cmh.2013.19.1.972.,Non-OADS,/arxiv_data1/oa_pdf/9e/d1/cmh-19-97.PMC3622863.pdf
"Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.DOI:10.1093/sysbio/syt003Advance Access publication January 25, 2013 Lateral Gene Transfer from the Dead GERGELY J. SZÖLL ˝OSI1,2,∗,ERICTANNIER1,2,3,NICOLAS LARTILLOT4,5,AND VINCENT DAUBIN1,2 1Laboratoire de Biométrie et Biologie Evolutive, Centre National de la Recherche Scientiﬁque, Unité Mixte de Recherche 5558, Université Lyon 1, F-69 622 Villeurbanne, France;2Université de Lyon, F-69000 Lyon, France;3Institut National de Recherche en Informatique et en Automatique Rhône-Alpes, F-38334 Montbonnot, France;4Département de Biochimie, Centre Robert-Cedergren pour la Bioinformatique, Université de Montréal, Québec, Canada; and 5Laboratoire d’Informatique, de Robotique et de Microélectronique de Montpellier , UMR 5506, CNRS-Université de Montpellier 2, 34095 Montpellier , France ∗Correspondence to be sent to: Laboratoire de Biométrie et Biologie Evolutive, Centre National de la Recherche Scientiﬁque, Unité Mixte de Recherche 5558, Université Lyon 1, F-69622 Villeurbanne, France; E-mail: ssolo@elte.hu.",Non-OADS,/arxiv_data1/oa_pdf/84/0a/syt003.PMC3622898.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Arago ´n, A.M. A measure for the impact of research.",Non-OADS,/arxiv_data1/oa_pdf/7e/04/srep01649.PMC3622913.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/48/65/srep01608.PMC3622914.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zeng, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/48/65/srep01608.PMC3622914.pdf
"http://www.eri.u- tokyo.ac.jp/namegaya/sumatera/surveylog/eindex.htm (2005), accessed on February 24, 2011.",OADS,/arxiv_data1/oa_pdf/79/7c/srep01655.PMC3622915.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/79/7c/srep01655.PMC3622915.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sun, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/79/7c/srep01655.PMC3622915.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xiao, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/b0/72/srep01654.PMC3622916.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Jin, H., Rhim, S.H., Im, J.",Non-OADS,/arxiv_data1/oa_pdf/83/4e/srep01651.PMC3622917.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/44/d7/srep01652.PMC3622918.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Martinez-Boubeta, C. et al.",Non-OADS,/arxiv_data1/oa_pdf/44/d7/srep01652.PMC3622918.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xiao, S., Li, R. & Chen, M. Detecting Sedimentary Cycles using Autocorrelation of Grain size.",Non-OADS,/arxiv_data1/oa_pdf/fa/8d/srep01653.PMC3622919.pdf
http://dx.doi.org/10.1371/journal.pone.0011147 .,Non-OADS,/arxiv_data1/oa_pdf/df/2c/mBio.00604-12.PMC3622922.pdf
http://dx.doi.org/10.1371/journal.ppat .1000734 .,Non-OADS,/arxiv_data1/oa_pdf/29/b0/mBio.00636-12.PMC3622923.pdf
"Despite similar density envelopesand apparently similar helix-rich folds, however, identity scores inpairwise alignments of TVV1-UH9, ScV-L-A, and HvV190S CPsare quite low, /H1102118% in each case (determined using EMBOSS Stretcher with default settings at http://www.ebi.ac.uk/Tools /psa/ ).",Non-OADS,/arxiv_data1/oa_pdf/c1/96/mBio.00056-13.PMC3622925.pdf
"The programRobEM ( http://cryoEM.ucsd.edu/programs.shtm ) was used to estimate defocus and astigmatism, extract particle images, and preprocess the im-ages as previously described (58).",OADS,/arxiv_data1/oa_pdf/c1/96/mBio.00056-13.PMC3622925.pdf
http://dx.doi .10.1371/journal.pone.0002879 .,Non-OADS,/arxiv_data1/oa_pdf/c1/96/mBio.00056-13.PMC3622925.pdf
http://dx.doi.10.1371/journal.ppat.1003225 .,Non-OADS,/arxiv_data1/oa_pdf/c1/96/mBio.00056-13.PMC3622925.pdf
http://dx.doi.org/10.1371/journal.ppat.1000216 .,Non-OADS,/arxiv_data1/oa_pdf/a5/b2/mBio.00098-13.PMC3622926.pdf
http://dx.doi.org /10.1371/journal.pone.0034307 .,Non-OADS,/arxiv_data1/oa_pdf/a5/b2/mBio.00098-13.PMC3622926.pdf
6:82. http://dx.doi.org/10.1186/1743 -422X-6-82 .,Non-OADS,/arxiv_data1/oa_pdf/a5/b2/mBio.00098-13.PMC3622926.pdf
6:86.http://dx.doi .org/10.1186/1743-422X-6-86 .,Non-OADS,/arxiv_data1/oa_pdf/a5/b2/mBio.00098-13.PMC3622926.pdf
http://dx.doi.org /10.1002/14651858 .CD004772.pub3.,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
9:59. http://dx.doi.org/10.1186/1741-7015-9 -59.,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.1097/QAI.0b013e31820a7f2f .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.1371/journal.pone.0014155 .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi .org/10.1371/journal.pbio.0040204 .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.1371/journal.pone.0045611 .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
8:87. http://dx.doi.org/10.1186/jbiol200 .,OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.1371/journal.pone .0054322 .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.1371/journal.pone.0031432 .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://www.twistdx .co.uk/images/uploads/docs/TwistDx_Combined_Manual_web.pdf .,Non-OADS,/arxiv_data1/oa_pdf/39/fc/mBio.00135-13.PMC3622927.pdf
http://dx.doi.org/10.4049/jimmunol .1202675 .,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/mBio.00162-13.PMC3622928.pdf
http://dx.doi.org/10.1128/mBio.00178-11 .,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/mBio.00162-13.PMC3622928.pdf
http://dx.doi.org/10.3791/2702 .,Non-OADS,/arxiv_data1/oa_pdf/e4/d7/mBio.00162-13.PMC3622928.pdf
A list of the mutants can be found at the following URL: http://app1.unmc.edu/fgx/ .,Non-OADS,/arxiv_data1/oa_pdf/9e/21/mBio.00166-13.PMC3622929.pdf
http://dx.doi.org/10.1371/journal.pone.0015703 .,Non-OADS,/arxiv_data1/oa_pdf/9e/21/mBio.00166-13.PMC3622929.pdf
http://dx.doi.org/10.1128/mBio.00537-12 .,Non-OADS,/arxiv_data1/oa_pdf/9e/21/mBio.00166-13.PMC3622929.pdf
http://dx.doi.org/10.1371/journal.pone.0011071 .,Non-OADS,/arxiv_data1/oa_pdf/9e/21/mBio.00166-13.PMC3622929.pdf
Sequences obtained by RACE were assembled into contigs using the CAP3 sequence assemblyprogram ( http://pbil.univ-lyon1.fr/cap3.php ).,OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
The cDNA sequence was translated using the ExPASy Translatetool ( http://web.expasy.org/translate/ ).,OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
Alignments of cryptochrome sequences were gen- erated using the software program MUSCLE (59) and the CLC sequenceviewer ( http://www.clcbio.com/index.php?id /H1100528).,OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
"All experimental data were log transformed to provide a normally distributed data set and then analyzed in the R software envi-ronment (version 2.12.1; R Foundation for Statistical Computing, Vi-enna, Austria [ http://www.R-project.org ]) by one-way analysis of vari- ance (ANOVA) followed by Tukey’s pairwise comparison.",OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
http://dx.doi.org/10 .1371/journal.pone.0012805 .,Non-OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
6:e4.http://dx.doi.org/10.1371/journal.pbio.0060004 .,Non-OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
BMC Genomics 7:154. http://dx.doi.org/10.1186/1471 -2164-7-154 .,OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
http://dx.doi.org/10.1371 /journal.pgen.1000442 .,Non-OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
http://dx.doi.org/10.1093 /nar/29.9.e45 .63.,Non-OADS,/arxiv_data1/oa_pdf/e3/5c/mBio.00167-13.PMC3622930.pdf
All sequences were retrieved fromthe Taxonomy Browser of NCBI ( http://www.ncbi.nlm.nih.gov/Taxonomy /Browser/wwwtax.cgi?mode /H11005Undef&id /H1100511118&lvl /H110053&keep/H110051&srchmode /H110051&unlock ).,OADS,/arxiv_data1/oa_pdf/00/5a/mBio.00191-13.PMC3622931.pdf
The tree was generated by using the neighbor-joining method in MEGA5 ( http://www.megasoftware.net/ ).,OADS,/arxiv_data1/oa_pdf/00/5a/mBio.00191-13.PMC3622931.pdf
http://dx.doi.org/10.1128/JVI.03368-12 .,Non-OADS,/arxiv_data1/oa_pdf/00/5a/mBio.00191-13.PMC3622931.pdf
http://dx.doi.org/10.1128 /JVI.03496-12 .,Non-OADS,/arxiv_data1/oa_pdf/00/5a/mBio.00191-13.PMC3622931.pdf
http://dx.doi.org/10.1371/journal.ppat .1000972 .,Non-OADS,/arxiv_data1/oa_pdf/fc/e4/mBio.00216-13.PMC3622934.pdf
http://dx.doi.org/10.1371/journal.ppat.1002895 .,Non-OADS,/arxiv_data1/oa_pdf/fc/e4/mBio.00216-13.PMC3622934.pdf
"The software programs mVISTA Limited Area Global Alignment of Nucleotides (LAGAN; http://genome.lbl.gov/vista/lagan/submit.shtml ) and Molecular Evolutionary Genetics Analysis (MEGA) version 4.0.2(http://www.megasoftware.net ) were used for global pairwise sequence alignment and phylogenetic analysis as previously described (14, 15, 18,36–41).",OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
"DNA sequence recombina-tion analysis was performed with SimPlot 3.5.1 software ( http://sray.med .som.jhmi.edu/SCRoftware/simplot/ ), including the options of Bootscan and SimPlot analysis, to identify possible recombination sites (42).",OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
Multisequence amino acid alignment was performed using CLC sequence viewer 6 ( http://www.clcbio.com /index.php?id /H1100528).,OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
"A model of the HAdV-D60 penton base was con- structed using Swiss-Model ( http://swissmodel.expasy.org/ ) for homol- ogy modeling (43, 44).",OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
"The model generated by Swiss-Model was evaluated by PRO-CHECK ( http://www.ebi.ac.uk/thornton-srv/software/PROCHECK/ ) and a Ramachandran plot, which identiﬁed 82.7% of residues in most-favored re-gions and 14.9% in additional allowed regions.",OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
UCSF Chimera software ( http://www.cgl.ucsf.edu/chimera ) (46) was used for visualization and analysis.,OADS,/arxiv_data1/oa_pdf/19/f4/mBio.00595-12.PMC3622935.pdf
The locations of the BamHI sites were se- lected based on the identiﬁcation of regions that are predicted to besurface-exposed in a Hopp-Woods hydrophobicity analysis ( http://www.vivo.colostate.edu/molkit/hydropathy/ ).,OADS,/arxiv_data1/oa_pdf/c2/62/mBio.00613-12.PMC3622936.pdf
http://dx.doi.org/10.1371/journal.ppat.1000828 .,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
http://dx.doi.org/10.1371 /journal.pbio.1000133 .,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
http://dx.doi.org/10.1371/journal.ppat.1002848 .,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
http://dx.doi.org/10.1371/journal.ppat.0020063 .,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
http://dx.doi.org/10.1371/journal.ppat.1000752 .,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
http://dx.doi.org/10.1186/gb-2010-11 -10-r106 .Role of Glycerol in C.albicans Bioﬁlm Formation March/April 2013 Volume 4 Issue 2 e00637-12®mbio.asm.org 9,Non-OADS,/arxiv_data1/oa_pdf/a5/21/mBio.00637-12.PMC3622937.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/09/25/neurintsurg-2012-010435.PMC3623027.pdf
"Document issued on June 18, 2007. http://www.fda.gov/MedicalDevices/ DeviceRegulationandGuidance?/GuidanceDocuments/ucm071403.htm (accessed 26Aug 2012).",Non-OADS,/arxiv_data1/oa_pdf/09/25/neurintsurg-2012-010435.PMC3623027.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/82/08/neurintsurg-2012-010422.PMC3623029.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Nordby KC, Fell AKM, Notø H, et al.",OADS,/arxiv_data1/oa_pdf/18/3c/oemed-2012-100879.PMC3623031.pdf
"38 The Tanzania Food, Drugs and Cosmetics Act of 2003. http://www.tfda.or.tz/ tfdaact.pdf (Last accessed 24 April 2012).",Non-OADS,/arxiv_data1/oa_pdf/18/3c/oemed-2012-100879.PMC3623031.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Menacker F, Declercq E, Macdorman MF.",Non-OADS,/arxiv_data1/oa_pdf/19/b0/fetalneonatal-2012-303157.PMC3623033.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/Correspondence to Martin P Ward Platt, Regional Maternity Survey Of ﬁce, 1-2 Claremont Terrace, Newcastle upon Tyne NE2 4AE, UK; m.p.ward-platt@ncl.ac.uk F190 Platt MPW.",Non-OADS,/arxiv_data1/oa_pdf/60/5e/fetalneonatal-2012-301837.PMC3623034.pdf
▸http://dx.doi.org/10.1136/fetalneonatal-2011-300488 Open Access Scan to access more free content Platt MPW.,Non-OADS,/arxiv_data1/oa_pdf/60/5e/fetalneonatal-2012-301837.PMC3623034.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/,Non-OADS,/arxiv_data1/oa_pdf/84/58/neurintsurg-2012-010304.PMC3623035.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ neurintsurg-2013-010715).,OADS,/arxiv_data1/oa_pdf/0d/31/neurintsurg-2013-010715.PMC3623036.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/0d/31/neurintsurg-2013-010715.PMC3623036.pdf
All statisticalanalyses were performed in R statistical software (V .2.14.1;http://cran.r-project.org/).,OADS,/arxiv_data1/oa_pdf/34/be/jnnp-2012-303618.PMC3623037.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Shaw LM, Korecka M, Clark CM, et al .",Non-OADS,/arxiv_data1/oa_pdf/34/be/jnnp-2012-303618.PMC3623037.pdf
"To view these ﬁles please visit the journal online (http://dx.doi.org/10.1136/jnnp-2012- 303182) For numbered af ﬁliations see end of article Correspondence to Dr David Devos, Départementde Pharmacologie Médicale, Université Lille Nord de France, CHRU de Lille, Lille F-59037,France;david.devos@chru-lille.fr Received 9 May 2012 Revised 28 August 2012Accepted 3 September 2012Published Online First 16 October 2012 To cite: Moreau C, Delval A, Tiffreau V, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/09/jnnp-2012-303182.PMC3623038.pdf
"See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1 Bloem BR, Grimbergen YA, Cramer M, et al.",Non-OADS,/arxiv_data1/oa_pdf/69/09/jnnp-2012-303182.PMC3623038.pdf
"Bronk Ramsey, C. OxCal v. 3.10. http://c14.arch.ox.ac.uk/embed.php?",Non-OADS,/arxiv_data1/oa_pdf/06/dd/srep01597.PMC3623374.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/06/dd/srep01597.PMC3623374.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kennett, D.J.",Non-OADS,/arxiv_data1/oa_pdf/06/dd/srep01597.PMC3623374.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:1-3 http://dx.doi.org/10.7774/cevr.2013.2.1.1pISSN 2287-3651 • eISSN 2287-366X  Received: October 30, 2012 Revised: November 5, 2012Accepted: November 12, 2012Vaccine industrialization in Korea: focus on major improvements and future  direction",Non-OADS,/arxiv_data1/oa_pdf/db/06/cevr-2-1.PMC3623495.pdf
"Jin Han Kang et al • Vaccine industrialization in Korea 2 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.1 experts who can design vaccine manufacturing facilities and map out operations,  a system that can carry out whole clinical trials, along with the development of domestic and foreign clinical research protocols and systems to carry these pro - cesses.",Non-OADS,/arxiv_data1/oa_pdf/db/06/cevr-2-1.PMC3623495.pdf
"Jin Han Kang et al • Vaccine industrialization in Korea 3 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.1NIP on inter-pandemic avian influenza vaccine as a strategy for eradication of in - fectious diseases, supporting the strategy for the main  tenance of target vaccines,  and revitalization of industrial and educational cooperation for technical sup - port.",Non-OADS,/arxiv_data1/oa_pdf/db/06/cevr-2-1.PMC3623495.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:19-25 http://dx.doi.org/10.7774/cevr.2013.2.1.19pISSN 2287-3651 • eISSN 2287-366X  Dong-Kun Yang, Ha-Hyun Kim,  Kyung-Woo Lee, Jae-Young Song Viral Disease Division, Animal, Plant and Fishery Quarantine Inspection Agency, Anyang, Korea Received: October 10, 2012 Revised: October 31, 2012Accepted: November 5, 2012 Corresponding author: Dong-Kun Yang, PhD Animal, Plant and Fishery Quarantine Inspection Agency, 175 Anyang-ro, Manan-gu,  Anyang 430-757, KoreaTel: +82-31-467-1783, Fax: +82-31-467-1797E-mail: yangdk@korea.kr No potential conflict of interest relevant to this  article was reported.An effective strategy for preventing rabies consists of controlling rabies in the host reservoir  with vaccination.",Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
"Dong-Kun Yang et al • The present and future of rabies vaccine 20 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19 domestic animals is mainly to minimize the important eco - nomic losses, as the vaccination of pet ani  mals protects indi - vidual animals when they are exposed to wild RABV .",Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
"Dong-Kun Yang et al • The present and future of rabies vaccine 21 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19has permitted the use of seven inactivated rabies vaccines for  immunizing pets and other animal species, including dogs, cats, cattle, goats, and fox, and these inactivated vaccines have been used to prevent animal rabies.",Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
"Dong-Kun Yang et al • The present and future of rabies vaccine 22 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19 blastoma cells infected with the recombinant virus, and they  produced substantially higher antibody titers.",Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
"Dong-Kun Yang et al • The present and future of rabies vaccine 23 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19provide efficient ways to induce a cell-mediated cytolytic  CD8+ T cell response, CD4+ T cells, and VNA [32].",Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
Dong-Kun Yang et al • The present and future of rabies vaccine 24 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19 of recombinant rabies viruses used for oral vaccination  of stray dogs and wildlife.,Non-OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
Dong-Kun Yang et al • The present and future of rabies vaccine 25 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.19One-time gene gun or intramuscular rabies DNA vaccina - tion of non-human primates: comparison of neutralizing  antibody responses and protection against rabies virus 1 year after vaccination.,OADS,/arxiv_data1/oa_pdf/6f/4b/cevr-2-19.PMC3623496.pdf
"This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non-Com - mercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, pro - vided the original work is properly cited.KOREAN  VACCINE  SOCIETY KOREAN  VACCINE  SOCIETYKOREAN  ACCINE  OCIETYV S http://www.ecevr.org/Clin Exp Vaccine Res 2013;2:26-33 http://dx.doi.org/10.7774/cevr.2013.2.1.26pISSN 2287-3651 • eISSN 2287-366X  Dong-Hun Lee, Chang-Seon Song Avian Disease Laboratory, College of Veterinary  Medicine, Konkuk University, Seoul, Korea Received: October 21, 2012 Revised: November 11, 2012Accepted: November 17, 2012 Corresponding author: Chang-Seon Song, PhD Avian Disease Laboratory, College of Veterinary Medicine, Konkuk University, 263 Achasan-ro, Gwangjin-gu, Seoul 143-701, Korea Tel: +82-2-450-3712, Fax: +82-2-455-3712E-mail: songcs@konkuk.ac.kr No potential conflict of interest relevant to this  article was reported.",Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
"Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 27 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26to respiratory disease and drops in egg production to severe,  systemic disease with near 100% mortality rates.",Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
"Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 28 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26 belong to the Korea group have continuously evolved by anti - genic drift and have undergone reassortment with aquatic  AIV isolates circulating in the Korean LBMs [9,21-26].",Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 29 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26the control of H5N1 HPAI.,OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 30 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26 the VLP vaccine against Korean H9N2 LPAI is developed and  evaluated in an specific pathogen-free (SPF) chicken model [33].,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 31 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26proved vaccination strategies and periodic updates of vac - cine seed strains are required to increase immunogenicity  and cross protective efficacy in chicken farms.,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 32 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26 zootiology of recurrent low pathogenic avian influenza by  H9N2 subtype virus in Korea.,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
http://dx.doi.org/10.1111/j.1750-2659.2012.00392.x.,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
http://dx.doi.org/ 10.1111/j.1750-2659.2012.00396.x.,Non-OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
Dong-Hun Lee et al • H9N2 AIV in Korea: evolution and vaccination 33 http://www.ecevr.org/ http://dx.doi.org/10.7774/cevr.2013.2.1.26Dis 2007;51(1 Suppl):484-9.,OADS,/arxiv_data1/oa_pdf/9c/b7/cevr-2-26.PMC3623497.pdf
